data_2n2m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n2m _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.5 m . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.571 0.224 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -126.5 138.69 53.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.2 mm -112.33 126.8 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -139.2 143.09 37.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.417 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.94 148.72 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.049 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.04 172.1 36.47 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -83.34 143.66 30.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.41 127.0 44.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.961 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -134.01 139.27 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.912 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 40.7 t -117.7 106.99 13.65 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.84 128.78 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.82 150.01 32.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.071 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.87 179.3 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 13' ' ' SER . 92.5 Cg_endo -78.16 159.98 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.402 2.068 . . . . 0.0 111.437 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 50' ' ' THR . 61.0 ttp180 -95.81 127.98 42.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.793 0.33 . . . . 0.0 110.759 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.29 171.55 35.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.82 146.59 50.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 47' ' ' PHE . 29.3 t-20 -121.89 120.8 35.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 tp -105.53 124.1 48.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.557 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.96 139.91 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.014 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -133.63 126.91 31.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.435 HH12 ' CD ' ' A' ' 122' ' ' GLN . 43.1 ttm180 -110.38 131.64 54.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.641 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -116.02 137.7 51.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.017 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.742 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.61 156.75 42.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -142.61 140.16 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 111.237 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.35 147.0 18.29 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.6 t -126.99 130.82 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.202 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.516 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.5 m-85 -125.36 136.23 53.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.09 148.16 33.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.374 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -151.11 149.44 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.67 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.476 ' HG1' ' N ' ' A' ' 51' ' ' ARG . 14.9 t -152.15 162.46 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.919 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.476 ' N ' ' HG1' ' A' ' 50' ' ' THR . 79.2 ttt-85 -149.03 141.02 23.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.578 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.512 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.1 p90 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -120.41 147.75 44.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.858 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -123.2 131.07 53.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.589 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.48 147.2 49.32 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.625 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.0 t -149.21 142.72 25.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.539 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.54 131.73 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.9 p -137.78 158.27 44.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.991 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.09 152.25 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.7 43.62 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.561 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.6 153.4 54.57 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.358 2.705 . . . . 0.0 112.863 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -126.31 129.57 71.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.727 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.2 t80 -127.11 128.55 46.4 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 59.0 ttm-85 -69.59 134.58 48.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.02 -51.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.972 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.415 ' OD1' ' CG1' ' A' ' 85' ' ' VAL . 17.5 m120 -126.71 -137.3 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -97.14 -4.92 38.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.381 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.35 20.04 0.48 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.415 ' CG1' ' OD1' ' A' ' 82' ' ' ASN . 5.0 p -144.07 142.1 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.048 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.7 p -138.51 152.93 48.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 111.225 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 tt -121.14 130.02 53.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.467 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.441 ' OH ' ' OG ' ' A' ' 134' ' ' SER . 53.4 p90 -140.34 157.73 45.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.848 0.356 . . . . 0.0 110.719 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.17 147.19 18.35 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.6 mt -114.43 127.91 56.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.677 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.61 142.26 48.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.921 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.6 -144.26 7.82 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.09 39.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 0.0 111.095 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.59 143.72 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.4 145.61 50.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 110.802 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -123.29 144.9 15.9 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.877 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.9 m . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.998 0.428 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.1 m -135.41 154.06 51.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.309 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.79 144.65 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.0 125.72 32.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -150.58 160.39 43.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.717 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.23 -165.01 35.78 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.506 ' O ' ' CD1' ' A' ' 135' ' ' TYR . . . -155.14 158.49 39.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.642 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.37 166.8 33.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 pp -143.2 159.58 42.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.839 0.352 . . . . 0.0 110.74 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.435 ' CD ' HH12 ' A' ' 34' ' ' ARG . 54.3 tt0 -117.03 128.64 55.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.182 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -127.98 126.74 41.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.447 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -118.99 93.19 46.43 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.44 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.13 -27.62 29.27 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.331 1.354 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -135.14 151.02 74.48 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.953 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.24 -36.6 78.46 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.0 1.8 . . . . 0.0 113.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -101.72 14.52 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.17 119.87 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.667 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.24 129.23 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.211 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.93 124.42 58.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -107.99 130.27 55.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.214 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -129.99 112.03 13.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.698 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.441 ' OG ' ' OH ' ' A' ' 88' ' ' TYR . 58.0 m -134.66 153.03 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' A' ' 119' ' ' ALA . 52.8 p90 -144.49 153.61 42.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.505 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -135.78 152.2 50.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 145' ' ' VAL . 47.4 t80 -143.71 133.09 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.612 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--O 1.239 0.512 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.456 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 mptt . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.473 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 58.4 t -119.85 125.64 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.408 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.67 125.31 6.36 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.4 m -129.58 137.32 50.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 111.865 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -133.91 151.02 51.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 64.7 mtt -133.43 137.48 45.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -136.06 129.6 32.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.94 40.15 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.814 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.12 161.02 42.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.416 -0.392 . . . . 0.0 109.97 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.79 -178.05 27.02 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.522 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.63 146.0 49.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.373 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.454 179.848 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.911 0.386 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -138.39 146.78 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 tt -120.44 138.2 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -128.08 148.66 50.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.56 151.81 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.222 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.21 -174.47 38.36 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.591 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -116.39 149.29 39.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.42 132.93 54.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -122.08 121.73 37.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.364 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.9 m -118.19 168.47 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.784 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -138.15 143.71 40.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.46 149.41 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.207 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 179.321 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.45 -0.309 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.81 156.12 27.22 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.467 1.444 . . . . 0.0 111.484 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -95.33 138.96 32.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.621 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.72 -168.31 20.68 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.24 160.07 41.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.689 HD22 ' NZ ' ' A' ' 32' ' ' LYS . 49.7 t30 -135.72 131.68 35.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.027 0.441 . . . . 0.0 112.028 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.35 136.76 53.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.822 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.689 ' NZ ' HD22 ' A' ' 30' ' ' ASN . 9.5 mtmm -125.53 140.36 52.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -127.08 144.81 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.342 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -123.3 132.07 53.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.391 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.486 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 95.1 m-85 -127.42 149.11 50.23 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.33 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 9.5 tp10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.14 154.82 40.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.827 0.346 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.25 142.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.748 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.67 150.76 17.93 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 t -136.97 137.21 39.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.422 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 92.7 m-85 -128.49 141.01 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.81 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.76 148.74 34.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -143.08 128.84 19.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.8 p -129.33 156.17 44.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.529 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.452 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 . . . . . 0 C--N 1.331 -0.229 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.769 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.8 t80 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.681 0.277 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -115.62 143.48 45.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.705 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.54 ' CE2' ' OG ' ' A' ' 72' ' ' SER . 83.5 t80 -127.65 121.39 30.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.14 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.23 133.91 55.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.54 ' OG ' ' CE2' ' A' ' 70' ' ' TYR . 67.1 m -134.65 141.37 46.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.34 134.96 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.008 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -140.57 158.67 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -158.7 152.41 23.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.53 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.58 164.7 35.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.665 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.99 160.61 36.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 123.166 2.577 . . . . 0.0 112.578 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.7 p -135.26 135.69 51.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.236 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.0 t80 -127.69 129.68 47.56 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 62.4 ttm-85 -71.85 128.68 36.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.22 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.3 mt -89.66 -51.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -127.86 -155.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.65 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.74 -39.99 93.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.293 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -140.87 35.01 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.155 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.1 t -127.77 126.29 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.9 m -130.67 142.54 50.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.8 tp -122.73 129.93 52.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.455 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -142.01 159.46 42.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.875 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.8 151.75 18.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.7 119.08 27.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.557 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -138.12 151.55 47.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.955 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -143.89 7.63 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.65 153.44 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 0.0 110.956 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.53 145.57 16.81 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -133.93 125.16 27.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.643 0.258 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.15 143.02 15.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.357 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.841 0.353 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.9 p -155.17 163.59 39.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.525 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -99.31 133.89 42.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.475 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.68 129.95 55.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.645 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -147.67 133.57 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -178.6 -169.98 40.04 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.41 158.58 44.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.623 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.18 169.6 33.21 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.82 162.3 40.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -141.69 151.68 43.22 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.22 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.09 147.05 41.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.617 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 39.1 t-20 -128.57 82.24 69.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.992 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.93 -26.56 15.27 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.809 1.673 . . . . 0.0 111.563 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 98.4 m-70 -135.14 148.53 66.99 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.771 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.66 -21.84 33.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.184 1.923 . . . . 0.0 113.098 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -100.03 -0.1 39.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.83 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -145.27 130.62 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.065 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 p -139.81 145.5 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.726 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.09 123.92 69.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.279 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -110.98 137.03 49.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -146.39 141.87 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.878 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.5 p -157.9 161.34 38.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.129 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.27 130.45 46.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.834 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -135.58 141.83 45.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 110.417 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -131.9 145.38 51.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.69 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.8 t -131.31 131.67 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.022 0.439 . . . . 0.0 112.016 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.32 143.6 16.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.9 m -124.77 130.38 52.29 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -116.91 136.14 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.548 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.458 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 79.4 mtm -131.58 127.81 37.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.404 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.6 tp -143.22 129.95 20.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.867 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.12 178.57 44.24 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.71 145.8 46.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.61 148.78 16.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.506 ' CE2' ' O ' ' A' ' 155' ' ' ARG . 91.8 t80 -134.45 130.05 36.16 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.506 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 85.7 mtp180 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.649 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.609 0.243 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 t -119.54 133.45 55.66 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.453 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.27 131.96 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.865 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -139.89 155.42 47.2 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.996 0.427 . . . . 0.0 110.818 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.8 mt -124.94 130.18 73.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.205 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.69 154.05 22.42 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.638 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.24 148.75 27.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.36 138.74 54.05 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 110.901 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -143.39 142.51 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.106 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.3 t -117.87 167.91 10.98 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.158 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -134.8 120.9 19.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.406 ' CG2' ' NH2' ' A' ' 52' ' ' ARG . 34.9 m -132.76 149.87 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.994 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--N 1.333 -0.13 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.169 179.327 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.48 159.06 16.98 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 122.011 1.807 . . . . 0.0 110.691 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -97.79 131.39 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.76 0.315 . . . . 0.0 110.711 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -156.81 176.05 34.2 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.96 149.18 49.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.727 0.298 . . . . 0.0 110.33 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.577 ' ND2' ' SD ' ' A' ' 149' ' ' MET . 27.7 t-20 -133.61 124.61 27.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.205 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.46 138.59 45.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.757 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.68 139.9 53.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.89 143.37 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.672 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.63 HH12 ' NE2' ' A' ' 122' ' ' GLN . 61.6 ttp180 -131.96 131.63 42.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 111.036 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -129.32 143.09 50.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -179.869 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.3 142.84 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.438 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -136.99 136.41 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.83 143.11 14.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.9 m -130.48 147.9 52.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.234 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.53 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 95.7 m-85 -127.69 141.81 51.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.454 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.04 33.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.27 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -145.86 124.93 12.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.4 p -128.89 157.73 40.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.379 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -145.29 128.6 16.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.302 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' NH2' ' CG2' ' A' ' 15' ' ' VAL . 64.0 ttm-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.235 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -119.55 143.61 47.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.664 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -124.98 138.0 54.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.969 0.414 . . . . 0.0 110.995 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -144.89 132.67 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.797 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.6 p -147.49 158.57 44.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.67 141.6 23.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.7 t -150.47 149.56 30.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 111.298 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.82 155.02 32.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.299 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -166.82 171.09 41.59 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.39 148.77 55.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.019 2.479 . . . . 0.0 112.442 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -126.53 130.06 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.441 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.423 ' O ' ' OG ' ' A' ' 86' ' ' SER . 98.5 m-85 -122.87 136.73 54.97 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.714 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.5 mtm-85 -86.22 131.71 34.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.962 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.28 -50.99 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.235 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' A' ' 84' ' ' TYR . 56.9 t30 -139.97 34.37 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.911 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 56.54 1.8 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.825 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.55 ' H ' ' C ' ' A' ' 82' ' ' ASN . 64.7 m-85 -120.87 -20.71 6.84 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.165 0.507 . . . . 0.0 109.666 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 p -144.28 140.57 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.462 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 79' ' ' PHE . 48.3 t -136.62 141.42 43.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 134.46 51.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.885 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -144.26 159.33 42.87 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.138 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.15 152.07 17.39 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.41 126.9 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.2 tp -129.27 126.71 39.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.722 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.13 -155.65 18.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.481 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.69 155.86 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.897 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.66 140.41 14.84 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -126.76 120.64 29.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.44 141.71 15.68 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.966 0.412 . . . . 0.0 111.062 -179.426 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.2 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.75 0.309 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.433 ' OG ' ' OG ' ' A' ' 138' ' ' SER . 93.4 p -151.68 165.58 33.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.557 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.95 140.79 29.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.476 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.46 131.62 56.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.832 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.1 132.92 29.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.64 178.41 34.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.487 -0.864 . . . . 0.0 111.61 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.52 155.13 39.84 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.4 155.38 26.29 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.56 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.606 ' CD2' ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -109.43 143.44 39.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.666 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.63 ' NE2' HH12 ' A' ' 34' ' ' ARG . 46.0 tt0 -119.87 123.72 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.288 . . . . 0.0 110.971 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.976 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -137.82 81.78 27.61 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.44 -28.17 18.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.661 1.574 . . . . 0.0 111.653 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 129' ' ' PHE . 97.9 m-70 -131.74 124.55 19.91 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.003 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -50.24 -33.74 37.37 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.79 1.66 . . . . 0.0 112.938 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -81.51 -12.09 58.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 126' ' ' HIS . 92.5 t80 -142.66 129.74 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.969 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.74 152.81 38.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.0 mt -117.1 125.8 74.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.268 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -116.95 113.82 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.34 128.15 54.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.074 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.4 p -157.34 161.11 39.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.984 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -149.83 156.0 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.277 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -145.24 156.32 43.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.162 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.55 159.22 43.44 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.156 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.433 ' OG ' ' OG ' ' A' ' 114' ' ' SER . 40.3 t . . . . . 0 C--O 1.235 0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.576 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 C--O 1.233 0.198 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 99.8 t -125.52 128.04 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.086 0.469 . . . . 0.0 112.146 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -124.48 129.63 7.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.9 m -126.47 132.38 51.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 111.854 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -116.84 141.1 48.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.577 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 78.2 mtm -128.66 137.74 51.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.01 0.433 . . . . 0.0 111.257 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -142.79 131.4 22.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.814 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -164.0 177.81 39.64 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.962 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.98 158.66 44.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.35 -160.56 13.78 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.07 160.36 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.939 0.4 . . . . 0.0 110.879 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.386 -179.827 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.652 0.263 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -132.61 138.21 47.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.486 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -127.76 138.91 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.707 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -149.79 145.5 26.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.78 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.56 159.23 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.96 -178.21 40.26 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.709 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.81 144.65 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.473 ' O ' ' NE2' ' A' ' 12' ' ' GLN . . . -125.3 136.55 53.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.111 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 11' ' ' ALA . 98.1 mm-40 -131.53 145.13 51.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.634 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 t -116.56 166.86 11.61 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -125.5 123.46 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -120.88 127.65 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.875 0.369 . . . . 0.0 111.54 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 C--N 1.333 -0.134 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.828 178.968 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.61 159.01 16.64 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.079 1.853 . . . . 0.0 110.473 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -99.77 137.6 38.01 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.849 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.68 177.87 36.91 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.79 147.5 47.5 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.329 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.438 ' CG ' ' SD ' ' A' ' 149' ' ' MET . 29.6 t-20 -132.77 123.84 26.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.034 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.741 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.524 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 98.8 mttt -121.98 140.77 52.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -140.86 128.55 21.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.235 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 122' ' ' GLN . 80.1 ttt180 -124.71 132.24 53.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.807 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -118.84 127.68 53.74 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.04 -179.137 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.63 127.34 75.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 110.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -136.42 137.44 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.28 149.4 19.43 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -137.4 139.8 40.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.94 139.43 49.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.569 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.71 139.4 43.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.994 0.425 . . . . 0.0 111.413 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -143.67 130.25 20.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.842 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -128.4 158.09 39.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.791 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -158.25 158.01 33.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.1 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 . . . . . 0 C--N 1.331 -0.222 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.888 179.811 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.558 0.218 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -134.35 128.45 33.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.277 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -130.22 128.01 40.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -136.5 131.01 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.211 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -147.83 159.69 43.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.943 0.402 . . . . 0.0 110.812 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.05 143.37 30.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.524 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t -147.21 147.78 30.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.982 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.15 156.08 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.338 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.41 171.54 43.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 154.84 57.06 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.206 2.604 . . . . 0.0 112.314 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.409 ' CG1' ' OG ' ' A' ' 86' ' ' SER . 97.7 t -122.28 127.59 75.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -107.16 122.6 46.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.442 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 8.3 tmm_? -89.56 129.13 36.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.35 -51.6 11.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.484 -0.486 . . . . 0.0 109.774 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 84' ' ' TYR . 57.8 t30 -154.67 38.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.549 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.442 ' H ' ' CG ' ' A' ' 80' ' ' ARG . 4.3 tm-20 72.57 -49.58 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.053 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.42 ' H ' ' C ' ' A' ' 82' ' ' ASN . 82.9 m-85 -71.04 -29.7 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.399 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.2 t -127.44 132.43 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.696 0.284 . . . . 0.0 110.974 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.409 ' OG ' ' CG1' ' A' ' 78' ' ' VAL . 45.0 t -138.51 135.24 34.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.281 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -108.73 130.23 55.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.067 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CZ ' ' C ' ' A' ' 120' ' ' GLY . 52.2 p90 -139.5 158.1 44.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.451 . . . . 0.0 111.155 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.09 151.39 16.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp -111.03 129.32 55.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.44 . . . . 0.0 110.897 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.01 125.93 22.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.587 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.29 -154.39 13.03 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.386 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.15 38.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.787 0.327 . . . . 0.0 110.696 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.66 147.86 16.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -129.7 122.4 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.35 140.97 16.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.52 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.527 0.078 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -150.64 158.38 44.08 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.363 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.0 127.58 47.43 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.17 114.55 27.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.109 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -145.59 130.71 18.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.846 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -177.24 -169.95 39.03 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.634 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.26 158.46 36.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.404 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -152.26 159.12 28.2 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.89 148.12 43.88 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.674 0.273 . . . . 0.0 110.628 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.523 ' OE1' ' NH1' ' A' ' 34' ' ' ARG . 63.3 tt0 -119.81 132.55 55.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -126.45 147.48 49.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -128.48 82.03 69.42 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.47 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.51 -41.27 74.75 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.497 2.131 . . . . 0.0 112.171 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.38 153.64 71.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.148 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.12 -38.0 80.27 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.945 1.764 . . . . 0.0 113.082 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -90.98 6.13 45.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -142.73 130.99 22.07 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.15 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.3 138.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -131.03 141.98 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.949 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -145.67 160.19 42.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.12 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -149.52 149.93 31.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.741 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.7 p -155.8 163.49 39.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 110.726 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -140.72 151.08 44.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.175 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 147' ' ' THR . 14.6 tm-20 -143.54 138.07 28.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.857 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -144.81 160.03 41.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.638 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.237 0.435 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.563 179.469 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp . . . . . 0 C--O 1.232 0.169 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.6 129.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.916 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.1 139.29 10.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 136' ' ' GLU . 88.2 m -131.25 133.16 45.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.623 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.547 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.438 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 24.7 ptp -139.18 149.74 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.063 0.458 . . . . 0.0 111.344 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.35 155.25 44.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.022 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.91 -174.79 42.76 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.85 160.21 42.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.66 -168.7 19.08 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.34 145.99 50.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.596 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.77 0.319 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t -137.68 140.35 40.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.681 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.1 mt -118.12 128.42 75.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -129.34 150.61 50.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -136.92 145.44 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.61 167.56 34.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.494 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -87.24 146.53 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.05 126.19 55.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.728 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' N ' ' OE1' ' A' ' 12' ' ' GLN . 25.2 mp0 -125.79 121.3 32.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.842 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -118.54 168.1 11.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -143.74 147.66 34.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.876 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.71 138.65 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.791 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.93 158.89 24.25 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.87 1.713 . . . . 0.0 111.288 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -100.05 148.8 24.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.624 0.25 . . . . 0.0 110.656 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.37 -175.73 38.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -125.41 148.18 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -126.04 120.56 30.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.813 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.66 141.17 37.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.68 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' NZ ' ' OG ' ' A' ' 46' ' ' SER . 6.0 tppt? -137.25 131.58 32.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.707 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -126.77 142.08 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.96 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -125.56 130.45 51.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -128.73 143.65 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.761 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 -179.774 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.82 158.49 42.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -139.46 135.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.724 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.98 142.65 17.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.516 ' OG ' ' NZ ' ' A' ' 32' ' ' LYS . 60.8 m -126.43 142.09 51.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.04 0.448 . . . . 0.0 111.146 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -130.18 142.1 50.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.685 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.09 143.44 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -147.58 130.17 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.222 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.2 p -129.49 159.36 36.54 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.639 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -145.12 140.99 28.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 C--O 1.231 0.086 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -112.45 139.35 48.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -127.84 128.34 45.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.66 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -136.28 129.82 32.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.903 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -137.68 141.63 41.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 111.308 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.98 130.87 71.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 t -149.46 149.96 31.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.092 0.472 . . . . 0.0 111.427 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.92 156.52 33.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.378 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.15 170.03 39.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.456 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.69 149.45 54.83 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.207 2.605 . . . . 0.0 112.893 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.6 t -126.48 129.24 71.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.358 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.53 127.35 43.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.352 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -72.53 135.06 45.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.2 mm -86.37 -50.92 13.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.049 0.452 . . . . 0.0 110.228 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 84' ' ' TYR . 6.1 m-20 173.84 165.11 0.19 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.124 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 45.2 -92.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.513 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ASN . 21.5 p90 -144.31 37.71 1.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.392 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -119.64 126.0 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 t -128.97 137.11 51.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.207 0.527 . . . . 0.0 111.175 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.28 123.81 50.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.2 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.42 158.9 43.2 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.147 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -124.6 150.88 17.17 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.18 125.08 53.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.9 mt -122.67 139.64 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.641 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 169.29 -159.18 32.02 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.665 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.83 153.21 39.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.95 0.405 . . . . 0.0 110.701 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.6 141.35 15.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.22 144.13 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.726 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -120.99 147.37 17.55 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.977 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.886 0.374 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.46 ' HG ' ' HG ' ' A' ' 138' ' ' SER . 96.5 p -156.14 167.58 29.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.546 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mp -99.37 143.6 29.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.04 137.33 53.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.434 . . . . 0.0 111.083 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.23 159.61 43.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.681 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.85 -170.25 43.37 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.06 153.19 34.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.412 . . . . 0.0 110.139 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.78 156.5 26.79 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.704 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.96 141.85 48.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.467 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -121.12 126.33 49.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.585 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -127.03 140.04 52.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.232 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -130.25 78.65 74.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.593 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.27 -25.79 11.11 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.141 1.894 . . . . 0.0 111.642 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.1 m-70 -127.33 119.22 21.85 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.899 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 -36.69 45.87 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.772 1.648 . . . . 0.0 113.108 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -82.16 -11.9 58.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' HIS . 89.6 t80 -143.62 129.61 19.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.245 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.12 153.15 38.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.48 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -119.15 136.91 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.602 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -128.52 114.91 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.975 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.842 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -156.89 164.53 37.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.189 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.58 152.65 40.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 149' ' ' MET . 49.9 mp0 -143.59 154.05 43.17 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.709 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.15 144.14 51.1 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.46 ' HG ' ' HG ' ' A' ' 114' ' ' SER . 46.0 t . . . . . 0 C--N 1.329 -0.294 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 91.6 t -129.24 133.14 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.954 0.406 . . . . 0.0 112.08 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.79 144.57 15.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.3 p -129.61 148.26 51.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.323 0.582 . . . . 0.0 112.01 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -141.07 137.96 33.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.819 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -139.09 146.36 40.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.578 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.24 132.32 23.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.915 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -170.69 -177.39 40.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.831 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.9 157.45 43.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.4 -165.03 10.14 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.43 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -149.13 157.22 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.758 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.129 -179.554 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.3 p -119.69 154.62 33.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.2 mt -119.59 125.35 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.542 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -136.54 150.81 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -131.63 147.01 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.229 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.06 -179.34 30.16 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -109.28 142.24 40.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.684 0.278 . . . . 0.0 110.292 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.32 128.19 55.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -124.93 120.29 31.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.165 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.408 ' OG ' ' CG1' ' A' ' 145' ' ' VAL . 39.3 t -99.84 106.76 18.65 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.424 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 121.03 16.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.34 125.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.081 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.9 tptm . . . . . 0 C--N 1.331 -0.23 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.414 -179.525 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -81.25 160.6 20.24 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.805 2.337 . . . . 0.0 111.147 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -93.49 134.27 35.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.474 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.23 36.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -126.8 149.07 49.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.752 0.31 . . . . 0.0 110.75 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 47' ' ' PHE . 50.4 t30 -124.63 120.65 32.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.647 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.52 140.55 31.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.498 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 87.6 tttt -136.68 133.18 35.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.048 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.13 146.37 51.08 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.419 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.688 HH21 HE22 ' A' ' 122' ' ' GLN . 42.1 ttm180 -111.05 132.78 53.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -125.37 142.91 51.23 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.396 0.435 . . . . 0.0 110.094 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 -179.671 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.51 149.45 31.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.176 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.48 155.04 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.343 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.08 134.55 7.9 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.0 m -130.22 146.17 51.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 94.9 m-85 -129.13 145.39 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.465 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.77 138.69 37.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -145.15 127.93 16.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.04 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.6 p -129.88 159.45 36.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.358 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.617 ' CZ ' ' HZ3' ' A' ' 69' ' ' LYS . 80.0 ttt180 -151.78 136.36 16.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.583 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.117 179.361 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 120.775 0.321 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.617 ' HZ3' ' CZ ' ' A' ' 51' ' ' ARG . 73.2 mmtt -101.02 135.93 41.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.09 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -124.67 133.85 53.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' A' ' 95' ' ' HIS . 87.5 t80 -143.39 131.3 21.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.266 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -142.0 141.82 32.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.467 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.2 t -117.82 125.03 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -129.44 149.64 51.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.99 158.96 12.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.13 166.43 34.0 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.5 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 155.11 46.16 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.027 2.485 . . . . 0.0 112.386 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.8 123.76 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.295 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.57 118.16 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.523 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -84.76 136.46 33.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.12 -51.16 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.763 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 84' ' ' TYR . 60.4 t30 -161.74 41.84 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 67.28 -37.62 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.556 ' H ' ' C ' ' A' ' 82' ' ' ASN . 78.5 m-85 -66.99 -38.01 85.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.57 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -144.22 146.88 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.4 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -139.1 150.2 45.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.639 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.8 mt -98.78 139.79 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.474 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.88 141.62 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.419 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.74 138.84 14.35 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.6 mt -112.03 117.91 33.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.74 133.05 39.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.666 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.57 -161.02 34.53 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.444 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 114' ' ' SER . . . -146.53 150.75 36.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.724 0.297 . . . . 0.0 110.452 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.25 142.96 16.12 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.414 ' O ' ' O ' ' A' ' 71' ' ' TYR . 78.7 m80 -135.15 148.81 49.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.12 152.87 20.93 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 -179.756 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.705 0.288 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 92.8 p -151.14 162.35 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.8 tp -100.2 125.84 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.396 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 123.05 45.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.6 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -143.3 131.59 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.109 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.35 -170.18 34.37 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.594 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.61 158.72 42.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 0.0 110.533 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.17 173.74 36.04 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.422 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 0.9 OUTLIER -135.75 170.02 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 0.0 110.501 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.688 HE22 HH21 ' A' ' 34' ' ' ARG . 52.4 tt0 -139.54 136.3 34.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -129.75 130.64 45.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.446 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 31.5 t-20 -106.66 99.28 24.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.231 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.38 -31.89 5.39 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.658 1.572 . . . . 0.0 111.439 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.3 m-70 -138.59 148.95 60.8 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.774 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.92 -25.97 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.998 1.799 . . . . 0.0 112.357 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -82.8 -25.58 32.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.647 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 126' ' ' HIS . 94.5 m-85 -132.91 144.28 50.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.298 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.52 153.0 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.285 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.6 pt -128.55 147.09 33.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.682 0.277 . . . . 0.0 110.422 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.527 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 61.0 t0 -146.71 133.62 20.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.474 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -124.05 124.72 43.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.68 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 66.4 m -133.97 152.35 51.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.316 . . . . 0.0 111.164 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.08 139.72 53.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.055 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -125.31 150.35 47.22 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.646 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -131.41 127.18 36.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 CA--C 1.523 -0.09 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.304 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.6 mptt . . . . . 0 C--O 1.231 0.125 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.408 ' CG1' ' OG ' ' A' ' 13' ' ' SER . 84.6 t -128.03 129.12 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.029 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.01 132.28 8.82 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 96.5 m -113.16 123.53 50.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.046 0.451 . . . . 0.0 111.285 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -95.72 135.49 37.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.496 ' O ' ' SD ' ' A' ' 149' ' ' MET . 1.8 tmt? -119.43 117.83 29.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.785 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -137.07 127.29 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.784 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -169.6 177.85 42.92 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.168 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.49 159.79 44.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.66 -160.91 14.59 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.38 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.04 160.11 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 0.0 110.673 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.516 -179.84 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.589 0.233 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.492 ' HG ' HH21 ' A' ' 34' ' ' ARG . 63.8 m -124.85 148.61 48.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.53 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -116.89 129.75 72.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.9 t -124.59 140.03 53.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.5 tt -126.91 145.57 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.136 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.12 -173.82 37.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.445 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -106.09 142.42 35.81 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.03 127.92 54.28 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -129.24 134.95 48.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.796 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.465 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 41.4 t -117.33 120.35 37.93 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.571 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.668 HH21 ' NZ ' ' A' ' 16' ' ' LYS . 61.2 ttt85 -67.53 120.1 13.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.361 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -133.25 131.52 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.668 ' NZ ' HH21 ' A' ' 14' ' ' ARG . 73.5 mmtt . . . . . 0 C--N 1.331 -0.199 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 13' ' ' SER . 93.4 Cg_endo -83.7 161.01 14.35 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.176 2.584 . . . . 0.0 111.093 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -92.12 132.09 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.3 169.65 33.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.56 138.86 49.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.582 ' ND2' ' SD ' ' A' ' 149' ' ' MET . 29.5 t-20 -115.09 119.52 36.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.407 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.47 129.18 51.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.56 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -132.56 147.16 52.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.87 145.05 51.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.201 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.676 HH11 HE22 ' A' ' 122' ' ' GLN . 61.5 ttp180 -124.96 132.67 53.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.15 142.91 51.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.0 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.032 -179.522 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.613 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.5 t -124.42 128.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.16 157.28 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.068 0.461 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.19 159.32 27.67 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -136.69 131.01 32.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.059 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.69 123.66 43.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.837 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.01 152.99 41.01 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.121 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -148.89 144.35 26.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.653 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.4 p -132.3 160.92 34.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -154.74 148.59 25.58 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.785 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 . . . . . 0 C--O 1.232 0.141 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.78 179.429 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.803 0.335 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.9 146.29 25.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -119.44 127.39 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 95' ' ' HIS . 98.5 m-85 -127.95 144.21 51.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.274 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -152.46 140.07 19.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.568 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.87 143.97 39.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.022 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.7 p -144.2 163.12 34.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.44 155.1 29.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.441 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.54 164.04 34.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.489 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.13 158.9 37.61 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.258 2.639 . . . . 0.0 112.291 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -135.7 135.35 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.8 t80 -128.15 129.72 46.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.708 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.531 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 36.4 mmt180 -67.61 136.58 54.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 75.5 mt -87.86 -51.86 12.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.052 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 2.7 m-20 162.9 -73.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.71 64.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.459 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 47.07 33.62 2.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -133.09 152.71 36.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 t -139.48 144.11 37.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 111.449 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 tp -111.11 129.84 55.8 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CZ ' ' C ' ' A' ' 120' ' ' GLY . 53.7 p90 -143.22 158.4 43.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.738 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -107.13 147.35 16.23 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.8 tp -128.38 119.97 26.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.33 160.91 38.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.836 0.351 . . . . 0.0 111.173 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.35 -143.96 8.89 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.63 150.79 36.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 110.937 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.61 140.6 16.44 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 71' ' ' TYR . 31.1 p80 -147.0 162.03 39.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.36 158.37 18.88 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.228 0.537 . . . . 0.0 110.616 -179.582 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.45 ' OG ' ' OG ' ' A' ' 138' ' ' SER . 33.5 t -160.2 158.21 29.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.7 mt -99.28 141.09 32.5 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.47 140.05 48.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.964 0.411 . . . . 0.0 111.164 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -150.93 159.1 44.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.205 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 165.84 -158.72 31.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.488 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.59 160.17 40.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.739 0.304 . . . . 0.0 110.502 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.444 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -144.43 156.05 26.62 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.29 146.06 44.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.516 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.676 HE22 HH11 ' A' ' 34' ' ' ARG . 63.6 tt0 -117.62 128.56 55.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.697 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -118.7 137.53 53.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.414 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -129.51 81.03 70.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.71 -27.23 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.762 1.641 . . . . 0.0 111.667 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -136.48 149.24 66.89 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.733 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.98 -22.97 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.068 1.845 . . . . 0.0 112.776 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.18 6.0 44.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.678 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -150.08 128.24 11.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.468 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.4 t -122.88 132.03 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.0 mt -115.16 126.02 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.087 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -146.61 160.44 42.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.72 138.59 17.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.429 ' OG ' ' OH ' ' A' ' 88' ' ' TYR . 62.2 m -135.94 151.83 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.776 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -142.13 148.52 38.45 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.015 0.436 . . . . 0.0 110.867 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -143.79 159.09 43.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.378 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -119.8 139.2 52.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.805 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.45 ' OG ' ' OG ' ' A' ' 114' ' ' SER . 37.2 t . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.232 0.137 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.57 131.53 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.317 0.579 . . . . 0.0 112.38 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.16 157.15 15.76 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 91.2 m -123.92 129.42 50.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.196 0.498 . . . . 0.0 111.606 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -129.53 119.94 24.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.582 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 79.0 mtm -132.07 134.48 45.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.38 142.12 30.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.96 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.33 -175.07 47.13 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.094 -1.051 . . . . 0.0 111.895 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.45 157.94 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.398 . . . . 0.0 109.938 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.52 -177.31 21.04 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.358 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -148.15 158.92 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.496 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.319 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.724 0.297 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.7 p -143.73 159.67 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.2 mt -118.24 130.93 72.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.671 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.4 t -134.5 140.73 46.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.706 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.39 148.76 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.376 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.56 -174.62 35.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -104.33 142.58 34.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.65 131.36 55.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.236 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -126.79 124.67 40.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.478 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.562 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 69.9 m -117.75 107.41 14.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -66.82 133.34 49.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -111.33 125.52 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.744 179.441 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.57 HD21 ' N ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.57 ' N ' HD21 ' A' ' 25' ' ' ASN . 97.6 Cg_endo -83.04 159.1 15.57 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.673 ' NH2' ' HE ' ' A' ' 51' ' ' ARG . 51.2 ptt85 -93.19 142.61 27.11 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.44 169.77 35.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -109.47 142.14 40.92 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.712 0.292 . . . . 0.0 110.575 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.473 ' OD1' ' SD ' ' A' ' 149' ' ' MET . 43.5 t30 -125.89 119.02 26.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.752 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.1 137.28 53.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -134.8 146.13 49.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.16 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.685 HH12 ' HH ' ' A' ' 88' ' ' TYR . 61.0 ttt85 -107.57 127.48 53.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -137.77 126.77 24.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.079 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.507 ' OE2' ' NH2' ' A' ' 34' ' ' ARG . 99.4 mt-10 . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.969 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' H ' HG12 ' A' ' 78' ' ' VAL . . . . . . . . 0 CA--C 1.525 0.718 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.48 157.64 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -137.94 134.3 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.442 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.8 132.96 11.32 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.7 m -128.68 139.93 51.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.08 142.11 49.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.744 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.67 139.33 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -142.41 126.74 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.274 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 p -128.78 159.24 36.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.419 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.673 ' HE ' ' NH2' ' A' ' 27' ' ' ARG . 41.2 ptt180 -157.57 161.18 38.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.355 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.557 HH21 ' CB ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.518 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -118.02 142.05 47.8 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -126.34 125.53 42.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.345 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -130.03 128.73 42.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.19 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -140.05 140.05 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.062 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.4 t -124.06 128.88 74.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.043 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -148.34 155.38 41.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.214 0.53 . . . . 0.0 111.166 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.75 158.33 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.182 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.22 153.58 25.15 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.603 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.66 159.03 31.94 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.74 2.293 . . . . 0.0 111.475 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 42' ' ' GLY . 7.9 p -131.61 119.25 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.455 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.66 120.12 35.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.914 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -80.54 128.44 33.59 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.157 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.5 mt -89.8 -52.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.808 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 84' ' ' TYR . 32.7 m120 -122.09 16.98 10.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.823 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 82' ' ' ASN . 16.9 tt0 76.17 -21.03 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.535 ' H ' ' C ' ' A' ' 82' ' ' ASN . 96.9 m-85 -104.17 -20.89 13.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.81 145.63 33.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.4 t -141.14 152.25 44.56 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.321 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.1 mt -102.48 138.8 38.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.391 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.685 ' HH ' HH12 ' A' ' 34' ' ' ARG . 48.9 m-85 -121.48 140.02 52.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.592 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.83 137.66 14.4 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.41 118.79 37.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.499 0.649 . . . . 0.0 111.877 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.7 tp -136.9 122.94 20.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.354 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -167.8 39.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.27 151.56 38.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 110.701 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.64 146.5 16.08 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -130.95 143.89 51.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.727 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -116.19 143.44 18.07 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.1 tttp . . . . . 0 C--N 1.332 -0.187 0 CA-C-O 120.857 0.36 . . . . 0.0 110.57 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 121.019 0.438 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.1 p -152.6 163.75 39.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.39 145.24 28.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.629 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.24 52.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.726 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -151.31 160.82 43.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.296 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 169.29 -160.77 34.2 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.878 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.78 158.54 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -157.66 174.97 35.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.24 165.81 27.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.917 0.389 . . . . 0.0 110.831 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.637 HE21 ' CG1' ' A' ' 130' ' ' VAL . 65.4 tt0 -135.11 135.34 41.11 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.207 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -127.66 126.95 42.92 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.009 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -125.24 85.64 57.99 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.59 -29.75 10.51 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.7 1.6 . . . . 0.0 111.652 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.64 123.58 21.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.762 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.15 -29.29 22.02 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.581 1.521 . . . . 0.0 112.522 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -82.06 -8.71 59.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.739 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -139.29 123.34 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.418 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.637 ' CG1' HE21 ' A' ' 122' ' ' GLN . 72.8 t -127.89 134.01 66.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.831 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.04 148.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.502 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -146.29 158.96 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.19 21.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.024 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.8 p -158.17 162.6 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.528 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -144.07 148.29 34.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -145.92 160.4 41.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.568 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -119.02 139.32 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.45 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.163 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.01 130.95 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.0 134.67 11.77 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.49 ' HG1' ' HG ' ' A' ' 13' ' ' SER . 93.9 m -125.0 131.7 53.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.278 0.561 . . . . 0.0 112.356 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -127.95 125.42 39.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.506 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.473 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 79.3 mtm -117.74 136.63 53.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 111.374 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 tt -136.91 130.17 31.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.58 177.66 41.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.851 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.13 158.94 44.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.45 -171.9 23.2 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -147.38 159.32 43.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 0.0 110.617 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.663 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.9 p . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.78 0.324 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 154' ' ' TYR . 47.7 t -147.01 141.39 26.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.594 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 pt -127.56 147.15 32.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -131.82 148.45 52.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.0 mt -121.09 129.44 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.062 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.01 156.53 26.87 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.27 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -83.72 146.02 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.39 120.0 40.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.768 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -118.5 118.46 31.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.848 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.3 m -118.44 167.73 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -125.21 137.57 54.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.7 t -115.39 126.56 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.531 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.33 -0.282 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.364 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 119.399 -0.334 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.63 158.96 35.69 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.433 1.422 . . . . 0.0 110.86 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.404 ' O ' ' OG1' ' A' ' 50' ' ' THR . 17.8 ptm180 -91.57 155.02 18.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.764 0.316 . . . . 0.0 110.945 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.3 175.07 43.09 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.92 149.59 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 47' ' ' PHE . 63.3 t30 -134.92 120.49 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -115.66 140.89 48.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.749 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.38 145.24 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.89 144.59 51.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.074 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -123.66 128.79 50.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.441 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 96.2 m-85 -128.91 148.63 50.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.442 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 17.5 tt0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.409 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.635 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.35 139.62 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.382 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.59 153.16 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.86 135.36 9.39 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.9 m -128.32 145.69 50.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.148 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.434 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 98.3 m-85 -124.37 140.49 52.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.513 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.33 137.96 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -150.99 150.34 30.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.783 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 8.9 t -150.27 155.24 39.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -156.02 163.24 39.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 . . . . . 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.796 0.332 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -124.08 141.65 51.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.3 144.59 51.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.998 0.427 . . . . 0.0 111.149 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -139.98 130.97 26.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.14 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -148.78 147.95 29.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 111.023 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 p -136.41 136.38 48.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.698 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -135.31 157.76 46.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.17 27.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.452 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.3 169.78 42.91 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.773 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.1 155.0 52.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.327 2.685 . . . . 0.0 112.794 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.6 t -126.69 130.51 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.754 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -126.91 125.76 42.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.404 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.69 137.33 54.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.97 -48.61 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.325 0.583 . . . . 0.0 110.139 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 51.4 t30 -134.73 -148.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.754 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.503 ' H ' ' CG ' ' A' ' 82' ' ' ASN . 99.3 mt-10 -88.71 -5.24 58.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -149.23 15.62 0.91 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.8 p -144.36 138.31 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.42 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.0 m -134.62 149.87 50.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.11 0.481 . . . . 0.0 111.847 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 tp -119.52 131.12 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.435 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -142.29 158.79 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.866 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.19 148.54 17.42 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.6 mt -119.16 135.9 54.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.98 146.83 31.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.599 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.86 -145.45 8.46 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.136 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.37 152.24 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.56 147.21 16.61 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -134.79 144.96 47.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.736 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.69 145.86 17.42 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.666 -179.919 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.771 0.319 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.436 ' OG ' ' OG ' ' A' ' 138' ' ' SER . 43.6 t -148.64 149.84 32.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.638 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mp -99.69 142.91 30.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.614 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.21 132.76 55.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.99 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -145.97 134.13 21.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.138 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.31 -169.68 34.53 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.806 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.66 159.27 44.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.016 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.54 169.31 31.06 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.805 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.421 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.6 OUTLIER -142.44 160.24 40.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.919 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.51 ' NE2' ' OD1' ' A' ' 132' ' ' ASP . 63.7 tt0 -140.34 137.41 34.07 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.616 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.421 ' CE2' ' CD1' ' A' ' 121' ' ' LEU . 69.6 m-85 -115.5 149.01 38.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.683 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -129.89 83.02 65.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.949 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.4 -22.8 24.56 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.72 1.613 . . . . 0.0 111.71 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.724 ' HD1' ' H ' ' A' ' 128' ' ' ASN . 65.7 t-80 -150.14 136.4 10.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.482 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.99 -39.43 50.07 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.921 1.747 . . . . 0.0 113.89 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.724 ' H ' ' HD1' ' A' ' 126' ' ' HIS . 54.7 p30 -84.14 -0.7 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.62 126.67 13.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.394 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 152.69 34.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.451 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.9 mt -114.51 125.85 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NE2' ' A' ' 122' ' ' GLN . 97.8 m-20 -105.73 132.46 51.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.193 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -136.14 127.33 28.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.781 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.8 t -158.03 151.62 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.858 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -139.07 149.16 44.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.683 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -142.46 153.57 43.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.775 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.59 147.26 49.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.163 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.436 ' OG ' ' OG ' ' A' ' 114' ' ' SER . 30.7 t . . . . . 0 C--N 1.332 -0.187 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--O 1.231 0.122 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.93 146.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.144 -0.623 . . . . 0.0 112.223 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.31 152.45 17.74 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 91.2 m -125.28 131.86 53.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 111.558 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -125.94 123.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.897 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 149' ' ' MET . 2.5 mpp? -117.47 129.57 55.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.932 0.396 . . . . 0.0 111.012 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.27 131.78 22.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.982 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -178.56 -169.03 38.74 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.575 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.42 155.86 47.34 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.88 -169.62 14.05 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.789 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.422 ' O ' ' OG ' ' A' ' 5' ' ' SER . 52.0 p90 -148.61 163.09 38.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.123 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.517 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.7 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.746 0.307 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.6 m -124.45 141.98 51.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.536 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.89 124.3 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -128.88 140.75 51.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.026 0.441 . . . . 0.0 111.311 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.8 pt -132.82 156.49 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.746 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.17 -174.18 38.76 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.119 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -113.72 145.91 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.7 140.99 38.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -131.69 138.1 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.696 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.447 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 67.2 m -117.33 109.39 16.77 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.239 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -68.66 129.15 39.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.02 129.43 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.635 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm . . . . . 0 C--N 1.333 -0.113 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.864 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.447 ' CD ' ' O ' ' A' ' 13' ' ' SER . 96.2 Cg_endo -84.73 160.42 12.23 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.766 2.311 . . . . 0.0 111.44 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.81 135.43 39.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.73 169.75 35.15 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.97 143.85 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.426 ' OD1' ' SD ' ' A' ' 149' ' ' MET . 29.5 t-20 -117.61 119.09 33.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -122.92 136.89 55.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.833 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -148.24 155.9 41.91 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -133.07 146.8 52.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.16 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -126.97 131.14 51.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.795 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.91 139.8 52.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.176 179.443 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.42 143.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.348 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -132.64 137.25 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.08 142.57 16.19 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -126.21 143.93 50.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.932 0.396 . . . . 0.0 111.102 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -130.08 146.01 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.807 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.41 141.55 35.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.03 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -128.79 137.28 51.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.21 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.4 m -128.06 134.9 49.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -146.38 143.99 29.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.874 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.832 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.587 0.232 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -132.22 115.99 16.39 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -134.46 129.29 35.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.279 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.06 160.82 40.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.287 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -147.59 145.02 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.092 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.29 126.96 74.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.121 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -132.85 156.64 46.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.53 154.81 29.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.36 170.66 43.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.477 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.4 154.46 50.81 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.21 2.607 . . . . 0.0 113.041 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.5 t -127.89 130.97 70.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.412 ' O ' ' OG ' ' A' ' 86' ' ' SER . 94.7 m-85 -127.15 146.42 50.4 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.175 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.79 126.77 52.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.6 tt -80.18 -37.42 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.72 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 84' ' ' TYR . 57.4 t30 -156.72 31.72 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.761 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 68.52 -42.66 0.48 Allowed 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.855 0.722 . . . . 0.0 109.812 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.549 ' H ' ' C ' ' A' ' 82' ' ' ASN . 66.5 t80 -63.96 -40.61 96.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.415 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.6 t -126.93 135.61 63.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.402 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 79' ' ' PHE . 42.2 t -129.05 134.77 48.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.02 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.0 tp -110.62 127.96 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.269 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.98 159.33 42.44 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.967 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.52 145.33 16.01 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -120.13 137.16 54.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.622 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.2 152.25 38.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.765 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.14 -147.13 9.76 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.348 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.95 150.57 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 0.0 110.96 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.75 139.76 15.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -145.95 135.03 22.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.15 158.94 27.85 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.771 0.319 . . . . 0.0 110.386 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 93.1 m . . . . . 0 CA--C 1.528 0.109 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.431 ' OG ' ' OG ' ' A' ' 138' ' ' SER . 46.7 t -148.96 150.73 33.36 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.027 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.49 140.93 32.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.54 132.69 56.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.895 0.379 . . . . 0.0 110.711 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -151.01 160.26 44.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.087 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.34 -166.78 39.97 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.727 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.18 156.77 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.0 170.28 30.06 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.597 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.95 156.38 46.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.375 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -132.0 129.18 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -115.12 148.21 39.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.796 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 55.6 t-20 -129.37 81.85 69.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.406 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -28.18 14.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.896 1.731 . . . . 0.0 112.131 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 70.6 m80 -135.68 148.18 64.45 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.079 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.81 -24.01 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.25 1.967 . . . . 0.0 112.854 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -99.96 4.52 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.777 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.65 128.66 8.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.98 152.78 37.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.29 148.12 27.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 133' ' ' ALA . 52.8 t0 -146.31 138.88 25.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.692 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.472 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -148.35 150.83 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.056 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 149' ' ' MET . 85.8 p -153.38 161.57 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.752 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -127.14 128.03 45.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.759 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -132.07 147.62 52.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.251 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -130.42 147.91 52.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.204 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.431 ' OG ' ' OG ' ' A' ' 114' ' ' SER . 32.7 t . . . . . 0 C--O 1.236 0.355 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 87.2 t -128.31 130.61 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.134 0.492 . . . . 0.0 112.28 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.31 138.02 14.54 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.6 m -111.56 132.77 54.3 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.165 0.483 . . . . 0.0 111.846 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -112.0 135.82 52.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.124 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.426 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 53.9 ttp -131.54 125.55 32.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.891 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.1 tp -143.04 129.82 20.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.711 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -176.81 -176.18 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.073 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.84 158.93 44.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.51 174.79 23.25 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.751 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -123.06 130.15 52.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.369 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.342 -179.892 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.85 177.54 54.34 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -71.04 141.14 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.805 0.336 . . . . 0.0 110.612 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 156' ' ' PHE . 63.5 m -129.8 154.64 47.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -126.5 138.69 53.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.2 mm -112.33 126.8 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -139.2 143.09 37.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.417 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.94 148.72 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.049 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.04 172.1 36.47 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -83.34 143.66 30.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.41 127.0 44.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.961 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -134.01 139.27 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.912 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 40.7 t -117.7 106.99 13.65 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.84 128.78 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.82 150.01 32.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.071 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -80.4 129.47 34.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.87 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -148.28 164.15 34.89 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.214 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.76 -39.98 86.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.579 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.64 15.93 0.03 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.221 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 21' ' ' LYS . 90.0 t80 -62.39 134.05 55.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.307 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' TYR . 0.4 OUTLIER 50.17 178.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.204 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.38 -52.38 5.41 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.215 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 59.5 p30 -99.42 7.01 45.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.551 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 50.26 33.69 7.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.816 0.341 . . . . 0.0 110.142 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.517 ' ND2' ' OD2' ' A' ' 23' ' ' ASP . 74.8 m-20 -103.05 115.17 64.53 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.51 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 13' ' ' SER . 92.5 Cg_endo -78.16 159.98 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.402 2.068 . . . . 0.0 111.437 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 50' ' ' THR . 61.0 ttp180 -95.81 127.98 42.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.793 0.33 . . . . 0.0 110.759 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.29 171.55 35.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.82 146.59 50.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 47' ' ' PHE . 29.3 t-20 -121.89 120.8 35.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 tp -105.53 124.1 48.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.557 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.96 139.91 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.014 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -133.63 126.91 31.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.435 HH12 ' CD ' ' A' ' 122' ' ' GLN . 43.1 ttm180 -110.38 131.64 54.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.641 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -116.02 137.7 51.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.017 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 59.42 65.85 1.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.742 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -58.97 -49.03 79.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.283 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 m120 41.05 -126.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.603 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.42 ' OD1' ' NE ' ' A' ' 80' ' ' ARG . 55.4 t30 -158.86 -55.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.826 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.72 -40.89 96.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -153.78 163.86 39.31 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.355 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.94 175.86 44.52 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.61 156.75 42.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -142.61 140.16 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 111.237 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.35 147.0 18.29 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.6 t -126.99 130.82 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.202 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.516 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.5 m-85 -125.36 136.23 53.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.09 148.16 33.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.374 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -151.11 149.44 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.67 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.476 ' HG1' ' N ' ' A' ' 51' ' ' ARG . 14.9 t -152.15 162.46 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.919 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.476 ' N ' ' HG1' ' A' ' 50' ' ' THR . 79.2 ttt-85 -149.03 141.02 23.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.578 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -69.98 137.63 51.58 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.49 84.76 0.1 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 55' ' ' GLU . 91.5 t80 -111.42 135.85 51.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 80.8 mm-40 -59.44 144.83 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.209 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.31 132.87 50.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.075 0.464 . . . . 0.0 111.089 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 t -150.81 147.45 27.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.862 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.443 ' CG1' ' O ' ' A' ' 58' ' ' VAL . 8.6 p -97.81 102.1 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.608 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -107.06 -18.24 13.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.278 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.88 -9.14 78.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 62' ' ' LYS . 97.4 m-85 -105.85 7.45 32.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.447 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 61' ' ' PHE . 2.3 mptp? 55.44 164.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.405 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.72 129.17 56.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.541 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.71 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.962 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 46.41 -97.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.91 -19.98 49.8 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.3 t0 48.45 56.73 7.08 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.281 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -132.22 161.35 33.63 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.847 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -120.41 147.75 44.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.858 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -123.2 131.07 53.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.589 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.48 147.2 49.32 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.625 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.0 t -149.21 142.72 25.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.539 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.54 131.73 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.9 p -137.78 158.27 44.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.991 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.09 152.25 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.7 43.62 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.561 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.6 153.4 54.57 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.358 2.705 . . . . 0.0 112.863 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -126.31 129.57 71.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.727 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.2 t80 -127.11 128.55 46.4 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 59.0 ttm-85 -69.59 134.58 48.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.02 -51.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.972 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.415 ' OD1' ' CG1' ' A' ' 85' ' ' VAL . 17.5 m120 -126.71 -137.3 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -97.14 -4.92 38.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.381 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.35 20.04 0.48 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.415 ' CG1' ' OD1' ' A' ' 82' ' ' ASN . 5.0 p -144.07 142.1 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.048 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.7 p -138.51 152.93 48.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 111.225 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 tt -121.14 130.02 53.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.467 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.441 ' OH ' ' OG ' ' A' ' 134' ' ' SER . 53.4 p90 -140.34 157.73 45.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.848 0.356 . . . . 0.0 110.719 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.17 147.19 18.35 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.6 mt -114.43 127.91 56.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.677 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.61 142.26 48.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.921 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.6 -144.26 7.82 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.09 39.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 0.0 111.095 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.59 143.72 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.4 145.61 50.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 110.802 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -123.29 144.9 15.9 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -125.06 141.74 51.93 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.34 140.69 30.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.408 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.15 134.33 44.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.469 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -95.66 135.88 36.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.018 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.2 p -87.5 114.3 23.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.121 0.486 . . . . 0.0 110.767 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.8 p -163.57 165.84 23.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.828 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.6 mt -106.16 112.56 39.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.527 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -146.89 162.15 39.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.133 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.75 -17.44 57.87 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -137.99 168.45 19.68 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.8 p -108.81 157.16 18.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -125.74 134.21 51.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.735 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.2 t -149.28 147.58 28.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.301 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -129.02 149.25 50.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.802 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.1 m -127.94 152.69 47.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.781 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -126.5 149.48 49.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.485 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.9 m -118.91 127.57 53.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.998 0.428 . . . . 0.0 110.948 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.1 m -135.41 154.06 51.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.309 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.79 144.65 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.0 125.72 32.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -150.58 160.39 43.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.717 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.23 -165.01 35.78 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.506 ' O ' ' CD1' ' A' ' 135' ' ' TYR . . . -155.14 158.49 39.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.642 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.37 166.8 33.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 pp -143.2 159.58 42.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.839 0.352 . . . . 0.0 110.74 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.435 ' CD ' HH12 ' A' ' 34' ' ' ARG . 54.3 tt0 -117.03 128.64 55.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.182 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -127.98 126.74 41.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.447 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -118.99 93.19 46.43 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.44 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.13 -27.62 29.27 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.331 1.354 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -135.14 151.02 74.48 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.953 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.24 -36.6 78.46 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.0 1.8 . . . . 0.0 113.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -101.72 14.52 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.17 119.87 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.667 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.24 129.23 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.211 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.93 124.42 58.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -107.99 130.27 55.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.214 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -129.99 112.03 13.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.698 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.441 ' OG ' ' OH ' ' A' ' 88' ' ' TYR . 58.0 m -134.66 153.03 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' A' ' 119' ' ' ALA . 52.8 p90 -144.49 153.61 42.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.505 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -135.78 152.2 50.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 145' ' ' VAL . 47.4 t80 -143.71 133.09 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.612 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.7 m -111.01 137.76 48.24 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -102.96 109.07 20.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.048 0.451 . . . . 0.0 111.996 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.96 145.63 45.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -59.69 -43.24 94.15 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.826 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 59.5 t0 -103.75 -32.03 9.55 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.2 t -104.33 129.05 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -106.64 126.26 52.05 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.473 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 58.4 t -119.85 125.64 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.408 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.67 125.31 6.36 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.4 m -129.58 137.32 50.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 111.865 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -133.91 151.02 51.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 64.7 mtt -133.43 137.48 45.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -136.06 129.6 32.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.94 40.15 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.814 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.12 161.02 42.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.416 -0.392 . . . . 0.0 109.97 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.79 -178.05 27.02 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.522 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.63 146.0 49.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.373 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -86.69 127.97 34.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.454 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' A' ' 4' ' ' SER . 82.1 t80 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.478 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.98 -178.09 48.35 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -71.95 138.0 47.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 110.28 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p -150.83 163.5 38.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.654 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -138.39 146.78 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 tt -120.44 138.2 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -128.08 148.66 50.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.56 151.81 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.222 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.21 -174.47 38.36 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.591 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -116.39 149.29 39.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.42 132.93 54.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -122.08 121.73 37.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.364 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.9 m -118.19 168.47 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.784 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -138.15 143.71 40.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.46 149.41 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.207 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.21 137.59 54.12 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -163.39 176.69 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.43 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.49 -43.83 93.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.093 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.41 98.88 1.77 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -75.48 144.3 42.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.037 0.446 . . . . 0.0 111.002 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -91.45 179.4 5.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.91 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.05 -49.39 77.85 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.978 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.643 ' C ' ' H ' ' A' ' 25' ' ' ASN . 96.9 m-20 -112.55 -14.08 13.25 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.688 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.09 -6.67 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.367 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.643 ' H ' ' C ' ' A' ' 23' ' ' ASP . 34.3 m120 -105.11 113.82 64.25 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 119.45 -0.309 . . . . 0.0 111.363 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.81 156.12 27.22 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.467 1.444 . . . . 0.0 111.484 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -95.33 138.96 32.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.621 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.72 -168.31 20.68 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.24 160.07 41.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.689 HD22 ' NZ ' ' A' ' 32' ' ' LYS . 49.7 t30 -135.72 131.68 35.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.027 0.441 . . . . 0.0 112.028 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.35 136.76 53.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.822 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.689 ' NZ ' HD22 ' A' ' 30' ' ' ASN . 9.5 mtmm -125.53 140.36 52.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -127.08 144.81 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.342 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -123.3 132.07 53.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.391 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.486 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 95.1 m-85 -127.42 149.11 50.23 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.33 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 9.5 tp10 81.45 163.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -72.38 145.87 47.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.671 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.495 ' CG ' HH21 ' A' ' 80' ' ' ARG . 53.6 p30 -84.56 4.84 30.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.463 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 62.9 t-20 -84.42 112.38 20.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.445 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 39' ' ' ASN . 11.3 t0 86.82 -66.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.694 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -152.95 162.87 40.79 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.067 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.57 -175.95 37.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.14 154.82 40.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.827 0.346 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.25 142.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.748 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.67 150.76 17.93 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 t -136.97 137.21 39.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.422 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 92.7 m-85 -128.49 141.01 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.81 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.76 148.74 34.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -143.08 128.84 19.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.8 p -129.33 156.17 44.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.529 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.452 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -83.95 119.33 24.77 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.769 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.93 137.62 3.45 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 90.6 t80 -112.11 73.71 0.83 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.603 0.239 . . . . 0.0 110.507 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -162.72 159.5 24.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.036 0.446 . . . . 0.0 111.016 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.18 154.27 28.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.7 t -78.83 133.77 37.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.6 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 59' ' ' ASP . 34.1 m -130.64 160.74 41.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.032 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 10.4 t0 76.91 -16.56 0.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.157 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 58' ' ' VAL . . . 81.12 0.82 89.47 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.86 8.88 42.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 0.0 110.548 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 55.12 -165.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.715 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.7 mt -120.05 153.46 36.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.483 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 tt -53.35 -24.26 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.947 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.87 -38.23 84.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.29 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.76 -5.39 73.09 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 54.42 42.75 31.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.672 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -71.41 133.24 45.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.279 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -115.62 143.48 45.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.705 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.54 ' CE2' ' OG ' ' A' ' 72' ' ' SER . 83.5 t80 -127.65 121.39 30.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.14 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.23 133.91 55.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.54 ' OG ' ' CE2' ' A' ' 70' ' ' TYR . 67.1 m -134.65 141.37 46.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.34 134.96 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.008 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -140.57 158.67 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -158.7 152.41 23.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.53 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.58 164.7 35.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.665 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.99 160.61 36.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 123.166 2.577 . . . . 0.0 112.578 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.7 p -135.26 135.69 51.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.236 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.0 t80 -127.69 129.68 47.56 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.495 HH21 ' CG ' ' A' ' 38' ' ' ASN . 62.4 ttm-85 -71.85 128.68 36.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.22 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.3 mt -89.66 -51.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -127.86 -155.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.65 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.74 -39.99 93.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.293 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -140.87 35.01 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.155 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.1 t -127.77 126.29 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.9 m -130.67 142.54 50.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.8 tp -122.73 129.93 52.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.455 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -142.01 159.46 42.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.875 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.8 151.75 18.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.7 119.08 27.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.557 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -138.12 151.55 47.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.955 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -143.89 7.63 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.65 153.44 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 0.0 110.956 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.53 145.57 16.81 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -133.93 125.16 27.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.643 0.258 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.15 143.02 15.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -114.78 126.74 55.18 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.357 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.79 148.45 35.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.433 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.9 147.28 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.598 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -104.07 120.51 41.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.4 t -91.41 117.21 29.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 111.503 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.1 p -163.31 165.92 23.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.899 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.6 mt -100.22 112.83 33.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.079 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -149.46 173.74 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.282 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.81 -38.24 93.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -137.34 163.49 30.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.7 p -109.34 157.28 19.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.904 0.383 . . . . 0.0 110.825 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.5 154.33 48.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.692 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.4 m -118.44 150.86 38.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.311 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.32 151.15 49.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.577 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.9 p -149.03 161.11 42.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.82 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -129.24 150.62 50.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p -126.08 150.06 48.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.9 p -155.17 163.59 39.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.525 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -99.31 133.89 42.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.475 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.68 129.95 55.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.645 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -147.67 133.57 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -178.6 -169.98 40.04 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.41 158.58 44.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.623 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.18 169.6 33.21 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.82 162.3 40.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -141.69 151.68 43.22 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.22 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.09 147.05 41.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.617 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 39.1 t-20 -128.57 82.24 69.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.992 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.93 -26.56 15.27 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.809 1.673 . . . . 0.0 111.563 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 98.4 m-70 -135.14 148.53 66.99 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.771 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.66 -21.84 33.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.184 1.923 . . . . 0.0 113.098 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -100.03 -0.1 39.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.83 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -145.27 130.62 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.065 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.5 p -139.81 145.5 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.726 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.09 123.92 69.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.279 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -110.98 137.03 49.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -146.39 141.87 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.878 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.5 p -157.9 161.34 38.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.129 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.27 130.45 46.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.834 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -135.58 141.83 45.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 110.417 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -131.9 145.38 51.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.69 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.8 m -109.91 127.14 54.55 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -107.11 106.78 17.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.861 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.17 151.15 38.16 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.29 -42.76 96.14 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.45 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -104.85 -32.61 8.73 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 68.7 t -105.71 121.47 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.8 116.38 31.84 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.8 t -131.31 131.67 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.022 0.439 . . . . 0.0 112.016 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.32 143.6 16.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.9 m -124.77 130.38 52.29 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -116.91 136.14 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.548 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.458 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 79.4 mtm -131.58 127.81 37.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.404 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.6 tp -143.22 129.95 20.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.867 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.12 178.57 44.24 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.71 145.8 46.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.61 148.78 16.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.506 ' CE2' ' O ' ' A' ' 155' ' ' ARG . 91.8 t80 -134.45 130.05 36.16 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.506 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 85.7 mtp180 -75.55 144.34 41.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.649 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 156' ' ' PHE . 46.2 p90 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.642 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.17 162.95 54.59 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -71.59 136.69 47.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 0.0 110.685 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.5 m -133.17 151.39 51.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.592 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 t -119.54 133.45 55.66 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.453 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.27 131.96 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.865 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -139.89 155.42 47.2 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.996 0.427 . . . . 0.0 110.818 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.8 mt -124.94 130.18 73.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.205 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.69 154.05 22.42 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.638 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.24 148.75 27.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.36 138.74 54.05 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 110.901 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -143.39 142.51 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.106 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.3 t -117.87 167.91 10.98 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.158 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -134.8 120.9 19.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.406 ' CG2' ' NH2' ' A' ' 52' ' ' ARG . 34.9 m -132.76 149.87 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.994 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -124.0 124.34 42.35 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.169 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -163.54 170.63 16.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.83 137.19 58.13 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.418 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.23 28.62 72.54 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -53.97 147.06 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.209 0.528 . . . . 0.0 111.508 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -70.62 156.73 39.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.408 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.3 -46.18 86.6 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.668 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 25' ' ' ASN . 96.9 m-20 -92.83 -13.25 29.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.494 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 50.33 7.94 0.03 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.632 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 23' ' ' ASP . 70.3 m-20 -105.81 113.67 63.63 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.48 159.06 16.98 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 122.011 1.807 . . . . 0.0 110.691 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -97.79 131.39 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.76 0.315 . . . . 0.0 110.711 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -156.81 176.05 34.2 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.96 149.18 49.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.727 0.298 . . . . 0.0 110.33 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.577 ' ND2' ' SD ' ' A' ' 149' ' ' MET . 27.7 t-20 -133.61 124.61 27.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.205 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.46 138.59 45.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.757 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.68 139.9 53.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.89 143.37 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.672 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.63 HH12 ' NE2' ' A' ' 122' ' ' GLN . 61.6 ttp180 -131.96 131.63 42.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 111.036 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -129.32 143.09 50.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -118.66 120.47 37.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -108.78 2.62 21.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.557 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -160.02 162.34 34.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.526 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 54.1 p30 -88.77 2.63 53.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.967 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -135.36 7.52 3.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.758 0.313 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -153.25 139.85 18.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.679 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.27 165.83 26.93 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.3 142.84 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.438 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -136.99 136.41 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.83 143.11 14.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.9 m -130.48 147.9 52.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.234 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.53 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 95.7 m-85 -127.69 141.81 51.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.454 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.04 33.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.27 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -145.86 124.93 12.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.4 p -128.89 157.73 40.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.379 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -145.29 128.6 16.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.302 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' NH2' ' CG2' ' A' ' 15' ' ' VAL . 64.0 ttm-85 -83.31 134.76 34.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.235 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' GLU . . . 72.19 29.48 66.48 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 73.6 t80 -60.73 77.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.09 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 53' ' ' GLY . 88.4 tt0 -156.75 144.48 19.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.165 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -58.15 129.49 42.23 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.232 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -150.03 149.7 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.689 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.34 126.35 70.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.493 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 t0 75.34 -50.88 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.566 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . 81.51 2.92 90.7 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.01 -48.85 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.88 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.72 -41.24 99.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.357 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 60' ' ' GLY . 87.9 mt -123.51 127.05 47.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.78 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 66' ' ' GLY . 95.2 mt -62.13 -44.94 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.151 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 67' ' ' ASP . 66.2 m-20 58.97 1.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.77 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.544 ' O ' ' CE2' ' A' ' 68' ' ' PHE . . . 69.32 -41.87 0.39 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 65' ' ' ASP . 54.1 t0 51.74 48.18 23.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.33 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 66' ' ' GLY . 69.7 m-85 -125.99 149.44 48.8 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -119.55 143.61 47.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.664 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -124.98 138.0 54.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.969 0.414 . . . . 0.0 110.995 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -144.89 132.67 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.797 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.6 p -147.49 158.57 44.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.67 141.6 23.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.7 t -150.47 149.56 30.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 111.298 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.82 155.02 32.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.299 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -166.82 171.09 41.59 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.39 148.77 55.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.019 2.479 . . . . 0.0 112.442 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -126.53 130.06 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.441 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.423 ' O ' ' OG ' ' A' ' 86' ' ' SER . 98.5 m-85 -122.87 136.73 54.97 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.714 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 39' ' ' ASN . 96.5 mtm-85 -86.22 131.71 34.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.962 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.28 -50.99 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.235 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' A' ' 84' ' ' TYR . 56.9 t30 -139.97 34.37 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.911 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 56.54 1.8 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.825 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.55 ' H ' ' C ' ' A' ' 82' ' ' ASN . 64.7 m-85 -120.87 -20.71 6.84 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.165 0.507 . . . . 0.0 109.666 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 p -144.28 140.57 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.462 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 79' ' ' PHE . 48.3 t -136.62 141.42 43.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 134.46 51.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.885 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -144.26 159.33 42.87 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.138 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.15 152.07 17.39 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.41 126.9 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.2 tp -129.27 126.71 39.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.722 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.13 -155.65 18.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.481 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.69 155.86 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.897 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.66 140.41 14.84 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -126.76 120.64 29.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.44 141.71 15.68 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -126.21 142.79 51.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.966 0.412 . . . . 0.0 111.062 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.414 ' O ' ' OG ' ' A' ' 109' ' ' SER . . . -137.97 126.86 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.937 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -132.28 146.13 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -112.81 135.5 53.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.7 t -98.66 114.22 26.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.45 . . . . 0.0 110.627 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.0 p -163.64 167.86 20.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.933 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.9 mm -105.79 112.58 39.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.044 0.45 . . . . 0.0 110.682 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -147.76 173.25 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.349 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.86 -37.53 92.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -137.39 160.54 38.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.659 0.266 . . . . 0.0 110.374 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.7 m -110.11 159.32 17.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -139.06 154.83 48.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.167 0.508 . . . . 0.0 111.179 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 98' ' ' ALA . 45.4 t -155.32 151.67 28.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.009 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -127.43 153.69 45.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.874 0.368 . . . . 0.0 110.998 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 89.3 p -147.37 163.23 37.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.514 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -125.51 148.27 48.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.2 m -121.69 131.39 54.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.556 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.433 ' OG ' ' OG ' ' A' ' 138' ' ' SER . 93.4 p -151.68 165.58 33.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.557 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.95 140.79 29.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.476 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.46 131.62 56.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.832 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.1 132.92 29.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.64 178.41 34.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.487 -0.864 . . . . 0.0 111.61 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.52 155.13 39.84 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.4 155.38 26.29 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.56 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.606 ' CD2' ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -109.43 143.44 39.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.666 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.63 ' NE2' HH12 ' A' ' 34' ' ' ARG . 46.0 tt0 -119.87 123.72 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.288 . . . . 0.0 110.971 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.976 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -137.82 81.78 27.61 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.44 -28.17 18.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.661 1.574 . . . . 0.0 111.653 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 129' ' ' PHE . 97.9 m-70 -131.74 124.55 19.91 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.003 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -50.24 -33.74 37.37 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.79 1.66 . . . . 0.0 112.938 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -81.51 -12.09 58.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 126' ' ' HIS . 92.5 t80 -142.66 129.74 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.969 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.74 152.81 38.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.0 mt -117.1 125.8 74.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.268 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -116.95 113.82 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.34 128.15 54.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.074 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.4 p -157.34 161.11 39.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.984 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -149.83 156.0 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.277 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -145.24 156.32 43.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.162 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.55 159.22 43.44 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.156 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.433 ' OG ' ' OG ' ' A' ' 114' ' ' SER . 40.3 t -119.03 136.64 54.02 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.576 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -102.61 109.03 20.51 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.037 0.446 . . . . 0.0 112.055 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.39 146.42 44.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.4 -42.29 95.61 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.984 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -103.37 -31.99 9.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 79.6 t -105.28 126.59 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -107.04 120.27 41.62 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 99.8 t -125.52 128.04 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.086 0.469 . . . . 0.0 112.146 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -124.48 129.63 7.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.9 m -126.47 132.38 51.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 111.854 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -116.84 141.1 48.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.577 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 78.2 mtm -128.66 137.74 51.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.01 0.433 . . . . 0.0 111.257 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -142.79 131.4 22.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.814 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -164.0 177.81 39.64 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.962 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.98 158.66 44.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.35 -160.56 13.78 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.07 160.36 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.939 0.4 . . . . 0.0 110.879 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -102.71 126.38 49.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.386 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.4 t80 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.54 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.5 -176.26 46.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.99 141.85 52.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.525 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 t -149.91 147.76 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.665 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -132.61 138.21 47.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.486 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -127.76 138.91 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.707 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -149.79 145.5 26.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.78 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.56 159.23 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.96 -178.21 40.26 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.709 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.81 144.65 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.473 ' O ' ' NE2' ' A' ' 12' ' ' GLN . . . -125.3 136.55 53.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.111 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 11' ' ' ALA . 98.1 mm-40 -131.53 145.13 51.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.634 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 t -116.56 166.86 11.61 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -125.5 123.46 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -120.88 127.65 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.875 0.369 . . . . 0.0 111.54 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -117.52 121.56 41.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.828 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -140.8 176.88 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.384 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.74 -39.81 86.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.79 142.96 20.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -91.12 151.34 21.03 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.206 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.56 ' CE ' HH22 ' A' ' 52' ' ' ARG . 11.9 tptp -124.52 153.09 42.6 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.11 -50.62 72.99 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.633 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.646 ' C ' ' H ' ' A' ' 25' ' ' ASN . 58.7 p30 -116.04 -14.38 11.21 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 63.5 mttp 53.62 -2.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.081 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.646 ' H ' ' C ' ' A' ' 23' ' ' ASP . 69.5 m-20 -105.79 114.44 62.85 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.61 159.01 16.64 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.079 1.853 . . . . 0.0 110.473 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.422 HH21 ' N ' ' A' ' 54' ' ' PHE . 96.3 mtm-85 -99.77 137.6 38.01 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.849 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.68 177.87 36.91 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.79 147.5 47.5 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.329 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.438 ' CG ' ' SD ' ' A' ' 149' ' ' MET . 29.6 t-20 -132.77 123.84 26.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.034 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.741 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.524 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 98.8 mttt -121.98 140.77 52.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -140.86 128.55 21.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.235 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 122' ' ' GLN . 80.1 ttt180 -124.71 132.24 53.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.807 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -118.84 127.68 53.74 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -76.37 73.9 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.04 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.3 -48.54 81.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.067 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 41' ' ' TRP . 63.1 t30 -152.01 149.38 28.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.043 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 37.8 p-10 -61.92 -41.64 98.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.633 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 67.8 t0 -64.23 -47.03 81.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.828 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' ASN . 96.5 m95 -132.39 144.98 50.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.76 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.22 163.2 19.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.63 127.34 75.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 110.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -136.42 137.44 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.28 149.4 19.43 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -137.4 139.8 40.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.94 139.43 49.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.569 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.71 139.4 43.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.994 0.425 . . . . 0.0 111.413 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -143.67 130.25 20.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.842 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -128.4 158.09 39.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.791 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -158.25 158.01 33.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.1 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.56 HH22 ' CE ' ' A' ' 21' ' ' LYS . 76.7 mtp85 -83.25 121.91 27.72 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.82 150.3 14.4 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' N ' HH21 ' A' ' 27' ' ' ARG . 91.4 t80 -111.9 116.03 29.97 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -161.27 158.92 27.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -66.72 134.04 51.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.458 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -104.53 125.37 50.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.588 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' A' ' 60' ' ' GLY . 94.9 t -119.87 126.92 75.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.526 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 t0 72.14 -48.38 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.628 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 58' ' ' VAL . . . 81.69 1.83 90.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -59.95 -48.88 79.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.555 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -75.62 142.54 42.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.484 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.81 2.15 40.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 66' ' ' GLY . 20.3 tt -57.95 -19.63 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 59.3 p30 -61.06 70.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.344 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 64' ' ' ILE . . . 90.21 -9.9 75.93 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 55.34 13.55 0.92 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.623 0.249 . . . . 0.0 110.677 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -140.51 129.72 23.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.691 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -134.35 128.45 33.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.277 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -130.22 128.01 40.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -136.5 131.01 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.211 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -147.83 159.69 43.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.943 0.402 . . . . 0.0 110.812 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.05 143.37 30.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.524 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t -147.21 147.78 30.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.982 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.15 156.08 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.338 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.41 171.54 43.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 154.84 57.06 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.206 2.604 . . . . 0.0 112.314 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.409 ' CG1' ' OG ' ' A' ' 86' ' ' SER . 97.7 t -122.28 127.59 75.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -107.16 122.6 46.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.442 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 8.3 tmm_? -89.56 129.13 36.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.35 -51.6 11.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.484 -0.486 . . . . 0.0 109.774 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 84' ' ' TYR . 57.8 t30 -154.67 38.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.549 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.442 ' H ' ' CG ' ' A' ' 80' ' ' ARG . 4.3 tm-20 72.57 -49.58 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.053 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.42 ' H ' ' C ' ' A' ' 82' ' ' ASN . 82.9 m-85 -71.04 -29.7 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.399 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.2 t -127.44 132.43 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.696 0.284 . . . . 0.0 110.974 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.409 ' OG ' ' CG1' ' A' ' 78' ' ' VAL . 45.0 t -138.51 135.24 34.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.281 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -108.73 130.23 55.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.067 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CZ ' ' C ' ' A' ' 120' ' ' GLY . 52.2 p90 -139.5 158.1 44.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.451 . . . . 0.0 111.155 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.09 151.39 16.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp -111.03 129.32 55.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.44 . . . . 0.0 110.897 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.01 125.93 22.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.587 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.29 -154.39 13.03 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.386 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.15 38.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.787 0.327 . . . . 0.0 110.696 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.66 147.86 16.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -129.7 122.4 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.35 140.97 16.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -134.88 129.83 35.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.52 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.92 136.57 53.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.355 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -132.49 131.55 41.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.407 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -95.12 122.91 38.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.3 t -86.96 117.09 25.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.118 0.485 . . . . 0.0 111.279 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.4 p -163.25 166.59 23.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.951 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.1 mt -106.99 112.61 40.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.168 0.508 . . . . 0.0 110.788 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -147.13 162.35 39.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.172 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.3 95.51 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -112.3 158.3 19.93 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.7 p -109.34 157.74 18.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 110.902 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -129.58 151.27 50.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.705 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 96.0 p -153.56 162.41 41.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.29 150.56 52.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.804 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.1 t -138.06 136.92 37.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.332 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.03 151.81 51.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.972 0.415 . . . . 0.0 111.236 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.5 t -132.4 149.01 52.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.629 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -150.64 158.38 44.08 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.363 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.0 127.58 47.43 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.17 114.55 27.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.109 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -145.59 130.71 18.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.846 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -177.24 -169.95 39.03 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.634 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.26 158.46 36.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.404 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -152.26 159.12 28.2 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.89 148.12 43.88 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.674 0.273 . . . . 0.0 110.628 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.523 ' OE1' ' NH1' ' A' ' 34' ' ' ARG . 63.3 tt0 -119.81 132.55 55.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -126.45 147.48 49.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -128.48 82.03 69.42 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.47 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.51 -41.27 74.75 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.497 2.131 . . . . 0.0 112.171 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.38 153.64 71.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.148 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.12 -38.0 80.27 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.945 1.764 . . . . 0.0 113.082 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -90.98 6.13 45.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -142.73 130.99 22.07 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.15 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.3 138.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -131.03 141.98 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.949 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -145.67 160.19 42.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.12 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -149.52 149.93 31.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.741 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.7 p -155.8 163.49 39.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 110.726 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -140.72 151.08 44.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.175 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 147' ' ' THR . 14.6 tm-20 -143.54 138.07 28.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.857 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -144.81 160.03 41.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.638 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.6 t -125.24 143.06 51.13 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.563 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -105.66 104.67 14.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.907 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.55 147.29 43.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -59.92 -43.92 94.61 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.966 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 143' ' ' VAL . 54.5 p-10 -104.55 -29.59 10.56 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 81.9 t -105.24 124.13 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -107.84 122.57 47.06 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.6 129.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.916 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.1 139.29 10.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 136' ' ' GLU . 88.2 m -131.25 133.16 45.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.623 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.547 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.438 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 24.7 ptp -139.18 149.74 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.063 0.458 . . . . 0.0 111.344 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.35 155.25 44.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.022 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.91 -174.79 42.76 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.85 160.21 42.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.66 -168.7 19.08 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.34 145.99 50.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.417 ' O ' ' OXT' ' A' ' 156' ' ' PHE . 60.1 ttp180 -95.77 125.44 40.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.596 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' A' ' 156' ' ' PHE . 81.6 t80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.569 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.401 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 25.7 tp10 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.401 ' H ' ' H3 ' ' A' ' 1' ' ' GLU . . . -178.76 -176.86 46.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.426 ' OE1' ' OE1' ' A' ' 36' ' ' GLU . 99.8 mt-10 -70.69 146.34 49.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 0.0 110.484 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 t -148.43 147.46 29.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t -137.68 140.35 40.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.681 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.1 mt -118.12 128.42 75.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -129.34 150.61 50.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -136.92 145.44 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.61 167.56 34.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.494 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -87.24 146.53 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.05 126.19 55.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.728 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' N ' ' OE1' ' A' ' 12' ' ' GLN . 25.2 mp0 -125.79 121.3 32.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.842 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -118.54 168.1 11.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -143.74 147.66 34.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.876 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.71 138.65 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -74.36 133.99 42.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 18' ' ' ASP . 21.0 tp10 -146.09 166.24 26.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.086 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 98.4 m-20 -59.74 -40.38 87.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.1 1.77 0.02 OUTLIER Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.18 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 21' ' ' LYS . 96.2 m-85 -73.48 146.25 45.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.615 ' HZ3' ' NH1' ' A' ' 52' ' ' ARG . 97.9 mttt 56.97 125.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.078 0.466 . . . . 0.0 111.412 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.6 tp -62.14 -48.24 80.98 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.644 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.79 -13.16 21.51 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.623 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mttp 50.37 22.54 1.03 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.268 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -104.62 114.1 64.34 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.93 158.89 24.25 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.87 1.713 . . . . 0.0 111.288 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -100.05 148.8 24.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.624 0.25 . . . . 0.0 110.656 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.37 -175.73 38.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -125.41 148.18 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -126.04 120.56 30.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.813 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.66 141.17 37.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.68 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' NZ ' ' OG ' ' A' ' 46' ' ' SER . 6.0 tppt? -137.25 131.58 32.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.707 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -126.77 142.08 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.96 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -125.56 130.45 51.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -128.73 143.65 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.761 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' OE1' ' OE1' ' A' ' 3' ' ' GLU . 99.5 mt-10 -105.27 116.59 32.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.59 -48.8 80.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.041 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -130.72 -64.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.373 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -168.92 -78.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.711 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.73 -39.71 92.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -100.39 146.69 26.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.252 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.47 178.21 38.33 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.82 158.49 42.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -139.46 135.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.724 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.98 142.65 17.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.516 ' OG ' ' NZ ' ' A' ' 32' ' ' LYS . 60.8 m -126.43 142.09 51.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.04 0.448 . . . . 0.0 111.146 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -130.18 142.1 50.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.685 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.09 143.44 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -147.58 130.17 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.222 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.2 p -129.49 159.36 36.54 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.639 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -145.12 140.99 28.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' NH1' ' HZ3' ' A' ' 21' ' ' LYS . 17.4 mmm180 -63.88 135.9 56.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.04 -173.39 42.24 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -112.1 149.05 32.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.775 0.322 . . . . 0.0 110.324 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 59.0 mp0 -139.6 158.48 44.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.919 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -64.95 154.47 37.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.083 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.3 m -77.76 143.94 37.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 110.769 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.29 161.56 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.434 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -58.31 146.99 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.297 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.02 -5.9 76.03 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.2 t80 55.97 106.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 0.0 111.007 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -129.98 -123.94 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.325 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 83.2 mt 55.14 66.54 1.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.82 -45.43 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.135 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 44.07 -113.16 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.657 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.7 -7.92 79.03 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.8 t0 53.02 51.22 16.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.745 0.307 . . . . 0.0 110.861 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -73.47 144.99 46.02 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -112.45 139.35 48.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -127.84 128.34 45.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.66 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -136.28 129.82 32.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.903 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -137.68 141.63 41.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 111.308 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.98 130.87 71.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 t -149.46 149.96 31.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.092 0.472 . . . . 0.0 111.427 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.92 156.52 33.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.378 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.15 170.03 39.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.456 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.69 149.45 54.83 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.207 2.605 . . . . 0.0 112.893 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.6 t -126.48 129.24 71.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.358 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.53 127.35 43.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.352 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -72.53 135.06 45.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.2 mm -86.37 -50.92 13.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.049 0.452 . . . . 0.0 110.228 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 84' ' ' TYR . 6.1 m-20 173.84 165.11 0.19 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.124 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 45.2 -92.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.513 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ASN . 21.5 p90 -144.31 37.71 1.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.392 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -119.64 126.0 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 t -128.97 137.11 51.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.207 0.527 . . . . 0.0 111.175 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.28 123.81 50.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.2 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.42 158.9 43.2 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.147 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -124.6 150.88 17.17 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.18 125.08 53.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.9 mt -122.67 139.64 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.641 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 169.29 -159.18 32.02 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.665 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.83 153.21 39.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.95 0.405 . . . . 0.0 110.701 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.6 141.35 15.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.22 144.13 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.726 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -120.99 147.37 17.55 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -127.1 140.61 52.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.977 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.29 143.85 31.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.019 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -134.17 149.44 51.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.984 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.32 138.87 49.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.949 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.0 p -87.31 114.4 23.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.024 0.44 . . . . 0.0 110.611 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.9 t -163.28 149.74 12.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.055 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.461 ' O ' ' CG2' ' A' ' 103' ' ' ILE . 20.3 tt -100.36 111.86 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.103 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -149.26 160.01 43.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.207 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.65 -39.97 95.85 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -105.17 165.91 10.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.2 p -108.74 156.13 19.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.91 0.386 . . . . 0.0 110.729 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -137.0 139.06 41.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.338 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.2 p -149.92 163.27 38.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.275 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -126.87 133.55 50.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.511 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.6 t -138.44 145.07 40.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.22 152.07 46.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.636 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.3 p -123.29 149.99 44.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.46 ' HG ' ' HG ' ' A' ' 138' ' ' SER . 96.5 p -156.14 167.58 29.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.546 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mp -99.37 143.6 29.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.04 137.33 53.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.434 . . . . 0.0 111.083 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.23 159.61 43.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.681 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.85 -170.25 43.37 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.06 153.19 34.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.412 . . . . 0.0 110.139 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -149.78 156.5 26.79 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.704 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.96 141.85 48.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.467 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -121.12 126.33 49.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.585 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -127.03 140.04 52.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.232 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -130.25 78.65 74.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.593 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.27 -25.79 11.11 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.141 1.894 . . . . 0.0 111.642 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.1 m-70 -127.33 119.22 21.85 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.899 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 -36.69 45.87 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.772 1.648 . . . . 0.0 113.108 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -82.16 -11.9 58.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' HIS . 89.6 t80 -143.62 129.61 19.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.245 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.12 153.15 38.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.48 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -119.15 136.91 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.602 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -128.52 114.91 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.975 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.842 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -156.89 164.53 37.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.189 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.58 152.65 40.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 149' ' ' MET . 49.9 mp0 -143.59 154.05 43.17 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.709 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.15 144.14 51.1 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.46 ' HG ' ' HG ' ' A' ' 114' ' ' SER . 46.0 t -138.19 124.47 20.47 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -109.97 140.06 44.4 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 143' ' ' VAL . 11.4 tp -110.34 156.52 20.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -49.42 -44.83 45.62 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.597 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -105.97 -33.25 7.98 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 140' ' ' LEU . 58.6 t -106.42 135.38 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -102.47 134.5 45.7 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 91.6 t -129.24 133.14 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.954 0.406 . . . . 0.0 112.08 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.79 144.57 15.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.3 p -129.61 148.26 51.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.323 0.582 . . . . 0.0 112.01 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -141.07 137.96 33.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.819 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -139.09 146.36 40.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.578 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.24 132.32 23.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.915 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -170.69 -177.39 40.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.831 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.9 157.45 43.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.4 -165.03 10.14 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.43 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -149.13 157.22 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.758 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -78.6 147.11 33.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.129 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.571 179.645 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.59 179.02 48.39 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.5 pm0 -72.21 161.53 30.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 0.0 110.986 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p -149.88 163.95 36.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.209 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.3 p -119.69 154.62 33.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.2 mt -119.59 125.35 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.542 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -136.54 150.81 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -131.63 147.01 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.229 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.06 -179.34 30.16 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -109.28 142.24 40.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.684 0.278 . . . . 0.0 110.292 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.32 128.19 55.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -124.93 120.29 31.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.165 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.408 ' OG ' ' CG1' ' A' ' 145' ' ' VAL . 39.3 t -99.84 106.76 18.65 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.424 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 121.03 16.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.34 125.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.081 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -61.46 125.76 24.94 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.414 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.72 -175.22 4.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.987 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -148.34 111.72 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.325 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.51 -6.79 80.42 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.063 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.459 ' CB ' ' HZ2' ' A' ' 24' ' ' LYS . 91.3 m-85 -91.07 127.69 36.59 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.822 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 20' ' ' TYR . 64.2 mttp 41.37 -166.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.757 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.87 -55.55 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.292 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 25' ' ' ASN . 67.2 m-20 -112.12 -13.55 13.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.012 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.459 ' HZ2' ' CB ' ' A' ' 20' ' ' TYR . 0.9 OUTLIER 60.47 36.94 20.05 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.347 0.594 . . . . 0.0 110.666 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 23' ' ' ASP . 2.3 m-20 -102.19 136.23 19.48 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.482 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -81.25 160.6 20.24 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.805 2.337 . . . . 0.0 111.147 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -93.49 134.27 35.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.474 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.23 36.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -126.8 149.07 49.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.752 0.31 . . . . 0.0 110.75 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 47' ' ' PHE . 50.4 t30 -124.63 120.65 32.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.647 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.52 140.55 31.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.498 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 87.6 tttt -136.68 133.18 35.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.048 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.13 146.37 51.08 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.419 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.688 HH21 HE22 ' A' ' 122' ' ' GLN . 42.1 ttm180 -111.05 132.78 53.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -125.37 142.91 51.23 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.396 0.435 . . . . 0.0 110.094 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -82.67 129.16 34.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.455 ' O ' ' O ' ' A' ' 41' ' ' TRP . 93.0 t80 -150.31 130.46 13.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.781 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 37' ' ' PHE . 54.6 t30 46.9 -174.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.127 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 38' ' ' ASN . 32.0 m120 -111.29 -32.52 6.72 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.112 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.69 -43.04 94.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.038 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.455 ' O ' ' O ' ' A' ' 37' ' ' PHE . 29.0 p90 -149.76 157.2 42.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.44 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.57 -171.48 20.49 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.51 149.45 31.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.176 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.48 155.04 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.343 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.08 134.55 7.9 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.0 m -130.22 146.17 51.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 94.9 m-85 -129.13 145.39 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.465 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.77 138.69 37.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -145.15 127.93 16.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.04 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.6 p -129.88 159.45 36.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.358 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.617 ' CZ ' ' HZ3' ' A' ' 69' ' ' LYS . 80.0 ttt180 -151.78 136.36 16.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.583 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -71.65 140.26 49.62 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.117 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.54 140.17 15.62 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -112.57 150.79 30.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.904 0.383 . . . . 0.0 110.598 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -148.49 141.21 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.097 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.01 115.71 4.66 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.156 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 m -149.73 171.78 16.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.571 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.18 153.38 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.999 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 41.5 -158.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.213 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.07 2.9 90.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 56.13 45.41 23.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.773 0.321 . . . . 0.0 110.53 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -69.64 149.33 48.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.412 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 65' ' ' ASP . 88.8 mt -97.17 148.69 22.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.669 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 66' ' ' GLY . 45.9 pt -64.44 -3.1 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.001 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 63' ' ' LEU . 57.0 m-20 61.06 -70.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.613 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 64' ' ' ILE . . . 92.48 -7.74 77.55 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 52.75 49.77 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.846 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -72.06 146.34 47.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.322 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.617 ' HZ3' ' CZ ' ' A' ' 51' ' ' ARG . 73.2 mmtt -101.02 135.93 41.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.09 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -124.67 133.85 53.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' A' ' 95' ' ' HIS . 87.5 t80 -143.39 131.3 21.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.266 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -142.0 141.82 32.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.467 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.2 t -117.82 125.03 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -129.44 149.64 51.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.99 158.96 12.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.13 166.43 34.0 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.5 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 155.11 46.16 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.027 2.485 . . . . 0.0 112.386 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.8 123.76 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.295 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.57 118.16 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.523 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -84.76 136.46 33.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.12 -51.16 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.763 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 84' ' ' TYR . 60.4 t30 -161.74 41.84 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 67.28 -37.62 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.556 ' H ' ' C ' ' A' ' 82' ' ' ASN . 78.5 m-85 -66.99 -38.01 85.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.57 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -144.22 146.88 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.4 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -139.1 150.2 45.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.639 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.8 mt -98.78 139.79 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.474 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.88 141.62 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.419 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.74 138.84 14.35 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.6 mt -112.03 117.91 33.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.74 133.05 39.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.666 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.57 -161.02 34.53 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.444 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 114' ' ' SER . . . -146.53 150.75 36.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.724 0.297 . . . . 0.0 110.452 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.25 142.96 16.12 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.414 ' O ' ' O ' ' A' ' 71' ' ' TYR . 78.7 m80 -135.15 148.81 49.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.12 152.87 20.93 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.456 ' HZ2' ' CB ' ' A' ' 111' ' ' SER . 73.5 mmtt -131.54 145.62 51.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.57 136.33 27.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.285 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -132.71 148.77 52.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.78 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -108.73 138.58 44.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.11 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.8 m -89.34 114.06 25.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.802 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.9 m -163.36 161.02 24.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.874 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.5 mt -103.17 112.47 36.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.788 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -149.85 157.39 43.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.227 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.97 96.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -104.92 165.96 10.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.4 p -108.85 159.18 16.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 0.0 110.823 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -134.31 138.51 45.02 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.476 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.0 p -153.47 162.58 41.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.29 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -131.2 151.63 51.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.707 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.456 ' CB ' ' HZ2' ' A' ' 97' ' ' LYS . 47.9 t -144.48 142.75 30.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.597 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -129.5 152.53 48.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.3 p -123.96 150.37 44.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.559 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 93' ' ' ALA . 92.8 p -151.14 162.35 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.8 tp -100.2 125.84 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.396 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 123.05 45.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.6 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -143.3 131.59 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.109 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.35 -170.18 34.37 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.594 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.61 158.72 42.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 0.0 110.533 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.17 173.74 36.04 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.422 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 0.9 OUTLIER -135.75 170.02 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 0.0 110.501 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.688 HE22 HH21 ' A' ' 34' ' ' ARG . 52.4 tt0 -139.54 136.3 34.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -129.75 130.64 45.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.446 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 31.5 t-20 -106.66 99.28 24.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.231 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.38 -31.89 5.39 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.658 1.572 . . . . 0.0 111.439 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.3 m-70 -138.59 148.95 60.8 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.774 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.92 -25.97 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.998 1.799 . . . . 0.0 112.357 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -82.8 -25.58 32.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.647 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 126' ' ' HIS . 94.5 m-85 -132.91 144.28 50.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.298 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.52 153.0 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.285 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.6 pt -128.55 147.09 33.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.682 0.277 . . . . 0.0 110.422 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.527 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 61.0 t0 -146.71 133.62 20.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.474 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -124.05 124.72 43.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.68 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 66.4 m -133.97 152.35 51.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.316 . . . . 0.0 111.164 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.08 139.72 53.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.055 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -125.31 150.35 47.22 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.646 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -131.41 127.18 36.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.6 m -125.14 131.05 53.31 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -109.78 96.26 6.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.925 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.494 ' CB ' ' O ' ' A' ' 143' ' ' VAL . 2.8 tp -68.79 157.16 36.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -56.05 -43.94 78.36 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.075 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -106.1 -33.86 7.73 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.995 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 140' ' ' LEU . 87.9 t -106.79 149.73 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -105.96 124.09 49.02 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.408 ' CG1' ' OG ' ' A' ' 13' ' ' SER . 84.6 t -128.03 129.12 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.029 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.01 132.28 8.82 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 96.5 m -113.16 123.53 50.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.046 0.451 . . . . 0.0 111.285 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -95.72 135.49 37.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 149' ' ' MET . 1.8 tmt? -119.43 117.83 29.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.785 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -137.07 127.29 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.784 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -169.6 177.85 42.92 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.168 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.49 159.79 44.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.66 -160.91 14.59 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.38 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.04 160.11 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 0.0 110.673 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -80.41 128.77 33.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.516 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 73.3 t80 . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.581 179.908 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.46 178.9 53.7 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -70.56 141.22 51.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.925 0.393 . . . . 0.0 110.53 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -150.35 162.43 40.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.491 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.492 ' HG ' HH21 ' A' ' 34' ' ' ARG . 63.8 m -124.85 148.61 48.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.53 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -116.89 129.75 72.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.9 t -124.59 140.03 53.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.5 tt -126.91 145.57 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.136 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.12 -173.82 37.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.445 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -106.09 142.42 35.81 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.03 127.92 54.28 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -129.24 134.95 48.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.796 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.465 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 41.4 t -117.33 120.35 37.93 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.571 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.668 HH21 ' NZ ' ' A' ' 16' ' ' LYS . 61.2 ttt85 -67.53 120.1 13.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.361 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -133.25 131.52 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.668 ' NZ ' HH21 ' A' ' 14' ' ' ARG . 73.5 mmtt -84.72 132.64 34.43 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -133.94 144.42 48.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.009 0.433 . . . . 0.0 111.364 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.71 -38.6 91.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.659 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.45 -136.88 0.71 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -65.66 139.62 58.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.377 . . . . 0.0 110.107 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -155.06 37.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.429 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.75 -42.42 99.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.857 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 25' ' ' ASN . 97.4 m-20 -110.79 -15.45 13.81 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.586 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.0 mttp 48.7 12.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.181 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 23' ' ' ASP . 67.9 m-20 -102.91 111.02 64.66 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 13' ' ' SER . 93.4 Cg_endo -83.7 161.01 14.35 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.176 2.584 . . . . 0.0 111.093 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -92.12 132.09 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.3 169.65 33.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.56 138.86 49.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.582 ' ND2' ' SD ' ' A' ' 149' ' ' MET . 29.5 t-20 -115.09 119.52 36.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.407 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.47 129.18 51.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.56 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -132.56 147.16 52.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.87 145.05 51.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.201 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.676 HH11 HE22 ' A' ' 122' ' ' GLN . 61.5 ttp180 -124.96 132.67 53.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.15 142.91 51.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.0 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -128.97 145.48 51.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.032 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -113.53 31.18 6.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.317 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 56.37 41.11 29.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.493 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -148.42 -179.85 7.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.336 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -81.47 1.64 32.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.424 ' CH2' ' CG2' ' A' ' 43' ' ' VAL . 92.2 t90 -122.66 123.39 41.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.184 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.7 175.46 19.04 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.424 ' CG2' ' CH2' ' A' ' 41' ' ' TRP . 92.5 t -124.42 128.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.16 157.28 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.068 0.461 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.19 159.32 27.67 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -136.69 131.01 32.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.059 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.69 123.66 43.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.837 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.01 152.99 41.01 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.121 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -148.89 144.35 26.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.653 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.4 p -132.3 160.92 34.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -154.74 148.59 25.58 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.785 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' CZ ' ' O ' ' A' ' 65' ' ' ASP . 89.2 mtm180 -83.57 149.84 26.32 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.78 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.25 166.17 53.84 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -110.52 122.82 48.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 110.956 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -133.84 148.2 51.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.304 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -81.73 126.65 32.07 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.462 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -150.76 146.48 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' ASP . 9.2 p -129.97 122.42 54.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.582 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 58' ' ' VAL . 99.3 m-20 45.38 -177.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.076 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 62' ' ' LYS . . . 80.35 -1.45 81.31 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 42.73 25.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.74 0.305 . . . . 0.0 110.471 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 60' ' ' GLY . 58.0 tptt -60.8 -45.98 92.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.625 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.9 mt -118.21 138.77 52.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 pt -99.59 -29.34 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.796 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.47 ' O ' ' CZ ' ' A' ' 52' ' ' ARG . 98.5 m-20 37.63 -107.27 0.05 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.039 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.49 -20.97 44.54 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.64 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 46.97 51.45 12.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.964 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -112.16 144.23 41.89 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.803 0.335 . . . . 0.0 110.58 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.9 146.29 25.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -119.44 127.39 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 95' ' ' HIS . 98.5 m-85 -127.95 144.21 51.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.274 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -152.46 140.07 19.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.568 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.87 143.97 39.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.022 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.7 p -144.2 163.12 34.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.44 155.1 29.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.441 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.54 164.04 34.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.489 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.13 158.9 37.61 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.258 2.639 . . . . 0.0 112.291 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.7 p -135.7 135.35 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.8 t80 -128.15 129.72 46.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.708 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.531 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 36.4 mmt180 -67.61 136.58 54.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 75.5 mt -87.86 -51.86 12.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.052 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 2.7 m-20 162.9 -73.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.71 64.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.459 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 47.07 33.62 2.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -133.09 152.71 36.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 t -139.48 144.11 37.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 111.449 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 tp -111.11 129.84 55.8 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CZ ' ' C ' ' A' ' 120' ' ' GLY . 53.7 p90 -143.22 158.4 43.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.738 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -107.13 147.35 16.23 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.8 tp -128.38 119.97 26.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.33 160.91 38.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.836 0.351 . . . . 0.0 111.173 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.35 -143.96 8.89 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.63 150.79 36.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 110.937 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.61 140.6 16.44 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 71' ' ' TYR . 31.1 p80 -147.0 162.03 39.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.36 158.37 18.88 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -124.68 143.83 50.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.228 0.537 . . . . 0.0 110.616 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.05 146.57 32.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.817 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -132.59 129.13 38.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.703 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -102.15 128.96 48.42 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.4 p -85.91 114.97 23.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.15 0.5 . . . . 0.0 111.156 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -163.17 168.39 20.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.892 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.67 113.65 44.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.013 0.435 . . . . 0.0 110.872 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -145.76 162.38 37.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.768 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.92 -9.32 62.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -136.97 171.11 15.0 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t -108.73 136.54 48.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.835 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -125.3 138.21 54.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.382 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.9 p -148.79 164.23 35.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.238 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -127.76 151.41 49.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.85 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 90.7 p -149.9 163.92 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.719 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -122.61 158.0 30.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.355 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.8 t -131.78 145.56 51.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.45 ' OG ' ' OG ' ' A' ' 138' ' ' SER . 33.5 t -160.2 158.21 29.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.7 mt -99.28 141.09 32.5 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.47 140.05 48.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.964 0.411 . . . . 0.0 111.164 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -150.93 159.1 44.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.205 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 165.84 -158.72 31.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.488 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.59 160.17 40.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.739 0.304 . . . . 0.0 110.502 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -144.43 156.05 26.62 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.29 146.06 44.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.516 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.676 HE22 HH11 ' A' ' 34' ' ' ARG . 63.6 tt0 -117.62 128.56 55.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.697 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -118.7 137.53 53.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.414 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -129.51 81.03 70.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.71 -27.23 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.762 1.641 . . . . 0.0 111.667 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -136.48 149.24 66.89 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.733 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.98 -22.97 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.068 1.845 . . . . 0.0 112.776 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.18 6.0 44.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.678 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -150.08 128.24 11.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.468 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.4 t -122.88 132.03 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.0 mt -115.16 126.02 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.087 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -146.61 160.44 42.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.72 138.59 17.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.429 ' OG ' ' OH ' ' A' ' 88' ' ' TYR . 62.2 m -135.94 151.83 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.776 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -142.13 148.52 38.45 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.015 0.436 . . . . 0.0 110.867 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -143.79 159.09 43.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.378 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -119.8 139.2 52.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.805 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.45 ' OG ' ' OG ' ' A' ' 114' ' ' SER . 37.2 t -139.1 133.37 31.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.13 140.41 44.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 143' ' ' VAL . 0.5 OUTLIER -117.96 156.2 28.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.443 ' H ' ' CD2' ' A' ' 140' ' ' LEU . 98.4 m-20 -58.0 -43.48 86.68 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.545 -177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.97 -33.45 7.92 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.97 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 140' ' ' LEU . 84.6 t -106.57 148.79 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -104.71 136.93 43.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.57 131.53 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.317 0.579 . . . . 0.0 112.38 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.16 157.15 15.76 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 91.2 m -123.92 129.42 50.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.196 0.498 . . . . 0.0 111.606 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -129.53 119.94 24.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.582 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 79.0 mtm -132.07 134.48 45.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.38 142.12 30.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.96 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.33 -175.07 47.13 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.094 -1.051 . . . . 0.0 111.895 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.45 157.94 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.398 . . . . 0.0 109.938 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.52 -177.31 21.04 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.358 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -148.15 158.92 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.496 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -75.96 138.55 41.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.6 t80 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.577 179.741 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.96 -179.64 52.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -70.13 142.09 52.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 110.249 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t -150.11 151.34 33.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.7 p -143.73 159.67 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.2 mt -118.24 130.93 72.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.671 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.4 t -134.5 140.73 46.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.706 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.39 148.76 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.376 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.56 -174.62 35.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -104.33 142.58 34.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.65 131.36 55.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.236 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -126.79 124.67 40.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.478 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.562 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 69.9 m -117.75 107.41 14.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -66.82 133.34 49.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -111.33 125.52 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -97.01 124.92 41.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.744 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -153.11 159.01 42.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.315 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -58.68 -43.91 90.09 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.41 144.63 36.1 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -91.65 140.9 29.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.889 0.376 . . . . 0.0 111.25 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -113.61 152.61 30.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.291 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 22' ' ' LEU . 10.4 mp -60.69 -48.9 79.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.634 ' C ' ' H ' ' A' ' 25' ' ' ASN . 97.0 m-20 -113.33 -14.7 12.78 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 55.63 -3.85 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.765 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -104.81 112.2 65.27 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.57 ' N ' HD21 ' A' ' 25' ' ' ASN . 97.6 Cg_endo -83.04 159.1 15.57 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.673 ' NH2' ' HE ' ' A' ' 51' ' ' ARG . 51.2 ptt85 -93.19 142.61 27.11 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.44 169.77 35.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -109.47 142.14 40.92 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.712 0.292 . . . . 0.0 110.575 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.473 ' OD1' ' SD ' ' A' ' 149' ' ' MET . 43.5 t30 -125.89 119.02 26.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.752 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.1 137.28 53.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -134.8 146.13 49.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.16 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.685 HH12 ' HH ' ' A' ' 88' ' ' TYR . 61.0 ttt85 -107.57 127.48 53.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -137.77 126.77 24.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.079 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.507 ' OE2' ' NH2' ' A' ' 34' ' ' ARG . 99.4 mt-10 -119.11 117.71 29.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.969 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -60.81 -48.81 80.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.976 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -155.53 61.72 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.152 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.6 m120 52.66 -138.76 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.6 t0 38.68 -106.51 0.05 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.963 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.578 ' HE1' ' CB ' ' A' ' 77' ' ' PRO . 58.7 t90 -100.0 123.39 44.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.098 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' H ' HG12 ' A' ' 78' ' ' VAL . . . -120.03 -166.71 13.31 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.48 157.64 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -137.94 134.3 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.442 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.8 132.96 11.32 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.7 m -128.68 139.93 51.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.08 142.11 49.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.744 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.67 139.33 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -142.41 126.74 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.274 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 p -128.78 159.24 36.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.419 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.673 ' HE ' ' NH2' ' A' ' 27' ' ' ARG . 41.2 ptt180 -157.57 161.18 38.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.355 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.557 HH21 ' CB ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.06 129.34 38.28 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.518 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.38 -178.25 41.4 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -112.47 147.88 35.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.674 0.273 . . . . 0.0 110.354 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -159.29 157.93 31.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -71.62 130.15 40.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.234 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -149.85 143.8 25.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.717 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 59' ' ' ASP . 10.3 p -130.54 137.29 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.439 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 60' ' ' GLY . 30.1 t0 42.65 -167.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.504 ' H ' ' CG ' ' A' ' 59' ' ' ASP . . . 88.82 -6.94 83.19 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 55.8 24.59 7.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 0.0 110.632 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -75.0 145.36 42.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.458 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.11 112.61 5.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.997 0.427 . . . . 0.0 111.006 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.8 pt -113.91 3.38 8.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.309 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 66' ' ' GLY . 27.2 t0 -65.5 -162.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.945 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.534 ' H ' ' CG ' ' A' ' 65' ' ' ASP . . . 100.76 -15.93 57.96 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.7 t0 49.04 52.93 13.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.94 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -72.53 143.52 48.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.047 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -118.02 142.05 47.8 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -126.34 125.53 42.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.345 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -130.03 128.73 42.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.19 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -140.05 140.05 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.062 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.4 t -124.06 128.88 74.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.043 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -148.34 155.38 41.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.214 0.53 . . . . 0.0 111.166 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.75 158.33 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.182 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.22 153.58 25.15 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.603 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.578 ' CB ' ' HE1' ' A' ' 41' ' ' TRP . 93.0 Cg_endo -77.66 159.03 31.94 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.74 2.293 . . . . 0.0 111.475 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 42' ' ' GLY . 7.9 p -131.61 119.25 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.455 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE1' ' CD1' ' A' ' 41' ' ' TRP . 96.5 m-85 -119.66 120.12 35.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.914 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -80.54 128.44 33.59 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.157 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.5 mt -89.8 -52.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.808 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 84' ' ' TYR . 32.7 m120 -122.09 16.98 10.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.823 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 82' ' ' ASN . 16.9 tt0 76.17 -21.03 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.535 ' H ' ' C ' ' A' ' 82' ' ' ASN . 96.9 m-85 -104.17 -20.89 13.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.81 145.63 33.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.4 t -141.14 152.25 44.56 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.321 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.1 mt -102.48 138.8 38.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.391 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.685 ' HH ' HH12 ' A' ' 34' ' ' ARG . 48.9 m-85 -121.48 140.02 52.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.592 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.83 137.66 14.4 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.41 118.79 37.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.499 0.649 . . . . 0.0 111.877 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.7 tp -136.9 122.94 20.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.354 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -167.8 39.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.27 151.56 38.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 110.701 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.64 146.5 16.08 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -130.95 143.89 51.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.727 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -116.19 143.44 18.07 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -130.44 126.76 37.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.857 0.36 . . . . 0.0 110.57 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.97 124.53 26.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.101 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.37 133.98 43.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.603 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -99.5 133.65 43.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.199 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.4 p -87.71 115.68 25.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.958 0.408 . . . . 0.0 110.719 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.6 p -162.82 166.37 24.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.184 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 103' ' ' ILE . 85.8 mt -108.47 113.45 44.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.81 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -146.7 165.15 30.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.354 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.48 -20.03 58.49 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -139.64 161.84 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -109.69 147.98 32.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.867 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 47.4 mp0 -127.01 149.4 49.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.494 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 96.9 p -154.7 163.7 39.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.367 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -127.35 134.39 49.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.588 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.8 t -135.78 136.69 40.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.555 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -130.57 151.3 51.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.397 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.3 p -125.45 150.82 46.98 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.019 0.438 . . . . 0.0 111.147 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.1 p -152.6 163.75 39.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.39 145.24 28.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.629 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.24 52.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.726 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -151.31 160.82 43.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.296 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 169.29 -160.77 34.2 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.878 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.78 158.54 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -157.66 174.97 35.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.24 165.81 27.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.917 0.389 . . . . 0.0 110.831 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.637 HE21 ' CG1' ' A' ' 130' ' ' VAL . 65.4 tt0 -135.11 135.34 41.11 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.207 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -127.66 126.95 42.92 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.009 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -125.24 85.64 57.99 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.59 -29.75 10.51 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.7 1.6 . . . . 0.0 111.652 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.64 123.58 21.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.762 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.15 -29.29 22.02 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.581 1.521 . . . . 0.0 112.522 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -82.06 -8.71 59.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.739 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -139.29 123.34 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.418 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.637 ' CG1' HE21 ' A' ' 122' ' ' GLN . 72.8 t -127.89 134.01 66.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.831 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.04 148.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.502 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -146.29 158.96 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.19 21.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.024 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.8 p -158.17 162.6 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.528 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -144.07 148.29 34.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -145.92 160.4 41.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.568 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -119.02 139.32 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.45 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.5 t -132.37 125.2 30.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -108.18 119.74 40.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.753 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -84.28 155.9 22.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -51.84 -44.93 63.79 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.093 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -104.71 -32.79 8.71 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.67 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 140' ' ' LEU . 77.6 t -105.94 153.04 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -107.3 135.96 47.93 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.01 130.95 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.0 134.67 11.77 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.49 ' HG1' ' HG ' ' A' ' 13' ' ' SER . 93.9 m -125.0 131.7 53.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.278 0.561 . . . . 0.0 112.356 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -127.95 125.42 39.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.506 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.473 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 79.3 mtm -117.74 136.63 53.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 111.374 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 tt -136.91 130.17 31.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.58 177.66 41.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.851 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.13 158.94 44.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.45 -171.9 23.2 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -147.38 159.32 43.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 0.0 110.617 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -77.94 128.96 34.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.663 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.7 t80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.671 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.07 -175.48 54.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' OE1' ' CZ ' ' A' ' 37' ' ' PHE . 49.5 mp0 -75.91 138.2 40.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.71 0.29 . . . . 0.0 110.258 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.9 p -150.92 162.27 41.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.605 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 154' ' ' TYR . 47.7 t -147.01 141.39 26.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.594 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 pt -127.56 147.15 32.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -131.82 148.45 52.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.0 mt -121.09 129.44 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.062 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.01 156.53 26.87 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.27 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -83.72 146.02 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.39 120.0 40.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.768 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -118.5 118.46 31.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.848 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.3 m -118.44 167.73 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -125.21 137.57 54.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.7 t -115.39 126.56 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.531 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -93.87 117.86 30.68 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 21' ' ' LYS . 87.9 tt0 -155.93 150.04 25.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.723 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -60.06 -42.41 94.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.055 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.55 149.19 50.4 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -84.49 142.6 29.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.927 0.394 . . . . 0.0 111.038 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 17' ' ' GLU . 64.0 mttp -130.56 150.18 51.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.102 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.46 -52.87 61.81 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.152 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.66 ' C ' ' H ' ' A' ' 25' ' ' ASN . 58.4 p30 -114.11 -14.06 12.39 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.34 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 23.4 ttmt 55.59 -6.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.454 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.66 ' H ' ' C ' ' A' ' 23' ' ' ASP . 53.2 m-20 -106.28 114.59 62.14 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 119.399 -0.334 . . . . 0.0 111.648 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.63 158.96 35.69 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.433 1.422 . . . . 0.0 110.86 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.404 ' O ' ' OG1' ' A' ' 50' ' ' THR . 17.8 ptm180 -91.57 155.02 18.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.764 0.316 . . . . 0.0 110.945 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.3 175.07 43.09 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.92 149.59 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 47' ' ' PHE . 63.3 t30 -134.92 120.49 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -115.66 140.89 48.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.749 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.38 145.24 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.89 144.59 51.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.074 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -123.66 128.79 50.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.441 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 96.2 m-85 -128.91 148.63 50.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.442 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 17.5 tt0 80.99 166.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.409 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CZ ' ' OE1' ' A' ' 3' ' ' GLU . 90.2 m-85 -76.49 141.42 41.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -100.82 16.65 24.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.521 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.14 -41.24 92.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.922 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.07 -38.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.964 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -153.44 141.37 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.735 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.14 178.16 30.36 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.35 139.62 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.382 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.59 153.16 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.86 135.36 9.39 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.9 m -128.32 145.69 50.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.148 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.434 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 98.3 m-85 -124.37 140.49 52.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.513 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.33 137.96 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -150.99 150.34 30.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.783 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 8.9 t -150.27 155.24 39.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -156.02 163.24 39.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -68.29 137.87 55.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.48 -170.58 44.75 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.88 131.32 46.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 0.0 110.373 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -134.04 159.31 41.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.538 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.1 145.74 45.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.2 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.4 m -118.65 149.92 40.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.7 t -118.6 130.82 72.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.108 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -58.85 145.13 42.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.551 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.44 -7.15 78.01 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.09 148.89 51.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.729 0.3 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -108.1 150.36 27.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.471 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.89 141.22 53.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.269 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 pt -113.34 3.67 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.12 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.28 -43.03 96.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.441 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.77 -1.29 79.14 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.9 t0 47.98 50.7 15.52 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.439 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -79.03 147.11 32.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.976 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -124.08 141.65 51.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.3 144.59 51.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.998 0.427 . . . . 0.0 111.149 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -139.98 130.97 26.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.14 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -148.78 147.95 29.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 111.023 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 p -136.41 136.38 48.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.698 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -135.31 157.76 46.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.17 27.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.452 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.3 169.78 42.91 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.773 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.1 155.0 52.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.327 2.685 . . . . 0.0 112.794 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.6 t -126.69 130.51 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.754 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -126.91 125.76 42.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.404 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.69 137.33 54.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.97 -48.61 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.325 0.583 . . . . 0.0 110.139 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 51.4 t30 -134.73 -148.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.754 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.503 ' H ' ' CG ' ' A' ' 82' ' ' ASN . 99.3 mt-10 -88.71 -5.24 58.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -149.23 15.62 0.91 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.8 p -144.36 138.31 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.42 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.0 m -134.62 149.87 50.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.11 0.481 . . . . 0.0 111.847 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 tp -119.52 131.12 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.435 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -142.29 158.79 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.866 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.19 148.54 17.42 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.6 mt -119.16 135.9 54.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.98 146.83 31.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.599 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.86 -145.45 8.46 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.136 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.37 152.24 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.56 147.21 16.61 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -134.79 144.96 47.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.736 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.69 145.86 17.42 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -117.65 137.56 52.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.666 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.91 147.25 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.348 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.56 129.62 39.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.483 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -99.84 124.55 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.4 t -87.06 116.78 25.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.252 0.548 . . . . 0.0 111.331 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.7 t -163.15 151.66 14.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.84 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.2 mt -99.7 112.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.206 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -149.4 160.81 43.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.013 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.64 -40.15 96.07 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -103.85 165.4 11.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 95.3 p -108.93 156.07 20.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 110.673 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 45.6 mp0 -133.32 154.96 50.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.874 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.2 p -149.78 162.38 40.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.156 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -129.33 150.16 50.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.929 0.395 . . . . 0.0 110.871 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.4 t -147.67 146.76 29.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.255 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -126.04 148.93 49.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.74 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.7 m -117.07 130.94 56.98 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.78 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.436 ' OG ' ' OG ' ' A' ' 138' ' ' SER . 43.6 t -148.64 149.84 32.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.638 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mp -99.69 142.91 30.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.614 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.21 132.76 55.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.99 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -145.97 134.13 21.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.138 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.31 -169.68 34.53 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.806 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.66 159.27 44.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.016 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.54 169.31 31.06 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.805 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.421 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.6 OUTLIER -142.44 160.24 40.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.919 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.51 ' NE2' ' OD1' ' A' ' 132' ' ' ASP . 63.7 tt0 -140.34 137.41 34.07 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.616 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.421 ' CE2' ' CD1' ' A' ' 121' ' ' LEU . 69.6 m-85 -115.5 149.01 38.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.683 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -129.89 83.02 65.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.949 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.4 -22.8 24.56 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.72 1.613 . . . . 0.0 111.71 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.724 ' HD1' ' H ' ' A' ' 128' ' ' ASN . 65.7 t-80 -150.14 136.4 10.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.482 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.99 -39.43 50.07 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.921 1.747 . . . . 0.0 113.89 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.724 ' H ' ' HD1' ' A' ' 126' ' ' HIS . 54.7 p30 -84.14 -0.7 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.62 126.67 13.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.394 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 152.69 34.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.451 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.9 mt -114.51 125.85 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NE2' ' A' ' 122' ' ' GLN . 97.8 m-20 -105.73 132.46 51.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.193 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -136.14 127.33 28.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.781 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.8 t -158.03 151.62 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.858 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -139.07 149.16 44.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.683 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -142.46 153.57 43.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.775 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.59 147.26 49.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.163 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.436 ' OG ' ' OG ' ' A' ' 114' ' ' SER . 30.7 t -128.89 127.56 42.06 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -106.85 120.61 42.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.307 0.575 . . . . 0.0 111.942 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -117.97 154.61 31.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.427 ' H ' ' CD2' ' A' ' 140' ' ' LEU . 98.1 m-20 -59.53 -42.63 92.76 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.9 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 66.3 t0 -105.63 -33.98 7.88 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.9 t -106.47 125.58 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -107.68 123.13 48.04 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.93 146.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.144 -0.623 . . . . 0.0 112.223 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.31 152.45 17.74 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 91.2 m -125.28 131.86 53.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 111.558 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -125.94 123.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.897 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 149' ' ' MET . 2.5 mpp? -117.47 129.57 55.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.932 0.396 . . . . 0.0 111.012 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.27 131.78 22.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.982 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -178.56 -169.03 38.74 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.575 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.42 155.86 47.34 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.88 -169.62 14.05 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.789 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.422 ' O ' ' OG ' ' A' ' 5' ' ' SER . 52.0 p90 -148.61 163.09 38.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.123 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -121.79 147.98 45.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.3 t80 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.548 -179.797 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.82 -178.93 48.8 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.61 138.55 48.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.817 0.341 . . . . 0.0 110.462 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.7 p -151.11 163.05 39.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.656 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.6 m -124.45 141.98 51.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.536 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.89 124.3 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -128.88 140.75 51.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.026 0.441 . . . . 0.0 111.311 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 45.8 pt -132.82 156.49 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.746 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.17 -174.18 38.76 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.119 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -113.72 145.91 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.7 140.99 38.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -131.69 138.1 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.696 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.447 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 67.2 m -117.33 109.39 16.77 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.239 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -68.66 129.15 39.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.02 129.43 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.635 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -107.35 118.95 38.06 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -162.24 167.66 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 0.0 110.787 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -84.96 104.58 15.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.59 -156.06 26.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.478 ' O ' ' CD1' ' A' ' 20' ' ' TYR . 54.5 p90 -49.99 129.1 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -164.42 39.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.119 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.61 -49.24 78.31 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.704 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 25' ' ' ASN . 58.4 p30 -113.63 -12.59 12.82 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.502 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 59.5 mtpt 52.39 3.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.06 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 23' ' ' ASP . 49.7 t-20 -103.64 110.27 63.56 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.668 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' CD ' ' O ' ' A' ' 13' ' ' SER . 96.2 Cg_endo -84.73 160.42 12.23 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.766 2.311 . . . . 0.0 111.44 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.81 135.43 39.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.73 169.75 35.15 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.97 143.85 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.426 ' OD1' ' SD ' ' A' ' 149' ' ' MET . 29.5 t-20 -117.61 119.09 33.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -122.92 136.89 55.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.833 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -148.24 155.9 41.91 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -133.07 146.8 52.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.16 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -126.97 131.14 51.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.795 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.91 139.8 52.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -159.72 147.54 17.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -65.88 -42.52 90.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -170.76 99.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 61.9 t-20 41.56 -117.78 0.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.742 0.306 . . . . 0.0 110.256 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 99.1 m-20 43.1 -98.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.346 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' ASN . 41.7 p90 -147.6 162.38 39.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.18 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.06 -167.05 21.92 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.42 143.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.348 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -132.64 137.25 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.08 142.57 16.19 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -126.21 143.93 50.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.932 0.396 . . . . 0.0 111.102 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -130.08 146.01 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.807 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.41 141.55 35.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.03 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -128.79 137.28 51.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.21 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.4 m -128.06 134.9 49.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -146.38 143.99 29.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.874 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.453 HH11 ' C ' ' A' ' 65' ' ' ASP . 79.9 ttt180 -53.48 145.34 14.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.2 -39.66 94.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -69.5 140.79 54.0 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.109 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -67.86 138.94 56.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.812 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.421 ' OE1' ' OD1' ' A' ' 67' ' ' ASP . 24.6 pt-20 -91.19 139.02 31.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.8 p -150.8 159.55 44.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.332 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.7 t -124.48 120.84 60.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.6 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -162.36 92.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.279 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.98 18.8 79.29 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 62.2 39.77 12.35 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.974 0.416 . . . . 0.0 110.51 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -128.15 152.36 48.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.7 mt 59.92 33.14 21.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.4 tt -63.83 -24.62 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 67' ' ' ASP . 68.1 m-20 57.86 36.61 26.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.917 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.91 -41.63 0.45 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 65' ' ' ASP . 54.4 t0 50.55 53.67 12.54 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.442 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -74.43 140.08 44.42 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.468 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -132.22 115.99 16.39 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -134.46 129.29 35.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.279 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.06 160.82 40.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.287 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -147.59 145.02 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.092 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.29 126.96 74.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.121 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -132.85 156.64 46.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.53 154.81 29.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.36 170.66 43.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.477 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.4 154.46 50.81 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.21 2.607 . . . . 0.0 113.041 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.5 t -127.89 130.97 70.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.412 ' O ' ' OG ' ' A' ' 86' ' ' SER . 94.7 m-85 -127.15 146.42 50.4 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.175 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.79 126.77 52.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.6 tt -80.18 -37.42 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.72 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 84' ' ' TYR . 57.4 t30 -156.72 31.72 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.761 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 68.52 -42.66 0.48 Allowed 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.855 0.722 . . . . 0.0 109.812 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.549 ' H ' ' C ' ' A' ' 82' ' ' ASN . 66.5 t80 -63.96 -40.61 96.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.415 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.6 t -126.93 135.61 63.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.402 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 79' ' ' PHE . 42.2 t -129.05 134.77 48.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.02 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.0 tp -110.62 127.96 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.269 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.98 159.33 42.44 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.967 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.52 145.33 16.01 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -120.13 137.16 54.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.622 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.2 152.25 38.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.765 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.14 -147.13 9.76 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.348 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.95 150.57 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 0.0 110.96 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.75 139.76 15.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -145.95 135.03 22.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.15 158.94 27.85 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -130.7 144.48 51.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.771 0.319 . . . . 0.0 110.386 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.58 111.61 8.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.405 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -133.24 131.26 40.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.404 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -149.36 159.28 44.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.202 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.9 t -139.34 120.18 14.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.225 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.7 t -163.76 174.96 10.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.071 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.4 mt -99.25 113.28 33.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.133 0.492 . . . . 0.0 109.765 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -148.66 175.38 11.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.02 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.84 -38.97 93.27 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -147.81 146.66 29.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.719 0.295 . . . . 0.0 110.315 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.3 m -132.62 144.28 50.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -163.68 141.45 7.43 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -128.21 149.15 50.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -168.58 152.95 5.91 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.824 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.5 t -105.78 134.73 48.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.388 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -108.12 139.69 42.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.25 0.548 . . . . 0.0 111.824 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 93.1 m -126.13 131.17 52.12 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.867 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.431 ' OG ' ' OG ' ' A' ' 138' ' ' SER . 46.7 t -148.96 150.73 33.36 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.027 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.49 140.93 32.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.54 132.69 56.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.895 0.379 . . . . 0.0 110.711 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -151.01 160.26 44.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.087 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.34 -166.78 39.97 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.727 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.18 156.77 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.0 170.28 30.06 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.597 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.95 156.38 46.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.375 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -132.0 129.18 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -115.12 148.21 39.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.796 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 55.6 t-20 -129.37 81.85 69.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.406 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -28.18 14.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.896 1.731 . . . . 0.0 112.131 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 70.6 m80 -135.68 148.18 64.45 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.079 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.81 -24.01 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.25 1.967 . . . . 0.0 112.854 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -99.96 4.52 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.777 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.65 128.66 8.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.98 152.78 37.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.29 148.12 27.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 133' ' ' ALA . 52.8 t0 -146.31 138.88 25.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.692 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.472 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -148.35 150.83 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.056 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 149' ' ' MET . 85.8 p -153.38 161.57 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.752 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -127.14 128.03 45.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.759 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -132.07 147.62 52.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.251 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -130.42 147.91 52.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.204 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.431 ' OG ' ' OG ' ' A' ' 114' ' ' SER . 32.7 t -115.92 125.01 52.01 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -103.82 112.32 25.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.408 ' CD2' ' H ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -119.61 151.79 38.1 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.408 ' H ' ' CD2' ' A' ' 140' ' ' LEU . 98.1 m-20 -60.52 -42.91 97.39 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.541 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -104.96 -32.28 8.83 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 67.2 t -105.42 123.84 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -108.15 115.17 29.62 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 87.2 t -128.31 130.61 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.134 0.492 . . . . 0.0 112.28 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.31 138.02 14.54 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.6 m -111.56 132.77 54.3 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.165 0.483 . . . . 0.0 111.846 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -112.0 135.82 52.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.124 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.426 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 53.9 ttp -131.54 125.55 32.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.891 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.1 tp -143.04 129.82 20.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.711 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -176.81 -176.18 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.073 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.84 158.93 44.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.51 174.79 23.25 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.751 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -123.06 130.15 52.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.369 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -75.77 129.85 37.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.342 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.402 ' OXT' ' CG ' ' A' ' 156' ' ' PHE . 67.9 t80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.541 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.5 m . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.571 0.224 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -126.5 138.69 53.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.2 mm -112.33 126.8 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -139.2 143.09 37.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.417 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.94 148.72 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.049 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.04 172.1 36.47 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -83.34 143.66 30.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -126.41 127.0 44.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.961 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -134.01 139.27 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.912 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 40.7 t -117.7 106.99 13.65 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 146' ' ' GLY . 80.0 ttt180 -68.84 128.78 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.82 150.01 32.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.071 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.87 179.3 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 13' ' ' SER . 92.5 Cg_endo -78.16 159.98 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.402 2.068 . . . . 0.0 111.437 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -95.81 127.98 42.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.793 0.33 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.29 171.55 35.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.82 146.59 50.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.489 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 10.7 t30 -121.89 120.8 35.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 tp -105.53 124.1 48.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.557 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.96 139.91 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.014 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -133.63 126.91 31.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.449 HH12 ' CD ' ' A' ' 122' ' ' GLN . 43.1 ttm180 -110.38 131.64 54.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.641 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -116.02 137.7 51.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.017 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.742 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.61 156.75 42.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -142.61 140.16 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 111.237 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.35 147.0 18.29 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.6 t -126.99 130.82 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.202 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.36 136.23 53.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.527 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.09 148.16 33.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.374 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -151.11 149.44 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.67 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.9 t -152.15 162.46 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.919 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -149.03 141.02 23.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.578 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.512 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.1 p90 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -120.41 147.75 44.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.858 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -123.2 131.07 53.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.589 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.48 147.2 49.32 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.625 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.0 t -149.21 142.72 25.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.539 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.54 131.73 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.9 p -137.78 158.27 44.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.991 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.09 152.25 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.7 43.62 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.561 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.6 153.4 54.57 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.358 2.705 . . . . 0.0 112.863 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.58 HG22 ' CB ' ' A' ' 88' ' ' TYR . 91.5 t -126.31 129.57 71.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.727 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.2 t80 -127.11 128.55 46.4 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 59.0 ttm-85 -69.59 134.58 48.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 87' ' ' LEU . 96.6 mt -88.02 -51.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.972 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.415 ' OD1' ' CG1' ' A' ' 85' ' ' VAL . 17.5 m120 -126.71 -137.3 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -97.14 -4.92 38.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.381 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.35 20.04 0.48 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' A' ' 81' ' ' ILE . 5.0 p -144.07 142.1 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.048 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.7 p -138.51 152.93 48.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 111.225 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 81' ' ' ILE . 3.0 tt -121.14 130.02 53.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.467 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.58 ' CB ' HG22 ' A' ' 78' ' ' VAL . 53.4 p90 -140.34 157.73 45.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.848 0.356 . . . . 0.0 110.719 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.17 147.19 18.35 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.624 ' O ' HD22 ' A' ' 91' ' ' LEU . 88.6 mt -114.43 127.91 56.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.677 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -133.61 142.26 48.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.921 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.6 -144.26 7.82 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.09 39.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 0.0 111.095 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.59 143.72 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.4 145.61 50.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 110.802 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -123.29 144.9 15.9 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.877 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.9 m . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.998 0.428 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.1 m -135.41 154.06 51.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.309 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.79 144.65 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.0 125.72 32.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -150.58 160.39 43.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.717 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.23 -165.01 35.78 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.732 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . . . -155.14 158.49 39.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.642 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.37 166.8 33.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 pp -143.2 159.58 42.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.839 0.352 . . . . 0.0 110.74 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.449 ' CD ' HH12 ' A' ' 34' ' ' ARG . 54.3 tt0 -117.03 128.64 55.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.182 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -127.98 126.74 41.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.447 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.83 ' OD1' HG13 ' A' ' 130' ' ' VAL . 63.3 m-20 -118.99 93.19 46.43 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.44 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.13 -27.62 29.27 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.331 1.354 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -135.14 151.02 74.48 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.953 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.24 -36.6 78.46 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.0 1.8 . . . . 0.0 113.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -101.72 14.52 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.17 119.87 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.667 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.83 HG13 ' OD1' ' A' ' 124' ' ' ASN . 98.7 t -125.24 129.23 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.211 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.93 124.42 58.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -107.99 130.27 55.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.214 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -129.99 112.03 13.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.698 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.441 ' OG ' ' OH ' ' A' ' 88' ' ' TYR . 58.0 m -134.66 153.03 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.732 ' OH ' ' HB3' ' A' ' 119' ' ' ALA . 52.8 p90 -144.49 153.61 42.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.505 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.429 ' OE2' HD12 ' A' ' 90' ' ' LEU . 78.1 mm-40 -135.78 152.2 50.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 145' ' ' VAL . 47.4 t80 -143.71 133.09 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.612 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--O 1.239 0.512 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.456 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 mptt . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.473 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 58.4 t -119.85 125.64 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.408 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 14' ' ' ARG . . . -118.67 125.31 6.36 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.4 m -129.58 137.32 50.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 111.865 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -133.91 151.02 51.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 64.7 mtt -133.43 137.48 45.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -136.06 129.6 32.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.94 40.15 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.814 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.12 161.02 42.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.416 -0.392 . . . . 0.0 109.97 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.79 -178.05 27.02 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.522 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.63 146.0 49.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.373 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.454 179.848 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.911 0.386 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -138.39 146.78 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 tt -120.44 138.2 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -128.08 148.66 50.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.56 151.81 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.222 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.21 -174.47 38.36 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.591 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -116.39 149.29 39.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.42 132.93 54.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -122.08 121.73 37.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.364 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.9 m -118.19 168.47 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.784 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -138.15 143.71 40.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.536 HG12 HG22 ' A' ' 145' ' ' VAL . 35.1 m -131.46 149.41 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.207 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 179.321 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.45 -0.309 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.81 156.12 27.22 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.467 1.444 . . . . 0.0 111.484 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -95.33 138.96 32.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.621 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.72 -168.31 20.68 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.24 160.07 41.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 47' ' ' PHE . 16.4 t-20 -135.72 131.68 35.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.027 0.441 . . . . 0.0 112.028 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.35 136.76 53.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.822 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -125.53 140.36 52.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.551 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -127.08 144.81 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.342 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -123.3 132.07 53.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.391 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.486 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 95.1 m-85 -127.42 149.11 50.23 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.33 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 9.5 tp10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.14 154.82 40.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.827 0.346 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.25 142.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.748 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.67 150.76 17.93 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 t -136.97 137.21 39.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.577 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 92.7 m-85 -128.49 141.01 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.81 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.76 148.74 34.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -143.08 128.84 19.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.8 p -129.33 156.17 44.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.529 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.452 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 . . . . . 0 C--N 1.331 -0.229 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.769 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.8 t80 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.681 0.277 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -115.62 143.48 45.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.705 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.529 ' CE2' ' OG ' ' A' ' 72' ' ' SER . 83.5 t80 -127.65 121.39 30.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.14 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.23 133.91 55.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.529 ' OG ' ' CE2' ' A' ' 70' ' ' TYR . 67.1 m -134.65 141.37 46.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.34 134.96 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.008 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -140.57 158.67 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -158.7 152.41 23.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.53 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.58 164.7 35.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.665 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.99 160.61 36.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 123.166 2.577 . . . . 0.0 112.578 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 88' ' ' TYR . 10.7 p -135.26 135.69 51.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.236 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.0 t80 -127.69 129.68 47.56 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 62.4 ttm-85 -71.85 128.68 36.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.22 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 87' ' ' LEU . 96.3 mt -89.66 -51.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -127.86 -155.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.65 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.74 -39.99 93.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.293 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -140.87 35.01 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.155 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.1 t -127.77 126.29 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.9 m -130.67 142.54 50.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HB2' HD11 ' A' ' 81' ' ' ILE . 62.8 tp -122.73 129.93 52.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.455 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' A' ' 78' ' ' VAL . 52.9 p90 -142.01 159.46 42.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.875 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.8 151.75 18.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.7 119.08 27.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.557 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -138.12 151.55 47.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.955 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -143.89 7.63 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.65 153.44 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 0.0 110.956 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.53 145.57 16.81 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -133.93 125.16 27.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.643 0.258 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.15 143.02 15.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.357 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.841 0.353 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.9 p -155.17 163.59 39.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.525 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -99.31 133.89 42.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.475 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.68 129.95 55.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.645 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -147.67 133.57 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -178.6 -169.98 40.04 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.41 158.58 44.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.623 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.18 169.6 33.21 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.82 162.3 40.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -141.69 151.68 43.22 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.22 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.09 147.05 41.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.617 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 39.1 t-20 -128.57 82.24 69.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.992 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.93 -26.56 15.27 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.809 1.673 . . . . 0.0 111.563 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 98.4 m-70 -135.14 148.53 66.99 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.771 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.66 -21.84 33.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.184 1.923 . . . . 0.0 113.098 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -100.03 -0.1 39.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.83 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -145.27 130.62 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.065 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 153' ' ' GLY . 3.5 p -139.81 145.5 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.726 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.09 123.92 69.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.279 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -110.98 137.03 49.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -146.39 141.87 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.878 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.5 p -157.9 161.34 38.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.129 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.27 130.45 46.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.834 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -135.58 141.83 45.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 110.417 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -131.9 145.38 51.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.69 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.941 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 15' ' ' VAL . 84.8 t -131.31 131.67 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.022 0.439 . . . . 0.0 112.016 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.32 143.6 16.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.9 m -124.77 130.38 52.29 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -116.91 136.14 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.548 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.527 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 79.4 mtm -131.58 127.81 37.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.404 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.6 tp -143.22 129.95 20.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.867 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.12 178.57 44.24 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.71 145.8 46.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -108.61 148.78 16.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.506 ' CE2' ' O ' ' A' ' 155' ' ' ARG . 91.8 t80 -134.45 130.05 36.16 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.506 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 85.7 mtp180 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.649 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.609 0.243 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 t -119.54 133.45 55.66 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.453 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.27 131.96 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.865 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -139.89 155.42 47.2 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.996 0.427 . . . . 0.0 110.818 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.8 mt -124.94 130.18 73.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.205 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.69 154.05 22.42 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.638 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.24 148.75 27.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -125.36 138.74 54.05 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 110.901 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -143.39 142.51 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.106 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.446 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 44.3 t -117.87 167.91 10.98 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.158 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -134.8 120.9 19.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.623 HG12 HG22 ' A' ' 145' ' ' VAL . 34.9 m -132.76 149.87 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.994 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--N 1.333 -0.13 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.169 179.327 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 13' ' ' SER . 91.3 Cg_endo -82.48 159.06 16.98 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 122.011 1.807 . . . . 0.0 110.691 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -97.79 131.39 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.76 0.315 . . . . 0.0 110.711 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.585 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -156.81 176.05 34.2 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.96 149.18 49.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.727 0.298 . . . . 0.0 110.33 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 10.1 t30 -133.61 124.61 27.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.205 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.46 138.59 45.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.757 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.68 139.9 53.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.89 143.37 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.672 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.637 HH12 ' NE2' ' A' ' 122' ' ' GLN . 61.6 ttp180 -131.96 131.63 42.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 111.036 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -129.32 143.09 50.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -179.869 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.3 142.84 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.438 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -136.99 136.41 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.83 143.11 14.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.9 m -130.48 147.9 52.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.234 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -127.69 141.81 51.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.454 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.04 33.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.27 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -145.86 124.93 12.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.585 HG22 ' HA3' ' A' ' 28' ' ' GLY . 82.4 p -128.89 157.73 40.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.379 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -145.29 128.6 16.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.302 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' NH2' ' CG2' ' A' ' 15' ' ' VAL . 64.0 ttm-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.235 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -119.55 143.61 47.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.664 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -124.98 138.0 54.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.969 0.414 . . . . 0.0 110.995 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -144.89 132.67 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.797 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.6 p -147.49 158.57 44.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.67 141.6 23.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.7 t -150.47 149.56 30.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 111.298 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.82 155.02 32.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.299 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -166.82 171.09 41.59 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.39 148.77 55.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.019 2.479 . . . . 0.0 112.442 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.59 HG22 ' CB ' ' A' ' 88' ' ' TYR . 71.9 t -126.53 130.06 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -122.87 136.73 54.97 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.5 mtm-85 -86.22 131.71 34.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.962 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.595 ' HB ' HG13 ' A' ' 85' ' ' VAL . 96.6 mt -88.28 -50.99 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.235 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 84' ' ' TYR . 56.9 t30 -139.97 34.37 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.911 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 56.54 1.8 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.825 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 82' ' ' ASN . 64.7 m-85 -120.87 -20.71 6.84 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.165 0.507 . . . . 0.0 109.666 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.595 HG13 ' HB ' ' A' ' 81' ' ' ILE . 6.7 p -144.28 140.57 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.462 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.3 t -136.62 141.42 43.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 134.46 51.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.885 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.59 ' CB ' HG22 ' A' ' 78' ' ' VAL . 54.7 p90 -144.26 159.33 42.87 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.15 152.07 17.39 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.41 126.9 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.2 tp -129.27 126.71 39.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.722 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.13 -155.65 18.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.481 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -148.69 155.86 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.897 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.66 140.41 14.84 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -126.76 120.64 29.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.44 141.71 15.68 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.966 0.412 . . . . 0.0 111.062 -179.426 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.2 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.75 0.309 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.474 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 93.4 p -151.68 165.58 33.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.557 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.95 140.79 29.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.476 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.46 131.62 56.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.832 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.1 132.92 29.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.64 178.41 34.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.487 -0.864 . . . . 0.0 111.61 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.52 155.13 39.84 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.446 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -144.4 155.38 26.29 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.56 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.868 HD22 ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -109.43 143.44 39.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.666 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.637 ' NE2' HH12 ' A' ' 34' ' ' ARG . 46.0 tt0 -119.87 123.72 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.288 . . . . 0.0 110.971 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.976 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.569 ' CG ' HG12 ' A' ' 130' ' ' VAL . 59.9 t-20 -137.82 81.78 27.61 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.44 -28.17 18.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.661 1.574 . . . . 0.0 111.653 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 129' ' ' PHE . 97.9 m-70 -131.74 124.55 19.91 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.003 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -50.24 -33.74 37.37 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.79 1.66 . . . . 0.0 112.938 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -81.51 -12.09 58.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 126' ' ' HIS . 92.5 t80 -142.66 129.74 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.969 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.569 HG12 ' CG ' ' A' ' 124' ' ' ASN . 34.2 m -130.74 152.81 38.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.0 mt -117.1 125.8 74.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.268 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -116.95 113.82 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.34 128.15 54.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.074 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.4 p -157.34 161.11 39.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.984 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -149.83 156.0 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.277 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -145.24 156.32 43.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.162 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.55 159.22 43.44 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.156 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.235 0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.576 179.504 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 C--O 1.233 0.198 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.623 HG22 HG12 ' A' ' 15' ' ' VAL . 99.8 t -125.52 128.04 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.086 0.469 . . . . 0.0 112.146 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -124.48 129.63 7.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.9 m -126.47 132.38 51.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 111.854 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -116.84 141.1 48.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.454 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 78.2 mtm -128.66 137.74 51.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.01 0.433 . . . . 0.0 111.257 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -142.79 131.4 22.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.814 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -164.0 177.81 39.64 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.962 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.98 158.66 44.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.35 -160.56 13.78 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.07 160.36 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.939 0.4 . . . . 0.0 110.879 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.386 -179.827 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.652 0.263 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -132.61 138.21 47.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.486 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -127.76 138.91 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.707 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -149.79 145.5 26.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.78 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.56 159.23 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.96 -178.21 40.26 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.709 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.81 144.65 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -125.3 136.55 53.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.111 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -131.53 145.13 51.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.634 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 t -116.56 166.86 11.61 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -125.5 123.46 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -120.88 127.65 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.875 0.369 . . . . 0.0 111.54 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 C--N 1.333 -0.134 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.828 178.968 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.61 159.01 16.64 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.079 1.853 . . . . 0.0 110.473 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -99.77 137.6 38.01 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.849 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.68 177.87 36.91 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.79 147.5 47.5 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.329 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 29.6 t-20 -132.77 123.84 26.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.034 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.741 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 98.8 mttt -121.98 140.77 52.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -140.86 128.55 21.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.235 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 122' ' ' GLN . 80.1 ttt180 -124.71 132.24 53.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.807 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -118.84 127.68 53.74 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.04 -179.137 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.63 127.34 75.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 110.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -136.42 137.44 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.28 149.4 19.43 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -137.4 139.8 40.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.94 139.43 49.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.569 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.71 139.4 43.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.994 0.425 . . . . 0.0 111.413 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -143.67 130.25 20.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.842 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -128.4 158.09 39.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.791 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -158.25 158.01 33.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.1 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 . . . . . 0 C--N 1.331 -0.222 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.888 179.811 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.558 0.218 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -134.35 128.45 33.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.277 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -130.22 128.01 40.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -136.5 131.01 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.211 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -147.83 159.69 43.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.943 0.402 . . . . 0.0 110.812 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.05 143.37 30.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.524 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.614 HG21 HD23 ' A' ' 90' ' ' LEU . 9.4 t -147.21 147.78 30.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.982 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.15 156.08 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.338 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.41 171.54 43.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 154.84 57.06 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.206 2.604 . . . . 0.0 112.314 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 88' ' ' TYR . 97.7 t -122.28 127.59 75.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -107.16 122.6 46.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.518 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 8.3 tmm_? -89.56 129.13 36.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.7 mp -89.35 -51.6 11.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.484 -0.486 . . . . 0.0 109.774 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -154.67 38.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.549 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.518 ' H ' ' CG ' ' A' ' 80' ' ' ARG . 4.3 tm-20 72.57 -49.58 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.053 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -71.04 -29.7 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.399 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.2 t -127.44 132.43 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.696 0.284 . . . . 0.0 110.974 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.409 ' OG ' ' CG1' ' A' ' 78' ' ' VAL . 45.0 t -138.51 135.24 34.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.281 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -108.73 130.23 55.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.067 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.467 ' HB3' HG22 ' A' ' 78' ' ' VAL . 52.2 p90 -139.5 158.1 44.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.451 . . . . 0.0 111.155 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.09 151.39 16.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 74' ' ' THR . 8.7 mp -111.03 129.32 55.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.44 . . . . 0.0 110.897 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -138.01 125.93 22.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.587 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.63 ' C ' ' HB3' ' A' ' 116' ' ' ALA . . . -179.29 -154.39 13.03 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.386 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.15 38.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.787 0.327 . . . . 0.0 110.696 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.66 147.86 16.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -129.7 122.4 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.35 140.97 16.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.52 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.527 0.078 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -150.64 158.38 44.08 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.363 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.0 127.58 47.43 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.63 ' HB3' ' C ' ' A' ' 92' ' ' GLY . . . -92.17 114.55 27.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.109 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -145.59 130.71 18.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.846 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -177.24 -169.95 39.03 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.634 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.26 158.46 36.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.404 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -152.26 159.12 28.2 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.89 148.12 43.88 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.674 0.273 . . . . 0.0 110.628 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.523 ' OE1' ' NH1' ' A' ' 34' ' ' ARG . 63.3 tt0 -119.81 132.55 55.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -126.45 147.48 49.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.728 ' OD1' HG23 ' A' ' 130' ' ' VAL . 69.5 m-20 -128.48 82.03 69.42 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.47 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.51 -41.27 74.75 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.497 2.131 . . . . 0.0 112.171 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.38 153.64 71.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.148 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.12 -38.0 80.27 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.945 1.764 . . . . 0.0 113.082 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -90.98 6.13 45.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -142.73 130.99 22.07 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.15 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.728 HG23 ' OD1' ' A' ' 124' ' ' ASN . 3.8 p -136.3 138.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -131.03 141.98 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.949 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.439 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -145.67 160.19 42.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.12 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -149.52 149.93 31.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.741 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.7 p -155.8 163.49 39.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 110.726 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -140.72 151.08 44.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.175 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 147' ' ' THR . 14.6 tm-20 -143.54 138.07 28.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.857 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -144.81 160.03 41.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.638 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.237 0.435 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.563 179.469 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp . . . . . 0 C--O 1.232 0.169 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.6 129.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.916 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.1 139.29 10.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 136' ' ' GLU . 88.2 m -131.25 133.16 45.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.623 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.547 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.438 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 24.7 ptp -139.18 149.74 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.063 0.458 . . . . 0.0 111.344 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.35 155.25 44.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.022 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.91 -174.79 42.76 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.85 160.21 42.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.66 -168.7 19.08 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.34 145.99 50.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.596 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.77 0.319 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t -137.68 140.35 40.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.681 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.1 mt -118.12 128.42 75.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -129.34 150.61 50.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -136.92 145.44 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.61 167.56 34.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.494 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -87.24 146.53 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -113.05 126.19 55.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.728 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' N ' ' OE1' ' A' ' 12' ' ' GLN . 25.2 mp0 -125.79 121.3 32.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.842 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -118.54 168.1 11.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -143.74 147.66 34.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.876 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.71 138.65 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.791 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.93 158.89 24.25 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.87 1.713 . . . . 0.0 111.288 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -100.05 148.8 24.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.624 0.25 . . . . 0.0 110.656 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.37 -175.73 38.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -125.41 148.18 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 51.1 t30 -126.04 120.56 30.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.813 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.66 141.17 37.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.68 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' CD ' ' OG ' ' A' ' 46' ' ' SER . 6.0 tppt? -137.25 131.58 32.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.707 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -126.77 142.08 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.96 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -125.56 130.45 51.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -128.73 143.65 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.761 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 -179.774 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.82 158.49 42.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -139.46 135.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.724 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.98 142.65 17.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.423 ' OG ' ' CD ' ' A' ' 32' ' ' LYS . 60.8 m -126.43 142.09 51.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.04 0.448 . . . . 0.0 111.146 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -130.18 142.1 50.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.685 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.09 143.44 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -147.58 130.17 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.222 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.2 p -129.49 159.36 36.54 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.639 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -145.12 140.99 28.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 C--O 1.231 0.086 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -112.45 139.35 48.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -127.84 128.34 45.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.66 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -136.28 129.82 32.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.903 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -137.68 141.63 41.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 111.308 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.98 130.87 71.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.467 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 12.4 t -149.46 149.96 31.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.092 0.472 . . . . 0.0 111.427 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.92 156.52 33.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.378 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.15 170.03 39.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.456 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.69 149.45 54.83 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.207 2.605 . . . . 0.0 112.893 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.526 HG22 ' CB ' ' A' ' 88' ' ' TYR . 74.6 t -126.48 129.24 71.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.358 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.53 127.35 43.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.352 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -72.53 135.06 45.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.2 mm -86.37 -50.92 13.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.049 0.452 . . . . 0.0 110.228 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 84' ' ' TYR . 6.1 m-20 173.84 165.11 0.19 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.124 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 45.2 -92.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.513 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ASN . 21.5 p90 -144.31 37.71 1.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.392 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -119.64 126.0 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.43 ' O ' HD13 ' A' ' 121' ' ' LEU . 40.7 t -128.97 137.11 51.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.207 0.527 . . . . 0.0 111.175 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -110.28 123.81 50.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.2 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.565 ' N ' HD13 ' A' ' 87' ' ' LEU . 53.2 p90 -142.42 158.9 43.2 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.147 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -124.6 150.88 17.17 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.18 125.08 53.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' C ' ' HG1' ' A' ' 74' ' ' THR . 87.9 mt -122.67 139.64 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.641 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 169.29 -159.18 32.02 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.665 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -146.83 153.21 39.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.95 0.405 . . . . 0.0 110.701 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.6 141.35 15.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.22 144.13 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.726 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -120.99 147.37 17.55 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.977 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.886 0.374 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.742 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 96.5 p -156.14 167.58 29.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.546 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mp -99.37 143.6 29.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.04 137.33 53.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.434 . . . . 0.0 111.083 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.23 159.61 43.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.681 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.85 -170.25 43.37 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.06 153.19 34.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.412 . . . . 0.0 110.139 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.469 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -149.78 156.5 26.79 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.704 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 120' ' ' GLY . 4.1 mm? -117.96 141.85 48.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.467 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -121.12 126.33 49.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.585 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -127.03 140.04 52.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.232 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -130.25 78.65 74.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.593 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.27 -25.79 11.11 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.141 1.894 . . . . 0.0 111.642 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.1 m-70 -127.33 119.22 21.85 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.899 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 -36.69 45.87 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.772 1.648 . . . . 0.0 113.108 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -82.16 -11.9 58.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' HIS . 89.6 t80 -143.62 129.61 19.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.245 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 152' ' ' ALA . 35.1 m -130.12 153.15 38.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.48 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -119.15 136.91 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.602 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -128.52 114.91 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.975 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.842 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -156.89 164.53 37.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.189 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.58 152.65 40.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 149' ' ' MET . 49.9 mp0 -143.59 154.05 43.17 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.709 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.15 144.14 51.1 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.329 -0.294 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.807 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 91.6 t -129.24 133.14 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.954 0.406 . . . . 0.0 112.08 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.79 144.57 15.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.3 p -129.61 148.26 51.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.323 0.582 . . . . 0.0 112.01 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -141.07 137.96 33.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.819 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -139.09 146.36 40.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.578 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -143.24 132.32 23.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.915 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.649 ' N ' HD13 ' A' ' 150' ' ' LEU . . . -170.69 -177.39 40.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.831 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 130' ' ' VAL . . . -148.9 157.45 43.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -140.4 -165.03 10.14 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.43 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -149.13 157.22 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.758 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.129 -179.554 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.3 p -119.69 154.62 33.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.2 mt -119.59 125.35 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.542 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -136.54 150.81 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -131.63 147.01 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.229 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.06 -179.34 30.16 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -109.28 142.24 40.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.684 0.278 . . . . 0.0 110.292 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -116.32 128.19 55.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HB3' HD22 ' A' ' 25' ' ' ASN . 97.4 mt-30 -124.93 120.29 31.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.165 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.437 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 39.3 t -99.84 106.76 18.65 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.424 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 121.03 16.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.34 125.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.081 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.9 tptm . . . . . 0 C--N 1.331 -0.23 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.414 -179.525 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.412 HD22 ' HB3' ' A' ' 12' ' ' GLN . 2.3 m-20 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HD2' ' H ' ' A' ' 13' ' ' SER . 71.3 Cg_endo -81.25 160.6 20.24 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.805 2.337 . . . . 0.0 111.147 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -93.49 134.27 35.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.474 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.23 36.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -126.8 149.07 49.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.752 0.31 . . . . 0.0 110.75 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 47' ' ' PHE . 15.9 t-20 -124.63 120.65 32.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.647 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.52 140.55 31.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.498 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 87.6 tttt -136.68 133.18 35.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.048 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.13 146.37 51.08 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.419 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -111.05 132.78 53.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 43' ' ' VAL . 96.8 m-85 -125.37 142.91 51.23 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.396 0.435 . . . . 0.0 110.094 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 -179.671 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 35' ' ' TYR . 33.8 m -133.51 149.45 31.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.176 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.48 155.04 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.343 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.08 134.55 7.9 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.0 m -130.22 146.17 51.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.579 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 94.9 m-85 -129.13 145.39 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.465 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.77 138.69 37.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -145.15 127.93 16.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.04 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.6 p -129.88 159.45 36.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.358 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.488 ' NE ' ' HZ3' ' A' ' 69' ' ' LYS . 80.0 ttt180 -151.78 136.36 16.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.583 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.117 179.361 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 120.775 0.321 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HZ3' ' NE ' ' A' ' 51' ' ' ARG . 73.2 mmtt -101.02 135.93 41.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.09 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -124.67 133.85 53.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' A' ' 95' ' ' HIS . 87.5 t80 -143.39 131.3 21.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.266 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -142.0 141.82 32.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.467 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.2 t -117.82 125.03 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -129.44 149.64 51.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.99 158.96 12.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.13 166.43 34.0 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.5 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 155.11 46.16 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.027 2.485 . . . . 0.0 112.386 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.8 123.76 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.295 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.57 118.16 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.523 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -84.76 136.46 33.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.12 -51.16 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.763 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 84' ' ' TYR . 60.4 t30 -161.74 41.84 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 67.28 -37.62 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 82' ' ' ASN . 78.5 m-85 -66.99 -38.01 85.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.57 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -144.22 146.88 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.4 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -139.1 150.2 45.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.639 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.8 mt -98.78 139.79 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.474 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.88 141.62 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.419 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.74 138.84 14.35 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 134' ' ' SER . 75.6 mt -112.03 117.91 33.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.74 133.05 39.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.666 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.57 -161.02 34.53 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.444 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -146.53 150.75 36.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.724 0.297 . . . . 0.0 110.452 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.25 142.96 16.12 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.429 ' CD2' HG22 ' A' ' 113' ' ' THR . 78.7 m80 -135.15 148.81 49.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.12 152.87 20.93 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 -179.756 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 95' ' ' HIS . 82.3 p . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.705 0.288 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.72 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 92.8 p -151.14 162.35 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.8 tp -100.2 125.84 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.396 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 123.05 45.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.6 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -143.3 131.59 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.109 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.35 -170.18 34.37 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.594 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.61 158.72 42.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 0.0 110.533 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.17 173.74 36.04 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -135.75 170.02 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 0.0 110.501 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -139.54 136.3 34.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -129.75 130.64 45.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.446 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 31.5 t-20 -106.66 99.28 24.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.231 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.38 -31.89 5.39 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.658 1.572 . . . . 0.0 111.439 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.3 m-70 -138.59 148.95 60.8 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.774 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.92 -25.97 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.998 1.799 . . . . 0.0 112.357 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -82.8 -25.58 32.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.647 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 126' ' ' HIS . 94.5 m-85 -132.91 144.28 50.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.298 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.52 153.0 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.285 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.6 pt -128.55 147.09 33.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.682 0.277 . . . . 0.0 110.422 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.527 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 61.0 t0 -146.71 133.62 20.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.474 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -124.05 124.72 43.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.68 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.635 ' HB3' HD11 ' A' ' 90' ' ' LEU . 66.4 m -133.97 152.35 51.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.316 . . . . 0.0 111.164 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.08 139.72 53.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.055 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.426 ' CG ' HD13 ' A' ' 90' ' ' LEU . 97.5 mt-10 -125.31 150.35 47.22 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.646 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -131.41 127.18 36.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 CA--C 1.523 -0.09 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.304 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.6 mptt . . . . . 0 C--O 1.231 0.125 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.415 HG13 ' OG ' ' A' ' 13' ' ' SER . 84.6 t -128.03 129.12 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.029 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.01 132.28 8.82 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 96.5 m -113.16 123.53 50.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.046 0.451 . . . . 0.0 111.285 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -95.72 135.49 37.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 149' ' ' MET . 1.8 tmt? -119.43 117.83 29.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.785 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -137.07 127.29 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.784 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -169.6 177.85 42.92 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.168 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.49 159.79 44.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.66 -160.91 14.59 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.38 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.04 160.11 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 0.0 110.673 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.516 -179.84 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.589 0.233 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.8 m -124.85 148.61 48.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.53 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -116.89 129.75 72.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.9 t -124.59 140.03 53.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.5 tt -126.91 145.57 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.136 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.12 -173.82 37.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.445 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -106.09 142.42 35.81 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -118.03 127.92 54.28 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -129.24 134.95 48.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.796 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.465 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 41.4 t -117.33 120.35 37.93 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.571 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.682 HH21 ' NZ ' ' A' ' 16' ' ' LYS . 61.2 ttt85 -67.53 120.1 13.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.361 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -133.25 131.52 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.682 ' NZ ' HH21 ' A' ' 14' ' ' ARG . 73.5 mmtt . . . . . 0 C--N 1.331 -0.199 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 13' ' ' SER . 93.4 Cg_endo -83.7 161.01 14.35 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.176 2.584 . . . . 0.0 111.093 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -92.12 132.09 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.3 169.65 33.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.56 138.86 49.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.648 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 29.5 t-20 -115.09 119.52 36.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.407 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.47 129.18 51.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.56 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -132.56 147.16 52.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.87 145.05 51.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.201 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 122' ' ' GLN . 61.5 ttp180 -124.96 132.67 53.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.15 142.91 51.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.0 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.032 -179.522 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 78' ' ' VAL . . . . . . . . 0 CA--C 1.524 0.613 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.5 t -124.42 128.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.16 157.28 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.068 0.461 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.19 159.32 27.67 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -136.69 131.01 32.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.059 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.69 123.66 43.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.837 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.01 152.99 41.01 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.121 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -148.89 144.35 26.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.653 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.4 p -132.3 160.92 34.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -154.74 148.59 25.58 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.785 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 . . . . . 0 C--O 1.232 0.141 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.78 179.429 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.803 0.335 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.9 146.29 25.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -119.44 127.39 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 95' ' ' HIS . 98.5 m-85 -127.95 144.21 51.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.274 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -152.46 140.07 19.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.568 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.87 143.97 39.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.022 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.7 p -144.2 163.12 34.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.44 155.1 29.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.441 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.54 164.04 34.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.489 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.13 158.9 37.61 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.258 2.639 . . . . 0.0 112.291 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 42' ' ' GLY . 8.7 p -135.7 135.35 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.8 t80 -128.15 129.72 46.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.708 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.531 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 36.4 mmt180 -67.61 136.58 54.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.669 HD11 ' HB2' ' A' ' 87' ' ' LEU . 75.5 mt -87.86 -51.86 12.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.052 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 2.7 m-20 162.9 -73.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.678 ' O ' HG13 ' A' ' 85' ' ' VAL . 98.6 mt-10 -67.71 64.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.459 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' ASN . 91.8 m-85 47.07 33.62 2.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 83' ' ' GLU . 30.2 m -133.09 152.71 36.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 t -139.48 144.11 37.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 111.449 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.669 ' HB2' HD11 ' A' ' 81' ' ' ILE . 63.6 tp -111.11 129.84 55.8 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CZ ' ' C ' ' A' ' 120' ' ' GLY . 53.7 p90 -143.22 158.4 43.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.738 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -107.13 147.35 16.23 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 90' ' ' LEU . 10.8 tp -128.38 119.97 26.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.33 160.91 38.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.836 0.351 . . . . 0.0 111.173 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.35 -143.96 8.89 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.63 150.79 36.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 110.937 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.61 140.6 16.44 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 71' ' ' TYR . 31.1 p80 -147.0 162.03 39.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.36 158.37 18.88 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.228 0.537 . . . . 0.0 110.616 -179.582 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.5 t -160.2 158.21 29.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.7 mt -99.28 141.09 32.5 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.47 140.05 48.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.964 0.411 . . . . 0.0 111.164 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -150.93 159.1 44.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.205 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 165.84 -158.72 31.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.488 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.59 160.17 40.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.739 0.304 . . . . 0.0 110.502 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.444 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -144.43 156.05 26.62 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.29 146.06 44.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.516 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.458 ' OE1' ' NH1' ' A' ' 34' ' ' ARG . 10.3 tt0 -117.62 128.56 55.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.697 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -118.7 137.53 53.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.414 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.81 ' OD1' HG13 ' A' ' 130' ' ' VAL . 68.4 m-20 -129.51 81.03 70.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.71 -27.23 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.762 1.641 . . . . 0.0 111.667 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -136.48 149.24 66.89 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.733 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.98 -22.97 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.068 1.845 . . . . 0.0 112.776 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.18 6.0 44.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.678 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -150.08 128.24 11.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.468 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.81 HG13 ' OD1' ' A' ' 124' ' ' ASN . 94.4 t -122.88 132.03 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.0 mt -115.16 126.02 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.087 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -146.61 160.44 42.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.72 138.59 17.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.2 m -135.94 151.83 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.776 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -142.13 148.52 38.45 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.015 0.436 . . . . 0.0 110.867 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.456 ' H ' ' HB ' ' A' ' 147' ' ' THR . 39.9 mt-10 -143.79 159.09 43.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.378 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -119.8 139.2 52.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.805 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.232 0.137 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.57 131.53 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.317 0.579 . . . . 0.0 112.38 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.16 157.15 15.76 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 136' ' ' GLU . 91.2 m -123.92 129.42 50.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.196 0.498 . . . . 0.0 111.606 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -129.53 119.94 24.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.582 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 79.0 mtm -132.07 134.48 45.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.38 142.12 30.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.96 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.33 -175.07 47.13 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.094 -1.051 . . . . 0.0 111.895 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 130' ' ' VAL . . . -149.45 157.94 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.398 . . . . 0.0 109.938 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.52 -177.31 21.04 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.358 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -148.15 158.92 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.496 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.319 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.724 0.297 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.7 p -143.73 159.67 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.2 mt -118.24 130.93 72.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.671 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.4 t -134.5 140.73 46.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.706 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.39 148.76 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.376 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.56 -174.62 35.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -104.33 142.58 34.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.615 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -112.65 131.36 55.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.795 ' CD ' HD22 ' A' ' 25' ' ' ASN . 22.5 mt-30 -126.79 124.67 40.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.478 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.562 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 69.9 m -117.75 107.41 14.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -66.82 133.34 49.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -111.33 125.52 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.744 179.441 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.795 HD22 ' CD ' ' A' ' 12' ' ' GLN . 58.6 t-20 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.576 ' CB ' HH21 ' A' ' 52' ' ' ARG . 97.6 Cg_endo -83.04 159.1 15.57 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.69 ' NH2' ' HE ' ' A' ' 51' ' ' ARG . 51.2 ptt85 -93.19 142.61 27.11 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -159.44 169.77 35.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -109.47 142.14 40.92 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.712 0.292 . . . . 0.0 110.575 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 43.5 t30 -125.89 119.02 26.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.752 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.1 137.28 53.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HE3' HD21 ' A' ' 30' ' ' ASN . 98.8 mttt -134.8 146.13 49.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.16 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.507 ' NH2' ' OE2' ' A' ' 36' ' ' GLU . 61.0 ttt85 -107.57 127.48 53.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -137.77 126.77 24.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.079 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.507 ' OE2' ' NH2' ' A' ' 34' ' ' ARG . 99.4 mt-10 . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.969 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 78' ' ' VAL . . . . . . . . 0 CA--C 1.525 0.718 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.48 157.64 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 76' ' ' GLY . 19.0 tt -137.94 134.3 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.442 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.8 132.96 11.32 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.7 m -128.68 139.93 51.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.08 142.11 49.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.744 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.67 139.33 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -142.41 126.74 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.274 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.522 HG22 ' HA3' ' A' ' 28' ' ' GLY . 77.3 p -128.78 159.24 36.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.419 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.69 ' HE ' ' NH2' ' A' ' 27' ' ' ARG . 41.2 ptt180 -157.57 161.18 38.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.355 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.576 HH21 ' CB ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.518 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -118.02 142.05 47.8 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -126.34 125.53 42.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.345 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' CE2' HG23 ' A' ' 73' ' ' VAL . 88.4 t80 -130.03 128.73 42.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.19 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -140.05 140.05 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.062 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.456 HG23 ' CE2' ' A' ' 71' ' ' TYR . 99.4 t -124.06 128.88 74.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.043 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -148.34 155.38 41.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.214 0.53 . . . . 0.0 111.166 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.75 158.33 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.182 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 44' ' ' ILE . . . -150.22 153.58 25.15 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.603 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.66 159.03 31.94 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.74 2.293 . . . . 0.0 111.475 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 78' ' ' VAL . 7.9 p -131.61 119.25 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.455 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.66 120.12 35.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.914 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -80.54 128.44 33.59 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.157 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' A' ' 85' ' ' VAL . 96.5 mt -89.8 -52.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.808 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 84' ' ' TYR . 32.7 m120 -122.09 16.98 10.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.823 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 82' ' ' ASN . 16.9 tt0 76.17 -21.03 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.496 ' H ' ' C ' ' A' ' 82' ' ' ASN . 96.9 m-85 -104.17 -20.89 13.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 81' ' ' ILE . 35.0 m -132.81 145.63 33.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.4 t -141.14 152.25 44.56 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.321 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HG ' HD11 ' A' ' 81' ' ' ILE . 86.1 mt -102.48 138.8 38.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.391 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' OH ' ' NH1' ' A' ' 34' ' ' ARG . 48.9 m-85 -121.48 140.02 52.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.592 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.83 137.66 14.4 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.41 118.79 37.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.499 0.649 . . . . 0.0 111.877 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.7 tp -136.9 122.94 20.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.354 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -167.8 39.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -145.27 151.56 38.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 110.701 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.64 146.5 16.08 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -130.95 143.89 51.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.727 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -116.19 143.44 18.07 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.1 tttp . . . . . 0 C--N 1.332 -0.187 0 CA-C-O 120.857 0.36 . . . . 0.0 110.57 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 121.019 0.438 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.547 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 88.1 p -152.6 163.75 39.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.39 145.24 28.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.629 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.24 52.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.726 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -151.31 160.82 43.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.296 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 169.29 -160.77 34.2 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.878 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.78 158.54 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -157.66 174.97 35.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.24 165.81 27.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.917 0.389 . . . . 0.0 110.831 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.677 HE21 ' CG1' ' A' ' 130' ' ' VAL . 65.4 tt0 -135.11 135.34 41.11 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.207 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -127.66 126.95 42.92 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.009 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.868 ' OD1' HG13 ' A' ' 130' ' ' VAL . 50.0 m-20 -125.24 85.64 57.99 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.59 -29.75 10.51 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.7 1.6 . . . . 0.0 111.652 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.64 123.58 21.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.762 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.15 -29.29 22.02 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.581 1.521 . . . . 0.0 112.522 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -82.06 -8.71 59.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.739 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -139.29 123.34 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.418 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.868 HG13 ' OD1' ' A' ' 124' ' ' ASN . 72.8 t -127.89 134.01 66.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.831 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.04 148.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.502 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -146.29 158.96 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.19 21.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.024 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.8 p -158.17 162.6 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.528 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -144.07 148.29 34.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -145.92 160.4 41.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.568 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -119.02 139.32 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.45 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.163 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.01 130.95 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.0 134.67 11.77 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.9 m -125.0 131.7 53.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.278 0.561 . . . . 0.0 112.356 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -127.95 125.42 39.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.506 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.473 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 79.3 mtm -117.74 136.63 53.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 111.374 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 tt -136.91 130.17 31.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.58 177.66 41.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.851 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.13 158.94 44.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.45 -171.9 23.2 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -147.38 159.32 43.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 0.0 110.617 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.663 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.9 p . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.78 0.324 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -147.01 141.39 26.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.594 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 pt -127.56 147.15 32.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -131.82 148.45 52.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.0 mt -121.09 129.44 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.062 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.01 156.53 26.87 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.27 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -83.72 146.02 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HB3' ' C ' ' A' ' 28' ' ' GLY . . . -107.39 120.0 40.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.768 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -118.5 118.46 31.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.848 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.3 m -118.44 167.73 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -125.21 137.57 54.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' HD3' ' A' ' 26' ' ' PRO . 87.7 t -115.39 126.56 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.531 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.33 -0.282 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.364 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 119.399 -0.334 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' HG23 ' A' ' 15' ' ' VAL . 73.2 Cg_endo -76.63 158.96 35.69 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.433 1.422 . . . . 0.0 110.86 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -91.57 155.02 18.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.764 0.316 . . . . 0.0 110.945 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' C ' ' HB3' ' A' ' 11' ' ' ALA . . . -168.3 175.07 43.09 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.92 149.59 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 47' ' ' PHE . 7.6 t-20 -134.92 120.49 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -115.66 140.89 48.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.749 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.38 145.24 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.89 144.59 51.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.074 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -123.66 128.79 50.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.441 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 96.2 m-85 -128.91 148.63 50.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.442 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 17.5 tt0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.409 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.635 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.35 139.62 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.382 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.59 153.16 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.86 135.36 9.39 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.9 m -128.32 145.69 50.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.148 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.584 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 98.3 m-85 -124.37 140.49 52.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.513 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.33 137.96 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -150.99 150.34 30.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.783 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.9 t -150.27 155.24 39.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -156.02 163.24 39.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 . . . . . 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.796 0.332 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -124.08 141.65 51.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.3 144.59 51.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.998 0.427 . . . . 0.0 111.149 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -139.98 130.97 26.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.14 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -148.78 147.95 29.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 111.023 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 p -136.41 136.38 48.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.698 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -135.31 157.76 46.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.17 27.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.452 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.3 169.78 42.91 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.773 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.1 155.0 52.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.327 2.685 . . . . 0.0 112.794 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.442 HG22 ' CB ' ' A' ' 88' ' ' TYR . 89.6 t -126.69 130.51 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.754 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -126.91 125.76 42.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.404 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.69 137.33 54.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 87' ' ' LEU . 92.1 mt -88.97 -48.61 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.325 0.583 . . . . 0.0 110.139 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 51.4 t30 -134.73 -148.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.754 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.47 ' H ' ' CG ' ' A' ' 82' ' ' ASN . 99.3 mt-10 -88.71 -5.24 58.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -149.23 15.62 0.91 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.632 HG13 ' HB ' ' A' ' 81' ' ' ILE . 3.8 p -144.36 138.31 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.42 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.0 m -134.62 149.87 50.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.11 0.481 . . . . 0.0 111.847 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.672 ' HB2' HD11 ' A' ' 81' ' ' ILE . 63.6 tp -119.52 131.12 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.435 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.442 ' CB ' HG22 ' A' ' 78' ' ' VAL . 52.4 p90 -142.29 158.79 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.866 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.19 148.54 17.42 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.6 mt -119.16 135.9 54.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.98 146.83 31.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.599 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.86 -145.45 8.46 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.136 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.37 152.24 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.56 147.21 16.61 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -134.79 144.96 47.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.736 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.69 145.86 17.42 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.666 -179.919 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.771 0.319 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.6 t -148.64 149.84 32.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.638 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 115' ' ' LEU . 2.7 mp -99.69 142.91 30.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.614 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.21 132.76 55.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.99 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -145.97 134.13 21.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.138 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.31 -169.68 34.53 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.806 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.66 159.27 44.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.016 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.54 169.31 31.06 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.805 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.421 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.6 OUTLIER -142.44 160.24 40.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.919 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.51 ' NE2' ' OD1' ' A' ' 132' ' ' ASP . 63.7 tt0 -140.34 137.41 34.07 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.616 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.421 ' CE2' ' CD1' ' A' ' 121' ' ' LEU . 69.6 m-85 -115.5 149.01 38.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.683 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -129.89 83.02 65.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.949 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.4 -22.8 24.56 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.72 1.613 . . . . 0.0 111.71 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.524 ' ND1' ' OD1' ' A' ' 128' ' ' ASN . 65.7 t-80 -150.14 136.4 10.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.482 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.99 -39.43 50.07 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.921 1.747 . . . . 0.0 113.89 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.524 ' OD1' ' ND1' ' A' ' 126' ' ' HIS . 54.7 p30 -84.14 -0.7 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.62 126.67 13.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.394 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 152.69 34.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.451 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.9 mt -114.51 125.85 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NE2' ' A' ' 122' ' ' GLN . 97.8 m-20 -105.73 132.46 51.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.193 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -136.14 127.33 28.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.781 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.8 t -158.03 151.62 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.858 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -139.07 149.16 44.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.683 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -142.46 153.57 43.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.775 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.59 147.26 49.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.163 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.7 t . . . . . 0 C--N 1.332 -0.187 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.324 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--O 1.231 0.122 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.93 146.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.144 -0.623 . . . . 0.0 112.223 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.31 152.45 17.74 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 91.2 m -125.28 131.86 53.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 111.558 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -125.94 123.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.897 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 149' ' ' MET . 2.5 mpp? -117.47 129.57 55.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.932 0.396 . . . . 0.0 111.012 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -143.27 131.78 22.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.982 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.642 ' N ' HD13 ' A' ' 150' ' ' LEU . . . -178.56 -169.03 38.74 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.575 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.42 155.86 47.34 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.88 -169.62 14.05 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.789 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -148.61 163.09 38.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.123 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.517 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.7 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.746 0.307 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.6 m -124.45 141.98 51.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.536 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.89 124.3 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -128.88 140.75 51.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.026 0.441 . . . . 0.0 111.311 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.512 HG22 HD22 ' A' ' 31' ' ' LEU . 45.8 pt -132.82 156.49 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.746 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.17 -174.18 38.76 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.119 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -113.72 145.91 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.7 140.99 38.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HG2' HD21 ' A' ' 25' ' ' ASN . 3.0 mp0 -131.69 138.1 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.696 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.447 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 67.2 m -117.33 109.39 16.77 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.239 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -68.66 129.15 39.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.02 129.43 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.635 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm . . . . . 0 C--N 1.333 -0.113 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.864 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.407 HD21 ' HG2' ' A' ' 12' ' ' GLN . 49.7 t-20 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.447 ' CD ' ' O ' ' A' ' 13' ' ' SER . 96.2 Cg_endo -84.73 160.42 12.23 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.766 2.311 . . . . 0.0 111.44 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.81 135.43 39.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.73 169.75 35.15 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.97 143.85 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.426 ' OD1' ' SD ' ' A' ' 149' ' ' MET . 29.5 t-20 -117.61 119.09 33.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.512 HD22 HG22 ' A' ' 8' ' ' ILE . 88.3 mt -122.92 136.89 55.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.833 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -148.24 155.9 41.91 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -133.07 146.8 52.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.16 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -126.97 131.14 51.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.795 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.91 139.8 52.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.176 179.443 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.42 143.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.348 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -132.64 137.25 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.08 142.57 16.19 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -126.21 143.93 50.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.932 0.396 . . . . 0.0 111.102 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -130.08 146.01 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.807 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.41 141.55 35.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.03 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -128.79 137.28 51.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.21 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.4 m -128.06 134.9 49.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -146.38 143.99 29.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.874 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.832 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.587 0.232 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -132.22 115.99 16.39 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -134.46 129.29 35.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.279 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.06 160.82 40.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.287 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -147.59 145.02 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.092 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.29 126.96 74.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.121 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -132.85 156.64 46.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.53 154.81 29.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.36 170.66 43.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.477 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.4 154.46 50.81 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.21 2.607 . . . . 0.0 113.041 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.5 t -127.89 130.97 70.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -127.15 146.42 50.4 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.175 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.79 126.77 52.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.6 tt -80.18 -37.42 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.72 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 84' ' ' TYR . 57.4 t30 -156.72 31.72 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.761 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 68.52 -42.66 0.48 Allowed 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.855 0.722 . . . . 0.0 109.812 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 82' ' ' ASN . 66.5 t80 -63.96 -40.61 96.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.415 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 84' ' ' TYR . 92.6 t -126.93 135.61 63.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.402 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.2 t -129.05 134.77 48.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.02 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.0 tp -110.62 127.96 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.269 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.98 159.33 42.44 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.967 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.52 145.33 16.01 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -120.13 137.16 54.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.622 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.2 152.25 38.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.765 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.14 -147.13 9.76 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.348 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.95 150.57 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 0.0 110.96 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.75 139.76 15.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -145.95 135.03 22.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.15 158.94 27.85 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.771 0.319 . . . . 0.0 110.386 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 93.1 m . . . . . 0 CA--C 1.528 0.109 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.7 t -148.96 150.73 33.36 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.027 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.49 140.93 32.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.54 132.69 56.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.895 0.379 . . . . 0.0 110.711 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -151.01 160.26 44.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.087 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.34 -166.78 39.97 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.727 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.18 156.77 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.0 170.28 30.06 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.597 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.95 156.38 46.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.375 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -132.0 129.18 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -115.12 148.21 39.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.796 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 55.6 t-20 -129.37 81.85 69.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.406 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -28.18 14.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.896 1.731 . . . . 0.0 112.131 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 70.6 m80 -135.68 148.18 64.45 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.079 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.81 -24.01 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.25 1.967 . . . . 0.0 112.854 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -99.96 4.52 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.777 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.65 128.66 8.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 153' ' ' GLY . 29.1 m -131.98 152.78 37.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.29 148.12 27.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 133' ' ' ALA . 52.8 t0 -146.31 138.88 25.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.692 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.472 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -148.35 150.83 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.056 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 149' ' ' MET . 85.8 p -153.38 161.57 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.752 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -127.14 128.03 45.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.759 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -132.07 147.62 52.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.251 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -130.42 147.91 52.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.204 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--O 1.236 0.355 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.866 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 87.2 t -128.31 130.61 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.134 0.492 . . . . 0.0 112.28 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.31 138.02 14.54 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.6 m -111.56 132.77 54.3 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.165 0.483 . . . . 0.0 111.846 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -112.0 135.82 52.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.124 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.426 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 53.9 ttp -131.54 125.55 32.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.891 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.1 tp -143.04 129.82 20.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.711 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -176.81 -176.18 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.073 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.84 158.93 44.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -142.51 174.79 23.25 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.751 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -123.06 130.15 52.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.369 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.342 -179.892 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.85 177.54 54.34 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -71.04 141.14 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.805 0.336 . . . . 0.0 110.612 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 156' ' ' PHE . 63.5 m -129.8 154.64 47.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -126.5 138.69 53.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.2 mm -112.33 126.8 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -139.2 143.09 37.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.417 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.94 148.72 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.049 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.04 172.1 36.47 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -83.34 143.66 30.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -126.41 127.0 44.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.961 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -134.01 139.27 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.912 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 40.7 t -117.7 106.99 13.65 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 146' ' ' GLY . 80.0 ttt180 -68.84 128.78 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.82 150.01 32.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.071 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -80.4 129.47 34.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.87 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' OE2' HD13 ' A' ' 64' ' ' ILE . 23.3 tp10 -148.28 164.15 34.89 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.214 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.76 -39.98 86.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.579 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.64 15.93 0.03 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.221 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 21' ' ' LYS . 90.0 t80 -62.39 134.05 55.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.307 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' TYR . 0.4 OUTLIER 50.17 178.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.204 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.38 -52.38 5.41 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.215 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 59.5 p30 -99.42 7.01 45.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.551 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 50.26 33.69 7.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.816 0.341 . . . . 0.0 110.142 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.517 ' ND2' ' OD2' ' A' ' 23' ' ' ASP . 74.8 m-20 -103.05 115.17 64.53 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.51 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 13' ' ' SER . 92.5 Cg_endo -78.16 159.98 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.402 2.068 . . . . 0.0 111.437 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -95.81 127.98 42.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.793 0.33 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.29 171.55 35.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.82 146.59 50.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.489 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 10.7 t30 -121.89 120.8 35.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 tp -105.53 124.1 48.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.557 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.96 139.91 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.014 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -133.63 126.91 31.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.449 HH12 ' CD ' ' A' ' 122' ' ' GLN . 43.1 ttm180 -110.38 131.64 54.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.641 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -116.02 137.7 51.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.017 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 59.42 65.85 1.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.742 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -58.97 -49.03 79.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.283 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 m120 41.05 -126.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.603 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.42 ' OD1' ' NE ' ' A' ' 80' ' ' ARG . 55.4 t30 -158.86 -55.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.826 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.72 -40.89 96.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -153.78 163.86 39.31 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.355 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.94 175.86 44.52 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.61 156.75 42.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -142.61 140.16 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 111.237 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.35 147.0 18.29 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.6 t -126.99 130.82 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.202 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -125.36 136.23 53.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.527 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.09 148.16 33.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.374 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -151.11 149.44 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.67 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.9 t -152.15 162.46 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.919 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -149.03 141.02 23.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.578 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -69.98 137.63 51.58 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.49 84.76 0.1 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 55' ' ' GLU . 91.5 t80 -111.42 135.85 51.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 80.8 mm-40 -59.44 144.83 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.209 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.31 132.87 50.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.075 0.464 . . . . 0.0 111.089 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 t -150.81 147.45 27.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.862 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.69 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.6 p -97.81 102.1 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.608 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -107.06 -18.24 13.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.278 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.88 -9.14 78.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 62' ' ' LYS . 97.4 m-85 -105.85 7.45 32.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.447 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 61' ' ' PHE . 2.3 mptp? 55.44 164.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.405 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.72 129.17 56.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.541 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.546 HD13 ' OE2' ' A' ' 17' ' ' GLU . 91.8 mt -62.71 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.962 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 46.41 -97.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.91 -19.98 49.8 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.3 t0 48.45 56.73 7.08 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.281 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -132.22 161.35 33.63 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.847 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -120.41 147.75 44.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.858 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -123.2 131.07 53.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.589 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.48 147.2 49.32 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.625 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.0 t -149.21 142.72 25.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.539 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.54 131.73 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.9 p -137.78 158.27 44.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.991 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.09 152.25 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.7 43.62 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.561 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.6 153.4 54.57 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.358 2.705 . . . . 0.0 112.863 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.58 HG22 ' CB ' ' A' ' 88' ' ' TYR . 91.5 t -126.31 129.57 71.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.727 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.2 t80 -127.11 128.55 46.4 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 59.0 ttm-85 -69.59 134.58 48.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 87' ' ' LEU . 96.6 mt -88.02 -51.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.972 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.415 ' OD1' ' CG1' ' A' ' 85' ' ' VAL . 17.5 m120 -126.71 -137.3 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -97.14 -4.92 38.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.381 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.35 20.04 0.48 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' A' ' 81' ' ' ILE . 5.0 p -144.07 142.1 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.048 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.7 p -138.51 152.93 48.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 111.225 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 81' ' ' ILE . 3.0 tt -121.14 130.02 53.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.467 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.58 ' CB ' HG22 ' A' ' 78' ' ' VAL . 53.4 p90 -140.34 157.73 45.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.848 0.356 . . . . 0.0 110.719 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.17 147.19 18.35 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.624 ' O ' HD22 ' A' ' 91' ' ' LEU . 88.6 mt -114.43 127.91 56.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.677 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -133.61 142.26 48.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.921 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.6 -144.26 7.82 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.09 39.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 0.0 111.095 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.59 143.72 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.4 145.61 50.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 110.802 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -123.29 144.9 15.9 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -125.06 141.74 51.93 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.34 140.69 30.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.408 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.15 134.33 44.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.469 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -95.66 135.88 36.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.018 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.2 p -87.5 114.3 23.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.121 0.486 . . . . 0.0 110.767 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.8 p -163.57 165.84 23.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.828 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.6 mt -106.16 112.56 39.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.527 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -146.89 162.15 39.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.133 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.75 -17.44 57.87 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -137.99 168.45 19.68 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.8 p -108.81 157.16 18.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -125.74 134.21 51.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.735 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.2 t -149.28 147.58 28.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.301 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -129.02 149.25 50.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.802 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.1 m -127.94 152.69 47.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.781 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -126.5 149.48 49.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.485 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.9 m -118.91 127.57 53.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.998 0.428 . . . . 0.0 110.948 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.1 m -135.41 154.06 51.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.309 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.79 144.65 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.0 125.72 32.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -150.58 160.39 43.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.717 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.23 -165.01 35.78 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.732 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . . . -155.14 158.49 39.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.642 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.37 166.8 33.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 pp -143.2 159.58 42.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.839 0.352 . . . . 0.0 110.74 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.449 ' CD ' HH12 ' A' ' 34' ' ' ARG . 54.3 tt0 -117.03 128.64 55.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.182 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -127.98 126.74 41.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.447 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.83 ' OD1' HG13 ' A' ' 130' ' ' VAL . 63.3 m-20 -118.99 93.19 46.43 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.44 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.13 -27.62 29.27 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.331 1.354 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -135.14 151.02 74.48 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.953 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.24 -36.6 78.46 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.0 1.8 . . . . 0.0 113.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -101.72 14.52 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.17 119.87 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.667 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.83 HG13 ' OD1' ' A' ' 124' ' ' ASN . 98.7 t -125.24 129.23 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.211 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.93 124.42 58.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -107.99 130.27 55.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.214 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -129.99 112.03 13.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.698 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.441 ' OG ' ' OH ' ' A' ' 88' ' ' TYR . 58.0 m -134.66 153.03 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.732 ' OH ' ' HB3' ' A' ' 119' ' ' ALA . 52.8 p90 -144.49 153.61 42.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.505 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.429 ' OE2' HD12 ' A' ' 90' ' ' LEU . 78.1 mm-40 -135.78 152.2 50.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 145' ' ' VAL . 47.4 t80 -143.71 133.09 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.612 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.7 m -111.01 137.76 48.24 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -102.96 109.07 20.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.048 0.451 . . . . 0.0 111.996 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.96 145.63 45.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -59.69 -43.24 94.15 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.826 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 59.5 t0 -103.75 -32.03 9.55 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.2 t -104.33 129.05 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -106.64 126.26 52.05 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.473 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 58.4 t -119.85 125.64 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.408 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 14' ' ' ARG . . . -118.67 125.31 6.36 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.4 m -129.58 137.32 50.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 111.865 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -133.91 151.02 51.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 64.7 mtt -133.43 137.48 45.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -136.06 129.6 32.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.94 40.15 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.814 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.12 161.02 42.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.416 -0.392 . . . . 0.0 109.97 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.79 -178.05 27.02 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.522 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.63 146.0 49.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.373 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -86.69 127.97 34.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.454 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' A' ' 4' ' ' SER . 82.1 t80 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.478 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.98 -178.09 48.35 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -71.95 138.0 47.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 110.28 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p -150.83 163.5 38.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.654 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -138.39 146.78 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 tt -120.44 138.2 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -128.08 148.66 50.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.56 151.81 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.222 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.21 -174.47 38.36 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.591 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -116.39 149.29 39.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.42 132.93 54.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -122.08 121.73 37.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.364 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.9 m -118.19 168.47 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.784 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -138.15 143.71 40.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 24' ' ' LYS . 35.1 m -131.46 149.41 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.207 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.21 137.59 54.12 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -163.39 176.69 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.43 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.49 -43.83 93.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.093 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.41 98.88 1.77 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -75.48 144.3 42.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.037 0.446 . . . . 0.0 111.002 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -91.45 179.4 5.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.91 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.05 -49.39 77.85 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.978 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.636 ' C ' ' H ' ' A' ' 25' ' ' ASN . 96.9 m-20 -112.55 -14.08 13.25 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.688 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.699 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.5 OUTLIER 55.09 -6.67 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.367 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.636 ' H ' ' C ' ' A' ' 23' ' ' ASP . 34.3 m120 -105.11 113.82 64.25 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 119.45 -0.309 . . . . 0.0 111.363 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.81 156.12 27.22 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.467 1.444 . . . . 0.0 111.484 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -95.33 138.96 32.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.621 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.72 -168.31 20.68 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.24 160.07 41.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 47' ' ' PHE . 16.4 t-20 -135.72 131.68 35.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.027 0.441 . . . . 0.0 112.028 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.35 136.76 53.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.822 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -125.53 140.36 52.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.551 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -127.08 144.81 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.342 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -123.3 132.07 53.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.391 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.486 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 95.1 m-85 -127.42 149.11 50.23 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.33 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 9.5 tp10 81.45 163.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -72.38 145.87 47.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.671 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.505 ' CG ' HH21 ' A' ' 80' ' ' ARG . 53.6 p30 -84.56 4.84 30.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.463 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 62.9 t-20 -84.42 112.38 20.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.445 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 39' ' ' ASN . 11.3 t0 86.82 -66.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.694 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -152.95 162.87 40.79 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.067 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.57 -175.95 37.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.14 154.82 40.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.827 0.346 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.25 142.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.748 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.67 150.76 17.93 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 t -136.97 137.21 39.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.577 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 92.7 m-85 -128.49 141.01 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.81 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.76 148.74 34.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -143.08 128.84 19.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.8 p -129.33 156.17 44.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.529 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.452 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -83.95 119.33 24.77 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.769 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.93 137.62 3.45 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 90.6 t80 -112.11 73.71 0.83 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.603 0.239 . . . . 0.0 110.507 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' OE2' HD13 ' A' ' 63' ' ' LEU . 24.2 pt-20 -162.72 159.5 24.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.036 0.446 . . . . 0.0 111.016 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.18 154.27 28.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.7 t -78.83 133.77 37.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.6 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 59' ' ' ASP . 34.1 m -130.64 160.74 41.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.032 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 10.4 t0 76.91 -16.56 0.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.157 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.82 89.47 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.86 8.88 42.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 0.0 110.548 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 55.12 -165.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.715 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.405 HD13 ' OE2' ' A' ' 55' ' ' GLU . 86.7 mt -120.05 153.46 36.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.483 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 tt -53.35 -24.26 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.947 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.87 -38.23 84.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.29 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.76 -5.39 73.09 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 54.42 42.75 31.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.672 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -71.41 133.24 45.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.279 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -115.62 143.48 45.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.705 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.529 ' CE2' ' OG ' ' A' ' 72' ' ' SER . 83.5 t80 -127.65 121.39 30.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.14 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.23 133.91 55.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.529 ' OG ' ' CE2' ' A' ' 70' ' ' TYR . 67.1 m -134.65 141.37 46.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.34 134.96 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.008 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -140.57 158.67 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -158.7 152.41 23.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.53 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.58 164.7 35.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.665 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.99 160.61 36.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 123.166 2.577 . . . . 0.0 112.578 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 88' ' ' TYR . 10.7 p -135.26 135.69 51.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.236 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.0 t80 -127.69 129.68 47.56 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.505 HH21 ' CG ' ' A' ' 38' ' ' ASN . 62.4 ttm-85 -71.85 128.68 36.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.22 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 87' ' ' LEU . 96.3 mt -89.66 -51.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -127.86 -155.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.65 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.74 -39.99 93.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.293 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -140.87 35.01 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.155 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.1 t -127.77 126.29 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.9 m -130.67 142.54 50.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HB2' HD11 ' A' ' 81' ' ' ILE . 62.8 tp -122.73 129.93 52.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.455 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' A' ' 78' ' ' VAL . 52.9 p90 -142.01 159.46 42.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.875 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.8 151.75 18.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.7 119.08 27.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.557 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -138.12 151.55 47.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.955 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -143.89 7.63 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.65 153.44 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 0.0 110.956 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.53 145.57 16.81 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -133.93 125.16 27.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.643 0.258 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.15 143.02 15.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -114.78 126.74 55.18 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.357 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.79 148.45 35.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.433 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.9 147.28 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.598 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -104.07 120.51 41.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.4 t -91.41 117.21 29.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 111.503 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.1 p -163.31 165.92 23.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.899 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.6 mt -100.22 112.83 33.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.079 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -149.46 173.74 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.282 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.81 -38.24 93.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -137.34 163.49 30.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.7 p -109.34 157.28 19.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.904 0.383 . . . . 0.0 110.825 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.5 154.33 48.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.692 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.4 m -118.44 150.86 38.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.311 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.32 151.15 49.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.577 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.9 p -149.03 161.11 42.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.82 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -129.24 150.62 50.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p -126.08 150.06 48.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.9 p -155.17 163.59 39.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.525 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -99.31 133.89 42.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.475 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.68 129.95 55.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.645 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -147.67 133.57 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -178.6 -169.98 40.04 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.41 158.58 44.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.623 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.18 169.6 33.21 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.82 162.3 40.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -141.69 151.68 43.22 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.22 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.09 147.05 41.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.617 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 39.1 t-20 -128.57 82.24 69.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.992 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.93 -26.56 15.27 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.809 1.673 . . . . 0.0 111.563 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 98.4 m-70 -135.14 148.53 66.99 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.771 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.66 -21.84 33.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.184 1.923 . . . . 0.0 113.098 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -100.03 -0.1 39.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.83 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -145.27 130.62 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.065 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 153' ' ' GLY . 3.5 p -139.81 145.5 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.726 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.09 123.92 69.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.279 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -110.98 137.03 49.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -146.39 141.87 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.878 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.5 p -157.9 161.34 38.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.129 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.27 130.45 46.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.834 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -135.58 141.83 45.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 110.417 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -131.9 145.38 51.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.69 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.8 m -109.91 127.14 54.55 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -107.11 106.78 17.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.861 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -118.17 151.15 38.16 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.775 ' H ' HD23 ' A' ' 140' ' ' LEU . 98.2 m-20 -60.29 -42.76 96.14 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.45 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -104.85 -32.61 8.73 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.535 HG12 HG23 ' A' ' 145' ' ' VAL . 68.7 t -105.71 121.47 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.8 116.38 31.84 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 15' ' ' VAL . 84.8 t -131.31 131.67 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.022 0.439 . . . . 0.0 112.016 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.32 143.6 16.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.9 m -124.77 130.38 52.29 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -116.91 136.14 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.548 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.527 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 79.4 mtm -131.58 127.81 37.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.404 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.6 tp -143.22 129.95 20.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.867 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.12 178.57 44.24 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.71 145.8 46.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -108.61 148.78 16.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.506 ' CE2' ' O ' ' A' ' 155' ' ' ARG . 91.8 t80 -134.45 130.05 36.16 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.506 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 85.7 mtp180 -75.55 144.34 41.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.649 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 156' ' ' PHE . 46.2 p90 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.642 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.17 162.95 54.59 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -71.59 136.69 47.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 0.0 110.685 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.5 m -133.17 151.39 51.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.592 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 t -119.54 133.45 55.66 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.453 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.27 131.96 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.865 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -139.89 155.42 47.2 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.996 0.427 . . . . 0.0 110.818 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.8 mt -124.94 130.18 73.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.205 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.69 154.05 22.42 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.638 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.24 148.75 27.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -125.36 138.74 54.05 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 110.901 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -143.39 142.51 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.106 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.446 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 44.3 t -117.87 167.91 10.98 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.158 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -134.8 120.9 19.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.623 HG12 HG22 ' A' ' 145' ' ' VAL . 34.9 m -132.76 149.87 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.994 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -124.0 124.34 42.35 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.169 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -163.54 170.63 16.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.83 137.19 58.13 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.418 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.23 28.62 72.54 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -53.97 147.06 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.209 0.528 . . . . 0.0 111.508 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -70.62 156.73 39.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.408 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.3 -46.18 86.6 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.668 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 25' ' ' ASN . 96.9 m-20 -92.83 -13.25 29.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.494 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 50.33 7.94 0.03 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.632 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 23' ' ' ASP . 70.3 m-20 -105.81 113.67 63.63 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 13' ' ' SER . 91.3 Cg_endo -82.48 159.06 16.98 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 122.011 1.807 . . . . 0.0 110.691 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -97.79 131.39 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.76 0.315 . . . . 0.0 110.711 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.585 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -156.81 176.05 34.2 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.96 149.18 49.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.727 0.298 . . . . 0.0 110.33 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 10.1 t30 -133.61 124.61 27.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.205 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.46 138.59 45.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.757 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.68 139.9 53.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.89 143.37 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.672 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.637 HH12 ' NE2' ' A' ' 122' ' ' GLN . 61.6 ttp180 -131.96 131.63 42.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 111.036 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -129.32 143.09 50.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -118.66 120.47 37.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -108.78 2.62 21.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.557 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -160.02 162.34 34.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.526 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 54.1 p30 -88.77 2.63 53.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.967 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -135.36 7.52 3.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.758 0.313 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -153.25 139.85 18.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.679 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.27 165.83 26.93 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.3 142.84 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.438 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -136.99 136.41 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.83 143.11 14.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.9 m -130.48 147.9 52.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.234 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -127.69 141.81 51.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.454 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.04 33.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.27 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -145.86 124.93 12.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.585 HG22 ' HA3' ' A' ' 28' ' ' GLY . 82.4 p -128.89 157.73 40.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.379 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -145.29 128.6 16.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.302 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' NH2' ' CG2' ' A' ' 15' ' ' VAL . 64.0 ttm-85 -83.31 134.76 34.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.235 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' GLU . . . 72.19 29.48 66.48 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 73.6 t80 -60.73 77.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.09 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 53' ' ' GLY . 88.4 tt0 -156.75 144.48 19.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.165 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -58.15 129.49 42.23 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.232 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -150.03 149.7 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.689 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.34 126.35 70.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.493 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 t0 75.34 -50.88 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.566 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . 81.51 2.92 90.7 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.01 -48.85 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.88 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.72 -41.24 99.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.357 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 60' ' ' GLY . 87.9 mt -123.51 127.05 47.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.78 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.872 HG22 ' H ' ' A' ' 66' ' ' GLY . 95.2 mt -62.13 -44.94 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.151 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 67' ' ' ASP . 66.2 m-20 58.97 1.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.77 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.872 ' H ' HG22 ' A' ' 64' ' ' ILE . . . 69.32 -41.87 0.39 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 65' ' ' ASP . 54.1 t0 51.74 48.18 23.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.33 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 66' ' ' GLY . 69.7 m-85 -125.99 149.44 48.8 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -119.55 143.61 47.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.664 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -124.98 138.0 54.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.969 0.414 . . . . 0.0 110.995 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -144.89 132.67 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.797 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.6 p -147.49 158.57 44.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.67 141.6 23.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.7 t -150.47 149.56 30.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 111.298 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.82 155.02 32.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.299 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -166.82 171.09 41.59 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.39 148.77 55.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.019 2.479 . . . . 0.0 112.442 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.59 HG22 ' CB ' ' A' ' 88' ' ' TYR . 71.9 t -126.53 130.06 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -122.87 136.73 54.97 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 39' ' ' ASN . 96.5 mtm-85 -86.22 131.71 34.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.962 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.595 ' HB ' HG13 ' A' ' 85' ' ' VAL . 96.6 mt -88.28 -50.99 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.235 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 84' ' ' TYR . 56.9 t30 -139.97 34.37 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.911 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 56.54 1.8 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.825 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 82' ' ' ASN . 64.7 m-85 -120.87 -20.71 6.84 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.165 0.507 . . . . 0.0 109.666 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.595 HG13 ' HB ' ' A' ' 81' ' ' ILE . 6.7 p -144.28 140.57 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.462 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.3 t -136.62 141.42 43.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 134.46 51.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.885 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.59 ' CB ' HG22 ' A' ' 78' ' ' VAL . 54.7 p90 -144.26 159.33 42.87 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.15 152.07 17.39 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.41 126.9 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.2 tp -129.27 126.71 39.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.722 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.13 -155.65 18.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.481 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -148.69 155.86 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.897 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.66 140.41 14.84 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -126.76 120.64 29.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.44 141.71 15.68 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -126.21 142.79 51.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.966 0.412 . . . . 0.0 111.062 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -137.97 126.86 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.937 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -132.28 146.13 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -112.81 135.5 53.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.7 t -98.66 114.22 26.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.45 . . . . 0.0 110.627 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HG ' ' HD2' ' A' ' 104' ' ' PHE . 91.0 p -163.64 167.86 20.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.933 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.9 mm -105.79 112.58 39.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.044 0.45 . . . . 0.0 110.682 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HD2' ' HG ' ' A' ' 102' ' ' SER . 63.6 m-85 -147.76 173.25 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.349 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.86 -37.53 92.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -137.39 160.54 38.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.659 0.266 . . . . 0.0 110.374 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.7 m -110.11 159.32 17.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -139.06 154.83 48.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.167 0.508 . . . . 0.0 111.179 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.4 t -155.32 151.67 28.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.009 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -127.43 153.69 45.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.874 0.368 . . . . 0.0 110.998 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 89.3 p -147.37 163.23 37.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.514 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -125.51 148.27 48.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.2 m -121.69 131.39 54.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.556 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.474 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 93.4 p -151.68 165.58 33.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.557 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.95 140.79 29.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.476 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.46 131.62 56.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.832 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.1 132.92 29.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.64 178.41 34.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.487 -0.864 . . . . 0.0 111.61 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.52 155.13 39.84 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.446 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -144.4 155.38 26.29 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.56 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.868 HD22 ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -109.43 143.44 39.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.666 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.637 ' NE2' HH12 ' A' ' 34' ' ' ARG . 46.0 tt0 -119.87 123.72 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.288 . . . . 0.0 110.971 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.976 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.569 ' CG ' HG12 ' A' ' 130' ' ' VAL . 59.9 t-20 -137.82 81.78 27.61 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.44 -28.17 18.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.661 1.574 . . . . 0.0 111.653 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 129' ' ' PHE . 97.9 m-70 -131.74 124.55 19.91 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.003 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -50.24 -33.74 37.37 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.79 1.66 . . . . 0.0 112.938 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -81.51 -12.09 58.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 126' ' ' HIS . 92.5 t80 -142.66 129.74 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.969 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.569 HG12 ' CG ' ' A' ' 124' ' ' ASN . 34.2 m -130.74 152.81 38.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.0 mt -117.1 125.8 74.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.268 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -116.95 113.82 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.34 128.15 54.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.074 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.4 p -157.34 161.11 39.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.984 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -149.83 156.0 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.277 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -145.24 156.32 43.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.162 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.55 159.22 43.44 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.156 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.3 t -119.03 136.64 54.02 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.576 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -102.61 109.03 20.51 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.037 0.446 . . . . 0.0 112.055 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.479 HD23 ' H ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -118.39 146.42 44.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.479 ' H ' HD23 ' A' ' 140' ' ' LEU . 98.3 m-20 -60.4 -42.29 95.61 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.984 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -103.37 -31.99 9.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 145' ' ' VAL . 79.6 t -105.28 126.59 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -107.04 120.27 41.62 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.623 HG22 HG12 ' A' ' 15' ' ' VAL . 99.8 t -125.52 128.04 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.086 0.469 . . . . 0.0 112.146 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -124.48 129.63 7.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.9 m -126.47 132.38 51.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 111.854 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -116.84 141.1 48.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.454 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 78.2 mtm -128.66 137.74 51.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.01 0.433 . . . . 0.0 111.257 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -142.79 131.4 22.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.814 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -164.0 177.81 39.64 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.962 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.98 158.66 44.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.35 -160.56 13.78 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.07 160.36 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.939 0.4 . . . . 0.0 110.879 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -102.71 126.38 49.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.386 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.4 t80 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.54 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.5 -176.26 46.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.99 141.85 52.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.525 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 t -149.91 147.76 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.665 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -132.61 138.21 47.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.486 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -127.76 138.91 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.707 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -149.79 145.5 26.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.78 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.56 159.23 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.96 -178.21 40.26 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.709 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.81 144.65 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -125.3 136.55 53.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.111 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -131.53 145.13 51.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.634 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 t -116.56 166.86 11.61 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -125.5 123.46 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -120.88 127.65 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.875 0.369 . . . . 0.0 111.54 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -117.52 121.56 41.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.828 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -140.8 176.88 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.384 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.74 -39.81 86.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.79 142.96 20.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -91.12 151.34 21.03 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.206 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.579 ' CE ' HH22 ' A' ' 52' ' ' ARG . 11.9 tptp -124.52 153.09 42.6 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.11 -50.62 72.99 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.633 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.608 ' C ' ' H ' ' A' ' 25' ' ' ASN . 58.7 p30 -116.04 -14.38 11.21 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 63.5 mttp 53.62 -2.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.081 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 23' ' ' ASP . 69.5 m-20 -105.79 114.44 62.85 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.61 159.01 16.64 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.079 1.853 . . . . 0.0 110.473 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.441 HH21 ' N ' ' A' ' 54' ' ' PHE . 96.3 mtm-85 -99.77 137.6 38.01 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.849 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.68 177.87 36.91 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.79 147.5 47.5 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.329 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 29.6 t-20 -132.77 123.84 26.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.034 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.741 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 98.8 mttt -121.98 140.77 52.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -140.86 128.55 21.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.235 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 122' ' ' GLN . 80.1 ttt180 -124.71 132.24 53.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.807 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -118.84 127.68 53.74 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -76.37 73.9 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.04 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.3 -48.54 81.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.067 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 41' ' ' TRP . 63.1 t30 -152.01 149.38 28.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.043 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 37.8 p-10 -61.92 -41.64 98.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.633 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 67.8 t0 -64.23 -47.03 81.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.828 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' ASN . 96.5 m95 -132.39 144.98 50.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.76 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.22 163.2 19.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.63 127.34 75.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 110.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -136.42 137.44 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.28 149.4 19.43 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -137.4 139.8 40.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.94 139.43 49.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.569 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.71 139.4 43.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.994 0.425 . . . . 0.0 111.413 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -143.67 130.25 20.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.842 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -128.4 158.09 39.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.791 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -158.25 158.01 33.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.1 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.579 HH22 ' CE ' ' A' ' 21' ' ' LYS . 76.7 mtp85 -83.25 121.91 27.72 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.82 150.3 14.4 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.441 ' N ' HH21 ' A' ' 27' ' ' ARG . 91.4 t80 -111.9 116.03 29.97 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -161.27 158.92 27.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -66.72 134.04 51.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.458 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -104.53 125.37 50.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.588 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -119.87 126.92 75.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.526 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 t0 72.14 -48.38 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.628 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.69 1.83 90.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -59.95 -48.88 79.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.555 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -75.62 142.54 42.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.484 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.81 2.15 40.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 66' ' ' GLY . 20.3 tt -57.95 -19.63 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 59.3 p30 -61.06 70.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.344 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 64' ' ' ILE . . . 90.21 -9.9 75.93 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 55.34 13.55 0.92 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.623 0.249 . . . . 0.0 110.677 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -140.51 129.72 23.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.691 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -134.35 128.45 33.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.277 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -130.22 128.01 40.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -136.5 131.01 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.211 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -147.83 159.69 43.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.943 0.402 . . . . 0.0 110.812 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.05 143.37 30.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.524 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.614 HG21 HD23 ' A' ' 90' ' ' LEU . 9.4 t -147.21 147.78 30.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.982 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.15 156.08 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.338 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.41 171.54 43.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 154.84 57.06 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.206 2.604 . . . . 0.0 112.314 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 88' ' ' TYR . 97.7 t -122.28 127.59 75.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -107.16 122.6 46.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.518 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 8.3 tmm_? -89.56 129.13 36.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.7 mp -89.35 -51.6 11.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.484 -0.486 . . . . 0.0 109.774 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -154.67 38.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.549 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.518 ' H ' ' CG ' ' A' ' 80' ' ' ARG . 4.3 tm-20 72.57 -49.58 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.053 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -71.04 -29.7 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.399 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.2 t -127.44 132.43 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.696 0.284 . . . . 0.0 110.974 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.409 ' OG ' ' CG1' ' A' ' 78' ' ' VAL . 45.0 t -138.51 135.24 34.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.281 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -108.73 130.23 55.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.067 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.467 ' HB3' HG22 ' A' ' 78' ' ' VAL . 52.2 p90 -139.5 158.1 44.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.451 . . . . 0.0 111.155 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.09 151.39 16.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 74' ' ' THR . 8.7 mp -111.03 129.32 55.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.44 . . . . 0.0 110.897 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -138.01 125.93 22.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.587 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.63 ' C ' ' HB3' ' A' ' 116' ' ' ALA . . . -179.29 -154.39 13.03 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.386 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.15 38.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.787 0.327 . . . . 0.0 110.696 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.66 147.86 16.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -129.7 122.4 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.35 140.97 16.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -134.88 129.83 35.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.52 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.92 136.57 53.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.355 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -132.49 131.55 41.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.407 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -95.12 122.91 38.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.3 t -86.96 117.09 25.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.118 0.485 . . . . 0.0 111.279 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.474 ' HG ' ' HE2' ' A' ' 104' ' ' PHE . 90.4 p -163.25 166.59 23.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.951 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.1 mt -106.99 112.61 40.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.168 0.508 . . . . 0.0 110.788 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.474 ' HE2' ' HG ' ' A' ' 102' ' ' SER . 63.2 m-85 -147.13 162.35 39.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.172 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.3 95.51 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -112.3 158.3 19.93 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.7 p -109.34 157.74 18.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 110.902 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -129.58 151.27 50.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.705 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 96.0 p -153.56 162.41 41.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.29 150.56 52.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.804 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.1 t -138.06 136.92 37.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.332 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.03 151.81 51.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.972 0.415 . . . . 0.0 111.236 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.5 t -132.4 149.01 52.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.629 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -150.64 158.38 44.08 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.363 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.0 127.58 47.43 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.63 ' HB3' ' C ' ' A' ' 92' ' ' GLY . . . -92.17 114.55 27.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.109 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -145.59 130.71 18.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.846 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -177.24 -169.95 39.03 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.634 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.26 158.46 36.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.404 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -152.26 159.12 28.2 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.89 148.12 43.88 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.674 0.273 . . . . 0.0 110.628 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.523 ' OE1' ' NH1' ' A' ' 34' ' ' ARG . 63.3 tt0 -119.81 132.55 55.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -126.45 147.48 49.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.728 ' OD1' HG23 ' A' ' 130' ' ' VAL . 69.5 m-20 -128.48 82.03 69.42 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.47 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.51 -41.27 74.75 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.497 2.131 . . . . 0.0 112.171 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.38 153.64 71.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.148 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.12 -38.0 80.27 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.945 1.764 . . . . 0.0 113.082 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -90.98 6.13 45.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -142.73 130.99 22.07 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.15 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.728 HG23 ' OD1' ' A' ' 124' ' ' ASN . 3.8 p -136.3 138.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -131.03 141.98 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.949 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.439 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -145.67 160.19 42.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.12 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -149.52 149.93 31.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.741 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.7 p -155.8 163.49 39.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 110.726 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -140.72 151.08 44.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.175 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 147' ' ' THR . 14.6 tm-20 -143.54 138.07 28.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.857 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -144.81 160.03 41.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.638 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.6 t -125.24 143.06 51.13 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.563 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -105.66 104.67 14.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.907 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.55 147.29 43.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -59.92 -43.92 94.61 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.966 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 143' ' ' VAL . 54.5 p-10 -104.55 -29.59 10.56 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 81.9 t -105.24 124.13 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -107.84 122.57 47.06 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.6 129.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.916 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.1 139.29 10.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 136' ' ' GLU . 88.2 m -131.25 133.16 45.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.623 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.547 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.438 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 24.7 ptp -139.18 149.74 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.063 0.458 . . . . 0.0 111.344 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.35 155.25 44.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.022 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.91 -174.79 42.76 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.85 160.21 42.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.66 -168.7 19.08 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.34 145.99 50.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.417 ' O ' ' OXT' ' A' ' 156' ' ' PHE . 60.1 ttp180 -95.77 125.44 40.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.596 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' A' ' 156' ' ' PHE . 81.6 t80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.569 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.76 -176.86 46.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.426 ' OE1' ' OE1' ' A' ' 36' ' ' GLU . 99.8 mt-10 -70.69 146.34 49.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 0.0 110.484 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 t -148.43 147.46 29.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t -137.68 140.35 40.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.681 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.1 mt -118.12 128.42 75.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -129.34 150.61 50.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -136.92 145.44 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.61 167.56 34.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.494 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -87.24 146.53 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -113.05 126.19 55.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.728 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' N ' ' OE1' ' A' ' 12' ' ' GLN . 25.2 mp0 -125.79 121.3 32.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.842 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -118.54 168.1 11.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -143.74 147.66 34.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.876 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.71 138.65 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -74.36 133.99 42.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 18' ' ' ASP . 21.0 tp10 -146.09 166.24 26.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.086 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 98.4 m-20 -59.74 -40.38 87.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.1 1.77 0.02 OUTLIER Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.18 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 21' ' ' LYS . 96.2 m-85 -73.48 146.25 45.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.575 ' HZ2' ' NH1' ' A' ' 52' ' ' ARG . 97.9 mttt 56.97 125.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.078 0.466 . . . . 0.0 111.412 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.6 tp -62.14 -48.24 80.98 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.644 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.79 -13.16 21.51 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.623 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mttp 50.37 22.54 1.03 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.268 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -104.62 114.1 64.34 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.93 158.89 24.25 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.87 1.713 . . . . 0.0 111.288 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -100.05 148.8 24.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.624 0.25 . . . . 0.0 110.656 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.37 -175.73 38.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -125.41 148.18 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 51.1 t30 -126.04 120.56 30.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.813 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.66 141.17 37.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.68 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' CD ' ' OG ' ' A' ' 46' ' ' SER . 6.0 tppt? -137.25 131.58 32.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.707 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -126.77 142.08 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.96 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -125.56 130.45 51.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -128.73 143.65 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.761 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' OE1' ' OE1' ' A' ' 3' ' ' GLU . 99.5 mt-10 -105.27 116.59 32.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.59 -48.8 80.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.041 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -130.72 -64.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.373 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -168.92 -78.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.711 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.73 -39.71 92.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -100.39 146.69 26.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.252 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.47 178.21 38.33 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.82 158.49 42.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -139.46 135.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.724 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.98 142.65 17.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.423 ' OG ' ' CD ' ' A' ' 32' ' ' LYS . 60.8 m -126.43 142.09 51.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.04 0.448 . . . . 0.0 111.146 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -130.18 142.1 50.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.685 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.09 143.44 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -147.58 130.17 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.222 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.2 p -129.49 159.36 36.54 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.639 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -145.12 140.99 28.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.575 ' NH1' ' HZ2' ' A' ' 21' ' ' LYS . 17.4 mmm180 -63.88 135.9 56.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.04 -173.39 42.24 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -112.1 149.05 32.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.775 0.322 . . . . 0.0 110.324 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 59.0 mp0 -139.6 158.48 44.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.919 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -64.95 154.47 37.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.083 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.517 ' HA ' HD11 ' A' ' 63' ' ' LEU . 66.3 m -77.76 143.94 37.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 110.769 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.29 161.56 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.434 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -58.31 146.99 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.297 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.02 -5.9 76.03 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.2 t80 55.97 106.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 0.0 111.007 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -129.98 -123.94 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.325 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 57' ' ' SER . 83.2 mt 55.14 66.54 1.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.834 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.82 -45.43 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.135 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 44.07 -113.16 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.657 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.7 -7.92 79.03 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.8 t0 53.02 51.22 16.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.745 0.307 . . . . 0.0 110.861 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -73.47 144.99 46.02 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -112.45 139.35 48.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -127.84 128.34 45.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.66 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -136.28 129.82 32.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.903 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -137.68 141.63 41.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 111.308 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.98 130.87 71.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.467 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 12.4 t -149.46 149.96 31.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.092 0.472 . . . . 0.0 111.427 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.92 156.52 33.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.378 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.15 170.03 39.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.456 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.69 149.45 54.83 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.207 2.605 . . . . 0.0 112.893 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.526 HG22 ' CB ' ' A' ' 88' ' ' TYR . 74.6 t -126.48 129.24 71.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.358 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.53 127.35 43.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.352 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -72.53 135.06 45.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.2 mm -86.37 -50.92 13.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.049 0.452 . . . . 0.0 110.228 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 84' ' ' TYR . 6.1 m-20 173.84 165.11 0.19 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.124 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 45.2 -92.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.513 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ASN . 21.5 p90 -144.31 37.71 1.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.392 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -119.64 126.0 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.43 ' O ' HD13 ' A' ' 121' ' ' LEU . 40.7 t -128.97 137.11 51.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.207 0.527 . . . . 0.0 111.175 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -110.28 123.81 50.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.2 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.565 ' N ' HD13 ' A' ' 87' ' ' LEU . 53.2 p90 -142.42 158.9 43.2 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.147 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -124.6 150.88 17.17 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.18 125.08 53.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' C ' ' HG1' ' A' ' 74' ' ' THR . 87.9 mt -122.67 139.64 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.641 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 169.29 -159.18 32.02 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.665 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -146.83 153.21 39.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.95 0.405 . . . . 0.0 110.701 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.6 141.35 15.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.22 144.13 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.726 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -120.99 147.37 17.55 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -127.1 140.61 52.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.977 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.29 143.85 31.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.019 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -134.17 149.44 51.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.984 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.32 138.87 49.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.949 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.0 p -87.31 114.4 23.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.024 0.44 . . . . 0.0 110.611 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.9 t -163.28 149.74 12.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.055 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 103' ' ' ILE . 20.3 tt -100.36 111.86 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.103 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -149.26 160.01 43.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.207 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.65 -39.97 95.85 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -105.17 165.91 10.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.2 p -108.74 156.13 19.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.91 0.386 . . . . 0.0 110.729 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -137.0 139.06 41.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.338 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.2 p -149.92 163.27 38.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.275 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -126.87 133.55 50.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.511 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.6 t -138.44 145.07 40.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.22 152.07 46.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.636 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.3 p -123.29 149.99 44.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.742 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 96.5 p -156.14 167.58 29.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.546 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mp -99.37 143.6 29.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.04 137.33 53.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.434 . . . . 0.0 111.083 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.23 159.61 43.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.681 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.85 -170.25 43.37 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.06 153.19 34.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.412 . . . . 0.0 110.139 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.469 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -149.78 156.5 26.79 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.704 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 120' ' ' GLY . 4.1 mm? -117.96 141.85 48.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.467 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -121.12 126.33 49.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.585 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -127.03 140.04 52.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.232 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -130.25 78.65 74.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.593 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.27 -25.79 11.11 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.141 1.894 . . . . 0.0 111.642 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.1 m-70 -127.33 119.22 21.85 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.899 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 -36.69 45.87 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.772 1.648 . . . . 0.0 113.108 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -82.16 -11.9 58.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' HIS . 89.6 t80 -143.62 129.61 19.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.245 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 152' ' ' ALA . 35.1 m -130.12 153.15 38.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.48 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -119.15 136.91 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.602 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -128.52 114.91 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.975 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.842 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -156.89 164.53 37.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.189 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.58 152.65 40.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 149' ' ' MET . 49.9 mp0 -143.59 154.05 43.17 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.709 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.15 144.14 51.1 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.0 t -138.19 124.47 20.47 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -109.97 140.06 44.4 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.429 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 11.4 tp -110.34 156.52 20.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -49.42 -44.83 45.62 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.597 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -105.97 -33.25 7.98 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.429 ' H ' ' HB3' ' A' ' 140' ' ' LEU . 58.6 t -106.42 135.38 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -102.47 134.5 45.7 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 91.6 t -129.24 133.14 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.954 0.406 . . . . 0.0 112.08 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.79 144.57 15.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.3 p -129.61 148.26 51.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.323 0.582 . . . . 0.0 112.01 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -141.07 137.96 33.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.819 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -139.09 146.36 40.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.578 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -143.24 132.32 23.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.915 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.649 ' N ' HD13 ' A' ' 150' ' ' LEU . . . -170.69 -177.39 40.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.831 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 130' ' ' VAL . . . -148.9 157.45 43.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -140.4 -165.03 10.14 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.43 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -149.13 157.22 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.758 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -78.6 147.11 33.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.129 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.571 179.645 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.59 179.02 48.39 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.5 pm0 -72.21 161.53 30.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 0.0 110.986 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p -149.88 163.95 36.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.209 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.3 p -119.69 154.62 33.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.2 mt -119.59 125.35 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.542 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -136.54 150.81 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -131.63 147.01 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.229 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.06 -179.34 30.16 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -109.28 142.24 40.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.684 0.278 . . . . 0.0 110.292 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -116.32 128.19 55.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HB3' HD22 ' A' ' 25' ' ' ASN . 97.4 mt-30 -124.93 120.29 31.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.165 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.437 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 39.3 t -99.84 106.76 18.65 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.424 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 121.03 16.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.34 125.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.081 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -61.46 125.76 24.94 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.414 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.72 -175.22 4.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.987 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -148.34 111.72 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.325 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.51 -6.79 80.42 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.063 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 21' ' ' LYS . 91.3 m-85 -91.07 127.69 36.59 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.822 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 20' ' ' TYR . 64.2 mttp 41.37 -166.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.757 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.87 -55.55 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.292 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 25' ' ' ASN . 67.2 m-20 -112.12 -13.55 13.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.012 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.47 36.94 20.05 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.347 0.594 . . . . 0.0 110.666 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 23' ' ' ASP . 2.3 m-20 -102.19 136.23 19.48 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.482 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HD2' ' H ' ' A' ' 13' ' ' SER . 71.3 Cg_endo -81.25 160.6 20.24 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.805 2.337 . . . . 0.0 111.147 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -93.49 134.27 35.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.474 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.23 36.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -126.8 149.07 49.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.752 0.31 . . . . 0.0 110.75 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 47' ' ' PHE . 15.9 t-20 -124.63 120.65 32.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.647 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.52 140.55 31.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.498 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 87.6 tttt -136.68 133.18 35.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.048 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.13 146.37 51.08 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.419 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -111.05 132.78 53.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 43' ' ' VAL . 96.8 m-85 -125.37 142.91 51.23 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.396 0.435 . . . . 0.0 110.094 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -82.67 129.16 34.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.455 ' O ' ' O ' ' A' ' 41' ' ' TRP . 93.0 t80 -150.31 130.46 13.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.781 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 37' ' ' PHE . 54.6 t30 46.9 -174.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.127 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -111.29 -32.52 6.72 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.112 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.69 -43.04 94.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.038 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.455 ' O ' ' O ' ' A' ' 37' ' ' PHE . 29.0 p90 -149.76 157.2 42.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.44 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.57 -171.48 20.49 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 35' ' ' TYR . 33.8 m -133.51 149.45 31.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.176 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.48 155.04 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.343 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.08 134.55 7.9 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.0 m -130.22 146.17 51.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.579 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 94.9 m-85 -129.13 145.39 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.465 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.77 138.69 37.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -145.15 127.93 16.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.04 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.6 p -129.88 159.45 36.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.358 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.488 ' NE ' ' HZ3' ' A' ' 69' ' ' LYS . 80.0 ttt180 -151.78 136.36 16.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.583 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -71.65 140.26 49.62 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.117 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.54 140.17 15.62 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -112.57 150.79 30.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.904 0.383 . . . . 0.0 110.598 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -148.49 141.21 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.097 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.01 115.71 4.66 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.156 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 m -149.73 171.78 16.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.571 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.18 153.38 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.999 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 41.5 -158.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.213 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.07 2.9 90.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 56.13 45.41 23.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.773 0.321 . . . . 0.0 110.53 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -69.64 149.33 48.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.412 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 20' ' ' TYR . 88.8 mt -97.17 148.69 22.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.669 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 66' ' ' GLY . 45.9 pt -64.44 -3.1 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.001 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 61.06 -70.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 64' ' ' ILE . . . 92.48 -7.74 77.55 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 52.75 49.77 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.846 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -72.06 146.34 47.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.322 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HZ3' ' NE ' ' A' ' 51' ' ' ARG . 73.2 mmtt -101.02 135.93 41.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.09 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -124.67 133.85 53.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' A' ' 95' ' ' HIS . 87.5 t80 -143.39 131.3 21.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.266 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -142.0 141.82 32.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.467 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.2 t -117.82 125.03 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -129.44 149.64 51.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.99 158.96 12.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.13 166.43 34.0 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.5 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 155.11 46.16 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.027 2.485 . . . . 0.0 112.386 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.8 123.76 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.295 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.57 118.16 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.523 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -84.76 136.46 33.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.12 -51.16 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.763 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 84' ' ' TYR . 60.4 t30 -161.74 41.84 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 67.28 -37.62 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 82' ' ' ASN . 78.5 m-85 -66.99 -38.01 85.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.57 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -144.22 146.88 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.4 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -139.1 150.2 45.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.639 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.8 mt -98.78 139.79 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.474 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.88 141.62 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.419 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.74 138.84 14.35 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 134' ' ' SER . 75.6 mt -112.03 117.91 33.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.74 133.05 39.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.666 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.57 -161.02 34.53 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.444 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -146.53 150.75 36.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.724 0.297 . . . . 0.0 110.452 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.25 142.96 16.12 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.429 ' CD2' HG22 ' A' ' 113' ' ' THR . 78.7 m80 -135.15 148.81 49.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.12 152.87 20.93 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -131.54 145.62 51.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.57 136.33 27.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.285 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -132.71 148.77 52.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.78 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -108.73 138.58 44.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.11 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.8 m -89.34 114.06 25.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.802 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.9 m -163.36 161.02 24.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.874 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.5 mt -103.17 112.47 36.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.788 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -149.85 157.39 43.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.227 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.97 96.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -104.92 165.96 10.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.4 p -108.85 159.18 16.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 0.0 110.823 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -134.31 138.51 45.02 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.476 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.0 p -153.47 162.58 41.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.29 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -131.2 151.63 51.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.707 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.9 t -144.48 142.75 30.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.597 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.504 ' NZ ' HD21 ' A' ' 140' ' ' LEU . 58.8 mtpt -129.5 152.53 48.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 95' ' ' HIS . 82.3 p -123.96 150.37 44.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.559 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.72 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 92.8 p -151.14 162.35 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.8 tp -100.2 125.84 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.396 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 123.05 45.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.6 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -143.3 131.59 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.109 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.35 -170.18 34.37 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.594 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.61 158.72 42.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 0.0 110.533 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.17 173.74 36.04 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -135.75 170.02 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 0.0 110.501 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -139.54 136.3 34.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -129.75 130.64 45.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.446 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 31.5 t-20 -106.66 99.28 24.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.231 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.38 -31.89 5.39 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.658 1.572 . . . . 0.0 111.439 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.3 m-70 -138.59 148.95 60.8 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.774 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.92 -25.97 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.998 1.799 . . . . 0.0 112.357 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -82.8 -25.58 32.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.647 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 126' ' ' HIS . 94.5 m-85 -132.91 144.28 50.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.298 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.52 153.0 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.285 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.6 pt -128.55 147.09 33.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.682 0.277 . . . . 0.0 110.422 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.527 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 61.0 t0 -146.71 133.62 20.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.474 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -124.05 124.72 43.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.68 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.635 ' HB3' HD11 ' A' ' 90' ' ' LEU . 66.4 m -133.97 152.35 51.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.316 . . . . 0.0 111.164 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.08 139.72 53.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.055 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.426 ' CG ' HD13 ' A' ' 90' ' ' LEU . 97.5 mt-10 -125.31 150.35 47.22 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.646 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -131.41 127.18 36.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.6 m -125.14 131.05 53.31 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -109.78 96.26 6.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.925 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.504 HD21 ' NZ ' ' A' ' 112' ' ' LYS . 2.8 tp -68.79 157.16 36.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -56.05 -43.94 78.36 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.075 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -106.1 -33.86 7.73 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.995 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 140' ' ' LEU . 87.9 t -106.79 149.73 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -105.96 124.09 49.02 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.415 HG13 ' OG ' ' A' ' 13' ' ' SER . 84.6 t -128.03 129.12 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.029 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.01 132.28 8.82 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 96.5 m -113.16 123.53 50.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.046 0.451 . . . . 0.0 111.285 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -95.72 135.49 37.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 149' ' ' MET . 1.8 tmt? -119.43 117.83 29.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.785 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -137.07 127.29 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.784 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -169.6 177.85 42.92 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.168 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.49 159.79 44.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.66 -160.91 14.59 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.38 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.04 160.11 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 0.0 110.673 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -80.41 128.77 33.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.516 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 73.3 t80 . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.581 179.908 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.46 178.9 53.7 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -70.56 141.22 51.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.925 0.393 . . . . 0.0 110.53 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -150.35 162.43 40.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.491 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.8 m -124.85 148.61 48.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.53 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -116.89 129.75 72.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.9 t -124.59 140.03 53.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.5 tt -126.91 145.57 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.136 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.12 -173.82 37.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.445 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -106.09 142.42 35.81 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -118.03 127.92 54.28 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -129.24 134.95 48.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.796 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.465 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 41.4 t -117.33 120.35 37.93 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.571 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.682 HH21 ' NZ ' ' A' ' 16' ' ' LYS . 61.2 ttt85 -67.53 120.1 13.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.361 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -133.25 131.52 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.682 ' NZ ' HH21 ' A' ' 14' ' ' ARG . 73.5 mmtt -84.72 132.64 34.43 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -133.94 144.42 48.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.009 0.433 . . . . 0.0 111.364 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.71 -38.6 91.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.659 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.45 -136.88 0.71 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -65.66 139.62 58.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.377 . . . . 0.0 110.107 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -155.06 37.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.429 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.75 -42.42 99.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.857 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 25' ' ' ASN . 97.4 m-20 -110.79 -15.45 13.81 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.586 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.0 mttp 48.7 12.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.181 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 23' ' ' ASP . 67.9 m-20 -102.91 111.02 64.66 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 13' ' ' SER . 93.4 Cg_endo -83.7 161.01 14.35 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.176 2.584 . . . . 0.0 111.093 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -92.12 132.09 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.3 169.65 33.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.56 138.86 49.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.648 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 29.5 t-20 -115.09 119.52 36.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.407 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.47 129.18 51.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.56 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -132.56 147.16 52.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.87 145.05 51.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.201 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 122' ' ' GLN . 61.5 ttp180 -124.96 132.67 53.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.15 142.91 51.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.0 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -128.97 145.48 51.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.032 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -113.53 31.18 6.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.317 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 56.37 41.11 29.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.493 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -148.42 -179.85 7.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.336 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -81.47 1.64 32.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.424 ' CH2' ' CG2' ' A' ' 43' ' ' VAL . 92.2 t90 -122.66 123.39 41.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.184 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -129.7 175.46 19.04 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.424 ' CG2' ' CH2' ' A' ' 41' ' ' TRP . 92.5 t -124.42 128.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.16 157.28 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.068 0.461 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.19 159.32 27.67 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -136.69 131.01 32.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.059 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.69 123.66 43.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.837 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.01 152.99 41.01 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.121 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -148.89 144.35 26.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.653 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.4 p -132.3 160.92 34.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -154.74 148.59 25.58 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.785 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' CZ ' ' O ' ' A' ' 65' ' ' ASP . 89.2 mtm180 -83.57 149.84 26.32 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.78 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.25 166.17 53.84 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -110.52 122.82 48.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 110.956 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -133.84 148.2 51.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.304 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -81.73 126.65 32.07 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.462 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.693 ' HB2' HD12 ' A' ' 63' ' ' LEU . 48.4 t -150.76 146.48 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.2 p -129.97 122.42 54.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.582 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 58' ' ' VAL . 99.3 m-20 45.38 -177.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.076 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 62' ' ' LYS . . . 80.35 -1.45 81.31 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 42.73 25.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.74 0.305 . . . . 0.0 110.471 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 60' ' ' GLY . 58.0 tptt -60.8 -45.98 92.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.625 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 57' ' ' SER . 88.9 mt -118.21 138.77 52.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.6 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 pt -99.59 -29.34 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.796 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.47 ' O ' ' CZ ' ' A' ' 52' ' ' ARG . 98.5 m-20 37.63 -107.27 0.05 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.039 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.49 -20.97 44.54 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.64 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 46.97 51.45 12.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.964 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -112.16 144.23 41.89 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.803 0.335 . . . . 0.0 110.58 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.9 146.29 25.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -119.44 127.39 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 95' ' ' HIS . 98.5 m-85 -127.95 144.21 51.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.274 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -152.46 140.07 19.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.568 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.87 143.97 39.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.022 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.7 p -144.2 163.12 34.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.44 155.1 29.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.441 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.54 164.04 34.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.489 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.13 158.9 37.61 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.258 2.639 . . . . 0.0 112.291 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 42' ' ' GLY . 8.7 p -135.7 135.35 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.8 t80 -128.15 129.72 46.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.708 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.531 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 36.4 mmt180 -67.61 136.58 54.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.669 HD11 ' HB2' ' A' ' 87' ' ' LEU . 75.5 mt -87.86 -51.86 12.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.052 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 2.7 m-20 162.9 -73.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.678 ' O ' HG13 ' A' ' 85' ' ' VAL . 98.6 mt-10 -67.71 64.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.459 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' ASN . 91.8 m-85 47.07 33.62 2.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 83' ' ' GLU . 30.2 m -133.09 152.71 36.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 t -139.48 144.11 37.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 111.449 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.669 ' HB2' HD11 ' A' ' 81' ' ' ILE . 63.6 tp -111.11 129.84 55.8 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CZ ' ' C ' ' A' ' 120' ' ' GLY . 53.7 p90 -143.22 158.4 43.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.738 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -107.13 147.35 16.23 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 90' ' ' LEU . 10.8 tp -128.38 119.97 26.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.33 160.91 38.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.836 0.351 . . . . 0.0 111.173 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.35 -143.96 8.89 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.63 150.79 36.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 110.937 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.61 140.6 16.44 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 71' ' ' TYR . 31.1 p80 -147.0 162.03 39.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.36 158.37 18.88 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -124.68 143.83 50.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.228 0.537 . . . . 0.0 110.616 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.05 146.57 32.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.817 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -132.59 129.13 38.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.703 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -102.15 128.96 48.42 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.4 p -85.91 114.97 23.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.15 0.5 . . . . 0.0 111.156 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -163.17 168.39 20.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.892 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.67 113.65 44.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.013 0.435 . . . . 0.0 110.872 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -145.76 162.38 37.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.768 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.92 -9.32 62.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -136.97 171.11 15.0 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t -108.73 136.54 48.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.835 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -125.3 138.21 54.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.382 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.9 p -148.79 164.23 35.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.238 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -127.76 151.41 49.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.85 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 90.7 p -149.9 163.92 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.719 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -122.61 158.0 30.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.355 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.8 t -131.78 145.56 51.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.5 t -160.2 158.21 29.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.7 mt -99.28 141.09 32.5 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.47 140.05 48.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.964 0.411 . . . . 0.0 111.164 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -150.93 159.1 44.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.205 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 165.84 -158.72 31.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.488 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.59 160.17 40.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.739 0.304 . . . . 0.0 110.502 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -144.43 156.05 26.62 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.29 146.06 44.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.516 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.458 ' OE1' ' NH1' ' A' ' 34' ' ' ARG . 10.3 tt0 -117.62 128.56 55.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.697 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -118.7 137.53 53.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.414 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.81 ' OD1' HG13 ' A' ' 130' ' ' VAL . 68.4 m-20 -129.51 81.03 70.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.71 -27.23 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.762 1.641 . . . . 0.0 111.667 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -136.48 149.24 66.89 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.733 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.98 -22.97 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.068 1.845 . . . . 0.0 112.776 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.18 6.0 44.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.678 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -150.08 128.24 11.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.468 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.81 HG13 ' OD1' ' A' ' 124' ' ' ASN . 94.4 t -122.88 132.03 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.0 mt -115.16 126.02 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.087 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -146.61 160.44 42.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.72 138.59 17.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.2 m -135.94 151.83 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.776 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -142.13 148.52 38.45 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.015 0.436 . . . . 0.0 110.867 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.456 ' H ' ' HB ' ' A' ' 147' ' ' THR . 39.9 mt-10 -143.79 159.09 43.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.378 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -119.8 139.2 52.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.805 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 t -139.1 133.37 31.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.13 140.41 44.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.76 HD23 ' H ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -117.96 156.2 28.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.313 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.76 ' H ' HD23 ' A' ' 140' ' ' LEU . 98.4 m-20 -58.0 -43.48 86.68 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.545 -177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.97 -33.45 7.92 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.97 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 140' ' ' LEU . 84.6 t -106.57 148.79 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -104.71 136.93 43.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.57 131.53 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.317 0.579 . . . . 0.0 112.38 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.16 157.15 15.76 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 136' ' ' GLU . 91.2 m -123.92 129.42 50.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.196 0.498 . . . . 0.0 111.606 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -129.53 119.94 24.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.582 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 79.0 mtm -132.07 134.48 45.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.38 142.12 30.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.96 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.33 -175.07 47.13 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.094 -1.051 . . . . 0.0 111.895 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 130' ' ' VAL . . . -149.45 157.94 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.398 . . . . 0.0 109.938 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.52 -177.31 21.04 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.358 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -148.15 158.92 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.496 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -75.96 138.55 41.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.6 t80 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.577 179.741 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.96 -179.64 52.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -70.13 142.09 52.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 110.249 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t -150.11 151.34 33.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.7 p -143.73 159.67 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.2 mt -118.24 130.93 72.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.671 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.4 t -134.5 140.73 46.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.706 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.39 148.76 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.376 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.56 -174.62 35.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -104.33 142.58 34.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.615 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -112.65 131.36 55.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.795 ' CD ' HD22 ' A' ' 25' ' ' ASN . 22.5 mt-30 -126.79 124.67 40.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.478 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.562 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 69.9 m -117.75 107.41 14.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -66.82 133.34 49.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -111.33 125.52 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' O ' HG13 ' A' ' 143' ' ' VAL . 64.6 tttm -97.01 124.92 41.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.744 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -153.11 159.01 42.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.315 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -58.68 -43.91 90.09 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.41 144.63 36.1 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -91.65 140.9 29.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.889 0.376 . . . . 0.0 111.25 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -113.61 152.61 30.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.291 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 22' ' ' LEU . 10.4 mp -60.69 -48.9 79.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.616 ' C ' ' H ' ' A' ' 25' ' ' ASN . 97.0 m-20 -113.33 -14.7 12.78 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 55.63 -3.85 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.765 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.795 HD22 ' CD ' ' A' ' 12' ' ' GLN . 58.6 t-20 -104.81 112.2 65.27 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.576 ' CB ' HH21 ' A' ' 52' ' ' ARG . 97.6 Cg_endo -83.04 159.1 15.57 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.69 ' NH2' ' HE ' ' A' ' 51' ' ' ARG . 51.2 ptt85 -93.19 142.61 27.11 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -159.44 169.77 35.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -109.47 142.14 40.92 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.712 0.292 . . . . 0.0 110.575 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 43.5 t30 -125.89 119.02 26.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.752 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.1 137.28 53.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HE3' HD21 ' A' ' 30' ' ' ASN . 98.8 mttt -134.8 146.13 49.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.16 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.507 ' NH2' ' OE2' ' A' ' 36' ' ' GLU . 61.0 ttt85 -107.57 127.48 53.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -137.77 126.77 24.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.079 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.507 ' OE2' ' NH2' ' A' ' 34' ' ' ARG . 99.4 mt-10 -119.11 117.71 29.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.969 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -60.81 -48.81 80.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.976 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -155.53 61.72 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.152 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.6 m120 52.66 -138.76 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.6 t0 38.68 -106.51 0.05 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.963 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.619 ' HE1' ' CB ' ' A' ' 77' ' ' PRO . 58.7 t90 -100.0 123.39 44.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.098 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.593 ' H ' HG13 ' A' ' 78' ' ' VAL . . . -120.03 -166.71 13.31 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.48 157.64 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 76' ' ' GLY . 19.0 tt -137.94 134.3 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.442 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.8 132.96 11.32 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.7 m -128.68 139.93 51.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.08 142.11 49.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.744 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.67 139.33 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -142.41 126.74 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.274 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.522 HG22 ' HA3' ' A' ' 28' ' ' GLY . 77.3 p -128.78 159.24 36.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.419 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.69 ' HE ' ' NH2' ' A' ' 27' ' ' ARG . 41.2 ptt180 -157.57 161.18 38.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.355 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.576 HH21 ' CB ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.06 129.34 38.28 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.518 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.38 -178.25 41.4 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -112.47 147.88 35.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.674 0.273 . . . . 0.0 110.354 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -159.29 157.93 31.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -71.62 130.15 40.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.234 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -149.85 143.8 25.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.717 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 59' ' ' ASP . 10.3 p -130.54 137.29 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.439 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 60' ' ' GLY . 30.1 t0 42.65 -167.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.48 ' H ' ' CG ' ' A' ' 59' ' ' ASP . . . 88.82 -6.94 83.19 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 55.8 24.59 7.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 0.0 110.632 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -75.0 145.36 42.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.458 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.11 112.61 5.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.997 0.427 . . . . 0.0 111.006 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.8 pt -113.91 3.38 8.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.309 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 66' ' ' GLY . 27.2 t0 -65.5 -162.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.945 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 65' ' ' ASP . . . 100.76 -15.93 57.96 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.7 t0 49.04 52.93 13.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.94 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -72.53 143.52 48.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.047 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -118.02 142.05 47.8 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -126.34 125.53 42.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.345 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' CE2' HG23 ' A' ' 73' ' ' VAL . 88.4 t80 -130.03 128.73 42.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.19 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -140.05 140.05 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.062 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.456 HG23 ' CE2' ' A' ' 71' ' ' TYR . 99.4 t -124.06 128.88 74.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.043 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -148.34 155.38 41.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.214 0.53 . . . . 0.0 111.166 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.75 158.33 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.182 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 44' ' ' ILE . . . -150.22 153.58 25.15 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.603 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.619 ' CB ' ' HE1' ' A' ' 41' ' ' TRP . 93.0 Cg_endo -77.66 159.03 31.94 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.74 2.293 . . . . 0.0 111.475 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.593 HG13 ' H ' ' A' ' 42' ' ' GLY . 7.9 p -131.61 119.25 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.455 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE1' ' CD1' ' A' ' 41' ' ' TRP . 96.5 m-85 -119.66 120.12 35.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.914 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -80.54 128.44 33.59 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.157 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' A' ' 85' ' ' VAL . 96.5 mt -89.8 -52.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.808 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 84' ' ' TYR . 32.7 m120 -122.09 16.98 10.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.823 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 82' ' ' ASN . 16.9 tt0 76.17 -21.03 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.496 ' H ' ' C ' ' A' ' 82' ' ' ASN . 96.9 m-85 -104.17 -20.89 13.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 81' ' ' ILE . 35.0 m -132.81 145.63 33.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.4 t -141.14 152.25 44.56 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.321 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HG ' HD11 ' A' ' 81' ' ' ILE . 86.1 mt -102.48 138.8 38.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.391 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' OH ' ' NH1' ' A' ' 34' ' ' ARG . 48.9 m-85 -121.48 140.02 52.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.592 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.83 137.66 14.4 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.41 118.79 37.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.499 0.649 . . . . 0.0 111.877 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.7 tp -136.9 122.94 20.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.354 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -167.8 39.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -145.27 151.56 38.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 110.701 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.64 146.5 16.08 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -130.95 143.89 51.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.727 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -116.19 143.44 18.07 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -130.44 126.76 37.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.857 0.36 . . . . 0.0 110.57 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.97 124.53 26.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.101 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.37 133.98 43.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.603 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -99.5 133.65 43.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.199 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.4 p -87.71 115.68 25.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.958 0.408 . . . . 0.0 110.719 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.6 p -162.82 166.37 24.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.184 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.8 mt -108.47 113.45 44.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.81 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -146.7 165.15 30.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.354 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.48 -20.03 58.49 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -139.64 161.84 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -109.69 147.98 32.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.867 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 47.4 mp0 -127.01 149.4 49.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.494 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 96.9 p -154.7 163.7 39.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.367 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -127.35 134.39 49.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.588 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.8 t -135.78 136.69 40.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.555 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -130.57 151.3 51.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.397 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.3 p -125.45 150.82 46.98 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.019 0.438 . . . . 0.0 111.147 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.547 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 88.1 p -152.6 163.75 39.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.39 145.24 28.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.629 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.24 52.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.726 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -151.31 160.82 43.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.296 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 169.29 -160.77 34.2 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.878 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.78 158.54 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -157.66 174.97 35.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.24 165.81 27.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.917 0.389 . . . . 0.0 110.831 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.677 HE21 ' CG1' ' A' ' 130' ' ' VAL . 65.4 tt0 -135.11 135.34 41.11 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.207 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -127.66 126.95 42.92 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.009 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.868 ' OD1' HG13 ' A' ' 130' ' ' VAL . 50.0 m-20 -125.24 85.64 57.99 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.59 -29.75 10.51 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.7 1.6 . . . . 0.0 111.652 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.64 123.58 21.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.762 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.15 -29.29 22.02 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.581 1.521 . . . . 0.0 112.522 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -82.06 -8.71 59.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.739 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -139.29 123.34 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.418 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.868 HG13 ' OD1' ' A' ' 124' ' ' ASN . 72.8 t -127.89 134.01 66.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.831 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.04 148.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.502 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -146.29 158.96 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.19 21.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.024 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.8 p -158.17 162.6 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.528 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -144.07 148.29 34.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -145.92 160.4 41.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.568 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -119.02 139.32 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.45 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.5 t -132.37 125.2 30.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -108.18 119.74 40.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.753 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -84.28 155.9 22.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -51.84 -44.93 63.79 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.093 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -104.71 -32.79 8.71 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.67 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 16' ' ' LYS . 77.6 t -105.94 153.04 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.418 ' N ' HG12 ' A' ' 143' ' ' VAL . 98.7 mttt -107.3 135.96 47.93 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.01 130.95 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.0 134.67 11.77 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.9 m -125.0 131.7 53.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.278 0.561 . . . . 0.0 112.356 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -127.95 125.42 39.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.506 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.473 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 79.3 mtm -117.74 136.63 53.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 111.374 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 tt -136.91 130.17 31.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.58 177.66 41.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.851 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.13 158.94 44.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.45 -171.9 23.2 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -147.38 159.32 43.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 0.0 110.617 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -77.94 128.96 34.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.663 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.7 t80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.671 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.07 -175.48 54.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' OE1' ' CZ ' ' A' ' 37' ' ' PHE . 49.5 mp0 -75.91 138.2 40.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.71 0.29 . . . . 0.0 110.258 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.9 p -150.92 162.27 41.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.605 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -147.01 141.39 26.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.594 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 pt -127.56 147.15 32.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -131.82 148.45 52.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.0 mt -121.09 129.44 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.062 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.01 156.53 26.87 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.27 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -83.72 146.02 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HB3' ' C ' ' A' ' 28' ' ' GLY . . . -107.39 120.0 40.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.768 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -118.5 118.46 31.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.848 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.3 m -118.44 167.73 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -125.21 137.57 54.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' HD3' ' A' ' 26' ' ' PRO . 87.7 t -115.39 126.56 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.531 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -93.87 117.86 30.68 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.449 ' OE1' ' NZ ' ' A' ' 21' ' ' LYS . 87.9 tt0 -155.93 150.04 25.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.723 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -60.06 -42.41 94.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.055 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 17' ' ' GLU . . . -63.55 149.19 50.4 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -84.49 142.6 29.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.927 0.394 . . . . 0.0 111.038 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' NZ ' ' OE1' ' A' ' 17' ' ' GLU . 64.0 mttp -130.56 150.18 51.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.102 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.46 -52.87 61.81 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.152 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' A' ' 25' ' ' ASN . 58.4 p30 -114.11 -14.06 12.39 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.34 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 23.4 ttmt 55.59 -6.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.454 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.626 ' H ' ' C ' ' A' ' 23' ' ' ASP . 53.2 m-20 -106.28 114.59 62.14 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 119.399 -0.334 . . . . 0.0 111.648 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' HG23 ' A' ' 15' ' ' VAL . 73.2 Cg_endo -76.63 158.96 35.69 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.433 1.422 . . . . 0.0 110.86 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -91.57 155.02 18.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.764 0.316 . . . . 0.0 110.945 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' C ' ' HB3' ' A' ' 11' ' ' ALA . . . -168.3 175.07 43.09 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.92 149.59 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 47' ' ' PHE . 7.6 t-20 -134.92 120.49 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -115.66 140.89 48.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.749 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.38 145.24 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.89 144.59 51.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.074 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -123.66 128.79 50.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.441 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 96.2 m-85 -128.91 148.63 50.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.442 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 17.5 tt0 80.99 166.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.409 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CZ ' ' OE1' ' A' ' 3' ' ' GLU . 90.2 m-85 -76.49 141.42 41.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -100.82 16.65 24.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.521 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.14 -41.24 92.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.922 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.07 -38.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.964 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -153.44 141.37 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.735 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.14 178.16 30.36 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.35 139.62 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.382 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.59 153.16 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.86 135.36 9.39 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.9 m -128.32 145.69 50.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.148 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.584 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 98.3 m-85 -124.37 140.49 52.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.513 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.33 137.96 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -150.99 150.34 30.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.783 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.9 t -150.27 155.24 39.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -156.02 163.24 39.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -68.29 137.87 55.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.48 -170.58 44.75 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.88 131.32 46.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 0.0 110.373 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -134.04 159.31 41.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.538 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.1 145.74 45.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.2 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.4 m -118.65 149.92 40.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.7 t -118.6 130.82 72.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.108 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -58.85 145.13 42.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.551 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.44 -7.15 78.01 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.09 148.89 51.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.729 0.3 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -108.1 150.36 27.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.471 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.89 141.22 53.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.269 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 pt -113.34 3.67 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.12 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.28 -43.03 96.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.441 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.77 -1.29 79.14 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.9 t0 47.98 50.7 15.52 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.439 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -79.03 147.11 32.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.976 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -124.08 141.65 51.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.3 144.59 51.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.998 0.427 . . . . 0.0 111.149 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -139.98 130.97 26.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.14 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -148.78 147.95 29.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 111.023 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 p -136.41 136.38 48.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.698 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -135.31 157.76 46.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.17 27.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.452 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.3 169.78 42.91 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.773 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.1 155.0 52.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.327 2.685 . . . . 0.0 112.794 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.442 HG22 ' CB ' ' A' ' 88' ' ' TYR . 89.6 t -126.69 130.51 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.754 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -126.91 125.76 42.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.404 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.69 137.33 54.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 87' ' ' LEU . 92.1 mt -88.97 -48.61 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.325 0.583 . . . . 0.0 110.139 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 51.4 t30 -134.73 -148.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.754 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.47 ' H ' ' CG ' ' A' ' 82' ' ' ASN . 99.3 mt-10 -88.71 -5.24 58.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -149.23 15.62 0.91 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.632 HG13 ' HB ' ' A' ' 81' ' ' ILE . 3.8 p -144.36 138.31 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.42 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.0 m -134.62 149.87 50.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.11 0.481 . . . . 0.0 111.847 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.672 ' HB2' HD11 ' A' ' 81' ' ' ILE . 63.6 tp -119.52 131.12 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.435 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.442 ' CB ' HG22 ' A' ' 78' ' ' VAL . 52.4 p90 -142.29 158.79 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.866 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.19 148.54 17.42 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.6 mt -119.16 135.9 54.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.98 146.83 31.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.599 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.86 -145.45 8.46 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.136 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.37 152.24 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.56 147.21 16.61 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -134.79 144.96 47.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.736 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.69 145.86 17.42 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -117.65 137.56 52.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.666 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 110' ' ' ARG . . . -143.91 147.25 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.348 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.56 129.62 39.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.483 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -99.84 124.55 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.4 t -87.06 116.78 25.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.252 0.548 . . . . 0.0 111.331 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.7 t -163.15 151.66 14.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.84 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.2 mt -99.7 112.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.206 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -149.4 160.81 43.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.013 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.64 -40.15 96.07 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -103.85 165.4 11.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 95.3 p -108.93 156.07 20.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 110.673 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 45.6 mp0 -133.32 154.96 50.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.874 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.2 p -149.78 162.38 40.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.156 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 98' ' ' ALA . 84.7 mtp180 -129.33 150.16 50.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.929 0.395 . . . . 0.0 110.871 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.4 t -147.67 146.76 29.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.255 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -126.04 148.93 49.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.74 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.7 m -117.07 130.94 56.98 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.78 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.6 t -148.64 149.84 32.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.638 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 115' ' ' LEU . 2.7 mp -99.69 142.91 30.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.614 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.21 132.76 55.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.99 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -145.97 134.13 21.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.138 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.31 -169.68 34.53 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.806 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.66 159.27 44.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.016 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.54 169.31 31.06 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.805 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.421 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.6 OUTLIER -142.44 160.24 40.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.919 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.51 ' NE2' ' OD1' ' A' ' 132' ' ' ASP . 63.7 tt0 -140.34 137.41 34.07 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.616 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.421 ' CE2' ' CD1' ' A' ' 121' ' ' LEU . 69.6 m-85 -115.5 149.01 38.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.683 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -129.89 83.02 65.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.949 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.4 -22.8 24.56 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.72 1.613 . . . . 0.0 111.71 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.524 ' ND1' ' OD1' ' A' ' 128' ' ' ASN . 65.7 t-80 -150.14 136.4 10.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.482 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.99 -39.43 50.07 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.921 1.747 . . . . 0.0 113.89 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.524 ' OD1' ' ND1' ' A' ' 126' ' ' HIS . 54.7 p30 -84.14 -0.7 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.62 126.67 13.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.394 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 152.69 34.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.451 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.9 mt -114.51 125.85 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NE2' ' A' ' 122' ' ' GLN . 97.8 m-20 -105.73 132.46 51.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.193 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -136.14 127.33 28.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.781 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.8 t -158.03 151.62 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.858 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -139.07 149.16 44.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.683 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -142.46 153.57 43.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.775 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.59 147.26 49.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.163 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.7 t -128.89 127.56 42.06 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -106.85 120.61 42.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.307 0.575 . . . . 0.0 111.942 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.79 HD23 ' H ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -117.97 154.61 31.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.79 ' H ' HD23 ' A' ' 140' ' ' LEU . 98.1 m-20 -59.53 -42.63 92.76 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.9 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 66.3 t0 -105.63 -33.98 7.88 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.9 t -106.47 125.58 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -107.68 123.13 48.04 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.93 146.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.144 -0.623 . . . . 0.0 112.223 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.31 152.45 17.74 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 91.2 m -125.28 131.86 53.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 111.558 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -125.94 123.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.897 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 149' ' ' MET . 2.5 mpp? -117.47 129.57 55.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.932 0.396 . . . . 0.0 111.012 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -143.27 131.78 22.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.982 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.642 ' N ' HD13 ' A' ' 150' ' ' LEU . . . -178.56 -169.03 38.74 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.575 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.42 155.86 47.34 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.88 -169.62 14.05 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.789 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -148.61 163.09 38.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.123 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -121.79 147.98 45.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.3 t80 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.548 -179.797 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.82 -178.93 48.8 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.61 138.55 48.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.817 0.341 . . . . 0.0 110.462 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.7 p -151.11 163.05 39.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.656 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.6 m -124.45 141.98 51.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.536 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.89 124.3 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -128.88 140.75 51.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.026 0.441 . . . . 0.0 111.311 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.512 HG22 HD22 ' A' ' 31' ' ' LEU . 45.8 pt -132.82 156.49 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.746 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.17 -174.18 38.76 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.119 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -113.72 145.91 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.7 140.99 38.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HG2' HD21 ' A' ' 25' ' ' ASN . 3.0 mp0 -131.69 138.1 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.696 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.447 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 67.2 m -117.33 109.39 16.77 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.239 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -68.66 129.15 39.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.02 129.43 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.635 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -107.35 118.95 38.06 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -162.24 167.66 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 0.0 110.787 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -84.96 104.58 15.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.59 -156.06 26.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' A' ' 20' ' ' TYR . 54.5 p90 -49.99 129.1 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -164.42 39.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.119 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.61 -49.24 78.31 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.704 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 25' ' ' ASN . 58.4 p30 -113.63 -12.59 12.82 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.502 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 59.5 mtpt 52.39 3.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.06 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 23' ' ' ASP . 49.7 t-20 -103.64 110.27 63.56 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.668 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' CD ' ' O ' ' A' ' 13' ' ' SER . 96.2 Cg_endo -84.73 160.42 12.23 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.766 2.311 . . . . 0.0 111.44 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.81 135.43 39.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.73 169.75 35.15 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.97 143.85 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.426 ' OD1' ' SD ' ' A' ' 149' ' ' MET . 29.5 t-20 -117.61 119.09 33.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.512 HD22 HG22 ' A' ' 8' ' ' ILE . 88.3 mt -122.92 136.89 55.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.833 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -148.24 155.9 41.91 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -133.07 146.8 52.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.16 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -126.97 131.14 51.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.795 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.91 139.8 52.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -159.72 147.54 17.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -65.88 -42.52 90.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -170.76 99.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 61.9 t-20 41.56 -117.78 0.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.742 0.306 . . . . 0.0 110.256 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 99.1 m-20 43.1 -98.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.346 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' ASN . 41.7 p90 -147.6 162.38 39.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.18 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.06 -167.05 21.92 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.42 143.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.348 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -132.64 137.25 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.08 142.57 16.19 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -126.21 143.93 50.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.932 0.396 . . . . 0.0 111.102 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -130.08 146.01 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.807 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.41 141.55 35.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.03 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -128.79 137.28 51.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.21 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.4 m -128.06 134.9 49.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -146.38 143.99 29.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.874 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.463 HH11 ' C ' ' A' ' 65' ' ' ASP . 79.9 ttt180 -53.48 145.34 14.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.2 -39.66 94.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 88.0 m-85 -69.5 140.79 54.0 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -67.86 138.94 56.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.812 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.421 ' OE1' ' OD1' ' A' ' 67' ' ' ASP . 24.6 pt-20 -91.19 139.02 31.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.8 p -150.8 159.55 44.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.332 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.7 t -124.48 120.84 60.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.6 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -162.36 92.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.279 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.98 18.8 79.29 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 62.2 39.77 12.35 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.974 0.416 . . . . 0.0 110.51 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -128.15 152.36 48.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.7 mt 59.92 33.14 21.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.753 HG23 ' H ' ' A' ' 66' ' ' GLY . 20.4 tt -63.83 -24.62 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.463 ' C ' HH11 ' A' ' 52' ' ' ARG . 68.1 m-20 57.86 36.61 26.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.917 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.753 ' H ' HG23 ' A' ' 64' ' ' ILE . . . 69.91 -41.63 0.45 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 65' ' ' ASP . 54.4 t0 50.55 53.67 12.54 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.442 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -74.43 140.08 44.42 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.468 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -132.22 115.99 16.39 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -134.46 129.29 35.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.279 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.06 160.82 40.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.287 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -147.59 145.02 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.092 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.29 126.96 74.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.121 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -132.85 156.64 46.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.53 154.81 29.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.36 170.66 43.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.477 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.4 154.46 50.81 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.21 2.607 . . . . 0.0 113.041 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.5 t -127.89 130.97 70.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -127.15 146.42 50.4 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.175 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.79 126.77 52.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.6 tt -80.18 -37.42 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.72 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 84' ' ' TYR . 57.4 t30 -156.72 31.72 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.761 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 68.52 -42.66 0.48 Allowed 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.855 0.722 . . . . 0.0 109.812 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 82' ' ' ASN . 66.5 t80 -63.96 -40.61 96.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.415 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 84' ' ' TYR . 92.6 t -126.93 135.61 63.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.402 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.2 t -129.05 134.77 48.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.02 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.0 tp -110.62 127.96 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.269 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.98 159.33 42.44 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.967 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.52 145.33 16.01 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -120.13 137.16 54.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.622 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.2 152.25 38.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.765 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.14 -147.13 9.76 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.348 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.95 150.57 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 0.0 110.96 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.75 139.76 15.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -145.95 135.03 22.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.15 158.94 27.85 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -130.7 144.48 51.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.771 0.319 . . . . 0.0 110.386 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.58 111.61 8.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.405 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -133.24 131.26 40.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.404 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -149.36 159.28 44.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.202 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.9 t -139.34 120.18 14.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.225 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.7 t -163.76 174.96 10.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.071 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.4 mt -99.25 113.28 33.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.133 0.492 . . . . 0.0 109.765 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -148.66 175.38 11.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.02 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.84 -38.97 93.27 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -147.81 146.66 29.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.719 0.295 . . . . 0.0 110.315 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.3 m -132.62 144.28 50.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -163.68 141.45 7.43 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -128.21 149.15 50.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -168.58 152.95 5.91 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.824 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.5 t -105.78 134.73 48.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.388 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -108.12 139.69 42.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.25 0.548 . . . . 0.0 111.824 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 93.1 m -126.13 131.17 52.12 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.867 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.7 t -148.96 150.73 33.36 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.027 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.49 140.93 32.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.54 132.69 56.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.895 0.379 . . . . 0.0 110.711 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -151.01 160.26 44.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.087 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.34 -166.78 39.97 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.727 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.18 156.77 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.0 170.28 30.06 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.597 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.95 156.38 46.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.375 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -132.0 129.18 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -115.12 148.21 39.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.796 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 55.6 t-20 -129.37 81.85 69.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.406 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -28.18 14.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.896 1.731 . . . . 0.0 112.131 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 70.6 m80 -135.68 148.18 64.45 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.079 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.81 -24.01 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.25 1.967 . . . . 0.0 112.854 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -99.96 4.52 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.777 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.65 128.66 8.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 153' ' ' GLY . 29.1 m -131.98 152.78 37.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.29 148.12 27.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 133' ' ' ALA . 52.8 t0 -146.31 138.88 25.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.692 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.472 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -148.35 150.83 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.056 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 149' ' ' MET . 85.8 p -153.38 161.57 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.752 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -127.14 128.03 45.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.759 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -132.07 147.62 52.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.251 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -130.42 147.91 52.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.204 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.7 t -115.92 125.01 52.01 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -103.82 112.32 25.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.76 HD23 ' H ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -119.61 151.79 38.1 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.76 ' H ' HD23 ' A' ' 140' ' ' LEU . 98.1 m-20 -60.52 -42.91 97.39 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.541 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -104.96 -32.28 8.83 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.612 HG12 HG23 ' A' ' 145' ' ' VAL . 67.2 t -105.42 123.84 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -108.15 115.17 29.62 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.612 HG23 HG12 ' A' ' 143' ' ' VAL . 87.2 t -128.31 130.61 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.134 0.492 . . . . 0.0 112.28 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.31 138.02 14.54 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.6 m -111.56 132.77 54.3 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.165 0.483 . . . . 0.0 111.846 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -112.0 135.82 52.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.124 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.426 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 53.9 ttp -131.54 125.55 32.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.891 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.1 tp -143.04 129.82 20.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.711 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -176.81 -176.18 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.073 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.84 158.93 44.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -142.51 174.79 23.25 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.751 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -123.06 130.15 52.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.369 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -75.77 129.85 37.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.342 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.402 ' OXT' ' CG ' ' A' ' 156' ' ' PHE . 67.9 t80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.541 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.5 m . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.571 0.224 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -126.5 138.69 53.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.2 mm -112.33 126.8 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -139.2 143.09 37.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.417 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.94 148.72 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.049 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.04 172.1 36.47 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -83.34 143.66 30.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -126.41 127.0 44.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.961 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -134.01 139.27 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.912 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 40.7 t -117.7 106.99 13.65 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 146' ' ' GLY . 80.0 ttt180 -68.84 128.78 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.82 150.01 32.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.071 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.87 179.3 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 13' ' ' SER . 92.5 Cg_endo -78.16 159.98 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.402 2.068 . . . . 0.0 111.437 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -95.81 127.98 42.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.793 0.33 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.29 171.55 35.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.82 146.59 50.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.693 HD22 ' HB2' ' A' ' 48' ' ' ALA . 29.3 t-20 -121.89 120.8 35.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 tp -105.53 124.1 48.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.557 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.96 139.91 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.014 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -133.63 126.91 31.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.449 HH12 ' CD ' ' A' ' 122' ' ' GLN . 43.1 ttm180 -110.38 131.64 54.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.641 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -116.02 137.7 51.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.017 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.742 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.61 156.75 42.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -142.61 140.16 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 111.237 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.35 147.0 18.29 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.6 t -126.99 130.82 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.202 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.516 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.5 m-85 -125.36 136.23 53.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.693 ' HB2' HD22 ' A' ' 30' ' ' ASN . . . -145.09 148.16 33.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.374 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -151.11 149.44 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.67 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.9 t -152.15 162.46 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.919 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -149.03 141.02 23.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.578 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.512 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.1 p90 . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -120.41 147.75 44.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.858 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -123.2 131.07 53.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.589 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.48 147.2 49.32 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.625 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.0 t -149.21 142.72 25.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.539 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.54 131.73 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.9 p -137.78 158.27 44.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.991 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.09 152.25 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.7 43.62 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.561 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.6 153.4 54.57 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.358 2.705 . . . . 0.0 112.863 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.58 HG22 ' CB ' ' A' ' 88' ' ' TYR . 91.5 t -126.31 129.57 71.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.727 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.2 t80 -127.11 128.55 46.4 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 59.0 ttm-85 -69.59 134.58 48.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 87' ' ' LEU . 96.6 mt -88.02 -51.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.972 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.415 ' OD1' ' CG1' ' A' ' 85' ' ' VAL . 17.5 m120 -126.71 -137.3 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -97.14 -4.92 38.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.381 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.35 20.04 0.48 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' A' ' 81' ' ' ILE . 5.0 p -144.07 142.1 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.048 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.7 p -138.51 152.93 48.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 111.225 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 81' ' ' ILE . 3.0 tt -121.14 130.02 53.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.467 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.58 ' CB ' HG22 ' A' ' 78' ' ' VAL . 53.4 p90 -140.34 157.73 45.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.848 0.356 . . . . 0.0 110.719 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.17 147.19 18.35 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.624 ' O ' HD22 ' A' ' 91' ' ' LEU . 88.6 mt -114.43 127.91 56.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.677 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -133.61 142.26 48.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.921 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.6 -144.26 7.82 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.09 39.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 0.0 111.095 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.59 143.72 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.4 145.61 50.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 110.802 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -123.29 144.9 15.9 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.877 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.9 m . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.998 0.428 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.1 m -135.41 154.06 51.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.309 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.79 144.65 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.0 125.72 32.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -150.58 160.39 43.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.717 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.23 -165.01 35.78 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.732 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . . . -155.14 158.49 39.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.642 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.37 166.8 33.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 pp -143.2 159.58 42.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.839 0.352 . . . . 0.0 110.74 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.449 ' CD ' HH12 ' A' ' 34' ' ' ARG . 54.3 tt0 -117.03 128.64 55.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.182 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -127.98 126.74 41.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.447 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.83 ' OD1' HG13 ' A' ' 130' ' ' VAL . 63.3 m-20 -118.99 93.19 46.43 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.44 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.13 -27.62 29.27 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.331 1.354 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -135.14 151.02 74.48 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.953 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.24 -36.6 78.46 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.0 1.8 . . . . 0.0 113.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -101.72 14.52 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.17 119.87 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.667 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.83 HG13 ' OD1' ' A' ' 124' ' ' ASN . 98.7 t -125.24 129.23 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.211 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.93 124.42 58.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -107.99 130.27 55.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.214 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -129.99 112.03 13.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.698 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.441 ' OG ' ' OH ' ' A' ' 88' ' ' TYR . 58.0 m -134.66 153.03 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.732 ' OH ' ' HB3' ' A' ' 119' ' ' ALA . 52.8 p90 -144.49 153.61 42.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.505 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.429 ' OE2' HD12 ' A' ' 90' ' ' LEU . 78.1 mm-40 -135.78 152.2 50.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 145' ' ' VAL . 47.4 t80 -143.71 133.09 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.612 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--O 1.239 0.512 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.456 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 mptt . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.473 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 58.4 t -119.85 125.64 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.408 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 14' ' ' ARG . . . -118.67 125.31 6.36 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.4 m -129.58 137.32 50.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 111.865 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -133.91 151.02 51.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 64.7 mtt -133.43 137.48 45.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -136.06 129.6 32.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.94 40.15 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.814 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.12 161.02 42.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.416 -0.392 . . . . 0.0 109.97 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.79 -178.05 27.02 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.522 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.63 146.0 49.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.373 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.454 179.848 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.911 0.386 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -138.39 146.78 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 tt -120.44 138.2 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -128.08 148.66 50.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.56 151.81 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.222 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.21 -174.47 38.36 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.591 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -116.39 149.29 39.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.42 132.93 54.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -122.08 121.73 37.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.364 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.9 m -118.19 168.47 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.784 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -138.15 143.71 40.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.536 HG12 HG22 ' A' ' 145' ' ' VAL . 35.1 m -131.46 149.41 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.207 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 179.321 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.45 -0.309 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.81 156.12 27.22 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.467 1.444 . . . . 0.0 111.484 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -95.33 138.96 32.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.621 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.72 -168.31 20.68 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.24 160.07 41.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.868 HD21 ' HZ3' ' A' ' 32' ' ' LYS . 49.7 t30 -135.72 131.68 35.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.027 0.441 . . . . 0.0 112.028 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.35 136.76 53.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.822 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.868 ' HZ3' HD21 ' A' ' 30' ' ' ASN . 9.5 mtmm -125.53 140.36 52.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -127.08 144.81 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.342 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -123.3 132.07 53.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.391 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.486 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 95.1 m-85 -127.42 149.11 50.23 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.33 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 9.5 tp10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.14 154.82 40.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.827 0.346 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.25 142.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.748 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.67 150.76 17.93 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 t -136.97 137.21 39.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.422 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 92.7 m-85 -128.49 141.01 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.81 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.76 148.74 34.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -143.08 128.84 19.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.8 p -129.33 156.17 44.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.529 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.452 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 . . . . . 0 C--N 1.331 -0.229 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.769 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.8 t80 . . . . . 0 CA--C 1.523 -0.071 0 CA-C-O 120.681 0.277 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -115.62 143.48 45.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.705 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.529 ' CE2' ' OG ' ' A' ' 72' ' ' SER . 83.5 t80 -127.65 121.39 30.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.14 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.23 133.91 55.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.529 ' OG ' ' CE2' ' A' ' 70' ' ' TYR . 67.1 m -134.65 141.37 46.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.34 134.96 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.008 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -140.57 158.67 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -158.7 152.41 23.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.53 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.58 164.7 35.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.665 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.99 160.61 36.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 123.166 2.577 . . . . 0.0 112.578 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 88' ' ' TYR . 10.7 p -135.26 135.69 51.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.236 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.0 t80 -127.69 129.68 47.56 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 62.4 ttm-85 -71.85 128.68 36.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.22 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 87' ' ' LEU . 96.3 mt -89.66 -51.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -127.86 -155.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.65 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.74 -39.99 93.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.293 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -140.87 35.01 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.155 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.1 t -127.77 126.29 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.9 m -130.67 142.54 50.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HB2' HD11 ' A' ' 81' ' ' ILE . 62.8 tp -122.73 129.93 52.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.455 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' A' ' 78' ' ' VAL . 52.9 p90 -142.01 159.46 42.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.875 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.8 151.75 18.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.7 119.08 27.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.557 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -138.12 151.55 47.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.955 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -143.89 7.63 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.65 153.44 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 0.0 110.956 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.53 145.57 16.81 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -133.93 125.16 27.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.643 0.258 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.15 143.02 15.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.357 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.841 0.353 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.9 p -155.17 163.59 39.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.525 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -99.31 133.89 42.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.475 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.68 129.95 55.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.645 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -147.67 133.57 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -178.6 -169.98 40.04 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.41 158.58 44.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.623 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.18 169.6 33.21 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.82 162.3 40.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -141.69 151.68 43.22 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.22 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.09 147.05 41.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.617 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 39.1 t-20 -128.57 82.24 69.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.992 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.93 -26.56 15.27 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.809 1.673 . . . . 0.0 111.563 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 98.4 m-70 -135.14 148.53 66.99 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.771 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.66 -21.84 33.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.184 1.923 . . . . 0.0 113.098 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -100.03 -0.1 39.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.83 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -145.27 130.62 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.065 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 153' ' ' GLY . 3.5 p -139.81 145.5 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.726 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.09 123.92 69.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.279 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -110.98 137.03 49.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -146.39 141.87 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.878 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.5 p -157.9 161.34 38.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.129 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.27 130.45 46.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.834 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -135.58 141.83 45.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 110.417 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -131.9 145.38 51.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.69 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 15' ' ' VAL . 84.8 t -131.31 131.67 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.022 0.439 . . . . 0.0 112.016 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.32 143.6 16.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.9 m -124.77 130.38 52.29 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -116.91 136.14 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.548 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.458 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 79.4 mtm -131.58 127.81 37.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.404 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.6 tp -143.22 129.95 20.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.867 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.12 178.57 44.24 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.71 145.8 46.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -108.61 148.78 16.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.506 ' CE2' ' O ' ' A' ' 155' ' ' ARG . 91.8 t80 -134.45 130.05 36.16 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.506 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 85.7 mtp180 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.649 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.609 0.243 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 t -119.54 133.45 55.66 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.453 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.27 131.96 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.865 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -139.89 155.42 47.2 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.996 0.427 . . . . 0.0 110.818 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.8 mt -124.94 130.18 73.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.205 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.69 154.05 22.42 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.638 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.24 148.75 27.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -125.36 138.74 54.05 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 110.901 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -143.39 142.51 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.106 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.446 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 44.3 t -117.87 167.91 10.98 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.158 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -134.8 120.9 19.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.623 HG12 HG22 ' A' ' 145' ' ' VAL . 34.9 m -132.76 149.87 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.994 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--N 1.333 -0.13 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.169 179.327 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 13' ' ' SER . 91.3 Cg_endo -82.48 159.06 16.98 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 122.011 1.807 . . . . 0.0 110.691 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -97.79 131.39 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.76 0.315 . . . . 0.0 110.711 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.585 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -156.81 176.05 34.2 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.96 149.18 49.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.727 0.298 . . . . 0.0 110.33 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.577 ' ND2' ' SD ' ' A' ' 149' ' ' MET . 27.7 t-20 -133.61 124.61 27.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.205 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.46 138.59 45.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.757 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.68 139.9 53.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.89 143.37 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.672 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.637 HH12 ' NE2' ' A' ' 122' ' ' GLN . 61.6 ttp180 -131.96 131.63 42.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 111.036 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -129.32 143.09 50.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -179.869 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.3 142.84 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.438 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -136.99 136.41 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.83 143.11 14.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.9 m -130.48 147.9 52.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.234 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.53 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 95.7 m-85 -127.69 141.81 51.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.454 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.04 33.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.27 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -145.86 124.93 12.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.585 HG22 ' HA3' ' A' ' 28' ' ' GLY . 82.4 p -128.89 157.73 40.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.379 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -145.29 128.6 16.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.302 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' NH2' ' CG2' ' A' ' 15' ' ' VAL . 64.0 ttm-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.235 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -119.55 143.61 47.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.664 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -124.98 138.0 54.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.969 0.414 . . . . 0.0 110.995 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -144.89 132.67 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.797 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.6 p -147.49 158.57 44.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.67 141.6 23.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.7 t -150.47 149.56 30.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 111.298 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.82 155.02 32.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.299 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -166.82 171.09 41.59 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.39 148.77 55.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.019 2.479 . . . . 0.0 112.442 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.59 HG22 ' CB ' ' A' ' 88' ' ' TYR . 71.9 t -126.53 130.06 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -122.87 136.73 54.97 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.5 mtm-85 -86.22 131.71 34.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.962 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.595 ' HB ' HG13 ' A' ' 85' ' ' VAL . 96.6 mt -88.28 -50.99 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.235 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 84' ' ' TYR . 56.9 t30 -139.97 34.37 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.911 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 56.54 1.8 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.825 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 82' ' ' ASN . 64.7 m-85 -120.87 -20.71 6.84 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.165 0.507 . . . . 0.0 109.666 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.595 HG13 ' HB ' ' A' ' 81' ' ' ILE . 6.7 p -144.28 140.57 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.462 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.3 t -136.62 141.42 43.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 134.46 51.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.885 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.59 ' CB ' HG22 ' A' ' 78' ' ' VAL . 54.7 p90 -144.26 159.33 42.87 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.15 152.07 17.39 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.41 126.9 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.2 tp -129.27 126.71 39.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.722 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.13 -155.65 18.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.481 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -148.69 155.86 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.897 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.66 140.41 14.84 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -126.76 120.64 29.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.44 141.71 15.68 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.966 0.412 . . . . 0.0 111.062 -179.426 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.2 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.75 0.309 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.474 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 93.4 p -151.68 165.58 33.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.557 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.95 140.79 29.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.476 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.46 131.62 56.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.832 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.1 132.92 29.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.64 178.41 34.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.487 -0.864 . . . . 0.0 111.61 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.52 155.13 39.84 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.446 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -144.4 155.38 26.29 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.56 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.868 HD22 ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -109.43 143.44 39.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.666 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.637 ' NE2' HH12 ' A' ' 34' ' ' ARG . 46.0 tt0 -119.87 123.72 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.288 . . . . 0.0 110.971 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.976 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.569 ' CG ' HG12 ' A' ' 130' ' ' VAL . 59.9 t-20 -137.82 81.78 27.61 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.44 -28.17 18.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.661 1.574 . . . . 0.0 111.653 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 129' ' ' PHE . 97.9 m-70 -131.74 124.55 19.91 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.003 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -50.24 -33.74 37.37 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.79 1.66 . . . . 0.0 112.938 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -81.51 -12.09 58.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 126' ' ' HIS . 92.5 t80 -142.66 129.74 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.969 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.569 HG12 ' CG ' ' A' ' 124' ' ' ASN . 34.2 m -130.74 152.81 38.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.0 mt -117.1 125.8 74.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.268 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -116.95 113.82 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.34 128.15 54.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.074 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.4 p -157.34 161.11 39.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.984 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -149.83 156.0 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.277 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -145.24 156.32 43.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.162 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.55 159.22 43.44 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.156 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.235 0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.576 179.504 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 C--O 1.233 0.198 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.623 HG22 HG12 ' A' ' 15' ' ' VAL . 99.8 t -125.52 128.04 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.086 0.469 . . . . 0.0 112.146 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -124.48 129.63 7.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.9 m -126.47 132.38 51.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 111.854 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -116.84 141.1 48.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.577 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 78.2 mtm -128.66 137.74 51.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.01 0.433 . . . . 0.0 111.257 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -142.79 131.4 22.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.814 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -164.0 177.81 39.64 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.962 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.98 158.66 44.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.35 -160.56 13.78 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.07 160.36 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.939 0.4 . . . . 0.0 110.879 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.386 -179.827 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.652 0.263 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -132.61 138.21 47.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.486 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -127.76 138.91 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.707 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -149.79 145.5 26.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.78 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.56 159.23 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.96 -178.21 40.26 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.709 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.81 144.65 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.473 ' O ' ' NE2' ' A' ' 12' ' ' GLN . . . -125.3 136.55 53.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.111 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 11' ' ' ALA . 98.1 mm-40 -131.53 145.13 51.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.634 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 t -116.56 166.86 11.61 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -125.5 123.46 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -120.88 127.65 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.875 0.369 . . . . 0.0 111.54 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 C--N 1.333 -0.134 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.828 178.968 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.61 159.01 16.64 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.079 1.853 . . . . 0.0 110.473 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -99.77 137.6 38.01 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.849 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.68 177.87 36.91 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.79 147.5 47.5 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.329 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 29.6 t-20 -132.77 123.84 26.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.034 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.741 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 98.8 mttt -121.98 140.77 52.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -140.86 128.55 21.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.235 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 122' ' ' GLN . 80.1 ttt180 -124.71 132.24 53.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.807 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -118.84 127.68 53.74 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.04 -179.137 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.63 127.34 75.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 110.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -136.42 137.44 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.28 149.4 19.43 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -137.4 139.8 40.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.94 139.43 49.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.569 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.71 139.4 43.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.994 0.425 . . . . 0.0 111.413 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -143.67 130.25 20.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.842 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -128.4 158.09 39.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.791 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -158.25 158.01 33.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.1 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 . . . . . 0 C--N 1.331 -0.222 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.888 179.811 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.558 0.218 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -134.35 128.45 33.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.277 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -130.22 128.01 40.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -136.5 131.01 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.211 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -147.83 159.69 43.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.943 0.402 . . . . 0.0 110.812 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.05 143.37 30.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.524 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.614 HG21 HD23 ' A' ' 90' ' ' LEU . 9.4 t -147.21 147.78 30.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.982 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.15 156.08 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.338 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.41 171.54 43.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 154.84 57.06 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.206 2.604 . . . . 0.0 112.314 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 88' ' ' TYR . 97.7 t -122.28 127.59 75.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -107.16 122.6 46.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.518 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 8.3 tmm_? -89.56 129.13 36.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.7 mp -89.35 -51.6 11.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.484 -0.486 . . . . 0.0 109.774 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -154.67 38.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.549 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.518 ' H ' ' CG ' ' A' ' 80' ' ' ARG . 4.3 tm-20 72.57 -49.58 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.053 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -71.04 -29.7 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.399 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.2 t -127.44 132.43 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.696 0.284 . . . . 0.0 110.974 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.409 ' OG ' ' CG1' ' A' ' 78' ' ' VAL . 45.0 t -138.51 135.24 34.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.281 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -108.73 130.23 55.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.067 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.467 ' HB3' HG22 ' A' ' 78' ' ' VAL . 52.2 p90 -139.5 158.1 44.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.451 . . . . 0.0 111.155 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.09 151.39 16.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 74' ' ' THR . 8.7 mp -111.03 129.32 55.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.44 . . . . 0.0 110.897 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -138.01 125.93 22.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.587 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.63 ' C ' ' HB3' ' A' ' 116' ' ' ALA . . . -179.29 -154.39 13.03 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.386 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.15 38.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.787 0.327 . . . . 0.0 110.696 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.66 147.86 16.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -129.7 122.4 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.35 140.97 16.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.52 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.527 0.078 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -150.64 158.38 44.08 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.363 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.0 127.58 47.43 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.63 ' HB3' ' C ' ' A' ' 92' ' ' GLY . . . -92.17 114.55 27.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.109 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -145.59 130.71 18.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.846 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -177.24 -169.95 39.03 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.634 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.26 158.46 36.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.404 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -152.26 159.12 28.2 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.89 148.12 43.88 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.674 0.273 . . . . 0.0 110.628 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.523 ' OE1' ' NH1' ' A' ' 34' ' ' ARG . 63.3 tt0 -119.81 132.55 55.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -126.45 147.48 49.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.728 ' OD1' HG23 ' A' ' 130' ' ' VAL . 69.5 m-20 -128.48 82.03 69.42 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.47 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.51 -41.27 74.75 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.497 2.131 . . . . 0.0 112.171 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.38 153.64 71.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.148 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.12 -38.0 80.27 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.945 1.764 . . . . 0.0 113.082 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -90.98 6.13 45.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -142.73 130.99 22.07 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.15 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.728 HG23 ' OD1' ' A' ' 124' ' ' ASN . 3.8 p -136.3 138.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -131.03 141.98 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.949 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.439 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -145.67 160.19 42.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.12 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -149.52 149.93 31.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.741 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.7 p -155.8 163.49 39.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 110.726 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -140.72 151.08 44.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.175 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 147' ' ' THR . 14.6 tm-20 -143.54 138.07 28.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.857 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -144.81 160.03 41.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.638 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.237 0.435 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.563 179.469 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp . . . . . 0 C--O 1.232 0.169 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.6 129.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.916 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.1 139.29 10.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 136' ' ' GLU . 88.2 m -131.25 133.16 45.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.623 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.547 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.438 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 24.7 ptp -139.18 149.74 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.063 0.458 . . . . 0.0 111.344 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.35 155.25 44.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.022 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.91 -174.79 42.76 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.85 160.21 42.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.66 -168.7 19.08 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.34 145.99 50.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.596 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.77 0.319 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t -137.68 140.35 40.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.681 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.1 mt -118.12 128.42 75.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -129.34 150.61 50.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -136.92 145.44 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.61 167.56 34.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.494 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -87.24 146.53 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -113.05 126.19 55.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.728 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' N ' ' OE1' ' A' ' 12' ' ' GLN . 25.2 mp0 -125.79 121.3 32.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.842 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -118.54 168.1 11.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -143.74 147.66 34.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.876 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.71 138.65 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.791 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.93 158.89 24.25 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.87 1.713 . . . . 0.0 111.288 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -100.05 148.8 24.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.624 0.25 . . . . 0.0 110.656 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.37 -175.73 38.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -125.41 148.18 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 51.1 t30 -126.04 120.56 30.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.813 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.66 141.17 37.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.68 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' CD ' ' OG ' ' A' ' 46' ' ' SER . 6.0 tppt? -137.25 131.58 32.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.707 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -126.77 142.08 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.96 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -125.56 130.45 51.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -128.73 143.65 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.761 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 -179.774 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.82 158.49 42.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -139.46 135.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.724 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.98 142.65 17.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.423 ' OG ' ' CD ' ' A' ' 32' ' ' LYS . 60.8 m -126.43 142.09 51.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.04 0.448 . . . . 0.0 111.146 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -130.18 142.1 50.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.685 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.09 143.44 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -147.58 130.17 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.222 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.2 p -129.49 159.36 36.54 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.639 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -145.12 140.99 28.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.801 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 C--O 1.231 0.086 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -112.45 139.35 48.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -127.84 128.34 45.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.66 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -136.28 129.82 32.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.903 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -137.68 141.63 41.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 111.308 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.98 130.87 71.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.467 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 12.4 t -149.46 149.96 31.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.092 0.472 . . . . 0.0 111.427 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.92 156.52 33.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.378 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.15 170.03 39.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.456 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.69 149.45 54.83 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.207 2.605 . . . . 0.0 112.893 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.526 HG22 ' CB ' ' A' ' 88' ' ' TYR . 74.6 t -126.48 129.24 71.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.358 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.53 127.35 43.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.352 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -72.53 135.06 45.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.2 mm -86.37 -50.92 13.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.049 0.452 . . . . 0.0 110.228 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 84' ' ' TYR . 6.1 m-20 173.84 165.11 0.19 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.124 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 45.2 -92.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.513 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ASN . 21.5 p90 -144.31 37.71 1.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.392 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -119.64 126.0 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.43 ' O ' HD13 ' A' ' 121' ' ' LEU . 40.7 t -128.97 137.11 51.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.207 0.527 . . . . 0.0 111.175 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -110.28 123.81 50.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.2 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.565 ' N ' HD13 ' A' ' 87' ' ' LEU . 53.2 p90 -142.42 158.9 43.2 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.147 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -124.6 150.88 17.17 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.18 125.08 53.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' C ' ' HG1' ' A' ' 74' ' ' THR . 87.9 mt -122.67 139.64 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.641 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 169.29 -159.18 32.02 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.665 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -146.83 153.21 39.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.95 0.405 . . . . 0.0 110.701 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.6 141.35 15.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.22 144.13 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.726 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -120.99 147.37 17.55 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.977 -179.841 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.462 0.13 0 CA-C-O 120.886 0.374 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.742 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 96.5 p -156.14 167.58 29.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.546 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mp -99.37 143.6 29.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.04 137.33 53.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.434 . . . . 0.0 111.083 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.23 159.61 43.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.681 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.85 -170.25 43.37 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.06 153.19 34.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.412 . . . . 0.0 110.139 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.469 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -149.78 156.5 26.79 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.704 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 120' ' ' GLY . 4.1 mm? -117.96 141.85 48.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.467 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -121.12 126.33 49.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.585 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -127.03 140.04 52.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.232 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -130.25 78.65 74.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.593 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.27 -25.79 11.11 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.141 1.894 . . . . 0.0 111.642 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.1 m-70 -127.33 119.22 21.85 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.899 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 -36.69 45.87 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.772 1.648 . . . . 0.0 113.108 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -82.16 -11.9 58.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' HIS . 89.6 t80 -143.62 129.61 19.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.245 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 152' ' ' ALA . 35.1 m -130.12 153.15 38.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.48 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -119.15 136.91 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.602 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -128.52 114.91 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.975 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.842 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -156.89 164.53 37.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.189 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.58 152.65 40.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 149' ' ' MET . 49.9 mp0 -143.59 154.05 43.17 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.709 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.15 144.14 51.1 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.329 -0.294 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.807 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 91.6 t -129.24 133.14 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.954 0.406 . . . . 0.0 112.08 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.79 144.57 15.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.3 p -129.61 148.26 51.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.323 0.582 . . . . 0.0 112.01 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -141.07 137.96 33.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.819 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -139.09 146.36 40.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.578 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -143.24 132.32 23.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.915 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.649 ' N ' HD13 ' A' ' 150' ' ' LEU . . . -170.69 -177.39 40.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.831 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 130' ' ' VAL . . . -148.9 157.45 43.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -140.4 -165.03 10.14 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.43 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -149.13 157.22 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.758 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.129 -179.554 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.3 p -119.69 154.62 33.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.2 mt -119.59 125.35 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.542 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -136.54 150.81 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -131.63 147.01 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.229 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.06 -179.34 30.16 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -109.28 142.24 40.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.684 0.278 . . . . 0.0 110.292 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -116.32 128.19 55.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HB3' HD22 ' A' ' 25' ' ' ASN . 97.4 mt-30 -124.93 120.29 31.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.165 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.437 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 39.3 t -99.84 106.76 18.65 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.424 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 121.03 16.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.34 125.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.081 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.9 tptm . . . . . 0 C--N 1.331 -0.23 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.414 -179.525 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.412 HD22 ' HB3' ' A' ' 12' ' ' GLN . 2.3 m-20 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HD2' ' H ' ' A' ' 13' ' ' SER . 71.3 Cg_endo -81.25 160.6 20.24 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.805 2.337 . . . . 0.0 111.147 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -93.49 134.27 35.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.474 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.23 36.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -126.8 149.07 49.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.752 0.31 . . . . 0.0 110.75 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 50.4 t30 -124.63 120.65 32.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.647 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.52 140.55 31.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.498 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 87.6 tttt -136.68 133.18 35.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.048 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.13 146.37 51.08 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.419 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.724 HH21 HE22 ' A' ' 122' ' ' GLN . 42.1 ttm180 -111.05 132.78 53.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 43' ' ' VAL . 96.8 m-85 -125.37 142.91 51.23 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.396 0.435 . . . . 0.0 110.094 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 -179.671 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.671 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 35' ' ' TYR . 33.8 m -133.51 149.45 31.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.176 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.48 155.04 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.343 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.08 134.55 7.9 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.0 m -130.22 146.17 51.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 94.9 m-85 -129.13 145.39 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.465 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.77 138.69 37.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -145.15 127.93 16.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.04 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.6 p -129.88 159.45 36.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.358 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.488 ' NE ' ' HZ3' ' A' ' 69' ' ' LYS . 80.0 ttt180 -151.78 136.36 16.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.583 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.117 179.361 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 120.775 0.321 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HZ3' ' NE ' ' A' ' 51' ' ' ARG . 73.2 mmtt -101.02 135.93 41.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.09 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -124.67 133.85 53.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' A' ' 95' ' ' HIS . 87.5 t80 -143.39 131.3 21.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.266 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -142.0 141.82 32.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.467 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.2 t -117.82 125.03 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -129.44 149.64 51.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.99 158.96 12.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.13 166.43 34.0 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.5 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 155.11 46.16 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.027 2.485 . . . . 0.0 112.386 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.8 123.76 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.295 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.57 118.16 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.523 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -84.76 136.46 33.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.12 -51.16 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.763 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 84' ' ' TYR . 60.4 t30 -161.74 41.84 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 67.28 -37.62 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 82' ' ' ASN . 78.5 m-85 -66.99 -38.01 85.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.57 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -144.22 146.88 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.4 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -139.1 150.2 45.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.639 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.8 mt -98.78 139.79 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.474 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.88 141.62 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.419 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.74 138.84 14.35 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 134' ' ' SER . 75.6 mt -112.03 117.91 33.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.74 133.05 39.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.666 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.57 -161.02 34.53 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.444 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -146.53 150.75 36.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.724 0.297 . . . . 0.0 110.452 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.25 142.96 16.12 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.429 ' CD2' HG22 ' A' ' 113' ' ' THR . 78.7 m80 -135.15 148.81 49.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.12 152.87 20.93 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 -179.756 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 95' ' ' HIS . 82.3 p . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.705 0.288 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.72 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 92.8 p -151.14 162.35 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.8 tp -100.2 125.84 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.396 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 123.05 45.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.6 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -143.3 131.59 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.109 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.35 -170.18 34.37 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.594 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.61 158.72 42.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 0.0 110.533 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.17 173.74 36.04 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -135.75 170.02 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 0.0 110.501 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.724 HE22 HH21 ' A' ' 34' ' ' ARG . 52.4 tt0 -139.54 136.3 34.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -129.75 130.64 45.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.446 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 31.5 t-20 -106.66 99.28 24.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.231 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.38 -31.89 5.39 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.658 1.572 . . . . 0.0 111.439 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.3 m-70 -138.59 148.95 60.8 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.774 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.92 -25.97 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.998 1.799 . . . . 0.0 112.357 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -82.8 -25.58 32.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.647 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 126' ' ' HIS . 94.5 m-85 -132.91 144.28 50.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.298 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.52 153.0 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.285 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.6 pt -128.55 147.09 33.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.682 0.277 . . . . 0.0 110.422 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.527 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 61.0 t0 -146.71 133.62 20.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.474 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -124.05 124.72 43.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.68 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.635 ' HB3' HD11 ' A' ' 90' ' ' LEU . 66.4 m -133.97 152.35 51.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.316 . . . . 0.0 111.164 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.08 139.72 53.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.055 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.426 ' CG ' HD13 ' A' ' 90' ' ' LEU . 97.5 mt-10 -125.31 150.35 47.22 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.646 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -131.41 127.18 36.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 CA--C 1.523 -0.09 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.304 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.6 mptt . . . . . 0 C--O 1.231 0.125 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.415 HG13 ' OG ' ' A' ' 13' ' ' SER . 84.6 t -128.03 129.12 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.029 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.01 132.28 8.82 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 96.5 m -113.16 123.53 50.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.046 0.451 . . . . 0.0 111.285 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -95.72 135.49 37.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 149' ' ' MET . 1.8 tmt? -119.43 117.83 29.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.785 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -137.07 127.29 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.784 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -169.6 177.85 42.92 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.168 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.49 159.79 44.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.66 -160.91 14.59 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.38 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.04 160.11 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 0.0 110.673 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.516 -179.84 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.589 0.233 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.8 m -124.85 148.61 48.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.53 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -116.89 129.75 72.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.9 t -124.59 140.03 53.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.5 tt -126.91 145.57 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.136 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.12 -173.82 37.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.445 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -106.09 142.42 35.81 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -118.03 127.92 54.28 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -129.24 134.95 48.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.796 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.465 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 41.4 t -117.33 120.35 37.93 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.571 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.682 HH21 ' NZ ' ' A' ' 16' ' ' LYS . 61.2 ttt85 -67.53 120.1 13.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.361 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -133.25 131.52 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.682 ' NZ ' HH21 ' A' ' 14' ' ' ARG . 73.5 mmtt . . . . . 0 C--N 1.331 -0.199 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 13' ' ' SER . 93.4 Cg_endo -83.7 161.01 14.35 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.176 2.584 . . . . 0.0 111.093 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -92.12 132.09 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.3 169.65 33.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.56 138.86 49.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.648 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 29.5 t-20 -115.09 119.52 36.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.407 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.47 129.18 51.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.56 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -132.56 147.16 52.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.87 145.05 51.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.201 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.691 HH11 HE22 ' A' ' 122' ' ' GLN . 61.5 ttp180 -124.96 132.67 53.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.15 142.91 51.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.0 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.032 -179.522 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 78' ' ' VAL . . . . . . . . 0 CA--C 1.524 0.613 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.5 t -124.42 128.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.16 157.28 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.068 0.461 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.19 159.32 27.67 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -136.69 131.01 32.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.059 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.69 123.66 43.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.837 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.01 152.99 41.01 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.121 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -148.89 144.35 26.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.653 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.4 p -132.3 160.92 34.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -154.74 148.59 25.58 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.785 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 . . . . . 0 C--O 1.232 0.141 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.78 179.429 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.803 0.335 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.9 146.29 25.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -119.44 127.39 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 95' ' ' HIS . 98.5 m-85 -127.95 144.21 51.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.274 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -152.46 140.07 19.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.568 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.87 143.97 39.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.022 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.7 p -144.2 163.12 34.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.44 155.1 29.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.441 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.54 164.04 34.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.489 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.13 158.9 37.61 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.258 2.639 . . . . 0.0 112.291 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 42' ' ' GLY . 8.7 p -135.7 135.35 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.8 t80 -128.15 129.72 46.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.708 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.531 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 36.4 mmt180 -67.61 136.58 54.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.669 HD11 ' HB2' ' A' ' 87' ' ' LEU . 75.5 mt -87.86 -51.86 12.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.052 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 2.7 m-20 162.9 -73.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.678 ' O ' HG13 ' A' ' 85' ' ' VAL . 98.6 mt-10 -67.71 64.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.459 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' ASN . 91.8 m-85 47.07 33.62 2.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 83' ' ' GLU . 30.2 m -133.09 152.71 36.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 t -139.48 144.11 37.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 111.449 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.669 ' HB2' HD11 ' A' ' 81' ' ' ILE . 63.6 tp -111.11 129.84 55.8 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CZ ' ' C ' ' A' ' 120' ' ' GLY . 53.7 p90 -143.22 158.4 43.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.738 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -107.13 147.35 16.23 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 90' ' ' LEU . 10.8 tp -128.38 119.97 26.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.33 160.91 38.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.836 0.351 . . . . 0.0 111.173 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.35 -143.96 8.89 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.63 150.79 36.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 110.937 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.61 140.6 16.44 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 71' ' ' TYR . 31.1 p80 -147.0 162.03 39.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.36 158.37 18.88 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.228 0.537 . . . . 0.0 110.616 -179.582 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.5 t -160.2 158.21 29.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.7 mt -99.28 141.09 32.5 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.47 140.05 48.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.964 0.411 . . . . 0.0 111.164 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -150.93 159.1 44.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.205 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 165.84 -158.72 31.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.488 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.59 160.17 40.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.739 0.304 . . . . 0.0 110.502 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.444 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -144.43 156.05 26.62 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.29 146.06 44.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.516 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.691 HE22 HH11 ' A' ' 34' ' ' ARG . 63.6 tt0 -117.62 128.56 55.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.697 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -118.7 137.53 53.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.414 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.81 ' OD1' HG13 ' A' ' 130' ' ' VAL . 68.4 m-20 -129.51 81.03 70.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.71 -27.23 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.762 1.641 . . . . 0.0 111.667 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -136.48 149.24 66.89 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.733 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.98 -22.97 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.068 1.845 . . . . 0.0 112.776 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.18 6.0 44.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.678 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -150.08 128.24 11.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.468 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.81 HG13 ' OD1' ' A' ' 124' ' ' ASN . 94.4 t -122.88 132.03 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.0 mt -115.16 126.02 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.087 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -146.61 160.44 42.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.72 138.59 17.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.2 m -135.94 151.83 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.776 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -142.13 148.52 38.45 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.015 0.436 . . . . 0.0 110.867 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.456 ' H ' ' HB ' ' A' ' 147' ' ' THR . 39.9 mt-10 -143.79 159.09 43.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.378 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -119.8 139.2 52.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.805 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.232 0.137 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.57 131.53 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.317 0.579 . . . . 0.0 112.38 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.16 157.15 15.76 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 136' ' ' GLU . 91.2 m -123.92 129.42 50.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.196 0.498 . . . . 0.0 111.606 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -129.53 119.94 24.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.582 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 79.0 mtm -132.07 134.48 45.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.38 142.12 30.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.96 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.33 -175.07 47.13 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.094 -1.051 . . . . 0.0 111.895 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 130' ' ' VAL . . . -149.45 157.94 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.398 . . . . 0.0 109.938 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.52 -177.31 21.04 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.358 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -148.15 158.92 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.496 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.319 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.724 0.297 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.7 p -143.73 159.67 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.2 mt -118.24 130.93 72.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.671 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.4 t -134.5 140.73 46.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.706 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.39 148.76 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.376 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.56 -174.62 35.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -104.33 142.58 34.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.615 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -112.65 131.36 55.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HG2' HD21 ' A' ' 25' ' ' ASN . 99.1 mt-30 -126.79 124.67 40.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.478 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.562 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 69.9 m -117.75 107.41 14.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -66.82 133.34 49.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -111.33 125.52 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.744 179.441 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.608 HD22 ' N ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.608 ' N ' HD22 ' A' ' 25' ' ' ASN . 97.6 Cg_endo -83.04 159.1 15.57 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.69 ' NH2' ' HE ' ' A' ' 51' ' ' ARG . 51.2 ptt85 -93.19 142.61 27.11 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -159.44 169.77 35.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -109.47 142.14 40.92 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.712 0.292 . . . . 0.0 110.575 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 43.5 t30 -125.89 119.02 26.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.752 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.1 137.28 53.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HE3' HD21 ' A' ' 30' ' ' ASN . 98.8 mttt -134.8 146.13 49.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.16 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.507 ' NH2' ' OE2' ' A' ' 36' ' ' GLU . 61.0 ttt85 -107.57 127.48 53.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -137.77 126.77 24.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.079 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.507 ' OE2' ' NH2' ' A' ' 34' ' ' ARG . 99.4 mt-10 . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.969 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 78' ' ' VAL . . . . . . . . 0 CA--C 1.525 0.718 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.48 157.64 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 76' ' ' GLY . 19.0 tt -137.94 134.3 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.442 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.8 132.96 11.32 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.7 m -128.68 139.93 51.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.08 142.11 49.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.744 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.67 139.33 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -142.41 126.74 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.274 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.522 HG22 ' HA3' ' A' ' 28' ' ' GLY . 77.3 p -128.78 159.24 36.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.419 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.69 ' HE ' ' NH2' ' A' ' 27' ' ' ARG . 41.2 ptt180 -157.57 161.18 38.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.355 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.576 HH21 ' CB ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.518 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -118.02 142.05 47.8 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -126.34 125.53 42.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.345 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' CE2' HG23 ' A' ' 73' ' ' VAL . 88.4 t80 -130.03 128.73 42.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.19 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -140.05 140.05 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.062 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.456 HG23 ' CE2' ' A' ' 71' ' ' TYR . 99.4 t -124.06 128.88 74.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.043 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -148.34 155.38 41.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.214 0.53 . . . . 0.0 111.166 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.75 158.33 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.182 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 44' ' ' ILE . . . -150.22 153.58 25.15 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.603 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.66 159.03 31.94 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.74 2.293 . . . . 0.0 111.475 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 78' ' ' VAL . 7.9 p -131.61 119.25 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.455 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.66 120.12 35.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.914 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -80.54 128.44 33.59 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.157 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' A' ' 85' ' ' VAL . 96.5 mt -89.8 -52.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.808 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 84' ' ' TYR . 32.7 m120 -122.09 16.98 10.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.823 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 82' ' ' ASN . 16.9 tt0 76.17 -21.03 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.496 ' H ' ' C ' ' A' ' 82' ' ' ASN . 96.9 m-85 -104.17 -20.89 13.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 81' ' ' ILE . 35.0 m -132.81 145.63 33.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.4 t -141.14 152.25 44.56 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.321 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HG ' HD11 ' A' ' 81' ' ' ILE . 86.1 mt -102.48 138.8 38.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.391 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' OH ' ' NH1' ' A' ' 34' ' ' ARG . 48.9 m-85 -121.48 140.02 52.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.592 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.83 137.66 14.4 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.41 118.79 37.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.499 0.649 . . . . 0.0 111.877 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.7 tp -136.9 122.94 20.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.354 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -167.8 39.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -145.27 151.56 38.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 110.701 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.64 146.5 16.08 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.459 ' HD2' HG22 ' A' ' 113' ' ' THR . 77.7 m80 -130.95 143.89 51.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.727 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -116.19 143.44 18.07 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.1 tttp . . . . . 0 C--N 1.332 -0.187 0 CA-C-O 120.857 0.36 . . . . 0.0 110.57 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.459 HG22 ' HD2' ' A' ' 95' ' ' HIS . 81.3 p . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 121.019 0.438 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.547 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 88.1 p -152.6 163.75 39.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.39 145.24 28.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.629 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.24 52.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.726 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -151.31 160.82 43.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.296 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 169.29 -160.77 34.2 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.878 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.78 158.54 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -157.66 174.97 35.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.24 165.81 27.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.917 0.389 . . . . 0.0 110.831 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.677 HE21 ' CG1' ' A' ' 130' ' ' VAL . 65.4 tt0 -135.11 135.34 41.11 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.207 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -127.66 126.95 42.92 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.009 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.868 ' OD1' HG13 ' A' ' 130' ' ' VAL . 50.0 m-20 -125.24 85.64 57.99 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.59 -29.75 10.51 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.7 1.6 . . . . 0.0 111.652 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.64 123.58 21.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.762 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.15 -29.29 22.02 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.581 1.521 . . . . 0.0 112.522 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -82.06 -8.71 59.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.739 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -139.29 123.34 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.418 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.868 HG13 ' OD1' ' A' ' 124' ' ' ASN . 72.8 t -127.89 134.01 66.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.831 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.04 148.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.502 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -146.29 158.96 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.19 21.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.024 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.8 p -158.17 162.6 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.528 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -144.07 148.29 34.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -145.92 160.4 41.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.568 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -119.02 139.32 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.45 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.163 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.01 130.95 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.0 134.67 11.77 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.9 m -125.0 131.7 53.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.278 0.561 . . . . 0.0 112.356 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -127.95 125.42 39.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.506 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.473 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 79.3 mtm -117.74 136.63 53.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 111.374 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 tt -136.91 130.17 31.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.58 177.66 41.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.851 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.13 158.94 44.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.45 -171.9 23.2 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -147.38 159.32 43.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 0.0 110.617 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.663 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.9 p . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.78 0.324 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -147.01 141.39 26.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.594 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 pt -127.56 147.15 32.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -131.82 148.45 52.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.0 mt -121.09 129.44 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.062 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.01 156.53 26.87 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.27 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -83.72 146.02 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HB3' ' C ' ' A' ' 28' ' ' GLY . . . -107.39 120.0 40.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.768 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -118.5 118.46 31.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.848 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.3 m -118.44 167.73 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -125.21 137.57 54.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' HD3' ' A' ' 26' ' ' PRO . 87.7 t -115.39 126.56 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.531 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.33 -0.282 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.364 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 119.399 -0.334 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' HG23 ' A' ' 15' ' ' VAL . 73.2 Cg_endo -76.63 158.96 35.69 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.433 1.422 . . . . 0.0 110.86 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -91.57 155.02 18.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.764 0.316 . . . . 0.0 110.945 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' C ' ' HB3' ' A' ' 11' ' ' ALA . . . -168.3 175.07 43.09 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.92 149.59 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 47' ' ' PHE . 63.3 t30 -134.92 120.49 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -115.66 140.89 48.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.749 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.38 145.24 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.89 144.59 51.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.074 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -123.66 128.79 50.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.441 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 96.2 m-85 -128.91 148.63 50.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.442 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 17.5 tt0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.409 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.635 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.35 139.62 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.382 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.59 153.16 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.86 135.36 9.39 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.9 m -128.32 145.69 50.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.148 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.434 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 98.3 m-85 -124.37 140.49 52.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.513 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.33 137.96 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -150.99 150.34 30.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.783 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.9 t -150.27 155.24 39.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -156.02 163.24 39.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 . . . . . 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.796 0.332 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -124.08 141.65 51.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.3 144.59 51.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.998 0.427 . . . . 0.0 111.149 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -139.98 130.97 26.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.14 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -148.78 147.95 29.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 111.023 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 p -136.41 136.38 48.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.698 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -135.31 157.76 46.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.17 27.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.452 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.3 169.78 42.91 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.773 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.1 155.0 52.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.327 2.685 . . . . 0.0 112.794 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.442 HG22 ' CB ' ' A' ' 88' ' ' TYR . 89.6 t -126.69 130.51 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.754 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -126.91 125.76 42.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.404 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.69 137.33 54.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 87' ' ' LEU . 92.1 mt -88.97 -48.61 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.325 0.583 . . . . 0.0 110.139 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 51.4 t30 -134.73 -148.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.754 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.47 ' H ' ' CG ' ' A' ' 82' ' ' ASN . 99.3 mt-10 -88.71 -5.24 58.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -149.23 15.62 0.91 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.632 HG13 ' HB ' ' A' ' 81' ' ' ILE . 3.8 p -144.36 138.31 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.42 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.0 m -134.62 149.87 50.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.11 0.481 . . . . 0.0 111.847 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.672 ' HB2' HD11 ' A' ' 81' ' ' ILE . 63.6 tp -119.52 131.12 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.435 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.442 ' CB ' HG22 ' A' ' 78' ' ' VAL . 52.4 p90 -142.29 158.79 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.866 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.19 148.54 17.42 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.6 mt -119.16 135.9 54.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.98 146.83 31.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.599 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.86 -145.45 8.46 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.136 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.37 152.24 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.56 147.21 16.61 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -134.79 144.96 47.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.736 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.69 145.86 17.42 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.666 -179.919 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.771 0.319 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.6 t -148.64 149.84 32.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.638 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 115' ' ' LEU . 2.7 mp -99.69 142.91 30.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.614 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.21 132.76 55.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.99 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -145.97 134.13 21.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.138 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.31 -169.68 34.53 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.806 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.66 159.27 44.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.016 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.54 169.31 31.06 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.805 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.421 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.6 OUTLIER -142.44 160.24 40.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.919 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.51 ' NE2' ' OD1' ' A' ' 132' ' ' ASP . 63.7 tt0 -140.34 137.41 34.07 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.616 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.421 ' CE2' ' CD1' ' A' ' 121' ' ' LEU . 69.6 m-85 -115.5 149.01 38.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.683 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -129.89 83.02 65.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.949 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.4 -22.8 24.56 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.72 1.613 . . . . 0.0 111.71 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.524 ' ND1' ' OD1' ' A' ' 128' ' ' ASN . 65.7 t-80 -150.14 136.4 10.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.482 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.99 -39.43 50.07 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.921 1.747 . . . . 0.0 113.89 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.524 ' OD1' ' ND1' ' A' ' 126' ' ' HIS . 54.7 p30 -84.14 -0.7 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.62 126.67 13.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.394 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 152.69 34.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.451 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.9 mt -114.51 125.85 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NE2' ' A' ' 122' ' ' GLN . 97.8 m-20 -105.73 132.46 51.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.193 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -136.14 127.33 28.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.781 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.8 t -158.03 151.62 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.858 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -139.07 149.16 44.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.683 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -142.46 153.57 43.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.775 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.59 147.26 49.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.163 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.7 t . . . . . 0 C--N 1.332 -0.187 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.324 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--O 1.231 0.122 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.93 146.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.144 -0.623 . . . . 0.0 112.223 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.31 152.45 17.74 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 91.2 m -125.28 131.86 53.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 111.558 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -125.94 123.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.897 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 149' ' ' MET . 2.5 mpp? -117.47 129.57 55.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.932 0.396 . . . . 0.0 111.012 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -143.27 131.78 22.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.982 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.642 ' N ' HD13 ' A' ' 150' ' ' LEU . . . -178.56 -169.03 38.74 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.575 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.42 155.86 47.34 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.88 -169.62 14.05 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.789 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -148.61 163.09 38.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.123 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.517 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.7 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.746 0.307 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.6 m -124.45 141.98 51.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.536 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.89 124.3 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -128.88 140.75 51.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.026 0.441 . . . . 0.0 111.311 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.512 HG22 HD22 ' A' ' 31' ' ' LEU . 45.8 pt -132.82 156.49 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.746 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.17 -174.18 38.76 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.119 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -113.72 145.91 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.7 140.99 38.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HG2' HD21 ' A' ' 25' ' ' ASN . 24.8 mp0 -131.69 138.1 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.696 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.447 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 67.2 m -117.33 109.39 16.77 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.239 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -68.66 129.15 39.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.02 129.43 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.635 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm . . . . . 0 C--N 1.333 -0.113 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.864 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.407 HD21 ' HG2' ' A' ' 12' ' ' GLN . 49.7 t-20 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.447 ' CD ' ' O ' ' A' ' 13' ' ' SER . 96.2 Cg_endo -84.73 160.42 12.23 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.766 2.311 . . . . 0.0 111.44 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.81 135.43 39.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.73 169.75 35.15 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.97 143.85 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.426 ' OD1' ' SD ' ' A' ' 149' ' ' MET . 29.5 t-20 -117.61 119.09 33.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.512 HD22 HG22 ' A' ' 8' ' ' ILE . 88.3 mt -122.92 136.89 55.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.833 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -148.24 155.9 41.91 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -133.07 146.8 52.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.16 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -126.97 131.14 51.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.795 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.91 139.8 52.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.176 179.443 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.585 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.42 143.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.348 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -132.64 137.25 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.08 142.57 16.19 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -126.21 143.93 50.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.932 0.396 . . . . 0.0 111.102 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -130.08 146.01 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.807 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.41 141.55 35.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.03 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -128.79 137.28 51.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.21 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.4 m -128.06 134.9 49.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -146.38 143.99 29.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.874 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.832 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.587 0.232 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -132.22 115.99 16.39 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -134.46 129.29 35.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.279 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.06 160.82 40.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.287 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -147.59 145.02 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.092 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.29 126.96 74.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.121 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -132.85 156.64 46.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.53 154.81 29.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.36 170.66 43.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.477 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.4 154.46 50.81 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.21 2.607 . . . . 0.0 113.041 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.5 t -127.89 130.97 70.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -127.15 146.42 50.4 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.175 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.79 126.77 52.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.6 tt -80.18 -37.42 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.72 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 84' ' ' TYR . 57.4 t30 -156.72 31.72 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.761 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 68.52 -42.66 0.48 Allowed 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.855 0.722 . . . . 0.0 109.812 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 82' ' ' ASN . 66.5 t80 -63.96 -40.61 96.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.415 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 84' ' ' TYR . 92.6 t -126.93 135.61 63.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.402 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.2 t -129.05 134.77 48.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.02 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.0 tp -110.62 127.96 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.269 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.98 159.33 42.44 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.967 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.52 145.33 16.01 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -120.13 137.16 54.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.622 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.2 152.25 38.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.765 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.14 -147.13 9.76 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.348 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.95 150.57 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 0.0 110.96 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.75 139.76 15.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -145.95 135.03 22.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.15 158.94 27.85 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.771 0.319 . . . . 0.0 110.386 179.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 93.1 m . . . . . 0 CA--C 1.528 0.109 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.7 t -148.96 150.73 33.36 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.027 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.49 140.93 32.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.54 132.69 56.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.895 0.379 . . . . 0.0 110.711 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -151.01 160.26 44.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.087 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.34 -166.78 39.97 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.727 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.18 156.77 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.0 170.28 30.06 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.597 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.95 156.38 46.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.375 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -132.0 129.18 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -115.12 148.21 39.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.796 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 55.6 t-20 -129.37 81.85 69.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.406 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -28.18 14.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.896 1.731 . . . . 0.0 112.131 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 70.6 m80 -135.68 148.18 64.45 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.079 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.81 -24.01 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.25 1.967 . . . . 0.0 112.854 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -99.96 4.52 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.777 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.65 128.66 8.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 153' ' ' GLY . 29.1 m -131.98 152.78 37.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.29 148.12 27.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 133' ' ' ALA . 52.8 t0 -146.31 138.88 25.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.692 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.472 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -148.35 150.83 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.056 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 149' ' ' MET . 85.8 p -153.38 161.57 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.752 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -127.14 128.03 45.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.759 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -132.07 147.62 52.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.251 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -130.42 147.91 52.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.204 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--O 1.236 0.355 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.866 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 87.2 t -128.31 130.61 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.134 0.492 . . . . 0.0 112.28 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.31 138.02 14.54 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.6 m -111.56 132.77 54.3 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.165 0.483 . . . . 0.0 111.846 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -112.0 135.82 52.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.124 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.426 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 53.9 ttp -131.54 125.55 32.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.891 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.1 tp -143.04 129.82 20.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.711 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -176.81 -176.18 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.073 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.84 158.93 44.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -142.51 174.79 23.25 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.751 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -123.06 130.15 52.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.369 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.342 -179.892 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.85 177.54 54.34 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -71.04 141.14 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.805 0.336 . . . . 0.0 110.612 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 156' ' ' PHE . 63.5 m -129.8 154.64 47.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -126.5 138.69 53.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.506 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.2 mm -112.33 126.8 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.374 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 t -139.2 143.09 37.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.417 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.9 tt -134.94 148.72 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.049 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.04 172.1 36.47 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -83.34 143.66 30.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -126.41 127.0 44.77 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.961 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -134.01 139.27 45.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.912 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 40.7 t -117.7 106.99 13.65 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.346 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 146' ' ' GLY . 80.0 ttt180 -68.84 128.78 37.89 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.82 150.01 32.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.071 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -80.4 129.47 34.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.87 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' OE2' HD13 ' A' ' 64' ' ' ILE . 23.3 tp10 -148.28 164.15 34.89 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.214 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.76 -39.98 86.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.579 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.64 15.93 0.03 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.221 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 21' ' ' LYS . 90.0 t80 -62.39 134.05 55.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.307 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 20' ' ' TYR . 0.4 OUTLIER 50.17 178.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.204 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.38 -52.38 5.41 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.215 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 59.5 p30 -99.42 7.01 45.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.551 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 50.26 33.69 7.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.816 0.341 . . . . 0.0 110.142 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.517 ' ND2' ' OD2' ' A' ' 23' ' ' ASP . 74.8 m-20 -103.05 115.17 64.53 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.51 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 13' ' ' SER . 92.5 Cg_endo -78.16 159.98 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.402 2.068 . . . . 0.0 111.437 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -95.81 127.98 42.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.793 0.33 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.29 171.55 35.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -127.82 146.59 50.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.693 HD22 ' HB2' ' A' ' 48' ' ' ALA . 29.3 t-20 -121.89 120.8 35.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 tp -105.53 124.1 48.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.557 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.96 139.91 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.014 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -133.63 126.91 31.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.449 HH12 ' CD ' ' A' ' 122' ' ' GLN . 43.1 ttm180 -110.38 131.64 54.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.641 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -116.02 137.7 51.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.017 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 59.42 65.85 1.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.742 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -58.97 -49.03 79.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.283 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 m120 41.05 -126.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.603 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.42 ' OD1' ' NE ' ' A' ' 80' ' ' ARG . 55.4 t30 -158.86 -55.02 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.826 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.72 -40.89 96.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -153.78 163.86 39.31 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.355 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.94 175.86 44.52 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.61 156.75 42.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -142.61 140.16 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.026 0.441 . . . . 0.0 111.237 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.35 147.0 18.29 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.6 t -126.99 130.82 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.202 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.516 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 96.5 m-85 -125.36 136.23 53.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.693 ' HB2' HD22 ' A' ' 30' ' ' ASN . . . -145.09 148.16 33.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.374 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -151.11 149.44 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.67 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.9 t -152.15 162.46 41.08 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.919 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -149.03 141.02 23.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.578 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -69.98 137.63 51.58 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.49 84.76 0.1 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 55' ' ' GLU . 91.5 t80 -111.42 135.85 51.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 80.8 mm-40 -59.44 144.83 45.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.209 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.31 132.87 50.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.075 0.464 . . . . 0.0 111.089 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.9 t -150.81 147.45 27.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.862 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.69 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.6 p -97.81 102.1 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.608 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -107.06 -18.24 13.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.278 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.88 -9.14 78.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 62' ' ' LYS . 97.4 m-85 -105.85 7.45 32.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.447 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 61' ' ' PHE . 2.3 mptp? 55.44 164.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.405 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.8 mt -111.72 129.17 56.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.541 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.546 HD13 ' OE2' ' A' ' 17' ' ' GLU . 91.8 mt -62.71 -45.68 98.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.962 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 46.41 -97.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.91 -19.98 49.8 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.3 t0 48.45 56.73 7.08 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.281 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -132.22 161.35 33.63 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.847 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -120.41 147.75 44.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.858 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -123.2 131.07 53.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.589 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.48 147.2 49.32 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.625 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.0 t -149.21 142.72 25.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.539 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.54 131.73 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.9 p -137.78 158.27 44.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.991 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.09 152.25 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.566 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.7 43.62 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.561 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.6 153.4 54.57 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.358 2.705 . . . . 0.0 112.863 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.58 HG22 ' CB ' ' A' ' 88' ' ' TYR . 91.5 t -126.31 129.57 71.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.727 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.2 t80 -127.11 128.55 46.4 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 59.0 ttm-85 -69.59 134.58 48.96 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.319 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 87' ' ' LEU . 96.6 mt -88.02 -51.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.972 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.415 ' OD1' ' CG1' ' A' ' 85' ' ' VAL . 17.5 m120 -126.71 -137.3 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.161 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -97.14 -4.92 38.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.381 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -154.35 20.04 0.48 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.612 HG13 ' HB ' ' A' ' 81' ' ' ILE . 5.0 p -144.07 142.1 24.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.048 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.7 p -138.51 152.93 48.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 111.225 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 81' ' ' ILE . 3.0 tt -121.14 130.02 53.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.467 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.58 ' CB ' HG22 ' A' ' 78' ' ' VAL . 53.4 p90 -140.34 157.73 45.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.848 0.356 . . . . 0.0 110.719 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.17 147.19 18.35 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.624 ' O ' HD22 ' A' ' 91' ' ' LEU . 88.6 mt -114.43 127.91 56.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.677 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.624 HD22 ' O ' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -133.61 142.26 48.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.921 179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.6 -144.26 7.82 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.22 154.09 39.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 0.0 111.095 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.59 143.72 16.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.4 145.61 50.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.783 0.325 . . . . 0.0 110.802 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -123.29 144.9 15.9 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -125.06 141.74 51.93 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.34 140.69 30.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.408 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.15 134.33 44.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.469 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -95.66 135.88 36.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.018 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.2 p -87.5 114.3 23.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.121 0.486 . . . . 0.0 110.767 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.8 p -163.57 165.84 23.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.828 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.6 mt -106.16 112.56 39.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.527 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -146.89 162.15 39.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.133 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.75 -17.44 57.87 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -137.99 168.45 19.68 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.8 p -108.81 157.16 18.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -125.74 134.21 51.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.735 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.2 t -149.28 147.58 28.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.301 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -129.02 149.25 50.92 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.802 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.1 m -127.94 152.69 47.57 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.781 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -126.5 149.48 49.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.485 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.9 m -118.91 127.57 53.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.998 0.428 . . . . 0.0 110.948 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.1 m -135.41 154.06 51.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.309 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.9 mt -77.79 144.65 36.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.0 125.72 32.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -150.58 160.39 43.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.717 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 175.23 -165.01 35.78 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.732 ' HB3' ' OH ' ' A' ' 135' ' ' TYR . . . -155.14 158.49 39.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.642 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.37 166.8 33.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 pp -143.2 159.58 42.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.839 0.352 . . . . 0.0 110.74 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.449 ' CD ' HH12 ' A' ' 34' ' ' ARG . 54.3 tt0 -117.03 128.64 55.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.182 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -127.98 126.74 41.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.447 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.83 ' OD1' HG13 ' A' ' 130' ' ' VAL . 63.3 m-20 -118.99 93.19 46.43 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.44 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.13 -27.62 29.27 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.331 1.354 . . . . 0.0 111.598 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -135.14 151.02 74.48 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.953 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -53.24 -36.6 78.46 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.0 1.8 . . . . 0.0 113.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -101.72 14.52 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.17 119.87 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.667 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.83 HG13 ' OD1' ' A' ' 124' ' ' ASN . 98.7 t -125.24 129.23 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.211 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.93 124.42 58.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -107.99 130.27 55.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.214 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -129.99 112.03 13.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.698 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.441 ' OG ' ' OH ' ' A' ' 88' ' ' TYR . 58.0 m -134.66 153.03 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.732 ' OH ' ' HB3' ' A' ' 119' ' ' ALA . 52.8 p90 -144.49 153.61 42.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.505 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.429 ' OE2' HD12 ' A' ' 90' ' ' LEU . 78.1 mm-40 -135.78 152.2 50.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.473 ' CD2' ' O ' ' A' ' 145' ' ' VAL . 47.4 t80 -143.71 133.09 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.612 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.7 m -111.01 137.76 48.24 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -102.96 109.07 20.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.048 0.451 . . . . 0.0 111.996 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.96 145.63 45.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -59.69 -43.24 94.15 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.826 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 59.5 t0 -103.75 -32.03 9.55 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.2 t -104.33 129.05 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -106.64 126.26 52.05 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.473 ' O ' ' CD2' ' A' ' 137' ' ' TYR . 58.4 t -119.85 125.64 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.408 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 14' ' ' ARG . . . -118.67 125.31 6.36 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.4 m -129.58 137.32 50.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 111.865 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -133.91 151.02 51.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.007 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.455 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 64.7 mtt -133.43 137.48 45.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -136.06 129.6 32.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.94 40.15 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.814 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.12 161.02 42.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.416 -0.392 . . . . 0.0 109.97 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.79 -178.05 27.02 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.522 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -124.63 146.0 49.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.373 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -86.69 127.97 34.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.454 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' A' ' 4' ' ' SER . 82.1 t80 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.478 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.98 -178.09 48.35 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -71.95 138.0 47.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 110.28 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p -150.83 163.5 38.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.654 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -138.39 146.78 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 tt -120.44 138.2 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.418 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -128.08 148.66 50.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.56 151.81 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.222 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.21 -174.47 38.36 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.591 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -116.39 149.29 39.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.42 132.93 54.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -122.08 121.73 37.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.364 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.9 m -118.19 168.47 10.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.784 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -138.15 143.71 40.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.699 HG22 ' O ' ' A' ' 24' ' ' LYS . 35.1 m -131.46 149.41 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.207 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.21 137.59 54.12 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -163.39 176.69 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.43 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.49 -43.83 93.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.093 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.41 98.88 1.77 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -75.48 144.3 42.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.037 0.446 . . . . 0.0 111.002 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -91.45 179.4 5.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.91 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.05 -49.39 77.85 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.978 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.636 ' C ' ' H ' ' A' ' 25' ' ' ASN . 96.9 m-20 -112.55 -14.08 13.25 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.688 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.699 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.5 OUTLIER 55.09 -6.67 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.367 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.636 ' H ' ' C ' ' A' ' 23' ' ' ASP . 34.3 m120 -105.11 113.82 64.25 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 119.45 -0.309 . . . . 0.0 111.363 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.81 156.12 27.22 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.467 1.444 . . . . 0.0 111.484 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -95.33 138.96 32.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.621 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.72 -168.31 20.68 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.24 160.07 41.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.868 HD21 ' HZ3' ' A' ' 32' ' ' LYS . 49.7 t30 -135.72 131.68 35.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.027 0.441 . . . . 0.0 112.028 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt -118.35 136.76 53.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.822 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.868 ' HZ3' HD21 ' A' ' 30' ' ' ASN . 9.5 mtmm -125.53 140.36 52.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -127.08 144.81 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.342 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -123.3 132.07 53.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.391 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.486 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 95.1 m-85 -127.42 149.11 50.23 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.33 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 9.5 tp10 81.45 163.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.326 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -72.38 145.87 47.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.671 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.505 ' CG ' HH21 ' A' ' 80' ' ' ARG . 53.6 p30 -84.56 4.84 30.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.463 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 62.9 t-20 -84.42 112.38 20.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.445 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 39' ' ' ASN . 11.3 t0 86.82 -66.14 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.694 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -152.95 162.87 40.79 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.067 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.57 -175.95 37.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.14 154.82 40.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.827 0.346 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.25 142.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.748 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.67 150.76 17.93 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 t -136.97 137.21 39.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.038 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.422 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 92.7 m-85 -128.49 141.01 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.81 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.76 148.74 34.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -143.08 128.84 19.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.402 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.8 p -129.33 156.17 44.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.529 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -159.4 155.25 26.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.452 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -83.95 119.33 24.77 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.769 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.93 137.62 3.45 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 90.6 t80 -112.11 73.71 0.83 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.603 0.239 . . . . 0.0 110.507 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' OE2' HD13 ' A' ' 63' ' ' LEU . 24.2 pt-20 -162.72 159.5 24.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.036 0.446 . . . . 0.0 111.016 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.18 154.27 28.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.553 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.7 t -78.83 133.77 37.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.6 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 59' ' ' ASP . 34.1 m -130.64 160.74 41.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.032 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 10.4 t0 76.91 -16.56 0.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.157 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.12 0.82 89.47 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.86 8.88 42.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 0.0 110.548 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 55.12 -165.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.715 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.405 HD13 ' OE2' ' A' ' 55' ' ' GLU . 86.7 mt -120.05 153.46 36.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.483 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 tt -53.35 -24.26 8.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.947 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.87 -38.23 84.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.29 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.76 -5.39 73.09 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 54.42 42.75 31.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 110.672 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -71.41 133.24 45.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.279 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -115.62 143.48 45.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.705 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.529 ' CE2' ' OG ' ' A' ' 72' ' ' SER . 83.5 t80 -127.65 121.39 30.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.14 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -115.23 133.91 55.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.621 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.529 ' OG ' ' CE2' ' A' ' 70' ' ' TYR . 67.1 m -134.65 141.37 46.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.34 134.96 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.008 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -140.57 158.67 43.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.99 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -158.7 152.41 23.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.53 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.58 164.7 35.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.665 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.99 160.61 36.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 123.166 2.577 . . . . 0.0 112.578 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 88' ' ' TYR . 10.7 p -135.26 135.69 51.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.236 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.0 t80 -127.69 129.68 47.56 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.505 HH21 ' CG ' ' A' ' 38' ' ' ASN . 62.4 ttm-85 -71.85 128.68 36.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.22 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 87' ' ' LEU . 96.3 mt -89.66 -51.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.76 0.314 . . . . 0.0 111.357 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -127.86 -155.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.65 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.74 -39.99 93.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.293 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -140.87 35.01 1.77 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.529 -0.468 . . . . 0.0 112.155 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.1 t -127.77 126.29 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.9 m -130.67 142.54 50.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.116 0.484 . . . . 0.0 111.387 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HB2' HD11 ' A' ' 81' ' ' ILE . 62.8 tp -122.73 129.93 52.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.455 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.447 ' HB3' HG23 ' A' ' 78' ' ' VAL . 52.9 p90 -142.01 159.46 42.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.875 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.8 151.75 18.12 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.7 119.08 27.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.557 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -138.12 151.55 47.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.955 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -143.89 7.63 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.65 153.44 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.881 0.372 . . . . 0.0 110.956 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.53 145.57 16.81 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -133.93 125.16 27.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.643 0.258 . . . . 0.0 110.483 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.15 143.02 15.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -114.78 126.74 55.18 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.357 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.79 148.45 35.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.433 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.9 147.28 52.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.598 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -104.07 120.51 41.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.4 t -91.41 117.21 29.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 111.503 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.1 p -163.31 165.92 23.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.899 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.6 mt -100.22 112.83 33.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.079 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -149.46 173.74 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.282 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.81 -38.24 93.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -137.34 163.49 30.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.7 p -109.34 157.28 19.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.904 0.383 . . . . 0.0 110.825 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.5 154.33 48.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.692 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.4 m -118.44 150.86 38.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.311 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.32 151.15 49.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.577 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 88.9 p -149.03 161.11 42.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.82 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -129.24 150.62 50.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.47 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p -126.08 150.06 48.44 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.9 p -155.17 163.59 39.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.525 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -99.31 133.89 42.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.475 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.68 129.95 55.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.645 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -147.67 133.57 19.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.436 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -178.6 -169.98 40.04 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.41 158.58 44.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.623 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.18 169.6 33.21 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.82 162.3 40.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -141.69 151.68 43.22 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.22 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.09 147.05 41.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.617 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 39.1 t-20 -128.57 82.24 69.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.992 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.93 -26.56 15.27 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.809 1.673 . . . . 0.0 111.563 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 98.4 m-70 -135.14 148.53 66.99 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.771 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.66 -21.84 33.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.184 1.923 . . . . 0.0 113.098 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -100.03 -0.1 39.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.83 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -145.27 130.62 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.065 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 153' ' ' GLY . 3.5 p -139.81 145.5 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.726 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.09 123.92 69.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.279 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -110.98 137.03 49.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -146.39 141.87 27.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.878 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 93.5 p -157.9 161.34 38.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.129 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.27 130.45 46.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.834 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -135.58 141.83 45.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.675 0.274 . . . . 0.0 110.417 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -131.9 145.38 51.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.69 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.8 m -109.91 127.14 54.55 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -107.11 106.78 17.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.861 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -118.17 151.15 38.16 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.775 ' H ' HD23 ' A' ' 140' ' ' LEU . 98.2 m-20 -60.29 -42.76 96.14 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.45 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -104.85 -32.61 8.73 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.535 HG12 HG23 ' A' ' 145' ' ' VAL . 68.7 t -105.71 121.47 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.8 116.38 31.84 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 15' ' ' VAL . 84.8 t -131.31 131.67 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.022 0.439 . . . . 0.0 112.016 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.32 143.6 16.46 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.9 m -124.77 130.38 52.29 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.89 0.376 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -116.91 136.14 53.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.548 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.458 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 79.4 mtm -131.58 127.81 37.9 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.404 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.6 tp -143.22 129.95 20.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.867 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.12 178.57 44.24 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.71 145.8 46.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 130' ' ' VAL . . . -108.61 148.78 16.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.506 ' CE2' ' O ' ' A' ' 155' ' ' ARG . 91.8 t80 -134.45 130.05 36.16 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.506 ' O ' ' CE2' ' A' ' 154' ' ' TYR . 85.7 mtp180 -75.55 144.34 41.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.649 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 156' ' ' PHE . 46.2 p90 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.642 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.17 162.95 54.59 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -71.59 136.69 47.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 0.0 110.685 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.5 m -133.17 151.39 51.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.592 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 t -119.54 133.45 55.66 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.453 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.8 mt -119.27 131.96 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.865 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -139.89 155.42 47.2 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.996 0.427 . . . . 0.0 110.818 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.8 mt -124.94 130.18 73.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.205 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.69 154.05 22.42 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.638 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -83.24 148.75 27.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -125.36 138.74 54.05 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.94 0.4 . . . . 0.0 110.901 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -143.39 142.51 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.106 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.446 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 44.3 t -117.87 167.91 10.98 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.158 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -134.8 120.9 19.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.623 HG12 HG22 ' A' ' 145' ' ' VAL . 34.9 m -132.76 149.87 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.994 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -124.0 124.34 42.35 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.169 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -163.54 170.63 16.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.83 137.19 58.13 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.418 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.23 28.62 72.54 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -53.97 147.06 13.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.209 0.528 . . . . 0.0 111.508 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -70.62 156.73 39.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.408 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.3 -46.18 86.6 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.668 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 25' ' ' ASN . 96.9 m-20 -92.83 -13.25 29.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.494 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 50.33 7.94 0.03 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 121.27 -0.172 . . . . 0.0 110.632 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 23' ' ' ASP . 70.3 m-20 -105.81 113.67 63.63 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HD2' ' H ' ' A' ' 13' ' ' SER . 91.3 Cg_endo -82.48 159.06 16.98 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 122.011 1.807 . . . . 0.0 110.691 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -97.79 131.39 44.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.76 0.315 . . . . 0.0 110.711 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.585 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -156.81 176.05 34.2 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.96 149.18 49.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.727 0.298 . . . . 0.0 110.33 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.577 ' ND2' ' SD ' ' A' ' 149' ' ' MET . 27.7 t-20 -133.61 124.61 27.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.205 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.46 138.59 45.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.757 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.68 139.9 53.53 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.89 143.37 50.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.672 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.637 HH12 ' NE2' ' A' ' 122' ' ' GLN . 61.6 ttp180 -131.96 131.63 42.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 111.036 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -129.32 143.09 50.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.976 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -118.66 120.47 37.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.518 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -108.78 2.62 21.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.557 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -160.02 162.34 34.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.526 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 54.1 p30 -88.77 2.63 53.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.967 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -135.36 7.52 3.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.758 0.313 . . . . 0.0 110.969 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.6 t90 -153.25 139.85 18.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.679 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.27 165.83 26.93 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.3 142.84 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.438 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -136.99 136.41 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.83 143.11 14.08 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.9 m -130.48 147.9 52.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.9 0.381 . . . . 0.0 111.234 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.53 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 95.7 m-85 -127.69 141.81 51.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.454 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.91 143.04 33.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.27 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -145.86 124.93 12.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.585 HG22 ' HA3' ' A' ' 28' ' ' GLY . 82.4 p -128.89 157.73 40.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.379 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -145.29 128.6 16.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.302 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' NH2' ' CG2' ' A' ' 15' ' ' VAL . 64.0 ttm-85 -83.31 134.76 34.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.235 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' GLU . . . 72.19 29.48 66.48 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 73.6 t80 -60.73 77.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.09 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 53' ' ' GLY . 88.4 tt0 -156.75 144.48 19.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.165 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -58.15 129.49 42.23 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.232 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -150.03 149.7 30.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.689 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.34 126.35 70.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.493 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 t0 75.34 -50.88 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.566 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . 81.51 2.92 90.7 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.01 -48.85 80.0 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.88 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.72 -41.24 99.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.357 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 60' ' ' GLY . 87.9 mt -123.51 127.05 47.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.78 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.872 HG22 ' H ' ' A' ' 66' ' ' GLY . 95.2 mt -62.13 -44.94 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.151 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 67' ' ' ASP . 66.2 m-20 58.97 1.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.77 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.872 ' H ' HG22 ' A' ' 64' ' ' ILE . . . 69.32 -41.87 0.39 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 65' ' ' ASP . 54.1 t0 51.74 48.18 23.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.33 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.544 ' CE2' ' O ' ' A' ' 66' ' ' GLY . 69.7 m-85 -125.99 149.44 48.8 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -119.55 143.61 47.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.664 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -124.98 138.0 54.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.969 0.414 . . . . 0.0 110.995 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -144.89 132.67 21.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.797 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.6 p -147.49 158.57 44.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.67 141.6 23.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.7 t -150.47 149.56 30.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.156 0.503 . . . . 0.0 111.298 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.82 155.02 32.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.299 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -166.82 171.09 41.59 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.39 148.77 55.39 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.019 2.479 . . . . 0.0 112.442 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.59 HG22 ' CB ' ' A' ' 88' ' ' TYR . 71.9 t -126.53 130.06 71.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -122.87 136.73 54.97 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 39' ' ' ASN . 96.5 mtm-85 -86.22 131.71 34.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.962 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.595 ' HB ' HG13 ' A' ' 85' ' ' VAL . 96.6 mt -88.28 -50.99 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.235 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 84' ' ' TYR . 56.9 t30 -139.97 34.37 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.911 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 56.54 1.8 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.825 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 82' ' ' ASN . 64.7 m-85 -120.87 -20.71 6.84 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.165 0.507 . . . . 0.0 109.666 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.595 HG13 ' HB ' ' A' ' 81' ' ' ILE . 6.7 p -144.28 140.57 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.462 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.3 t -136.62 141.42 43.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 134.46 51.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.885 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.59 ' CB ' HG22 ' A' ' 78' ' ' VAL . 54.7 p90 -144.26 159.33 42.87 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -119.15 152.07 17.39 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.0 mt -109.41 126.9 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.2 tp -129.27 126.71 39.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.722 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.13 -155.65 18.53 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.481 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -148.69 155.86 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.912 0.387 . . . . 0.0 110.897 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.66 140.41 14.84 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -126.76 120.64 29.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.882 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -107.44 141.71 15.68 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -126.21 142.79 51.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.966 0.412 . . . . 0.0 111.062 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -137.97 126.86 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.937 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -132.28 146.13 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.878 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -112.81 135.5 53.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.7 t -98.66 114.22 26.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.45 . . . . 0.0 110.627 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HG ' ' HD2' ' A' ' 104' ' ' PHE . 91.0 p -163.64 167.86 20.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.933 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.9 mm -105.79 112.58 39.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.044 0.45 . . . . 0.0 110.682 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HD2' ' HG ' ' A' ' 102' ' ' SER . 63.6 m-85 -147.76 173.25 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.349 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.86 -37.53 92.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -137.39 160.54 38.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.659 0.266 . . . . 0.0 110.374 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.7 m -110.11 159.32 17.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -139.06 154.83 48.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.167 0.508 . . . . 0.0 111.179 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.4 t -155.32 151.67 28.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.009 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -127.43 153.69 45.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.874 0.368 . . . . 0.0 110.998 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 89.3 p -147.37 163.23 37.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.514 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -125.51 148.27 48.94 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.2 m -121.69 131.39 54.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.556 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.474 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 93.4 p -151.68 165.58 33.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.557 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.95 140.79 29.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.476 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.46 131.62 56.88 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.832 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -140.1 132.92 29.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.64 178.41 34.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.487 -0.864 . . . . 0.0 111.61 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -149.52 155.13 39.84 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.446 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -144.4 155.38 26.29 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.56 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.868 HD22 ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -109.43 143.44 39.02 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.666 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.637 ' NE2' HH12 ' A' ' 34' ' ' ARG . 46.0 tt0 -119.87 123.72 44.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.288 . . . . 0.0 110.971 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.1 140.46 51.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.976 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.569 ' CG ' HG12 ' A' ' 130' ' ' VAL . 59.9 t-20 -137.82 81.78 27.61 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.44 -28.17 18.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.661 1.574 . . . . 0.0 111.653 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 129' ' ' PHE . 97.9 m-70 -131.74 124.55 19.91 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.003 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -50.24 -33.74 37.37 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.79 1.66 . . . . 0.0 112.938 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -81.51 -12.09 58.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 126' ' ' HIS . 92.5 t80 -142.66 129.74 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.969 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.569 HG12 ' CG ' ' A' ' 124' ' ' ASN . 34.2 m -130.74 152.81 38.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.588 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 85.0 mt -117.1 125.8 74.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.268 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -116.95 113.82 22.95 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.34 128.15 54.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.074 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.4 p -157.34 161.11 39.07 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.984 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -149.83 156.0 41.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.277 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -145.24 156.32 43.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.162 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.55 159.22 43.44 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.156 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.3 t -119.03 136.64 54.02 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.576 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -102.61 109.03 20.51 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.037 0.446 . . . . 0.0 112.055 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.479 HD23 ' H ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -118.39 146.42 44.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.479 ' H ' HD23 ' A' ' 140' ' ' LEU . 98.3 m-20 -60.4 -42.29 95.61 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.984 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -103.37 -31.99 9.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 145' ' ' VAL . 79.6 t -105.28 126.59 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -107.04 120.27 41.62 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.623 HG22 HG12 ' A' ' 15' ' ' VAL . 99.8 t -125.52 128.04 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.086 0.469 . . . . 0.0 112.146 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -124.48 129.63 7.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.9 m -126.47 132.38 51.45 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.08 0.466 . . . . 0.0 111.854 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.1 m-90 -116.84 141.1 48.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.577 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 78.2 mtm -128.66 137.74 51.8 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.01 0.433 . . . . 0.0 111.257 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.0 tp -142.79 131.4 22.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.814 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -164.0 177.81 39.64 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.962 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.98 158.66 44.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.35 -160.56 13.78 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.07 160.36 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.939 0.4 . . . . 0.0 110.879 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -102.71 126.38 49.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.386 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.4 t80 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.54 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.5 -176.26 46.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.99 141.85 52.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.525 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.1 t -149.91 147.76 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.665 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 t -132.61 138.21 47.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.486 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -127.76 138.91 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.707 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -149.79 145.5 26.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.78 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.6 pt -129.56 159.23 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.96 -178.21 40.26 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.709 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.81 144.65 29.52 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.473 ' O ' ' NE2' ' A' ' 12' ' ' GLN . . . -125.3 136.55 53.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.111 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 11' ' ' ALA . 98.1 mm-40 -131.53 145.13 51.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.634 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.7 t -116.56 166.86 11.61 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -125.5 123.46 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -120.88 127.65 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-O 120.875 0.369 . . . . 0.0 111.54 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -117.52 121.56 41.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.828 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -140.8 176.88 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.384 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.74 -39.81 86.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.79 142.96 20.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -91.12 151.34 21.03 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.206 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.579 ' CE ' HH22 ' A' ' 52' ' ' ARG . 11.9 tptp -124.52 153.09 42.6 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.8 tp -60.11 -50.62 72.99 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.633 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.608 ' C ' ' H ' ' A' ' 25' ' ' ASN . 58.7 p30 -116.04 -14.38 11.21 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 63.5 mttp 53.62 -2.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.081 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 23' ' ' ASP . 69.5 m-20 -105.79 114.44 62.85 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.61 159.01 16.64 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.079 1.853 . . . . 0.0 110.473 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.441 HH21 ' N ' ' A' ' 54' ' ' PHE . 96.3 mtm-85 -99.77 137.6 38.01 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.849 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.68 177.87 36.91 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.79 147.5 47.5 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.329 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 29.6 t-20 -132.77 123.84 26.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.034 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.66 140.48 38.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.741 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 98.8 mttt -121.98 140.77 52.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -140.86 128.55 21.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.235 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 122' ' ' GLN . 80.1 ttt180 -124.71 132.24 53.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.807 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -118.84 127.68 53.74 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.894 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -76.37 73.9 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.04 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.3 -48.54 81.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.067 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' O ' ' O ' ' A' ' 41' ' ' TRP . 63.1 t30 -152.01 149.38 28.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.043 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 37.8 p-10 -61.92 -41.64 98.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.633 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 67.8 t0 -64.23 -47.03 81.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.828 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' ASN . 96.5 m95 -132.39 144.98 50.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.76 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.22 163.2 19.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.63 127.34 75.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.732 0.301 . . . . 0.0 110.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -136.42 137.44 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.824 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.28 149.4 19.43 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -137.4 139.8 40.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.94 139.43 49.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.569 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.71 139.4 43.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.994 0.425 . . . . 0.0 111.413 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -143.67 130.25 20.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.842 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.3 p -128.4 158.09 39.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.791 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -158.25 158.01 33.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.1 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.579 HH22 ' CE ' ' A' ' 21' ' ' LYS . 76.7 mtp85 -83.25 121.91 27.72 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.82 150.3 14.4 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.441 ' N ' HH21 ' A' ' 27' ' ' ARG . 91.4 t80 -111.9 116.03 29.97 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -161.27 158.92 27.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -66.72 134.04 51.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.458 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.8 t -104.53 125.37 50.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.588 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -119.87 126.92 75.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.526 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 t0 72.14 -48.38 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.628 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.69 1.83 90.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -59.95 -48.88 79.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.555 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -75.62 142.54 42.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.484 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -100.81 2.15 40.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.477 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 66' ' ' GLY . 20.3 tt -57.95 -19.63 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.857 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 59.3 p30 -61.06 70.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.344 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 64' ' ' ILE . . . 90.21 -9.9 75.93 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 55.34 13.55 0.92 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.623 0.249 . . . . 0.0 110.677 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -140.51 129.72 23.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.691 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -134.35 128.45 33.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.277 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -130.22 128.01 40.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.6 t80 -136.5 131.01 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.211 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -147.83 159.69 43.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.943 0.402 . . . . 0.0 110.812 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.05 143.37 30.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.524 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.614 HG21 HD23 ' A' ' 90' ' ' LEU . 9.4 t -147.21 147.78 30.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.982 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.15 156.08 33.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.338 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.41 171.54 43.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.16 154.84 57.06 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.206 2.604 . . . . 0.0 112.314 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 88' ' ' TYR . 97.7 t -122.28 127.59 75.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.538 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -107.16 122.6 46.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.518 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 8.3 tmm_? -89.56 129.13 36.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.638 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.7 mp -89.35 -51.6 11.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 120.484 -0.486 . . . . 0.0 109.774 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -154.67 38.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.549 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.518 ' H ' ' CG ' ' A' ' 80' ' ' ARG . 4.3 tm-20 72.57 -49.58 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.053 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -71.04 -29.7 65.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.399 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.2 t -127.44 132.43 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 120.696 0.284 . . . . 0.0 110.974 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.409 ' OG ' ' CG1' ' A' ' 78' ' ' VAL . 45.0 t -138.51 135.24 34.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.281 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.8 tp -108.73 130.23 55.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.067 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.467 ' HB3' HG22 ' A' ' 78' ' ' VAL . 52.2 p90 -139.5 158.1 44.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.451 . . . . 0.0 111.155 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.09 151.39 16.92 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 74' ' ' THR . 8.7 mp -111.03 129.32 55.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.023 0.44 . . . . 0.0 110.897 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -138.01 125.93 22.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.587 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.63 ' C ' ' HB3' ' A' ' 116' ' ' ALA . . . -179.29 -154.39 13.03 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.386 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.15 38.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.787 0.327 . . . . 0.0 110.696 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -124.66 147.86 16.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -129.7 122.4 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.768 0.318 . . . . 0.0 110.606 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.35 140.97 16.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -134.88 129.83 35.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.52 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.92 136.57 53.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.355 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -132.49 131.55 41.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.407 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -95.12 122.91 38.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 31.3 t -86.96 117.09 25.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.118 0.485 . . . . 0.0 111.279 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.474 ' HG ' ' HE2' ' A' ' 104' ' ' PHE . 90.4 p -163.25 166.59 23.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.951 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.1 mt -106.99 112.61 40.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.168 0.508 . . . . 0.0 110.788 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.474 ' HE2' ' HG ' ' A' ' 102' ' ' SER . 63.2 m-85 -147.13 162.35 39.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.172 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.3 95.51 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -112.3 158.3 19.93 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.7 p -109.34 157.74 18.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 110.902 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -129.58 151.27 50.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.705 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 96.0 p -153.56 162.41 41.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.29 150.56 52.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.804 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.1 t -138.06 136.92 37.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.332 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.03 151.81 51.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.972 0.415 . . . . 0.0 111.236 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.5 t -132.4 149.01 52.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.629 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -150.64 158.38 44.08 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.363 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.0 127.58 47.43 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.822 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.63 ' HB3' ' C ' ' A' ' 92' ' ' GLY . . . -92.17 114.55 27.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.109 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -145.59 130.71 18.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.846 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -177.24 -169.95 39.03 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.634 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.26 158.46 36.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.404 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -152.26 159.12 28.2 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.89 148.12 43.88 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.674 0.273 . . . . 0.0 110.628 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.523 ' OE1' ' NH1' ' A' ' 34' ' ' ARG . 63.3 tt0 -119.81 132.55 55.63 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.522 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -126.45 147.48 49.8 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.728 ' OD1' HG23 ' A' ' 130' ' ' VAL . 69.5 m-20 -128.48 82.03 69.42 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.47 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.51 -41.27 74.75 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.497 2.131 . . . . 0.0 112.171 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -139.38 153.64 71.01 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.148 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.12 -38.0 80.27 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.945 1.764 . . . . 0.0 113.082 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -90.98 6.13 45.98 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -142.73 130.99 22.07 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.15 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.728 HG23 ' OD1' ' A' ' 124' ' ' ASN . 3.8 p -136.3 138.51 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -131.03 141.98 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.949 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.439 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -145.67 160.19 42.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.12 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -149.52 149.93 31.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.741 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 92.7 p -155.8 163.49 39.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 110.726 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -140.72 151.08 44.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.175 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 147' ' ' THR . 14.6 tm-20 -143.54 138.07 28.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.857 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -144.81 160.03 41.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.638 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.6 t -125.24 143.06 51.13 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.563 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -105.66 104.67 14.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.907 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.55 147.29 43.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -59.92 -43.92 94.61 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.966 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 143' ' ' VAL . 54.5 p-10 -104.55 -29.59 10.56 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 81.9 t -105.24 124.13 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -107.84 122.57 47.06 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.0 t -127.6 129.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.916 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.1 139.29 10.82 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 136' ' ' GLU . 88.2 m -131.25 133.16 45.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.623 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.547 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.438 ' SD ' ' CG ' ' A' ' 30' ' ' ASN . 24.7 ptp -139.18 149.74 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.063 0.458 . . . . 0.0 111.344 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.9 pp -143.35 155.25 44.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.022 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -175.91 -174.79 42.76 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.691 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.85 160.21 42.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.292 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.66 -168.7 19.08 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.34 145.99 50.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.385 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.417 ' O ' ' OXT' ' A' ' 156' ' ' PHE . 60.1 ttp180 -95.77 125.44 40.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.596 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' A' ' 156' ' ' PHE . 81.6 t80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.569 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.76 -176.86 46.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.426 ' OE1' ' OE1' ' A' ' 36' ' ' GLU . 99.8 mt-10 -70.69 146.34 49.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 0.0 110.484 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 t -148.43 147.46 29.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.6 t -137.68 140.35 40.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.681 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.1 mt -118.12 128.42 75.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 m -129.34 150.61 50.63 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -136.92 145.44 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.61 167.56 34.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.494 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -87.24 146.53 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -113.05 126.19 55.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.728 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' N ' ' OE1' ' A' ' 12' ' ' GLN . 25.2 mp0 -125.79 121.3 32.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.842 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -118.54 168.1 11.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.63 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -143.74 147.66 34.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.876 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.71 138.65 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.135 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -74.36 133.99 42.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 18' ' ' ASP . 21.0 tp10 -146.09 166.24 26.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.086 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 98.4 m-20 -59.74 -40.38 87.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.1 1.77 0.02 OUTLIER Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.18 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 21' ' ' LYS . 96.2 m-85 -73.48 146.25 45.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.575 ' HZ2' ' NH1' ' A' ' 52' ' ' ARG . 97.9 mttt 56.97 125.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.078 0.466 . . . . 0.0 111.412 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.6 tp -62.14 -48.24 80.98 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.644 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.79 -13.16 21.51 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.623 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 mttp 50.37 22.54 1.03 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.268 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -104.62 114.1 64.34 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.93 158.89 24.25 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.87 1.713 . . . . 0.0 111.288 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -100.05 148.8 24.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.624 0.25 . . . . 0.0 110.656 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.37 -175.73 38.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -125.41 148.18 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 51.1 t30 -126.04 120.56 30.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.813 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.66 141.17 37.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.68 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' CD ' ' OG ' ' A' ' 46' ' ' SER . 6.0 tppt? -137.25 131.58 32.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.707 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -126.77 142.08 51.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.96 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -125.56 130.45 51.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.114 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -128.73 143.65 50.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.761 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' OE1' ' OE1' ' A' ' 3' ' ' GLU . 99.5 mt-10 -105.27 116.59 32.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.59 -48.8 80.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.041 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -130.72 -64.8 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.373 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -168.92 -78.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.711 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.73 -39.71 92.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -100.39 146.69 26.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.252 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.47 178.21 38.33 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.82 158.49 42.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -139.46 135.54 40.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.724 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.98 142.65 17.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.423 ' OG ' ' CD ' ' A' ' 32' ' ' LYS . 60.8 m -126.43 142.09 51.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.04 0.448 . . . . 0.0 111.146 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -130.18 142.1 50.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.685 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.09 143.44 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.387 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 tm0? -147.58 130.17 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.222 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.2 p -129.49 159.36 36.54 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.639 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -145.12 140.99 28.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.425 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.575 ' NH1' ' HZ2' ' A' ' 21' ' ' LYS . 17.4 mmm180 -63.88 135.9 56.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.04 -173.39 42.24 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -112.1 149.05 32.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.775 0.322 . . . . 0.0 110.324 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 59.0 mp0 -139.6 158.48 44.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.919 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -64.95 154.47 37.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.083 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.517 ' HA ' HD11 ' A' ' 63' ' ' LEU . 66.3 m -77.76 143.94 37.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 110.769 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.29 161.56 39.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.434 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -58.31 146.99 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.297 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.02 -5.9 76.03 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.2 t80 55.97 106.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 0.0 111.007 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -129.98 -123.94 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.325 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 57' ' ' SER . 83.2 mt 55.14 66.54 1.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.834 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.82 -45.43 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.135 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 44.07 -113.16 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.657 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.7 -7.92 79.03 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.8 t0 53.02 51.22 16.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.745 0.307 . . . . 0.0 110.861 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -73.47 144.99 46.02 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -112.45 139.35 48.1 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -127.84 128.34 45.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.66 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -136.28 129.82 32.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.903 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -137.68 141.63 41.1 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 111.308 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.98 130.87 71.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.511 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.467 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 12.4 t -149.46 149.96 31.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.092 0.472 . . . . 0.0 111.427 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.92 156.52 33.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.378 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.15 170.03 39.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.456 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.69 149.45 54.83 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 123.207 2.605 . . . . 0.0 112.893 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.526 HG22 ' CB ' ' A' ' 88' ' ' TYR . 74.6 t -126.48 129.24 71.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.358 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.53 127.35 43.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.352 . . . . 0.0 111.194 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -72.53 135.06 45.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.441 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.2 mm -86.37 -50.92 13.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.049 0.452 . . . . 0.0 110.228 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 84' ' ' TYR . 6.1 m-20 173.84 165.11 0.19 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.124 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 45.2 -92.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.513 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ASN . 21.5 p90 -144.31 37.71 1.25 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.392 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -119.64 126.0 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.43 ' O ' HD13 ' A' ' 121' ' ' LEU . 40.7 t -128.97 137.11 51.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.207 0.527 . . . . 0.0 111.175 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 88' ' ' TYR . 0.2 OUTLIER -110.28 123.81 50.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.2 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.565 ' N ' HD13 ' A' ' 87' ' ' LEU . 53.2 p90 -142.42 158.9 43.2 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.147 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -124.6 150.88 17.17 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.18 125.08 53.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 110.621 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' C ' ' HG1' ' A' ' 74' ' ' THR . 87.9 mt -122.67 139.64 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.641 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 169.29 -159.18 32.02 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.665 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -146.83 153.21 39.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.95 0.405 . . . . 0.0 110.701 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.6 141.35 15.27 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -133.22 144.13 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.629 0.252 . . . . 0.0 110.726 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -120.99 147.37 17.55 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -127.1 140.61 52.15 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.977 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.29 143.85 31.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.019 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -134.17 149.44 51.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.984 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.32 138.87 49.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.949 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 80.0 p -87.31 114.4 23.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.024 0.44 . . . . 0.0 110.611 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.9 t -163.28 149.74 12.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.055 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.687 HG23 ' O ' ' A' ' 103' ' ' ILE . 20.3 tt -100.36 111.86 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.103 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -149.26 160.01 43.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.207 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.65 -39.97 95.85 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -105.17 165.91 10.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 98.2 p -108.74 156.13 19.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.91 0.386 . . . . 0.0 110.729 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -137.0 139.06 41.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.338 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.2 p -149.92 163.27 38.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.275 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -126.87 133.55 50.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.511 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.6 t -138.44 145.07 40.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.22 152.07 46.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.636 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.3 p -123.29 149.99 44.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.742 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 96.5 p -156.14 167.58 29.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.546 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mp -99.37 143.6 29.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.04 137.33 53.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.434 . . . . 0.0 111.083 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.23 159.61 43.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.681 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 173.85 -170.25 43.37 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.953 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.06 153.19 34.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.412 . . . . 0.0 110.139 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.469 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -149.78 156.5 26.79 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.704 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 120' ' ' GLY . 4.1 mm? -117.96 141.85 48.0 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.467 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -121.12 126.33 49.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.585 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -127.03 140.04 52.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.232 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -130.25 78.65 74.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.593 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.27 -25.79 11.11 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.141 1.894 . . . . 0.0 111.642 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.1 m-70 -127.33 119.22 21.85 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.899 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.07 -36.69 45.87 Favored 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 121.772 1.648 . . . . 0.0 113.108 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -82.16 -11.9 58.46 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' HIS . 89.6 t80 -143.62 129.61 19.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.245 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.576 ' O ' ' HB1' ' A' ' 152' ' ' ALA . 35.1 m -130.12 153.15 38.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.48 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.7 tt -119.15 136.91 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.602 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -128.52 114.91 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.975 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.31 132.6 55.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.842 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 91.4 p -156.89 164.53 37.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.189 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -145.58 152.65 40.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.427 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 149' ' ' MET . 49.9 mp0 -143.59 154.05 43.17 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.709 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -127.15 144.14 51.1 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.0 t -138.19 124.47 20.47 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -109.97 140.06 44.4 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.429 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 11.4 tp -110.34 156.52 20.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -49.42 -44.83 45.62 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.597 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -105.97 -33.25 7.98 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.429 ' H ' ' HB3' ' A' ' 140' ' ' LEU . 58.6 t -106.42 135.38 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -102.47 134.5 45.7 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 91.6 t -129.24 133.14 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.954 0.406 . . . . 0.0 112.08 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.79 144.57 15.91 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.3 p -129.61 148.26 51.48 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.323 0.582 . . . . 0.0 112.01 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -141.07 137.96 33.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.819 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -139.09 146.36 40.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.578 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -143.24 132.32 23.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.915 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.649 ' N ' HD13 ' A' ' 150' ' ' LEU . . . -170.69 -177.39 40.68 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.831 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 130' ' ' VAL . . . -148.9 157.45 43.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -140.4 -165.03 10.14 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.43 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -149.13 157.22 43.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.758 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -78.6 147.11 33.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.129 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.571 179.645 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.59 179.02 48.39 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.5 pm0 -72.21 161.53 30.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.908 0.385 . . . . 0.0 110.986 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p -149.88 163.95 36.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.209 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.3 p -119.69 154.62 33.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 86.2 mt -119.59 125.35 74.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.542 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -136.54 150.81 48.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.676 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -131.63 147.01 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.229 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.06 -179.34 30.16 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -109.28 142.24 40.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.684 0.278 . . . . 0.0 110.292 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -116.32 128.19 55.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.445 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HB3' HD22 ' A' ' 25' ' ' ASN . 97.4 mt-30 -124.93 120.29 31.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.165 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.437 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 39.3 t -99.84 106.76 18.65 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.424 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.37 121.03 16.93 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.458 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.7 t -107.34 125.96 63.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.081 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -61.46 125.76 24.94 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.414 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.72 -175.22 4.32 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.987 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -148.34 111.72 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.325 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.51 -6.79 80.42 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.063 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 21' ' ' LYS . 91.3 m-85 -91.07 127.69 36.59 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.822 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 20' ' ' TYR . 64.2 mttp 41.37 -166.82 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.757 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.87 -55.55 3.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.292 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 25' ' ' ASN . 67.2 m-20 -112.12 -13.55 13.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.012 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.47 36.94 20.05 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.347 0.594 . . . . 0.0 110.666 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 23' ' ' ASP . 2.3 m-20 -102.19 136.23 19.48 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.482 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HD2' ' H ' ' A' ' 13' ' ' SER . 71.3 Cg_endo -81.25 160.6 20.24 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.805 2.337 . . . . 0.0 111.147 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -93.49 134.27 35.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.474 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.02 -179.23 36.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -126.8 149.07 49.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.752 0.31 . . . . 0.0 110.75 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 50.4 t30 -124.63 120.65 32.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.647 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.52 140.55 31.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.498 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 87.6 tttt -136.68 133.18 35.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.048 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.13 146.37 51.08 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.419 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.724 HH21 HE22 ' A' ' 122' ' ' GLN . 42.1 ttm180 -111.05 132.78 53.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.688 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 43' ' ' VAL . 96.8 m-85 -125.37 142.91 51.23 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 123.396 0.435 . . . . 0.0 110.094 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -82.67 129.16 34.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.455 ' O ' ' O ' ' A' ' 41' ' ' TRP . 93.0 t80 -150.31 130.46 13.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.781 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 37' ' ' PHE . 54.6 t30 46.9 -174.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.127 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -111.29 -32.52 6.72 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.112 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.69 -43.04 94.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.038 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.455 ' O ' ' O ' ' A' ' 37' ' ' PHE . 29.0 p90 -149.76 157.2 42.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.44 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.57 -171.48 20.49 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 35' ' ' TYR . 33.8 m -133.51 149.45 31.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.176 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.48 155.04 22.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.343 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.08 134.55 7.9 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.0 m -130.22 146.17 51.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 94.9 m-85 -129.13 145.39 51.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.465 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.77 138.69 37.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -145.15 127.93 16.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.04 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 61.6 p -129.88 159.45 36.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.358 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.488 ' NE ' ' HZ3' ' A' ' 69' ' ' LYS . 80.0 ttt180 -151.78 136.36 16.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.583 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -71.65 140.26 49.62 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.117 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.54 140.17 15.62 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -112.57 150.79 30.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.904 0.383 . . . . 0.0 110.598 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -148.49 141.21 24.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.097 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.01 115.71 4.66 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.156 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.2 m -149.73 171.78 16.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.571 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.18 153.38 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.999 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 41.5 -158.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.213 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.07 2.9 90.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 56.13 45.41 23.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.773 0.321 . . . . 0.0 110.53 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -69.64 149.33 48.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.412 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 20' ' ' TYR . 88.8 mt -97.17 148.69 22.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.669 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 66' ' ' GLY . 45.9 pt -64.44 -3.1 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.001 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 61.06 -70.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 64' ' ' ILE . . . 92.48 -7.74 77.55 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 52.75 49.77 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.846 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -72.06 146.34 47.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.322 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HZ3' ' NE ' ' A' ' 51' ' ' ARG . 73.2 mmtt -101.02 135.93 41.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.09 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -124.67 133.85 53.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.149 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' ' O ' ' A' ' 95' ' ' HIS . 87.5 t80 -143.39 131.3 21.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.266 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -142.0 141.82 32.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.467 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.2 t -117.82 125.03 73.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -129.44 149.64 51.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -166.99 158.96 12.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.13 166.43 34.0 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.5 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 155.11 46.16 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.027 2.485 . . . . 0.0 112.386 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.8 123.76 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.295 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.57 118.16 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.523 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -84.76 136.46 33.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.0 mm -88.12 -51.16 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.763 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 84' ' ' TYR . 60.4 t30 -161.74 41.84 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.326 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 67.28 -37.62 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 82' ' ' ASN . 78.5 m-85 -66.99 -38.01 85.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.57 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -144.22 146.88 20.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.4 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -139.1 150.2 45.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.639 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.8 mt -98.78 139.79 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.474 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -116.88 141.62 48.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.419 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.74 138.84 14.35 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.635 HD11 ' HB3' ' A' ' 134' ' ' SER . 75.6 mt -112.03 117.91 33.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.74 133.05 39.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.666 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.57 -161.02 34.53 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.444 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -146.53 150.75 36.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.724 0.297 . . . . 0.0 110.452 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.25 142.96 16.12 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.429 ' CD2' HG22 ' A' ' 113' ' ' THR . 78.7 m80 -135.15 148.81 49.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.12 152.87 20.93 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -131.54 145.62 51.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 110.44 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.57 136.33 27.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.285 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -132.71 148.77 52.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.78 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -108.73 138.58 44.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.11 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.8 m -89.34 114.06 25.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.802 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.9 m -163.36 161.02 24.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.874 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.5 mt -103.17 112.47 36.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.788 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -149.85 157.39 43.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.227 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.97 96.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -104.92 165.96 10.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 97.4 p -108.85 159.18 16.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.877 0.37 . . . . 0.0 110.823 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -134.31 138.51 45.02 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.476 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 95.0 p -153.47 162.58 41.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.29 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -131.2 151.63 51.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.707 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.9 t -144.48 142.75 30.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.597 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.504 ' NZ ' HD21 ' A' ' 140' ' ' LEU . 58.8 mtpt -129.5 152.53 48.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.566 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 95' ' ' HIS . 82.3 p -123.96 150.37 44.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.559 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.72 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 92.8 p -151.14 162.35 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.8 tp -100.2 125.84 46.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.396 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 123.05 45.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.6 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -143.3 131.59 22.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.109 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.35 -170.18 34.37 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.594 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -152.61 158.72 42.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 0.0 110.533 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.17 173.74 36.04 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -135.75 170.02 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 0.0 110.501 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.724 HE22 HH21 ' A' ' 34' ' ' ARG . 52.4 tt0 -139.54 136.3 34.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.712 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -129.75 130.64 45.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.446 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 31.5 t-20 -106.66 99.28 24.25 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.231 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.38 -31.89 5.39 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.658 1.572 . . . . 0.0 111.439 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 129' ' ' PHE . 98.3 m-70 -138.59 148.95 60.8 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.774 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.92 -25.97 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.998 1.799 . . . . 0.0 112.357 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -82.8 -25.58 32.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.647 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 126' ' ' HIS . 94.5 m-85 -132.91 144.28 50.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.021 0.439 . . . . 0.0 111.298 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.52 153.0 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.285 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.6 pt -128.55 147.09 33.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.682 0.277 . . . . 0.0 110.422 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.527 ' OD2' ' NZ ' ' A' ' 32' ' ' LYS . 61.0 t0 -146.71 133.62 20.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.474 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -124.05 124.72 43.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.68 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.635 ' HB3' HD11 ' A' ' 90' ' ' LEU . 66.4 m -133.97 152.35 51.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.316 . . . . 0.0 111.164 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.08 139.72 53.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.055 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.426 ' CG ' HD13 ' A' ' 90' ' ' LEU . 97.5 mt-10 -125.31 150.35 47.22 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.646 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -131.41 127.18 36.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.6 m -125.14 131.05 53.31 Favored 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -109.78 96.26 6.14 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.925 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.504 HD21 ' NZ ' ' A' ' 112' ' ' LYS . 2.8 tp -68.79 157.16 36.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -56.05 -43.94 78.36 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.075 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -106.1 -33.86 7.73 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.995 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.494 ' O ' ' CB ' ' A' ' 140' ' ' LEU . 87.9 t -106.79 149.73 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -105.96 124.09 49.02 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.415 HG13 ' OG ' ' A' ' 13' ' ' SER . 84.6 t -128.03 129.12 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.029 -178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.01 132.28 8.82 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 96.5 m -113.16 123.53 50.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.046 0.451 . . . . 0.0 111.285 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -95.72 135.49 37.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.849 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 149' ' ' MET . 1.8 tmt? -119.43 117.83 29.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.785 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.2 tp -137.07 127.29 26.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.784 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -169.6 177.85 42.92 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.168 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.49 159.79 44.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -166.66 -160.91 14.59 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.38 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.04 160.11 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 0.0 110.673 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -80.41 128.77 33.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.516 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 73.3 t80 . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.581 179.908 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.46 178.9 53.7 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -70.56 141.22 51.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.925 0.393 . . . . 0.0 110.53 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -150.35 162.43 40.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.491 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.8 m -124.85 148.61 48.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.53 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.6 mt -116.89 129.75 72.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.543 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.9 t -124.59 140.03 53.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.713 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.5 tt -126.91 145.57 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.136 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.12 -173.82 37.11 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.445 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -106.09 142.42 35.81 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -118.03 127.92 54.28 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.764 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -129.24 134.95 48.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.796 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.465 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 41.4 t -117.33 120.35 37.93 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.571 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.682 HH21 ' NZ ' ' A' ' 16' ' ' LYS . 61.2 ttt85 -67.53 120.1 13.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.361 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -133.25 131.52 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.682 ' NZ ' HH21 ' A' ' 14' ' ' ARG . 73.5 mmtt -84.72 132.64 34.43 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -133.94 144.42 48.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.009 0.433 . . . . 0.0 111.364 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.71 -38.6 91.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.659 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.45 -136.88 0.71 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -65.66 139.62 58.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.377 . . . . 0.0 110.107 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -155.06 37.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.429 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.75 -42.42 99.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.857 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 25' ' ' ASN . 97.4 m-20 -110.79 -15.45 13.81 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.586 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.0 mttp 48.7 12.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.181 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 23' ' ' ASP . 67.9 m-20 -102.91 111.02 64.66 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 112.422 0.526 . . . . 0.0 112.422 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 13' ' ' SER . 93.4 Cg_endo -83.7 161.01 14.35 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 C-N-CA 123.176 2.584 . . . . 0.0 111.093 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -92.12 132.09 36.87 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.432 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.3 169.65 33.28 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.56 138.86 49.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.648 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 29.5 t-20 -115.09 119.52 36.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.407 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -122.47 129.18 51.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.56 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -132.56 147.16 52.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.87 145.05 51.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.201 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.691 HH11 HE22 ' A' ' 122' ' ' GLN . 61.5 ttp180 -124.96 132.67 53.24 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.743 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -125.15 142.91 51.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.0 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -128.97 145.48 51.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.032 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -113.53 31.18 6.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.317 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 56.37 41.11 29.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.493 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -148.42 -179.85 7.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.336 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.1 p30 -81.47 1.64 32.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.69 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.424 ' CH2' ' CG2' ' A' ' 43' ' ' VAL . 92.2 t90 -122.66 123.39 41.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.184 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -129.7 175.46 19.04 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.424 ' CG2' ' CH2' ' A' ' 41' ' ' TRP . 92.5 t -124.42 128.11 73.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.9 pt -128.16 157.28 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.068 0.461 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.19 159.32 27.67 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -136.69 131.01 32.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.059 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.69 123.66 43.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.837 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.01 152.99 41.01 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.121 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -148.89 144.35 26.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.653 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.4 p -132.3 160.92 34.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.46 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -154.74 148.59 25.58 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.785 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' CZ ' ' O ' ' A' ' 65' ' ' ASP . 89.2 mtm180 -83.57 149.84 26.32 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.78 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.25 166.17 53.84 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -110.52 122.82 48.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 110.956 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -133.84 148.2 51.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.304 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -81.73 126.65 32.07 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.462 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.693 ' HB2' HD12 ' A' ' 63' ' ' LEU . 48.4 t -150.76 146.48 26.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.2 p -129.97 122.42 54.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.582 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 58' ' ' VAL . 99.3 m-20 45.38 -177.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.076 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 62' ' ' LYS . . . 80.35 -1.45 81.31 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 42.73 25.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.74 0.305 . . . . 0.0 110.471 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 60' ' ' GLY . 58.0 tptt -60.8 -45.98 92.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.625 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 57' ' ' SER . 88.9 mt -118.21 138.77 52.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.6 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 pt -99.59 -29.34 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.796 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.47 ' O ' ' CZ ' ' A' ' 52' ' ' ARG . 98.5 m-20 37.63 -107.27 0.05 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.039 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.49 -20.97 44.54 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.64 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 46.97 51.45 12.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.964 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -112.16 144.23 41.89 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.803 0.335 . . . . 0.0 110.58 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.9 146.29 25.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -119.44 127.39 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 95' ' ' HIS . 98.5 m-85 -127.95 144.21 51.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.274 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -152.46 140.07 19.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.568 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.87 143.97 39.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.022 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.7 p -144.2 163.12 34.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.44 155.1 29.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.441 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.54 164.04 34.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.489 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.13 158.9 37.61 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.258 2.639 . . . . 0.0 112.291 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 42' ' ' GLY . 8.7 p -135.7 135.35 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.744 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 80' ' ' ARG . 93.8 t80 -128.15 129.72 46.97 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.708 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.531 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 36.4 mmt180 -67.61 136.58 54.66 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.669 HD11 ' HB2' ' A' ' 87' ' ' LEU . 75.5 mt -87.86 -51.86 12.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.052 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 2.7 m-20 162.9 -73.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.678 ' O ' HG13 ' A' ' 85' ' ' VAL . 98.6 mt-10 -67.71 64.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.459 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' ASN . 91.8 m-85 47.07 33.62 2.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 83' ' ' GLU . 30.2 m -133.09 152.71 36.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.9 t -139.48 144.11 37.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 111.449 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.669 ' HB2' HD11 ' A' ' 81' ' ' ILE . 63.6 tp -111.11 129.84 55.8 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CZ ' ' C ' ' A' ' 120' ' ' GLY . 53.7 p90 -143.22 158.4 43.65 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.738 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -107.13 147.35 16.23 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 90' ' ' LEU . 10.8 tp -128.38 119.97 26.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.33 160.91 38.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.836 0.351 . . . . 0.0 111.173 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.35 -143.96 8.89 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -145.63 150.79 36.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 110.937 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.61 140.6 16.44 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 71' ' ' TYR . 31.1 p80 -147.0 162.03 39.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.725 0.297 . . . . 0.0 110.832 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.36 158.37 18.88 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -124.68 143.83 50.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.228 0.537 . . . . 0.0 110.616 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -144.05 146.57 32.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.817 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -132.59 129.13 38.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.703 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -102.15 128.96 48.42 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.4 p -85.91 114.97 23.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.15 0.5 . . . . 0.0 111.156 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -163.17 168.39 20.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.892 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 84.2 mt -109.67 113.65 44.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.013 0.435 . . . . 0.0 110.872 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -145.76 162.38 37.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.768 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.92 -9.32 62.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -136.97 171.11 15.0 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t -108.73 136.54 48.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.835 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -125.3 138.21 54.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.382 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 87.9 p -148.79 164.23 35.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.238 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -127.76 151.41 49.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.85 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 90.7 p -149.9 163.92 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.719 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -122.61 158.0 30.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.355 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 9.8 t -131.78 145.56 51.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.5 t -160.2 158.21 29.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.7 mt -99.28 141.09 32.5 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -132.47 140.05 48.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.964 0.411 . . . . 0.0 111.164 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -150.93 159.1 44.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.205 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 165.84 -158.72 31.73 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.488 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -155.59 160.17 40.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.739 0.304 . . . . 0.0 110.502 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' C ' ' CZ ' ' A' ' 88' ' ' TYR . . . -144.43 156.05 26.62 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.29 146.06 44.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.516 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.691 HE22 HH11 ' A' ' 34' ' ' ARG . 63.6 tt0 -117.62 128.56 55.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.697 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -118.7 137.53 53.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.414 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.81 ' OD1' HG13 ' A' ' 130' ' ' VAL . 68.4 m-20 -129.51 81.03 70.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.71 -27.23 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.762 1.641 . . . . 0.0 111.667 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -136.48 149.24 66.89 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.733 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.98 -22.97 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.068 1.845 . . . . 0.0 112.776 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.18 6.0 44.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.678 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -150.08 128.24 11.99 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.468 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.81 HG13 ' OD1' ' A' ' 124' ' ' ASN . 94.4 t -122.88 132.03 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.0 mt -115.16 126.02 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.087 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -146.61 160.44 42.17 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.72 138.59 17.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.2 m -135.94 151.83 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.776 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -142.13 148.52 38.45 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.015 0.436 . . . . 0.0 110.867 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.456 ' H ' ' HB ' ' A' ' 147' ' ' THR . 39.9 mt-10 -143.79 159.09 43.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.378 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -119.8 139.2 52.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.805 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 t -139.1 133.37 31.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.13 140.41 44.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.76 HD23 ' H ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -117.96 156.2 28.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.76 ' H ' HD23 ' A' ' 140' ' ' LEU . 98.4 m-20 -58.0 -43.48 86.68 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.545 -177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.97 -33.45 7.92 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.97 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 140' ' ' LEU . 84.6 t -106.57 148.79 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -104.71 136.93 43.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.57 131.53 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.317 0.579 . . . . 0.0 112.38 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -120.16 157.15 15.76 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 136' ' ' GLU . 91.2 m -123.92 129.42 50.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.196 0.498 . . . . 0.0 111.606 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -129.53 119.94 24.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.582 ' SD ' ' ND2' ' A' ' 30' ' ' ASN . 79.0 mtm -132.07 134.48 45.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.38 142.12 30.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.96 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.33 -175.07 47.13 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.094 -1.051 . . . . 0.0 111.895 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 130' ' ' VAL . . . -149.45 157.94 43.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.398 . . . . 0.0 109.938 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.52 -177.31 21.04 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.358 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -148.15 158.92 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.496 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -75.96 138.55 41.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.087 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.6 t80 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.577 179.741 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.96 -179.64 52.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -70.13 142.09 52.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 110.249 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t -150.11 151.34 33.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 94.7 p -143.73 159.67 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 88.2 mt -118.24 130.93 72.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.671 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.4 t -134.5 140.73 46.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.706 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.39 148.76 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.376 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.56 -174.62 35.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -104.33 142.58 34.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 110.504 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.615 ' HB2' ' HB2' ' A' ' 30' ' ' ASN . . . -112.65 131.36 55.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HG2' HD21 ' A' ' 25' ' ' ASN . 99.1 mt-30 -126.79 124.67 40.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.478 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.562 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 69.9 m -117.75 107.41 14.13 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -66.82 133.34 49.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -111.33 125.52 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' O ' HG13 ' A' ' 143' ' ' VAL . 64.6 tttm -97.01 124.92 41.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.744 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -153.11 159.01 42.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.315 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -58.68 -43.91 90.09 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.41 144.63 36.1 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -91.65 140.9 29.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.889 0.376 . . . . 0.0 111.25 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -113.61 152.61 30.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.291 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 22' ' ' LEU . 10.4 mp -60.69 -48.9 79.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.616 ' C ' ' H ' ' A' ' 25' ' ' ASN . 97.0 m-20 -113.33 -14.7 12.78 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.6 mttp 55.63 -3.85 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.765 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.616 ' H ' ' C ' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -104.81 112.2 65.27 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.608 ' N ' HD22 ' A' ' 25' ' ' ASN . 97.6 Cg_endo -83.04 159.1 15.57 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.69 ' NH2' ' HE ' ' A' ' 51' ' ' ARG . 51.2 ptt85 -93.19 142.61 27.11 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 50' ' ' THR . . . -159.44 169.77 35.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -109.47 142.14 40.92 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.712 0.292 . . . . 0.0 110.575 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 43.5 t30 -125.89 119.02 26.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.752 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.1 137.28 53.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.524 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HE3' HD21 ' A' ' 30' ' ' ASN . 98.8 mttt -134.8 146.13 49.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.16 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.507 ' NH2' ' OE2' ' A' ' 36' ' ' GLU . 61.0 ttt85 -107.57 127.48 53.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -137.77 126.77 24.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.079 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.507 ' OE2' ' NH2' ' A' ' 34' ' ' ARG . 99.4 mt-10 -119.11 117.71 29.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.969 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -60.81 -48.81 80.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.976 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -155.53 61.72 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.152 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.6 m120 52.66 -138.76 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.6 t0 38.68 -106.51 0.05 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.963 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.619 ' HE1' ' CB ' ' A' ' 77' ' ' PRO . 58.7 t90 -100.0 123.39 44.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.098 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.593 ' H ' HG13 ' A' ' 78' ' ' VAL . . . -120.03 -166.71 13.31 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.48 157.64 41.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 76' ' ' GLY . 19.0 tt -137.94 134.3 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.442 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.8 132.96 11.32 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.079 -1.209 . . . . 0.0 110.079 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.7 m -128.68 139.93 51.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.08 142.11 49.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.744 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.67 139.33 31.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -142.41 126.74 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.274 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.522 HG22 ' HA3' ' A' ' 28' ' ' GLY . 77.3 p -128.78 159.24 36.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.419 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.69 ' HE ' ' NH2' ' A' ' 27' ' ' ARG . 41.2 ptt180 -157.57 161.18 38.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.355 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.576 HH21 ' CB ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.06 129.34 38.28 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.518 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.38 -178.25 41.4 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -112.47 147.88 35.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.674 0.273 . . . . 0.0 110.354 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -159.29 157.93 31.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -71.62 130.15 40.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.234 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -149.85 143.8 25.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.717 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 59' ' ' ASP . 10.3 p -130.54 137.29 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.439 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 60' ' ' GLY . 30.1 t0 42.65 -167.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.48 ' H ' ' CG ' ' A' ' 59' ' ' ASP . . . 88.82 -6.94 83.19 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 55.8 24.59 7.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 0.0 110.632 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -75.0 145.36 42.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.458 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.11 112.61 5.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.997 0.427 . . . . 0.0 111.006 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.8 pt -113.91 3.38 8.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.309 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 66' ' ' GLY . 27.2 t0 -65.5 -162.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.945 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 65' ' ' ASP . . . 100.76 -15.93 57.96 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.7 t0 49.04 52.93 13.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.94 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -72.53 143.52 48.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.047 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -118.02 142.05 47.8 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.771 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -126.34 125.53 42.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.345 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' CE2' HG23 ' A' ' 73' ' ' VAL . 88.4 t80 -130.03 128.73 42.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.19 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -140.05 140.05 36.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.062 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.456 HG23 ' CE2' ' A' ' 71' ' ' TYR . 99.4 t -124.06 128.88 74.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.043 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -148.34 155.38 41.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.214 0.53 . . . . 0.0 111.166 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.75 158.33 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.182 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 44' ' ' ILE . . . -150.22 153.58 25.15 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.603 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.619 ' CB ' ' HE1' ' A' ' 41' ' ' TRP . 93.0 Cg_endo -77.66 159.03 31.94 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.74 2.293 . . . . 0.0 111.475 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.593 HG13 ' H ' ' A' ' 42' ' ' GLY . 7.9 p -131.61 119.25 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.455 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE1' ' CD1' ' A' ' 41' ' ' TRP . 96.5 m-85 -119.66 120.12 35.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.914 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -80.54 128.44 33.59 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.157 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' A' ' 85' ' ' VAL . 96.5 mt -89.8 -52.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.808 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 84' ' ' TYR . 32.7 m120 -122.09 16.98 10.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.823 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 82' ' ' ASN . 16.9 tt0 76.17 -21.03 0.33 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.496 ' H ' ' C ' ' A' ' 82' ' ' ASN . 96.9 m-85 -104.17 -20.89 13.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.381 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 81' ' ' ILE . 35.0 m -132.81 145.63 33.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.4 t -141.14 152.25 44.56 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.321 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HG ' HD11 ' A' ' 81' ' ' ILE . 86.1 mt -102.48 138.8 38.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.391 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' OH ' ' NH1' ' A' ' 34' ' ' ARG . 48.9 m-85 -121.48 140.02 52.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.592 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.83 137.66 14.4 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.41 118.79 37.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.499 0.649 . . . . 0.0 111.877 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.7 tp -136.9 122.94 20.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.354 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.7 -167.8 39.44 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 114' ' ' SER . . . -145.27 151.56 38.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.934 0.397 . . . . 0.0 110.701 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.64 146.5 16.08 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.459 ' HD2' HG22 ' A' ' 113' ' ' THR . 77.7 m80 -130.95 143.89 51.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.727 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -116.19 143.44 18.07 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -130.44 126.76 37.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.857 0.36 . . . . 0.0 110.57 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.97 124.53 26.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.101 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -133.37 133.98 43.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.603 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -99.5 133.65 43.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.199 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.4 p -87.71 115.68 25.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.958 0.408 . . . . 0.0 110.719 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 89.6 p -162.82 166.37 24.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.184 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.8 mt -108.47 113.45 44.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.81 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -146.7 165.15 30.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.354 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.48 -20.03 58.49 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -139.64 161.84 36.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.3 m -109.69 147.98 32.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.867 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 47.4 mp0 -127.01 149.4 49.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.494 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 96.9 p -154.7 163.7 39.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.367 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -127.35 134.39 49.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.588 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.8 t -135.78 136.69 40.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.555 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -130.57 151.3 51.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.397 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.459 HG22 ' HD2' ' A' ' 95' ' ' HIS . 81.3 p -125.45 150.82 46.98 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.019 0.438 . . . . 0.0 111.147 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.547 ' O ' ' HB1' ' A' ' 93' ' ' ALA . 88.1 p -152.6 163.75 39.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.39 145.24 28.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.629 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.24 52.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.977 0.418 . . . . 0.0 110.726 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -151.31 160.82 43.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.296 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 169.29 -160.77 34.2 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.878 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.78 158.54 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.549 -0.326 . . . . 0.0 110.336 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -157.66 174.97 35.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.24 165.81 27.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.917 0.389 . . . . 0.0 110.831 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.677 HE21 ' CG1' ' A' ' 130' ' ' VAL . 65.4 tt0 -135.11 135.34 41.11 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.207 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -127.66 126.95 42.92 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.009 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.868 ' OD1' HG13 ' A' ' 130' ' ' VAL . 50.0 m-20 -125.24 85.64 57.99 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.266 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.59 -29.75 10.51 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.7 1.6 . . . . 0.0 111.652 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -129.64 123.58 21.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.762 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.15 -29.29 22.02 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 121.581 1.521 . . . . 0.0 112.522 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -82.06 -8.71 59.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.739 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -139.29 123.34 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.418 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.868 HG13 ' OD1' ' A' ' 124' ' ' ASN . 72.8 t -127.89 134.01 66.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.831 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.04 148.23 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.502 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -146.29 158.96 43.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.93 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -155.26 145.19 21.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.024 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.8 p -158.17 162.6 37.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.528 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -144.07 148.29 34.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -145.92 160.4 41.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.568 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -119.02 139.32 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.45 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.5 t -132.37 125.2 30.3 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -108.18 119.74 40.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.753 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -84.28 155.9 22.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -51.84 -44.93 63.79 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.093 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -104.71 -32.79 8.71 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.67 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 16' ' ' LYS . 77.6 t -105.94 153.04 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.418 ' N ' HG12 ' A' ' 143' ' ' VAL . 98.7 mttt -107.3 135.96 47.93 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.4 t -130.01 130.95 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.0 134.67 11.77 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.9 m -125.0 131.7 53.38 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.278 0.561 . . . . 0.0 112.356 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -127.95 125.42 39.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.506 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.473 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 79.3 mtm -117.74 136.63 53.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 111.374 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 tt -136.91 130.17 31.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.58 177.66 41.33 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.981 -1.104 . . . . 0.0 111.851 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.13 158.94 44.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.251 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.45 -171.9 23.2 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -147.38 159.32 43.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 0.0 110.617 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -77.94 128.96 34.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.663 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.7 t80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.671 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.07 -175.48 54.75 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' OE1' ' CZ ' ' A' ' 37' ' ' PHE . 49.5 mp0 -75.91 138.2 40.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.71 0.29 . . . . 0.0 110.258 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.9 p -150.92 162.27 41.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.605 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.7 t -147.01 141.39 26.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.594 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 pt -127.56 147.15 32.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.722 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -131.82 148.45 52.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.0 mt -121.09 129.44 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.062 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.01 156.53 26.87 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.27 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -83.72 146.02 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HB3' ' C ' ' A' ' 28' ' ' GLY . . . -107.39 120.0 40.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.768 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -118.5 118.46 31.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.848 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.3 m -118.44 167.73 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -125.21 137.57 54.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' HD3' ' A' ' 26' ' ' PRO . 87.7 t -115.39 126.56 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.531 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -93.87 117.86 30.68 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.449 ' OE1' ' NZ ' ' A' ' 21' ' ' LYS . 87.9 tt0 -155.93 150.04 25.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.723 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -60.06 -42.41 94.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.055 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 17' ' ' GLU . . . -63.55 149.19 50.4 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -84.49 142.6 29.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.927 0.394 . . . . 0.0 111.038 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' NZ ' ' OE1' ' A' ' 17' ' ' GLU . 64.0 mttp -130.56 150.18 51.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.102 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.46 -52.87 61.81 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.152 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' A' ' 25' ' ' ASN . 58.4 p30 -114.11 -14.06 12.39 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.34 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 23.4 ttmt 55.59 -6.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.454 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.626 ' H ' ' C ' ' A' ' 23' ' ' ASP . 53.2 m-20 -106.28 114.59 62.14 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 119.399 -0.334 . . . . 0.0 111.648 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' HG23 ' A' ' 15' ' ' VAL . 73.2 Cg_endo -76.63 158.96 35.69 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.433 1.422 . . . . 0.0 110.86 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -91.57 155.02 18.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.764 0.316 . . . . 0.0 110.945 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' C ' ' HB3' ' A' ' 11' ' ' ALA . . . -168.3 175.07 43.09 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.92 149.59 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 47' ' ' PHE . 63.3 t30 -134.92 120.49 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.364 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -115.66 140.89 48.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.749 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.38 145.24 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.89 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.89 144.59 51.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.074 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -123.66 128.79 50.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.441 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' GLU . 96.2 m-85 -128.91 148.63 50.93 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.442 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 17.5 tt0 80.99 166.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.409 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CZ ' ' OE1' ' A' ' 3' ' ' GLU . 90.2 m-85 -76.49 141.42 41.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -100.82 16.65 24.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.521 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -60.14 -41.24 92.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.922 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.07 -38.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.964 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -153.44 141.37 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.735 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.14 178.16 30.36 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.35 139.62 45.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.382 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.59 153.16 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.172 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.86 135.36 9.39 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.9 m -128.32 145.69 50.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 0.0 111.148 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.434 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 98.3 m-85 -124.37 140.49 52.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.513 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.33 137.96 34.53 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -150.99 150.34 30.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.783 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.9 t -150.27 155.24 39.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -156.02 163.24 39.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -68.29 137.87 55.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.48 -170.58 44.75 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -100.88 131.32 46.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 0.0 110.373 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -134.04 159.31 41.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.538 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -60.1 145.74 45.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.2 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.4 m -118.65 149.92 40.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 67.7 t -118.6 130.82 72.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.108 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -58.85 145.13 42.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.551 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.44 -7.15 78.01 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.09 148.89 51.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.729 0.3 . . . . 0.0 110.549 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -108.1 150.36 27.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.471 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.89 141.22 53.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.269 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 pt -113.34 3.67 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.12 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.28 -43.03 96.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.441 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.77 -1.29 79.14 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.9 t0 47.98 50.7 15.52 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.439 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -79.03 147.11 32.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.976 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -124.08 141.65 51.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.005 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -130.3 144.59 51.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.998 0.427 . . . . 0.0 111.149 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.8 t80 -139.98 130.97 26.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.14 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.8 t -148.78 147.95 29.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 111.023 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 p -136.41 136.38 48.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.698 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.0 p -135.31 157.76 46.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.17 27.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.452 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.3 169.78 42.91 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.773 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.1 155.0 52.59 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.327 2.685 . . . . 0.0 112.794 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.442 HG22 ' CB ' ' A' ' 88' ' ' TYR . 89.6 t -126.69 130.51 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.754 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -126.91 125.76 42.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.404 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.69 137.33 54.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.752 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 87' ' ' LEU . 92.1 mt -88.97 -48.61 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.325 0.583 . . . . 0.0 110.139 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 83' ' ' GLU . 51.4 t30 -134.73 -148.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.754 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.47 ' H ' ' CG ' ' A' ' 82' ' ' ASN . 99.3 mt-10 -88.71 -5.24 58.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.029 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -149.23 15.62 0.91 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.632 HG13 ' HB ' ' A' ' 81' ' ' ILE . 3.8 p -144.36 138.31 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.42 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.0 m -134.62 149.87 50.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.11 0.481 . . . . 0.0 111.847 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.672 ' HB2' HD11 ' A' ' 81' ' ' ILE . 63.6 tp -119.52 131.12 55.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.435 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.442 ' CB ' HG22 ' A' ' 78' ' ' VAL . 52.4 p90 -142.29 158.79 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.866 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.19 148.54 17.42 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.6 mt -119.16 135.9 54.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.891 0.377 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -145.98 146.83 31.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.599 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.86 -145.45 8.46 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.136 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.37 152.24 38.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.898 0.38 . . . . 0.0 111.113 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -123.56 147.21 16.61 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -134.79 144.96 47.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.736 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.69 145.86 17.42 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -117.65 137.56 52.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.877 0.37 . . . . 0.0 110.666 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 110' ' ' ARG . . . -143.91 147.25 33.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.348 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.56 129.62 39.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.483 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -99.84 124.55 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.4 t -87.06 116.78 25.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.252 0.548 . . . . 0.0 111.331 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.7 t -163.15 151.66 14.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.84 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.2 mt -99.7 112.9 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.206 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -149.4 160.81 43.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.013 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.64 -40.15 96.07 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -103.85 165.4 11.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 95.3 p -108.93 156.07 20.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.788 0.328 . . . . 0.0 110.673 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 45.6 mp0 -133.32 154.96 50.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.874 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.2 p -149.78 162.38 40.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.156 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 98' ' ' ALA . 84.7 mtp180 -129.33 150.16 50.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.929 0.395 . . . . 0.0 110.871 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.4 t -147.67 146.76 29.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.255 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -126.04 148.93 49.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.74 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.7 m -117.07 130.94 56.98 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.78 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.6 t -148.64 149.84 32.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.638 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 115' ' ' LEU . 2.7 mp -99.69 142.91 30.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.614 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.21 132.76 55.38 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.99 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -145.97 134.13 21.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.138 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -171.31 -169.68 34.53 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.806 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.66 159.27 44.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.016 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -151.54 169.31 31.06 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.805 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.421 ' CD1' ' CE2' ' A' ' 123' ' ' PHE . 0.6 OUTLIER -142.44 160.24 40.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.422 . . . . 0.0 109.919 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.51 ' NE2' ' OD1' ' A' ' 132' ' ' ASP . 63.7 tt0 -140.34 137.41 34.07 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.616 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.421 ' CE2' ' CD1' ' A' ' 121' ' ' LEU . 69.6 m-85 -115.5 149.01 38.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.683 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -129.89 83.02 65.15 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.949 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.4 -22.8 24.56 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.72 1.613 . . . . 0.0 111.71 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.524 ' ND1' ' OD1' ' A' ' 128' ' ' ASN . 65.7 t-80 -150.14 136.4 10.7 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.482 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.99 -39.43 50.07 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.921 1.747 . . . . 0.0 113.89 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.524 ' OD1' ' ND1' ' A' ' 126' ' ' HIS . 54.7 p30 -84.14 -0.7 53.04 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.62 126.67 13.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.394 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 152.69 34.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.451 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 86.9 mt -114.51 125.85 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.15 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.51 ' OD1' ' NE2' ' A' ' 122' ' ' GLN . 97.8 m-20 -105.73 132.46 51.83 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.193 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -136.14 127.33 28.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.781 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.8 t -158.03 151.62 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.858 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -139.07 149.16 44.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.683 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -142.46 153.57 43.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.775 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -126.59 147.26 49.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.163 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.7 t -128.89 127.56 42.06 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -106.85 120.61 42.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.307 0.575 . . . . 0.0 111.942 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.79 HD23 ' H ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -117.97 154.61 31.65 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.79 ' H ' HD23 ' A' ' 140' ' ' LEU . 98.1 m-20 -59.53 -42.63 92.76 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.9 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 66.3 t0 -105.63 -33.98 7.88 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.9 t -106.47 125.58 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -107.68 123.13 48.04 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.93 146.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.144 -0.623 . . . . 0.0 112.223 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.31 152.45 17.74 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 91.2 m -125.28 131.86 53.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.982 0.42 . . . . 0.0 111.558 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -125.94 123.71 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.897 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 149' ' ' MET . 2.5 mpp? -117.47 129.57 55.9 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.932 0.396 . . . . 0.0 111.012 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.642 HD13 ' N ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -143.27 131.78 22.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.982 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.642 ' N ' HD13 ' A' ' 150' ' ' LEU . . . -178.56 -169.03 38.74 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.575 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.42 155.86 47.34 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.88 -169.62 14.05 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.789 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -148.61 163.09 38.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.123 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -121.79 147.98 45.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.825 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.3 t80 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.548 -179.797 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.82 -178.93 48.8 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.61 138.55 48.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.817 0.341 . . . . 0.0 110.462 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.7 p -151.11 163.05 39.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.656 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.6 m -124.45 141.98 51.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.536 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mm -116.89 124.3 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -128.88 140.75 51.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.026 0.441 . . . . 0.0 111.311 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.512 HG22 HD22 ' A' ' 31' ' ' LEU . 45.8 pt -132.82 156.49 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.746 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.17 -174.18 38.76 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.119 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -113.72 145.91 40.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.7 140.99 38.97 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HG2' HD21 ' A' ' 25' ' ' ASN . 24.8 mp0 -131.69 138.1 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.696 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.447 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 67.2 m -117.33 109.39 16.77 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.239 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -68.66 129.15 39.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.02 129.43 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.635 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -107.35 118.95 38.06 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -162.24 167.66 23.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 0.0 110.787 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -84.96 104.58 15.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.59 -156.06 26.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' A' ' 20' ' ' TYR . 54.5 p90 -49.99 129.1 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -164.42 39.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.119 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.61 -49.24 78.31 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.704 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 25' ' ' ASN . 58.4 p30 -113.63 -12.59 12.82 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.502 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 59.5 mtpt 52.39 3.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.06 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 23' ' ' ASP . 49.7 t-20 -103.64 110.27 63.56 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.668 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' CD ' ' O ' ' A' ' 13' ' ' SER . 96.2 Cg_endo -84.73 160.42 12.23 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 122.766 2.311 . . . . 0.0 111.44 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.81 135.43 39.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.73 169.75 35.15 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.19 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.97 143.85 51.09 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.426 ' OD1' ' SD ' ' A' ' 149' ' ' MET . 29.5 t-20 -117.61 119.09 33.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.512 HD22 HG22 ' A' ' 8' ' ' ILE . 88.3 mt -122.92 136.89 55.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.833 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -148.24 155.9 41.91 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.939 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -133.07 146.8 52.0 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.16 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 -126.97 131.14 51.13 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.768 0.318 . . . . 0.0 110.795 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.91 139.8 52.38 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -159.72 147.54 17.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -65.88 -42.52 90.24 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.782 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -170.76 99.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.462 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 61.9 t-20 41.56 -117.78 0.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.742 0.306 . . . . 0.0 110.256 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 99.1 m-20 43.1 -98.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.346 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' ASN . 41.7 p90 -147.6 162.38 39.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.18 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.06 -167.05 21.92 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.42 143.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.672 0.272 . . . . 0.0 110.348 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 tt -132.64 137.25 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.08 142.57 16.19 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -126.21 143.93 50.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.932 0.396 . . . . 0.0 111.102 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -130.08 146.01 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.807 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -140.41 141.55 35.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.03 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -128.79 137.28 51.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.21 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 96.4 m -128.06 134.9 49.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -146.38 143.99 29.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.874 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.463 HH11 ' C ' ' A' ' 65' ' ' ASP . 79.9 ttt180 -53.48 145.34 14.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.2 -39.66 94.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' H ' ' HG2' ' A' ' 52' ' ' ARG . 88.0 m-85 -69.5 140.79 54.0 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -67.86 138.94 56.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.812 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.421 ' OE1' ' OD1' ' A' ' 67' ' ' ASP . 24.6 pt-20 -91.19 139.02 31.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.654 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.8 p -150.8 159.55 44.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.332 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 75.7 t -124.48 120.84 60.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.6 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -162.36 92.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.279 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.98 18.8 79.29 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 62.2 39.77 12.35 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.974 0.416 . . . . 0.0 110.51 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -128.15 152.36 48.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.7 mt 59.92 33.14 21.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.753 HG23 ' H ' ' A' ' 66' ' ' GLY . 20.4 tt -63.83 -24.62 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.423 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.463 ' C ' HH11 ' A' ' 52' ' ' ARG . 68.1 m-20 57.86 36.61 26.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.917 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.753 ' H ' HG23 ' A' ' 64' ' ' ILE . . . 69.91 -41.63 0.45 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 65' ' ' ASP . 54.4 t0 50.55 53.67 12.54 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.442 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -74.43 140.08 44.42 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.468 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -132.22 115.99 16.39 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.323 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -134.46 129.29 35.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.279 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.06 160.82 40.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.287 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -147.59 145.02 28.85 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.092 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.1 t -122.29 126.96 74.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.121 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -132.85 156.64 46.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.014 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -157.53 154.81 29.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.36 170.66 43.74 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.477 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.4 154.46 50.81 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.21 2.607 . . . . 0.0 113.041 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.5 t -127.89 130.97 70.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -127.15 146.42 50.4 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.175 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.79 126.77 52.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.6 tt -80.18 -37.42 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.72 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 84' ' ' TYR . 57.4 t30 -156.72 31.72 0.31 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.761 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 68.52 -42.66 0.48 Allowed 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.855 0.722 . . . . 0.0 109.812 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 82' ' ' ASN . 66.5 t80 -63.96 -40.61 96.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.415 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 84' ' ' TYR . 92.6 t -126.93 135.61 63.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.402 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.2 t -129.05 134.77 48.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.02 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.0 tp -110.62 127.96 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.269 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.98 159.33 42.44 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.967 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.52 145.33 16.01 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -120.13 137.16 54.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.913 0.387 . . . . 0.0 110.622 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.2 152.25 38.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.765 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.14 -147.13 9.76 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.348 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.95 150.57 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 0.0 110.96 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.75 139.76 15.87 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -145.95 135.03 22.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 0.0 110.624 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.15 158.94 27.85 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -130.7 144.48 51.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.771 0.319 . . . . 0.0 110.386 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.58 111.61 8.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.405 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -133.24 131.26 40.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.404 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -149.36 159.28 44.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.202 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.9 t -139.34 120.18 14.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.225 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.7 t -163.76 174.96 10.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.071 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.4 mt -99.25 113.28 33.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.133 0.492 . . . . 0.0 109.765 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -148.66 175.38 11.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.02 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.84 -38.97 93.27 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -147.81 146.66 29.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.719 0.295 . . . . 0.0 110.315 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.3 m -132.62 144.28 50.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -163.68 141.45 7.43 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.064 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -128.21 149.15 50.58 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -168.58 152.95 5.91 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.824 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.5 t -105.78 134.73 48.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.388 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -108.12 139.69 42.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.25 0.548 . . . . 0.0 111.824 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 93.1 m -126.13 131.17 52.12 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.867 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.7 t -148.96 150.73 33.36 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.027 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mp -83.49 140.93 32.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.369 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.54 132.69 56.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.895 0.379 . . . . 0.0 110.711 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -151.01 160.26 44.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.087 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.34 -166.78 39.97 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.727 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.18 156.77 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.0 170.28 30.06 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.597 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.95 156.38 46.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.375 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -132.0 129.18 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.013 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -115.12 148.21 39.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.796 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 126' ' ' HIS . 55.6 t-20 -129.37 81.85 69.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.406 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 -28.18 14.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.896 1.731 . . . . 0.0 112.131 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.436 ' O ' ' OD1' ' A' ' 124' ' ' ASN . 70.6 m80 -135.68 148.18 64.45 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.079 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.81 -24.01 34.77 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.25 1.967 . . . . 0.0 112.854 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -99.96 4.52 44.96 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.799 -0.361 . . . . 0.0 111.777 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -154.65 128.66 8.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 153' ' ' GLY . 29.1 m -131.98 152.78 37.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.607 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.4 pt -123.29 148.12 27.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.668 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 133' ' ' ALA . 52.8 t0 -146.31 138.88 25.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.692 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.472 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -148.35 150.83 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.056 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 149' ' ' MET . 85.8 p -153.38 161.57 42.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.752 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -127.14 128.03 45.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.759 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -132.07 147.62 52.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.251 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -130.42 147.91 52.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.204 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.7 t -115.92 125.01 52.01 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -103.82 112.32 25.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.76 HD23 ' H ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -119.61 151.79 38.1 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.76 ' H ' HD23 ' A' ' 140' ' ' LEU . 98.1 m-20 -60.52 -42.91 97.39 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.541 -178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -104.96 -32.28 8.83 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.612 HG12 HG23 ' A' ' 145' ' ' VAL . 67.2 t -105.42 123.84 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -108.15 115.17 29.62 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.612 HG23 HG12 ' A' ' 143' ' ' VAL . 87.2 t -128.31 130.61 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.134 0.492 . . . . 0.0 112.28 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.31 138.02 14.54 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.6 m -111.56 132.77 54.3 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.165 0.483 . . . . 0.0 111.846 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -112.0 135.82 52.15 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.124 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.426 ' SD ' ' OD1' ' A' ' 30' ' ' ASN . 53.9 ttp -131.54 125.55 32.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.891 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.1 tp -143.04 129.82 20.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.711 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -176.81 -176.18 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.073 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.84 158.93 44.52 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.426 ' O ' HG22 ' A' ' 130' ' ' VAL . . . -142.51 174.79 23.25 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.751 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -123.06 130.15 52.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.369 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -75.77 129.85 37.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.342 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.402 ' OXT' ' CG ' ' A' ' 156' ' ' PHE . 67.9 t80 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.541 -179.979 . . . . . . . . 1 1 . 1 stop_ save_